þ
|
Preliminary Proxy
Statement
|
o
|
CONFIDENTIAL, FOR USE OF THE
COMMISSION ONLY (AS PERMITTED BY RULE
14a-6(e)(2))
|
o
|
Definitive Proxy
Statement
|
o
|
Definitive Additional
Materials
|
o
|
Soliciting Material Pursuant to
ss.240.14a-12
|
o
|
No fee
required.
|
þ
|
Fee computed on table below per
Exchange Act
Rules 14a-6(i)(1) and 0-11.
|
(1)
|
Title of each class of securities
to which transaction
applies:
|
|
Common
shares, CHF 4.51 par value per share, of PARIS RE Holdings Limited
(“Paris Re”).
|
(2)
|
Aggregate number of securities to
which transaction applies:
|
(3)
|
Per unit price or other underlying
value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated
and state how it was
determined):
|
(4)
|
Proposed maximum aggregate value of
transaction:
|
|
$1,710,010,342.88
|
(5)
|
Total fee
paid:
|
o
|
Fee paid previously with
preliminary materials.
|
o
|
Check box if any part of the fee
is offset as provided
by Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date of its
filing.
|
(1)
|
Amount Previously
Paid:
|
(2)
|
Form, Schedule or Registration
Statement No.:
|
(3)
|
Filing
Party:
|
(4)
|
Date
Filed:
|
|
·
|
the
proposal to issue PartnerRe common shares and securities exercisable or
exchangeable for PartnerRe common shares to the holders of Paris Re
securities in connection with the transactions, which proposal we refer to
as the “share issuance proposal;”
|
|
·
|
the
proposal to increase the size of the board of directors of PartnerRe from
11 to 12, which proposal we refer to as the “board size proposal;”
and
|
|
·
|
the
proposal to amend PartnerRe’s 2005 Employee Equity Plan, as amended and
restated, which proposal we refer to as the “2005 employee equity plan,”
to increase the PartnerRe common shares available for issuance and to
increase the number of PartnerRe common shares that may be awarded as
restricted shares or restricted share units, which we refer to as the
“equity plan proposal.”
|
|
1.
|
To
vote on the proposal to approve the issuance of PartnerRe common shares
and securities exercisable or exchangeable for PartnerRe common shares to
the holders of securities of PARIS RE Holdings Limited, which we refer to
as “Paris Re,” on the terms and conditions set out
in:
|
|
·
|
the
purchase agreement dated as of July 4, 2009, as amended, among PartnerRe,
the selling Paris Re shareholders named therein and, with respect to
selected provisions, Paris Re, pursuant to which a wholly-owned,
Swiss-domiciled subsidiary of PartnerRe formed for the purpose of the
acquisition, which we refer to as the “acquisition subsidiary,” will
acquire approximately 57.5% of the outstanding Paris Re common shares,
which we refer to as the “block
purchase;”
|
|
·
|
the
additional purchase agreements entered into between PartnerRe and certain
other Paris Re shareholders pursuant to which the acquisition subsidiary
will acquire simultaneously with the closing of the block purchase, 19.5%
of the outstanding Paris Re common shares in the aggregate;
and
|
|
·
|
the
transaction agreement dated as of July 4, 2009 between PartnerRe and Paris
Re providing for the acquisition by the acquisition subsidiary of all
remaining outstanding Paris Re common shares and Paris Re warrants through
a voluntary public exchange offer to be followed by a
merger.
|
|
2.
|
To
vote on the proposal to increase the size of the board of directors of
PartnerRe from 11 to 12, which proposal we refer to as the “board size
proposal.”
|
|
3.
|
To
vote on the proposal to amend PartnerRe’s 2005 Employee Equity Plan, as
amended and restated, which we refer to as the “2005 employee equity
plan,” to increase the PartnerRe common shares available for issuance and
to increase the number of PartnerRe common shares that may be awarded as
restricted shares or restricted share units, which proposal we refer as
the “equity plan proposal.”
|
|
4.
|
To
transact other business as may properly come before the meeting or any
properly reconvened meeting following an adjournment or postponement
thereof.
|
QUESTIONS AND ANSWERS ABOUT THE
SPECIAL GENERAL MEETING AND THE TRANSACTIONS
|
1
|
SUMMARY
|
9
|
The
Companies
|
9
|
The Special General
Meeting
|
9
|
The
Transactions
|
10
|
The Transaction Documents and
Related Agreements
|
18
|
Selected Historical Consolidated
Financial Information of PartnerRe
|
24
|
Selected Historical Consolidated
Financial Information of Paris Re
|
25
|
Selected Unaudited Pro Forma
Condensed Combined Financial Information
|
27
|
Market Prices and Dividend
Information
|
29
|
Comparative Historical and Pro
Forma Per Share Information
|
30
|
Exchange Rate
Information
|
31
|
RISK
FACTORS
|
32
|
Risk Factors Relating to
Paris Re
|
32
|
Risk Factors Relating to the
Combined Entity Following the Transactions
|
39
|
Risk Factors Relating to the
Transactions
|
41
|
THE SPECIAL GENERAL
MEETING
|
47
|
Date, Time and
Place
|
47
|
Vote Required of PartnerRe
Shareholders; Quorum Requirements
|
47
|
Shares Owned by PartnerRe
Directors and Executive Officers
|
48
|
Voting of
Proxies
|
48
|
Shares Entitled to
Vote
|
49
|
Revocation of
Proxies
|
49
|
Solicitation of
Proxies
|
49
|
THE
COMPANIES
|
50
|
PartnerRe
|
50
|
Paris Re
|
50
|
STRATEGY OF PARTNERRE FOLLOWING
THE TRANSACTIONS
|
51
|
THE
TRANSACTIONS
|
53
|
Structure of the
Transactions
|
53
|
Tangible Book Value Per Share
Adjustment and Termination Right
|
57
|
Post-Block Purchase Closing
Dividend Adjustment
|
58
|
Ownership of PartnerRe Following
the Transactions
|
59
|
Background to the
Transactions
|
60
|
PartnerRe’s Reasons for the
Transactions and Recommendation of the PartnerRe Board of
Directors
|
66
|
Opinion of UBS Securities
LLC
|
70
|
Management Assumptions Prepared
for Purposes of the UBS Opinion
|
78
|
Engagement of Greenhill & Co.,
LLC
|
78
|
Interests of Certain Persons in
the Transactions
|
78
|
Sources of Funds, Fees and
Expenses
|
79
|
Closing Date of the
Transactions
|
80
|
Stock Exchange Listing of
PartnerRe Common Shares
|
80
|
Material United States Federal Income Tax Consequences
of the Transactions
|
80
|
Regulatory
Matters
|
80
|
Dissenters’
Rights
|
83
|
THE BLOCK PURCHASE
AGREEMENT
|
84
|
Purchase and Sale
|
84
|
Timing of Closing of the Block
Purchase
|
84
|
Fractional
Shares
|
84
|
Representations and
Warranties
|
84
|
Covenants and Other
Agreements
|
85
|
Conditions to the Closing of the
Block Purchase
|
87
|
Termination of the Block Purchase
Agreement
|
88
|
Expenses
|
89
|
Amendment;
Waiver
|
89
|
Specific
Performance
|
89
|
THE TRANSACTION
AGREEMENT
|
90
|
The Exchange
Offer
|
90
|
Post-Block Purchase Constitution
of Paris Re Board of
Directors
|
91
|
Tangible Book Value Per Share
Adjustment
|
91
|
The Merger
|
93
|
Treatment of Paris Re Share Options, Restricted
Share Units and Warrants
|
94
|
Post-Block Purchase Closing
Dividend Adjustment
|
94
|
Fractional
Shares
|
94
|
Representations and
Warranties
|
94
|
Certain
Covenants
|
97
|
Employee
Matters
|
106
|
Termination of the Transaction
Agreement
|
106
|
Termination
Fees
|
108
|
Expenses
|
108
|
Amendment;
Waiver
|
108
|
Specific
Performance
|
109
|
THE PRE-ANNOUNCEMENT PURCHASE
AGREEMENTS
|
110
|
Purchase and Sale
|
110
|
Covenants and Other
Agreements
|
110
|
Expenses
|
111
|
Amendment;
Waiver
|
111
|
Specific
Performance
|
111
|
THE POST-ANNOUNCEMENT PURCHASE
AGREEMENTS
|
112
|
ANCILLARY AGREEMENTS RELATING TO
THE TRANSACTIONS
|
118
|
PROPOSAL NO. 1: The Share Issuance
Proposal
|
124
|
PROPOSAL NO. 2: The Board Size
Proposal
|
125
|
PROPOSAL NO. 3: The Equity Plan
Proposal
|
127
|
UNAUDITED PRO FORMA CONDENSED
COMBINED FINANCIAL INFORMATION
|
131
|
ACCOUNTING
TREATMENT
|
146
|
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT OF PARTNERRE
|
147
|
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT OF PARTNERRE AFTER GIVING EFFECT TO THE
TRANSACTIONS
|
150
|
BUSINESS OF PARIS RE
|
151
|
MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF PARIS RE
|
155
|
OTHER
MATTERS
|
183
|
SPECIAL NOTE REGARDING
FORWARD-LOOKING STATEMENTS
|
183
|
WHERE YOU CAN FIND MORE
INFORMATION
|
183
|
INCORPORATION BY
REFERENCE
|
184
|
INDEX TO FINANCIAL STATEMENTS OF
PARIS RE
|
F-1
|
ANNEX A: OPINION OF UBS
SECURITIES LLC
|
A-1
|
A:
|
On
July 4, 2009, PartnerRe entered into definitive agreements to effect a
multi-step acquisition of all of the outstanding common shares and
warrants of Paris Re, a French-listed, Swiss-domiciled diversified
reinsurer.
|
|
As
a first step in the acquisition, PartnerRe will cause a wholly-owned,
Swiss-domiciled subsidiary of PartnerRe formed for the purpose of the
acquisition, which we refer to as the “acquisition subsidiary,” to
purchase all of the Paris Re common shares and Paris Re warrants held by
six private equity firms and their related investment vehicles pursuant to
the terms of a purchase agreement. We refer to this purchase as
the “block purchase,” the purchase agreement governing the purchase (as
amended) as the “block purchase agreement” and the shareholders selling
their shares pursuant to the block purchase agreement as the “block
sellers.” Under the block purchase agreement, PartnerRe will
acquire approximately 57.5% of the outstanding Paris Re common
shares. These shares, when added together with the
approximately 6.1% of the outstanding Paris Re common shares that
PartnerRe purchased from certain other Paris Re shareholders prior to the
announcement of the Paris Re acquisition, whom we refer to as the
“pre-announcement sellers,” and the additional 19.5% of the outstanding
Paris Re common shares that PartnerRe has subsequently committed to
acquire simultaneously with the closing of the block purchase from certain
other Paris Re shareholders, whom we refer to as the “post-announcement
sellers,” will give PartnerRe an aggregate ownership of approximately
83.1% of the outstanding Paris Re common shares following the closing of
the block purchase. We refer to the purchases from the
pre-announcement sellers and the post-announcement sellers as the
“pre-announcement purchases” and “post-announcement purchases,”
respectively. See “The Block Purchase Agreement,” “The
Pre-Announcement Purchase Agreements” and “The Post-Announcement Purchase
Agreements.”
|
|
Following
the closing of the block purchase, and subject to certain conditions,
PartnerRe will cause the acquisition subsidiary to commence a voluntary
public exchange offer, which we refer to as the “exchange offer,” for all
remaining outstanding Paris Re common shares and Paris Re
warrants. The exchange offer will be commenced pursuant to the
terms of a transaction agreement dated July 4, 2009 between PartnerRe and
Paris Re, which we refer to as the “transaction agreement.” If,
after completion of the exchange offer, PartnerRe and its affiliates own
at least 90% of the outstanding Paris Re common shares, PartnerRe will
effect a compulsory merger, which we refer to as the “merger,” in
accordance with Swiss law to acquire all remaining outstanding Paris Re
common shares. In the merger, Paris Re will be merged into the
acquisition subsidiary, with the acquisition subsidiary surviving the
merger. See “The Transaction Agreement—The Exchange Offer” and
“The Transaction Agreement—The
Merger.”
|
|
The
transactions described above are collectively referred to herein as the
“transactions,” and the block purchase agreement, the transaction
agreement and the agreements governing the pre-announcement purchases and
post-announcement purchases are collectively referred to herein as the
“transaction documents.”
|
A:
|
PartnerRe
shareholders will not receive any cash or securities pursuant to the
transactions. You will continue to hold your existing PartnerRe
common shares.
|
A:
|
In
each step of the transactions (including the block purchase, the
pre-announcement purchases, the post-announcement purchases, the exchange
offer and the merger), PartnerRe has exchanged or will exchange 0.300
PartnerRe common shares for each Paris Re common share and 0.167 PartnerRe
common shares for each Paris Re warrant. We refer to this per
share and per warrant consideration as the “per share consideration” and
the “per warrant consideration,” respectively. The per share
consideration and per warrant consideration are each subject to adjustment
in certain circumstances, including, where applicable, the tangible book
value per share adjustment and the post-block purchase closing dividend
adjustment described below.
|
|
Immediately
prior to the closing of the block purchase, Paris Re intends, subject to
obtaining the requisite regulatory approvals, to effect an extraordinary
cash distribution by way of a capital reduction to all holders of Paris Re
common shares immediately prior to the closing of the block purchase in
the amount of CHF 4.17 per Paris Re common share (the Swiss franc
equivalent of $3.85 as of July 7, 2009, the date on which Paris Re fixed
the U.S. dollar/Swiss franc currency exchange rate to be used for the
extraordinary cash distribution). We refer to this cash
distribution as the “share capital repayment.” To the extent
that the share capital repayment is not made in full immediately prior to
the closing of the block purchase, the remaining portion will be paid (i)
to the block sellers and the post-announcement sellers in the form of a
promissory note issued by PartnerRe at the closing of the block purchase
and (ii) to all other holders of Paris Re common shares in the form of
cash by way of a capital distribution from Paris Re immediately prior to
the settlement of the exchange offer. See “The Transaction
Agreement—Certain Covenants—Share Capital Repayment” and “The Block
Purchase Agreement—Purchase and
Sale.”
|
|
The
pre-announcement sellers will receive a payment of $3.85 for each Paris Re
common share sold to PartnerRe in the pre-announcement purchases at the
earlier of the closing of the block purchase and the termination of the
transaction agreement (net of dividends paid or payable on the PartnerRe
common shares with respect to the period after the completion of the
pre-announcement purchases and prior to the earlier of the closing of the
block purchase and the termination of the transaction
agreement). This payment to the pre-announcement sellers will
be made irrespective of whether the block purchase closes or the share
capital repayment or any portion thereof is paid and is intended to
compensate the pre-announcement sellers for the aggregate U.S. dollar
amount that would be payable on the Paris Re common shares sold in the
pre-announcement purchases had they not been sold prior to the payment of
the share capital repayment. See “The Pre-Announcement Purchase
Agreements—Purchase and Sale.”
|
A:
|
The
tangible book value per share adjustment provides for an adjustment,
upwards or downwards, to the per share consideration and the per warrant
consideration if the percentage decline in Paris Re’s or PartnerRe’s
tangible book value per share during the period from March 31, 2009 to a
date shortly before the closing of the block purchase is more than 15%
greater than the percentage decline, if any, in the other party’s tangible
book value per share during the same period. The adjustment, if
any, to the per share consideration and per warrant consideration will be
calculated pursuant to a formula described under “The
Transactions—Tangible Book Value Per Share Adjustment and Termination
Right.” In addition, if the percentage decline in one party’s
tangible book value per share during the period from March 31, 2009 to a
date shortly before closing of the block purchase is more than 40% greater
than the percentage decline, if any, in the other party’s tangible book
value per share during the same period, the other party will have the
right to terminate the transaction agreement and the block purchase
agreement prior to the closing of the block purchase. See “The
Transactions—Tangible Book Value Per Share Adjustment and Termination
Right.”
|
A:
|
The
post-block purchase closing dividend adjustment provides for an upwards
adjustment to the per share consideration payable in the exchange offer
and the merger to reflect any dividends declared on the PartnerRe common
shares having a record date on or after the closing of the block purchase
and prior to the settlement of the exchange offer. Since the
PartnerRe common shares issued to the block sellers, the pre-announcement
sellers and the post-announcement sellers prior to or simultaneously with
the closing of the block purchase will be entitled to dividends on the
PartnerRe common shares with a record date on or after the closing of the
block purchase to the same extent as all other outstanding PartnerRe
common shares, the post-block purchase closing dividend adjustment is
intended to ensure that all other holders of Paris Re common shares,
representing approximately 16.9% of the outstanding Paris Re common
shares, similarly participate in PartnerRe dividends on or after the
closing of the block purchase and prior to the settlement of the exchange
offer. The exchange offer, which is expected to be completed in
the first quarter of 2010, is the first opportunity that these other
holders will have to exchange their Paris Re common shares for PartnerRe
common shares and to thereafter directly participate in dividends on the
PartnerRe common shares. Holders of Paris Re common shares that
do not validly tender their Paris Re common shares in the exchange offer
and continue to hold their shares through the merger will not participate
in, and the per share consideration will not be adjusted for, dividends
declared on the PartnerRe common shares having a record date after the
settlement of the exchange offer and prior to the effective time of the
merger. See “The Transaction Agreement—Post-Block Purchase
Closing Dividend Adjustment.”
|
A:
|
Consummation
of the block purchase and the other transactions is subject to a number of
conditions, including (i) approval by the holders of PartnerRe common
shares of the share issuance proposal and the board size proposal set
forth in this proxy statement, (ii) obtaining certain regulatory
approvals, the expiration or termination of the applicable
Hart-Scott-Rodino waiting period and obtaining certain foreign antitrust
approvals, (iii) approval for listing of the PartnerRe common shares to be
issued in the block purchase on the New York Stock Exchange and the
listing of the PartnerRe common shares on Euronext Paris or another
European Union stock exchange selected by PartnerRe, (iv) evidence that
PartnerRe designees on Paris Re’s board of directors will comprise a
majority of Paris Re’s board of directors immediately following the
closing of the block purchase and (v) certain other customary closing
conditions.
|
|
In
addition, even if the block purchase closes, PartnerRe’s obligation to
commence the exchange offer is subject to a number of conditions,
including (i) approval for listing of the PartnerRe common shares to be
issued in the exchange offer and the merger on the New York Stock Exchange
and on Euronext Paris or another European Union stock exchange selected by
PartnerRe, (ii) the exchange offer on the terms proposed having been
declared compliant by the Autorité des Marchés
Financiers (the French market authority) without any requirement
that PartnerRe provide for a cash alternative under the French tender
offer rules, (iii) the absence of PartnerRe having a reasonable basis to
believe that the opinion of the independent expert to be rendered under
French law in connection with the exchange offer on the terms proposed
would not satisfy the requirements of French law and (iv) certain other
customary conditions.
|
|
Finally,
PartnerRe may only effect the merger under Swiss law if PartnerRe owns at
least 90% of the outstanding Paris Re common shares following the
settlement of the exchange offer.
|
|
For
a more detailed description of the conditions to the transactions, please
see the sections captioned “The Block Purchase Agreement—Conditions to the
Closing of the Block Purchase,” “The Transaction Agreement—The Exchange
Offer” and “The Transaction Agreement—The
Merger.”
|
A:
|
Yes.
The combined entity may not achieve the expected benefits of the
transactions because of the risks and uncertainties discussed in the
section entitled “Risk Factors” beginning on page 32 of this proxy
statement. In
|
A:
|
The
block purchase is expected to close in the fourth quarter of 2009 and the
exchange offer and the merger are expected to close in the first quarter
of 2010. However, the exact timing of the completion of the transactions
cannot be predicted because they are subject to approval by the holders of
PartnerRe common shares, certain regulatory approvals and other conditions
described in this proxy statement.
|
|
In
addition, it is possible for the block purchase to be completed, but for
the exchange offer and the merger to fail to be completed. Since the
conditions of the respective transaction documents are not identical, this
could occur, for example, if every condition of the block purchase
agreement were satisfied, but one or more conditions of the commencement
of the exchange offer were not satisfied or waived. Similarly, it is
possible for the block purchase and exchange offer to be completed, but
for the merger to not occur because, for example, PartnerRe does not own,
directly or indirectly, at least 90% of the outstanding Paris Re common
shares following the settlement of the exchange offer. If,
following the exchange offer, PartnerRe does not own sufficient Paris Re
common shares to effect the merger, PartnerRe may acquire additional Paris
Re common shares through open market purchases, privately negotiated
transactions or otherwise upon the terms and at the prices negotiated at
that time, which may be more or less favorable than the per share
consideration. PartnerRe has not yet determined whether it
would seek to effect these additional purchases of Paris Re common shares
if it did not acquire sufficient Paris Re common shares in the exchange
offer to effect the merger and expects to make this determination based on
the facts and circumstances existing at the appropriate
time.
|
|
For
a more detailed description of the conditions to the transactions, please
see the sections captioned “The Block Purchase Agreement—Conditions to the
Closing of the Block Purchase,” “The Transaction Agreement—The Exchange
Offer” and “The Transaction Agreement—The
Merger.”
|
A:
|
We
do not anticipate any changes to PartnerRe’s dividend policy as a result
of the transactions. We pay quarterly dividends to our
shareholders based on a quarterly determination of our board of directors.
The payment by us of dividends in the future will continue to be
determined by our board of directors and will depend upon, among other
things, our earnings, capital requirements and financial condition, as
well as other relevant factors.
|
A:
|
There
are no material U.S. federal income tax consequences to PartnerRe’s
current shareholders that will result from PartnerRe’s issuance of
additional PartnerRe common shares pursuant to the transactions. See “The
Transactions—Material United States Federal Income Tax Consequences of the
Transactions.”
|
A:
|
The
special general meeting of the PartnerRe shareholders will be held
at p.m. local time
on
,
, 2009, at 5th Floor, Wellesley House South, 90 Pitts Bay Road, Pembroke
HM 08, Bermuda.
|
A:
|
You
are being asked to vote on a proposal to issue PartnerRe common shares and
securities exercisable or exchangeable for PartnerRe common shares to the
holders of Paris Re securities in connection with the
transactions. We refer to this proposal as the “share issuance
proposal.” The transaction documents provide
|
|
In
addition, you are being asked to vote on a proposal to increase the size
of the board of directors of PartnerRe from 11 to 12. We refer
to this proposal as the “board size proposal.” If the board
size proposal is approved, the increase in the size of the PartnerRe board
of directors will only be effective if the block purchase
closes. The transaction documents provide that PartnerRe
shareholder approval of the board size proposal is a condition to the
completion of the block purchase.
|
|
Finally,
you are being asked to vote on a proposal to amend PartnerRe’s 2005
Employee Equity Plan, as amended and restated, which we refer to as the
“2005 employee equity plan,” to increase the shares available for issuance
and to increase the number of shares that may be awarded as restricted
shares or restricted share units. We refer to this proposal as
the “equity plan proposal.” If the equity plan proposal is
approved, the amendments to the 2005 employee equity plan will only be
effective if the block purchase closes. Approval of the equity
plan proposal is not a condition to the completion of the
transactions.
|
A:
|
The
board of directors of PartnerRe recommends that you vote (i) “FOR” the share issuance
proposal, (ii) “FOR” the board size
proposal and (iii) “FOR” the equity plan
proposal.
|
A:
|
The
rules of the New York Stock Exchange, the principal securities exchange on
which PartnerRe common shares are listed, require the approval of holders
of PartnerRe common shares of the issuance of the PartnerRe common shares
and securities exercisable or exchangeable for PartnerRe common shares in
the transactions because the issuance (including the PartnerRe common
shares previously issued in the pre-announcement purchases) exceeds 20% of
the number of PartnerRe common shares outstanding prior to the
issuance. Specifically, the PartnerRe common shares issuable
pursuant to the transactions (including PartnerRe common shares that will
become subject to share options, restricted share units and warrants to
acquire PartnerRe common shares upon the conversion of Paris Re share
options, restricted share units and warrants pursuant to the merger or
that may be issuable under liquidity agreements entered into with French
employees, in each case, as described under “The Transaction
Agreement—Treatment of Paris Re Share Options, Restricted Share Units and
Warrants”) represent approximately 47.2% of the PartnerRe common shares
outstanding prior to the issuances in connection with the pre-announcement
purchases based on the “base case assumptions” described under “The
Transactions—Ownership of PartnerRe Following the
Transactions.” See “Proposal No. 1: The Share Issuance
Proposal.”
|
A:
|
Pursuant
to the transaction agreement, PartnerRe has agreed to cause one of the
existing directors on the Paris Re board of directors that is not an
affiliate of any block seller to be appointed to the PartnerRe board of
directors effective upon the closing of the block purchase, subject to the
approval of that person by PartnerRe’s Nominating and Governance
Committee. To comply with this provision of the block purchase
agreement, the board of directors of PartnerRe is proposing that its size
be increased from 11 to 12 in order to create a vacancy that can be filled
by the existing Paris Re director in accordance with the transaction
agreement. Under PartnerRe’s Bye-Laws, any change in the size
of the PartnerRe board of directors above its current size requires
approval of PartnerRe shareholders. See “Proposal No. 2: The
Board Size Proposal.”
|
A:
|
The
rules of the New York Stock Exchange, the principal securities exchange on
which PartnerRe common shares are listed, require the approval of holders
of PartnerRe common shares to materially increase the number of shares
available under the 2005 employee equity plan. Pursuant to the
terms of the 2005 employee equity plan, the number of PartnerRe common
shares that may be awarded is capped at 1,531,764. In addition,
the number of PartnerRe common shares that may be awarded as either
restricted shares or restricted share units is
|
A:
|
If
you do not vote by proxy or in person at the special general meeting, it
will be more difficult for us to obtain the necessary quorum to conduct
business at our special general
meeting.
|
A:
|
In
order for PartnerRe’s shareholders to approve the board size proposal, the
holders of at least 25% of the outstanding common shares as of the record
date must be present at the special general meeting, in person or by
proxy. Assuming that this quorum requirement is met, the board size
proposal will be decided by a simple majority of votes
cast.
|
|
In
order for PartnerRe’s shareholders to approve the share issuance proposal
and the equity plan proposal, New York Stock Exchange rules impose special
requirements that must be met. The total number of votes cast at the
special general meeting must represent over 50% of the PartnerRe common
shares entitled to vote on the proposal. We refer to this as the “‘vote
cast’ quorum requirement.” Assuming that this “vote cast” quorum
requirement is met, the share issuance proposal and the equity plan
proposal will each pass if a majority of votes cast are in favor of that
proposal.
|
|
Failure
to submit a proxy or to attend the meeting and vote could result in the
failure to obtain the necessary quorum for one or more of the proposals,
which would prevent the proposals from being approved. Abstaining from
voting may have the effect of making it less likely that a proposal will
be approved. See “The Special General Meeting—Vote Required of
PartnerRe Shareholders; Quorum
Requirements.”
|
A:
|
The
transaction documents provide that PartnerRe shareholder approval of the
share issuance proposal and the board size proposal are conditions to the
completion of the transactions. If the transactions are not
consummated, this will result in the loss of a strategic opportunity that
the PartnerRe board of directors has determined is in the best interests
of PartnerRe’s shareholders. It will also require us to pay a
termination fee of $75 million to Paris
Re.
|
|
If
the transactions are not completed, PartnerRe will continue to own
approximately 6.1% of the outstanding Paris Re common shares that it
acquired at a premium to the then-current market price for the Paris Re
common shares in the pre-announcement purchases. While
PartnerRe has not yet determined whether it would seek to sell these Paris
Re common shares should the remainder of the transactions not be
completed, these shares may be difficult to sell due to the limited public
trading market for the Paris Re common shares. PartnerRe has
also incurred costs and expenses associated with the transactions,
including legal, accounting and financial advisory fees, that will not be
offset by any gains or the realization of any efficiencies resulting from
the completion of the transactions.
|
|
The
completion of the transactions is not contingent on the approval of the
equity plan proposal. If the equity plan proposal is not
approved and the transactions are completed, however, the failure to
approve the equity plan proposal will limit PartnerRe’s ability to make
grants of equity awards under the 2005 employee equity plan, adversely
affecting PartnerRe’s ability to implement its long-term equity
goals.
|
A:
|
You
can vote at the special general meeting if you owned PartnerRe common
shares at the close of business
on
, 2009, the record date for the special general meeting. At the
close of business on the record date, there were outstanding
approximately PartnerRe common shares
(net of treasury shares).
|
A:
|
No. PartnerRe
shareholders have no dissenters’ rights under Bermuda law in connection
with the transactions. See “The Transactions—Dissenters’
Rights.”
|
A:
|
Upon
completion of the transactions in their entirety and assuming the “base
case assumptions” described under “The Transactions—Ownership of PartnerRe
Following the Transactions,” holders of Paris Re common shares and Paris
Re warrants who receive PartnerRe common shares pursuant to the
transactions will represent approximately 31.1% of PartnerRe’s outstanding
common shares.
|
A:
|
If
you are a holder of record or PartnerRe common shares, after carefully
reading and considering the information contained in this proxy statement,
please complete, sign and date your proxy and return it in the enclosed
return envelope as soon as possible, so that your PartnerRe common shares
may be represented at the special general meeting. If you sign
and send in your proxy and do not indicate how you wish to vote, PartnerRe
will count your proxy as a vote in favor of the proposals. If
you are a registered shareholder, you can also authorize the voting of
your PartnerRe common shares (i) over the internet by visiting the web
address www.proxyvote.com and following the instructions provided and (ii)
by telephone by dialing 1-800-690-6903 and following the recorded
instructions. The telephone and internet voting facilities
close at 11:59 p.m. Eastern Time
on
, 2009. If you hold PartnerRe common shares in “street name”
through an account with a bank or a broker, see the discussion
below.
|
A:
|
Your
bank or broker will vote your PartnerRe common shares only if you provide
instructions to your bank or broker on how to vote. You should
follow the directions provided by your bank or broker regarding how to
instruct your bank or broker to vote your shares. Without
instructions, your shares will not be voted and will have no effect on the
vote for the proposals. This will make it less likely that the
quorum requirements for the votes on the share issuance proposal, the
board size proposal and the equity plan proposal can be
met.
|
A:
|
Yes. You
can change your vote at any time before your proxy is voted at the special
general meeting. If you are a registered shareholder, you can
do this in one of three ways. First, you can send a written
notice stating that you would like to revoke your
proxy. Second, you may change your vote by voting again by
telephone or over the internet prior to 11:59 p.m. Eastern Time
on
, 2009. Third, you may change your vote by voting at the
special general meeting if you are a registered shareholder. If
you intend to change your vote at the special general meeting you must
provide our secretary oral or written notice either at or prior to the
meeting. We will not assume that you wish to change a previous
vote simply because you attend the special general
meeting.
|
|
If
your PartnerRe common shares are held in “street name” by a bank or
broker, you may change your vote by obtaining a legal proxy from your bank
or broker or by submitting new voting instructions to your bank or broker
in accordance with the procedures established by it. A legal
proxy is an authorization to vote the PartnerRe common shares your bank or
broker holds in its name for your benefit. Please contact your
bank or broker and follow its directions in order to change your
vote.
|
Q:
|
What
do I need to do to attend the special general
meeting?
|
A:
|
The
special general meeting is open to all holders of outstanding PartnerRe
common shares as of the record date to attend and vote your PartnerRe
common shares (or change your vote). If you hold PartnerRe
common shares in “street name” through an account with a bank or broker,
you also need to obtain a legal proxy from that entity. The
legal proxy obtained from your bank or broker will serve as an admission
ticket and authorize you to vote your PartnerRe common shares (or change
your vote) at the special general meeting. Shareholders who do
not have valid picture identification and a legal proxy (if required) may
not be admitted to the special general meeting. We encourage
all shareholders, even those who plan to attend the special general
meeting, to vote in advance. If you intend to vote at the
special general meeting, you must provide our secretary oral or written
notice either at or prior to the
meeting.
|
A:
|
If
you have any questions about the transactions, the proposals or the
special general meeting, or if you need additional copies of this proxy
statement or the enclosed proxy, you should
contact:
|
|
·
|
a
proposal to issue PartnerRe common shares and securities exercisable or
exchangeable for PartnerRe common shares to the holders of Paris Re
securities in connection with the transactions described below, which
proposal we refer to as the “share issuance
proposal;”
|
|
·
|
a
proposal to increase the size of the board of directors of PartnerRe from
11 to 12 which proposal we refer to as the “board size proposal;”
and
|
|
·
|
a
proposal to amend PartnerRe’s 2005 Employee Equity Plan, as amended and
restated, which we refer to as the “2005 employee equity plan,” to
increase the PartnerRe common shares available for issuance and to
increase the number of PartnerRe common shares that may be awarded by
PartnerRe as restricted shares or restricted share units, which proposal
we refer to as the “equity plan
proposal.”
|
|
·
|
each
block seller and each post-announcement seller will receive the remaining
per share portion of the share capital repayment in the form of a
promissory note issued by PartnerRe at the closing of the block purchase
(for an explanation of the terms of the promissory notes, see “The Block
Purchase Agreement—Purchase and Sale” and “The Post-Announcement Purchase
Agreements—Purchase and Sale”); and
|
|
·
|
each
other holder of Paris Re common shares that holds Paris Re common shares
on the relevant record date occurring shortly prior to the settlement of
the exchange offer (including PartnerRe with respect to the Paris Re
common shares owned by PartnerRe and its subsidiaries at that time) will
receive the remaining per share portion in the form of cash by way of a
capital distribution from Paris Re immediately prior to the settlement of
the exchange offer. This cash payment, however, will only be
paid if the exchange offer is settled. See “Summary—The Transactions—Share
Capital Repayment” below.
|
|
·
|
upwards
if the percentage decline in PartnerRe’s tangible book value per share
from March 31, 2009 to the measurement date is greater than that of Paris
Re’s; and
|
|
·
|
downwards
if the percentage decline in Paris Re’s tangible book value per share from
March 31, 2009 to the measurement date is greater than that of
PartnerRe’s.
|
|
·
|
from
July 4, 2009, when there were 80.6 million Paris Re common shares
outstanding (net of treasury shares), until the completion of the
transactions, no additional Paris Re common shares will be issued
(including upon the exercise or conversion of options, restricted share
units, warrants or other securities exercisable, convertible or
exchangeable for Paris Re common
shares);
|
|
·
|
from
July 4, 2009, when there were 56.7 million PartnerRe common shares
outstanding (net of treasury shares), until the completion of the
transactions, except for issuances in connection with the transactions, no
additional PartnerRe common shares will be issued (including upon the
exercise or conversion of options, restricted share units, warrants or
other securities exercisable, convertible or exchangeable for PartnerRe
common shares);
|
|
·
|
PartnerRe
will acquire 100% of the outstanding Paris Re common shares and Paris Re
warrants in the transactions;
|
|
·
|
no
adjustment will be made to the per share consideration and per warrant
consideration pursuant to the tangible book value adjustment;
and
|
|
·
|
PartnerRe
will not declare any dividends on the PartnerRe common shares with a
record date between the closing of the block purchase and the exchange
offer and, as a result, no adjustment will be made to the per share
consideration pursuant to the post-block purchase closing dividend
adjustment.
|
|
·
|
in
addition to the PartnerRe common shares issued in connection with the
transactions, additional Paris Re common shares or PartnerRe common shares
are issued prior to the completion of the transactions (including upon the
exercise or conversion of options, restricted share units, warrants or
other securities exercisable, convertible or exchangeable for Paris Re
common shares or PartnerRe common shares), in each case, in accordance
with the limitations set forth in the transaction
agreement;
|
|
·
|
PartnerRe
acquires less than all of the outstanding Paris Re warrants in the
transactions;
|
|
·
|
the
per share consideration and per warrant consideration are adjusted upwards
or downwards pursuant to the tangible book value per share adjustment;
or
|
|
·
|
for
purposes of the post-block purchase closing dividend adjustment, PartnerRe
declares one or more dividends on the PartnerRe common shares with a
record date between the closing of the block purchase and the exchange
offer, in which case the increase in the number of PartnerRe common shares
issued will be determined based on the formula described above under
“Summary—Post-Block Purchase Closing Dividend Adjustment” and would be
dependent on both the aggregate amount of dividends so declared as well as
the average price per PartnerRe common share during the applicable
measurement period.
|
|
·
|
the
payment of the share capital repayment, subject to the closing of the
block purchase;
|
|
·
|
the
appointment of individuals designated by PartnerRe comprising a majority
of Paris Re’s board of directors, subject to and effective upon the
closing of the block purchase; and
|
|
·
|
an
amendment to Paris Re’s articles of incorporation (i) to remove a
provision thereof purporting to require a cash takeover bid for any
acquisition of more than one-third of the Paris Re voting rights and (ii)
to
|
|
·
|
absence
of applicable law prohibiting or preventing the completion of the block
purchase, the exchange offer or the
merger;
|
|
·
|
expiration,
termination or receipt of any applicable waiting period (or extension
thereof) or approval under the Hart-Scott-Rodino Antitrust Improvements
Act of 1976, as amended and any applicable foreign antitrust law, in each
case, without the imposition of a “burdensome condition” (for an
explanation of the term “burdensome condition,” see “The Transaction
Agreement—Certain Covenants—Reasonable Best Efforts
Covenant”);
|
|
·
|
receipt
of all insurance regulatory approvals required in connection with the
block purchase, the exchange offer and the merger without the imposition
of a “burdensome condition;”
|
|
·
|
receipt
of all required approvals of any governmental authority (other than those
referred to in the two immediately preceding bullet points) without the
imposition of a “burdensome
condition;”
|
|
·
|
approval
for the listing of the PartnerRe common shares on Euronext Paris or
another European Union stock exchange or, in PartnerRe’s reasonable
judgment, such listing is reasonably expected to occur prior to the
settlement of the exchange offer;
|
|
·
|
approval
for listing on the New York Stock Exchange of the PartnerRe common shares
to be issued in the block purchase;
|
|
·
|
the
effectiveness of, and the absence of any stop order with respect to, the
registration statement on Form S-4, if required, to be filed in connection
with the exchange offer (or, in PartnerRe’s reasonable judgment, no
reasonable basis to believe that the Form S-4 will not be declared
effective prior to the settlement of the exchange
offer);
|
|
·
|
approval
by the PartnerRe shareholders of the share issuance proposal and, unless
the condition is waived, the board size
proposal;
|
|
·
|
the
approval by the Paris Re shareholders of the matters requiring Paris Re
shareholder approval;
|
|
·
|
receipt
of exemptive and no-action relief, if necessary, from the SEC permitting
PartnerRe to settle the exchange offer in accordance with the French
tender offer rules;
|
|
·
|
accuracy
as of the closing of the block purchase of the representations and
warranties made by PartnerRe, Paris Re and the block sellers to the extent
specified in the block purchase agreement and transaction
agreement;
|
|
·
|
performance
in all material respects by PartnerRe, Paris Re and the block sellers of
the obligations required to be performed by it at or prior to
closing;
|
|
·
|
receipt
of evidence that, immediately following the closing of the block purchase,
the individuals designated by PartnerRe to Paris Re’s board of directors
will comprise a majority of Paris Re’s board of directors;
and
|
|
·
|
effectiveness
in accordance with Swiss law of the amendment to Paris Re’s articles of
incorporation.
|
|
·
|
absence
of any law prohibiting or preventing the completion of the exchange offer
or the merger;
|
|
·
|
the
effectiveness of, and the absence of any stop order with respect to, the
registration statement on Form S-4, if required, to be filed in connection
with the exchange offer;
|
|
·
|
receipt
of exemptive and no-action relief, if necessary, from the SEC permitting
PartnerRe to settle the exchange offer in accordance with the French
tender offer rules;
|
|
·
|
the
absence of PartnerRe having a reasonable basis to believe that the
“independent expert” (as further described in this document) would render
an opinion that the exchange offer on the terms proposed would not satisfy
the regulations of the Autorité des Marchés
Financiers, the French market authority, which we refer to as the
“AMF;” and
|
|
·
|
the
exchange offer on the terms proposed being declared compliant by the AMF
without imposing any requirement that if not satisfied would require a
cash alternative in accordance with the French tender offer rules (other
than certain requirements accepted by PartnerRe as of the execution date
of the transaction agreement).
|
|
·
|
the
closing of the block purchase has not occurred on or before March 15,
2010, subject to automatic extension if the time for calculating the
tangible book value per share adjustment is delayed under certain
circumstances;
|
|
·
|
the
transaction agreement has been
terminated;
|
|
·
|
any
applicable law makes consummation of the transactions illegal or otherwise
prohibited; or
|
|
·
|
the
other party has breached any of its covenants or agreements or any
representation or warranty that would, if occurring at the closing of the
block purchase, result in the failure of a closing condition to the
terminating party’s obligations and which breach is not cured (or cannot
be cured) within the applicable cure
period.
|
|
·
|
by
either PartnerRe or Paris Re if the block purchase agreement has
terminated prior to the closing of the block
purchase;
|
|
·
|
by
either PartnerRe or Paris Re if either (i) the settlement of the exchange
offer has not occurred within five months after the closing of the block
purchase or (ii) the effective time of the merger has not occurred within
three months after the settlement of the exchange
offer;
|
|
·
|
by
either PartnerRe or Paris Re if any applicable law makes consummation of
the transactions illegal or otherwise
prohibited;
|
|
·
|
by
either PartnerRe or Paris Re if prior to the closing of the block
purchase, the PartnerRe shareholder approvals required to consummate the
transactions have not been
obtained;
|
|
·
|
by
PartnerRe or Paris Re if prior to the closing of the block purchase, it is
determined that the decline in other party’s tangible book value per share
during the period from March 31, 2009 to the measurement date is more than
40% greater than the percentage decline in its tangible book value per
share during the same period;
|
|
·
|
by
PartnerRe or Paris Re if the other party has breached any of its covenants
or agreements or any representation or warranty that would, if occurring
at the closing of the block purchase, result in the
failure
|
|
·
|
by
PartnerRe if prior to the closing of the block purchase, the Paris Re
shareholder approvals required to consummate the transactions have not
been obtained;
|
|
·
|
by
Paris Re if prior to the closing of the block purchase, PartnerRe’s board
of directors has withdrawn or modified its recommendations relating to the
PartnerRe shareholder approvals or, in certain circumstances, has failed
to reaffirm its recommendation; or
|
|
·
|
by
Paris Re if prior to the receipt of the PartnerRe shareholder approvals,
there has been a breach of PartnerRe’s non-solicitation obligations (as
further described in this
document).
|
|
·
|
PartnerRe’s
board of directors has withdrawn or modified its recommendations relating
to the PartnerRe shareholder approvals required to consummate the
transactions in a manner adverse to Paris Re or, in certain circumstances,
has failed to reaffirm its recommendation;
or
|
|
·
|
the
PartnerRe shareholder approvals required to consummate the transactions
have not been obtained.
|
|
·
|
in
the case of the PartnerRe board of directors, the PartnerRe board of
directors determines in good faith, after consultation with outside legal
counsel, that such action is required by its fiduciary duties under
Bermuda law; and
|
|
·
|
in
the case of the Paris Re board of directors, if following the receipt of a
superior proposal, the Paris Re board of directors determines in good
faith, after consultation with outside legal counsel, that such action is
required by its fiduciary duties under Swiss
law.
|
|
·
|
initiating
or soliciting or knowingly facilitating or encouraging any inquiry or the
making of any proposal, sometimes referred to as an acquisition proposal,
involving a merger, business combination, sale
of
|
|
·
|
participating
in any discussions or negotiations with or furnishing any non-public
information to any third party seeking to make or who has made an
acquisition proposal;
|
|
·
|
granting
any waiver or release under any standstill or similar agreement;
or
|
|
·
|
entering
into any agreement in principle, letter of intent or other similar
instrument relating to an acquisition
proposal.
|
For
the years ended December 31,
|
Three
Months Ended
March
31,
|
|||||||||||||||||||||||||||
2008
|
2007
|
2006
|
2005
|
2004
|
2009
|
2008
|
||||||||||||||||||||||
(in
millions of U.S. dollars or shares, except ratios and per share
data)
|
||||||||||||||||||||||||||||
Statement
of Operations Data
|
||||||||||||||||||||||||||||
Gross
premiums written
|
$ | 4,028 | $ | 3,810 | $ | 3,734 | $ | 3,665 | $ | 3,888 | $ | 1,340 | $ | 1,439 | ||||||||||||||
Net
premiums written
|
3,989 | 3,757 | 3,689 | 3,616 | 3,853 | 1,308 | 1,412 | |||||||||||||||||||||
Net
premiums earned
|
$ | 3,928 | $ | 3,777 | $ | 3,667 | $ | 3,599 | $ | 3,734 | $ | 866 | $ | 910 | ||||||||||||||
Net
investment income
|
573 | 523 | 449 | 365 | 298 | 133 | 137 | |||||||||||||||||||||
Net
realized and unrealized investment (losses) gains
|
(531 | ) | (72 | ) | 47 | 207 | 117 | (70 | ) | 25 | ||||||||||||||||||
Net
realized gain on purchase of capital efficient notes
|
— | — | — | — | — | 89 | — | |||||||||||||||||||||
Other
income (loss)
|
10 | (17 | ) | 24 | 35 | 17 | 5 | 2 | ||||||||||||||||||||
Total
revenues
|
3,980 | 4,211 | 4,187 | 4,206 | 4,166 | 1,023 | 1,074 | |||||||||||||||||||||
Losses
and loss expenses and life policy benefits
|
2,609 | 2,082 | 2,111 | 3,087 | 2,476 | 519 | 590 | |||||||||||||||||||||
Total
expenses
|
3,918 | 3,328 | 3,355 | 4,244 | 3,673 | 815 | 903 | |||||||||||||||||||||
Income
(loss) before taxes and interest in (losses) earnings of equity
investments
|
62 | 883 | 832 | (38 | ) | 493 | 208 | 171 | ||||||||||||||||||||
Income
tax expense
|
10 | 82 | 95 | 23 | 7 | 60 | 43 | |||||||||||||||||||||
Interest
in (losses) earnings of equity investments
|
(5 | ) | (83 | ) | 12 | 10 | 6 | (6 | ) | 1 |
For
the years ended December 31,
|
Three
Months Ended
March
31,
|
|||||||||||||||||||||||||||
2008
|
2007
|
2006
|
2005
|
2004
|
2009
|
2008
|
||||||||||||||||||||||
(in
millions of U.S. dollars or shares, except ratios and per share
data)
|
||||||||||||||||||||||||||||
Net
income (loss)
|
$ | 47 | $ | 718 | $ | 749 | $ | (51 | ) | $ | 492 | $ | 142 | $ | 129 | |||||||||||||
Basic
net income (loss) per common share
|
$ | 0.22 | $ | 12.18 | $ | 12.58 | $ | (1.56 | ) | $ | 8.80 | $ | 2.35 | $ | 2.22 | |||||||||||||
Diluted
net income (loss) per common share
|
$ | 0.22 | $ | 11.87 | $ | 12.37 | $ | (1.56 | ) | $ | 8.71 | $ | 2.32 | $ | 2.16 | |||||||||||||
Dividends
declared and paid per common share
|
$ | 1.84 | $ | 1.72 | $ | 1.60 | $ | 1.52 | $ | 1.36 | $ | 0.47 | $ | 0.46 | ||||||||||||||
Weighted
average number of common and common share equivalents
outstanding
|
55.6 | 57.6 | 57.8 | 55.0 | 54.0 | 57.3 | 55.7 | |||||||||||||||||||||
Non-life
Ratios
|
||||||||||||||||||||||||||||
Loss
ratio(1)
|
63.9 | % | 50.8 | % | 54.8 | % | 87.3 | % | 65.6 | % | 55.9 | % | 61.3 | % | ||||||||||||||
Acquisition
ratio(2)
|
23.3 | 22.9 | 23.1 | 23.0 | 23.0 | 23.7 | 23.5 | |||||||||||||||||||||
Other
operating expense ratio(3)
|
6.9 | 6.7 | 6.5 | 6.0 | 6.0 | 7.4 | 7.5 | |||||||||||||||||||||
Combined
ratio(4)
|
94.1 | % | 80.4 | % | 84.4 | % | 116.3 | % | 94.6 | % | 87.0 | % | 92.3 | % |
At
December 31,
|
At
March 31,
|
|||||||||||||||||||||||||||
2008
|
2007
|
2006
|
2005
|
2004
|
2009
|
2008
|
||||||||||||||||||||||
(in
millions of U.S. dollars or shares, except per share data)
|
||||||||||||||||||||||||||||
Balance
Sheet Data
|
||||||||||||||||||||||||||||
Total
investments and cash
|
$ | 11,724 | $ | 11,572 | $ | 10,679 | $ | 9,579 | $ | 8,398 | $ | 11,402 | $ | 12,189 | ||||||||||||||
Total
assets
|
16,279 | 16,149 | 15,034 | 13,783 | 12,717 | 16,275 | 17,453 | |||||||||||||||||||||
Unpaid
losses and loss expenses and policy benefits for life and annuity
contracts
|
8,943 | 8,773 | 8,301 | 7,962 | 7,044 | 8,815 | 9,174 | |||||||||||||||||||||
Long-term
debt
|
200 | 620 | 620 | 620 | 220 | 200 | 620 | |||||||||||||||||||||
Debt
related to senior notes
|
250 | — | — | — | — | 250 | — | |||||||||||||||||||||
Debt
related to capital efficient notes
|
258 | 258 | 258 | — | — | 71 | 258 | |||||||||||||||||||||
Debt
related to trust preferred securities
|
— | — | — | 206 | 206 | — | — | |||||||||||||||||||||
Total
shareholders’ equity
|
4,199 | 4,322 | 3,786 | 3,093 | 3,352 | 4,282 | 4,473 | |||||||||||||||||||||
Diluted
book value per common and common share equivalents
outstanding
|
$ | 63.95 | $ | 67.96 | $ | 56.07 | $ | 44.57 | $ | 50.99 | $ | 65.55 | $ | 70.93 | ||||||||||||||
Number
of common shares outstanding, net of treasury shares
|
56.5 | 54.3 | 57.1 | 56.7 | 54.9 | 56.6 | 54.3 |
For
the years ended
December 31, |
Period
from March 27 to December 31,
|
For
the three months ended
March 31, |
||||||||||||||||||
2008
|
2007
|
2006
|
2009
|
2008
|
||||||||||||||||
(in
millions of U.S. dollars or shares, except for ratios and per share
data)
|
||||||||||||||||||||
Income
Statement
|
||||||||||||||||||||
Gross
written premiums
|
$ | 1,403 | $ | 1,277 | $ | 723 | $ | 667 | $ | 775 | ||||||||||
Net
written premiums
|
1,197 | 1,150 | 707 | 575 | 641 | |||||||||||||||
Net
earned premiums
|
$ | 1,211 | $ | 1,168 | $ | 587 | $ | 299 | $ | 282 | ||||||||||
Claims
net of retrocession(1)
|
(892 | ) | (722 | ) | (254 | ) | (202 | ) | (171 | ) | ||||||||||
Commissions
and brokerage net of retrocession
|
(197 | ) | (203 | ) | (122 | ) | (46 | ) | (52 | ) | ||||||||||
Net
underwriting income
|
123 | 243 | 211 | 51 | 59 | |||||||||||||||
Net
financial income (loss) including debt expense
|
62 | 112 | 139 | 120 | (114 | ) | ||||||||||||||
Net
income from investments in associates using the equity
method
|
— | 1 | 1 | — | — | |||||||||||||||
General
expenses
|
(155 | ) | (139 | ) | (97 | ) | (28 | ) | (40 | ) | ||||||||||
Amortization
of intangibles
|
(62 | ) | (128 | ) | (101 | ) | (22 | ) | (33 | ) | ||||||||||
Recognition
of negative goodwill
|
— | — | 341 | — | — | |||||||||||||||
Net
(loss) income before tax
|
(32 | ) | 88 | 495 | 122 | (128 | ) | |||||||||||||
Income
tax
|
(3 | ) | (1 | ) | (58 | ) | (3 | ) | (2 | ) | ||||||||||
Total
net (loss) income
|
$ | (34 | ) | $ | 87 | $ | 437 | $ | 119 | $ | (130 | ) | ||||||||
(Loss)
earnings per share
|
$ | (0.41 | ) | $ | 1.04 | $ | 187.88 | $ | 1.47 | $ | (1.52 | ) | ||||||||
Diluted
(loss) earnings per share
|
$ | (0.41 | ) | $ | 1.00 | $ | 187.88 | $ | 1.46 | $ | (1.47 | ) | ||||||||
Ratios
|
||||||||||||||||||||
Total
loss ratio net of reinsurance(2)
|
73.6 | % | 61.8 | % | 43.2 | % | 67.4 | % | 60.8 | % | ||||||||||
General
and administrative expense ratio(3)
|
12.8 | % | 11.9 | % | 16.5 | % | 9.3 | % | 14.2 | % | ||||||||||
Net
commissions and brokerage expense ratio(4)
|
16.2 | % | 17.3 | % | 20.8 | % | 15.5 | % | 18.3 | % | ||||||||||
Total
net expense ratio(5)
|
29.0 | % | 29.2 | % | 37.3 | % | 24.8 | % | 32.5 | % | ||||||||||
Combined
ratio(6)
|
102.6 | % | 91.1 | % | 80.5 | % | 92.2 | % | 93.3 | % |
At
December 31,
|
At
March 31,
|
|||||||||||||||
2008
|
2007
|
2006
|
2009
|
|||||||||||||
(in
millions of U.S. dollars)
|
||||||||||||||||
Balance
Sheet Data
|
||||||||||||||||
Total
intangible assets
|
$ | 225 | $ | 307 | $ | 370 | $ | 194 | ||||||||
Total
financial invested assets
|
4,680 | 5,157 | 3,750 | 4,555 | ||||||||||||
Ceded
technical reserves
|
230 | 126 | 74 | 282 | ||||||||||||
Deferred
tax assets
|
19 | 3 | 11 | 32 | ||||||||||||
Total
other assets
|
857 | 821 | 775 | 1,189 | ||||||||||||
Cash
and cash equivalents
|
381 | 452 | 1,444 | 502 | ||||||||||||
Total
assets
|
$ | 6,392 | $ | 6,866 | $ | 6,424 | $ | 6,754 | ||||||||
Total
shareholders’ equity
|
$ | 2,172 | $ | 2,474 | $ | 2,091 | $ | 2,045 | ||||||||
Total
liabilities relating to reinsurance and investment
contracts
|
3,788 | 3,989 | 3,650 | 4,064 | ||||||||||||
Total
other liabilities(7)
|
432 | 403 | 683 | 645 | ||||||||||||
Total
liabilities and shareholders’ equity
|
$ | 6,392 | $ | 6,866 | $ | 6,424 | $ | 6,754 |
(1)
|
Claims
net of retrocession, which is sometimes referred to as a “claims charge,”
consists of major losses and attritional losses. A “major” loss
is defined as any event involving multiple insured risks causing a pre-tax
loss to Paris Re, gross of reinsurance, in excess of U.S.
$30 million, to all operating lines combined. All other
losses are referred to as “attritional” or “non-major”
losses.
|
(2)
|
Claims
net of retrocession, divided by net earned premiums. The total
loss ratio net of reinsurance is net of any positive or negative
development on prior years.
|
(3)
|
Sum
of general and administrative expenses, divided by net earned
premiums.
|
(4)
|
Sum
of commissions and brokerage net of retrocession, including acquisition
and operational expenses, divided by net earned
premiums.
|
(5)
|
Sum
of commissions and brokerage net of retrocession, including acquisition
and operational expenses and general and administrative expenses, divided
by net earned premiums.
|
(6)
|
Sum
of the total loss ratio net of reinsurance and the total net expense
ratio.
|
(7)
|
Other
liabilities consist of (a) payables arising from reinsurance operations,
technical accruals on ceded reinsurance and other payables, (b) provisions
for risks and charges, (c) deferred tax liabilities, and (d)
debts.
|
Pro
Forma Combined
|
||||||||
For
the Year Ended December 31, 2008
|
For
the Three Months Ended March 31, 2009
|
|||||||
(in
millions of U.S. dollars or shares, except per share data)
|
||||||||
Statement
of Operations Data
|
||||||||
Gross
premiums written
|
$ | 5,431 | $ | 2,008 | ||||
Net
premiums written
|
5,186 | 1,883 | ||||||
Net
premiums earned
|
$ | 5,139 | $ | 1,166 | ||||
Net
investment income
|
782 | 172 | ||||||
Net
realized and unrealized investment losses
|
(512 | ) | (82 | ) | ||||
Net
realized gain on purchase of capital efficient notes
|
— | 89 | ||||||
Other
income
|
9 | 4 | ||||||
Total
revenues
|
5,418 | 1,349 | ||||||
Losses
and loss expense and life policy benefits
|
3,501 | 721 | ||||||
Total
expenses
|
5,332 | 1,014 | ||||||
Income
before taxes and interest in losses of equity investments
|
86 | 335 | ||||||
Income
tax expense
|
22 | 64 | ||||||
Interest
in losses of equity investments
|
(6 | ) | (6 | ) | ||||
Net
income
|
$ | 58 | $ | 265 | ||||
Basic
net income per common share
|
$ | 0.30 | $ | 3.12 | ||||
Diluted
net income per common share
|
$ | 0.29 | $ | 3.09 | ||||
Weighted
average number of common shares outstanding
|
80.1 | 82.2 | ||||||
Weighted
average number of common and common share equivalents
outstanding
|
81.4 | 83.1 | ||||||
Pro
Forma Combined
|
||||
At
March 31, 2009
|
||||
(in
millions of U.S. dollars or shares, except per share data)
|
||||
Balance
Sheet Data
|
||||
Total
investments and cash
|
$ | 13,780 | ||
Funds
held by reinsured companies
|
3,093 | |||
Intangible
assets
|
237 | |||
Goodwill
|
551 | |||
Total
assets
|
22,685 | |||
Unpaid
losses and loss expense and policy benefits for life and annuity
contracts
|
12,037 |
Pro
Forma Combined
|
||||
At
March 31, 2009
|
||||
(in
millions of U.S. dollars or shares, except per share data)
|
||||
Debt
obligations
|
521 | |||
Total
shareholders’ equity
|
6,042 | |||
Diluted
book value per common and common share equivalents
outstanding
|
$ | 66.41 | ||
Common
and common share equivalents outstanding
|
83.2 |
PartnerRe
Common
Shares
|
Paris
Re
Common
Shares
|
|||||||||||||||||||||||
High(1)
|
Low(1)
|
Dividends
|
High(1)
|
Low(1)
|
Dividends
(2)
|
|||||||||||||||||||
Annual
Data
|
||||||||||||||||||||||||
2004
|
$ | 62.80 | $ | 50.08 | $ | 1.36 | € | N/A | € | N/A | € | N/A | ||||||||||||
2005
|
71.00 | 56.00 | 1.52 | N/A | N/A | N/A | ||||||||||||||||||
2006
|
71.78 | 59.10 | 1.60 | N/A | N/A | N/A | ||||||||||||||||||
2007
|
84.75 | 66.83 | 1.72 | 19.50 | 13.60 | N/A | ||||||||||||||||||
2008
|
83.20 | 47.70 | 1.84 | 16.69 | 9.75 | N/A | ||||||||||||||||||
Quarterly
Data
|
||||||||||||||||||||||||
2007
|
||||||||||||||||||||||||
First
Quarter
|
$ | 72.00 | $ | 66.83 | $ | 0.43 | € | N/A | € | N/A | € | N/A | ||||||||||||
Second
Quarter
|
78.21 | 67.97 | 0.43 | N/A | N/A | N/A | ||||||||||||||||||
Third
Quarter
|
80.25 | 67.82 | 0.43 | 19.50 | 16.10 | N/A | ||||||||||||||||||
Fourth
Quarter
|
84.75 | 77.66 | 0.43 | 16.95 | 13.60 | N/A | ||||||||||||||||||
2008
|
||||||||||||||||||||||||
First
Quarter
|
$ | 83.20 | $ | 73.60 | $ | 0.46 | € | 16.69 | € | 13.10 | € | N/A | ||||||||||||
Second
Quarter
|
78.31 | 69.13 | 0.46 | 15.29 | 12.75 | N/A | ||||||||||||||||||
Third
Quarter
|
76.96 | 60.60 | 0.46 | 14.00 | 10.25 | N/A | ||||||||||||||||||
Fourth
Quarter
|
74.26 | 47.70 | 0.46 | 13.50 | 9.75 | N/A | ||||||||||||||||||
2009
|
||||||||||||||||||||||||
First
Quarter
|
$ | 73.37 | $ | 53.92 | $ | 0.47 | € | 13.42 | € | 9.30 | € | N/A | ||||||||||||
Second
Quarter
|
69.93 | 60.80 | 0.47 | 14.90 | 11.50 | N/A | ||||||||||||||||||
Monthly
Data
|
||||||||||||||||||||||||
2009
|
||||||||||||||||||||||||
January
|
$ | 73.37 | $ | 64.38 | $ | N/A | € | 11.95 | € | 9.30 | € | N/A | ||||||||||||
February
|
68.82 | 60.26 | N/A | 13.42 | 11.50 | N/A | ||||||||||||||||||
March
|
64.39 | 53.92 | 0.47 | 13.00 | 10.80 | N/A | ||||||||||||||||||
April
|
69.93 | 60.80 | N/A | 14.90 | 12.98 | N/A | ||||||||||||||||||
May
|
68.49 | 62.23 | N/A | 14.70 | 12.35 | N/A | ||||||||||||||||||
June
|
68.38 | 63.83 | 0.47 | 13.75 | 11.50 | N/A | ||||||||||||||||||
July
|
69.80 | 61.24 | N/A | 15.15 | 11.60 | N/A |
(1)
|
Based
on the bid prices per PartnerRe common share and Paris Re common share, as
reported on the New York Stock Exchange and the Euronext Paris, as
applicable.
|
(2)
|
Although
Paris Re has not made distributions to its shareholders in the form of
dividends for the periods indicated, two distributions to shareholders
have been made in the form of share capital reductions: on July 11, 2008,
Paris Re completed a
|
Paris
Re
Common
Shares
|
PartnerRe
Common
Shares
|
Equivalent
Price per
Paris
Re
Common
Share(1)
|
||||||||||||||||||
€
|
USD
|
USD
|
€ | USD | ||||||||||||||||
July
2, 2009
|
11.60 | 16.26 | 64.60 | 17.68 | 23.23 | |||||||||||||||
, 2009
|
(1)
|
The
equivalent price per Paris Re common share amounts are calculated by
multiplying the closing sale price of PartnerRe common shares on those
dates by the exchange ratio in the transactions of 0.300 PartnerRe common
shares for each Paris Re common share (assuming the base case assumptions
described under “The Transactions—Ownership of PartnerRe Following the
Transactions”) and adding the $3.85 per Paris Re common share
(representing the U.S. dollar equivalent of CHF 4.17 as of July 7, 2009)
cash consideration.
|
Historical
|
Pro
Forma
|
|||||||||||||||
PartnerRe
|
Paris
Re(1)
|
Combined
|
Paris
Re Equivalent(2)
|
|||||||||||||
Basic
net income per common share:
|
||||||||||||||||
Quarter
ended March 31, 2009
|
$ | 2.35 | $ | 1.56 | $ | 3.12 | $ | 0.94 | ||||||||
Year
ended December 31, 2008
|
$ | 0.22 | $ | 0.26 | $ | 0.30 | $ | 0.09 | ||||||||
Diluted
net income per common share:
|
||||||||||||||||
Quarter
ended March 31, 2009
|
$ | 2.32 | $ | 1.55 | $ | 3.09 | $ | 0.93 | ||||||||
Year
ended December 31, 2008
|
$ | 0.22 | $ | 0.26 | $ | 0.29 | $ | 0.09 | ||||||||
Cash
dividends declared per common share:
|
||||||||||||||||
Quarter
ended March 31, 2009
|
$ | 0.47 | N/A | $ | 0.47 | $ | 0.14 | |||||||||
Year
ended December 31, 2008
|
$ | 1.84 | N/A | $ | 1.84 | $ | 0.55 | |||||||||
Book value per common
share:
|
||||||||||||||||
At
March 31, 2009(3)
|
$ | 66.49 | $ | 23.74 | $ | 67.10 | $ | 23.98 | ||||||||
Diluted book value per common
share:
|
||||||||||||||||
At
March 31, 2009(3)
|
$ | 65.55 | $ | 23.62 | $ | 66.41 | $ | 23.77 | ||||||||
(1)
|
Paris
Re’s per share amounts have been prepared on the basis of IFRS, as
adjusted by Paris Re for certain differences between IFRS and U.S.
GAAP. See “Unaudited Pro Forma Condensed Combined Financial
Information.”
|
(2)
|
The
Paris Re equivalent pro forma share amounts are calculated by multiplying
the pro forma combined PartnerRe and Paris Re share amounts by the
exchange ratio in the transactions of 0.300 PartnerRe common shares for
each Paris Re common share, assuming the base case assumptions described
under “The Transactions—Ownership of PartnerRe Following the
Transactions.”
|
(3)
|
For
purposes of calculating the equivalent Paris Re book value per common
share, the $3.85 per Paris Re common share (representing the U.S. dollar
equivalent of CHF 4.17 as of July 7, 2009) cash consideration is added to
the equivalent per share amounts.
|
|
·
|
the
frequency and the severity of natural or man-made catastrophic
events;
|
|
·
|
the
levels of market capacity and demand for
reinsurance;
|
|
·
|
price
competition;
|
|
·
|
general
economic conditions; and
|
|
·
|
changes
in legislation, case law and prevailing concepts of
liability.
|
|
·
|
current
and prospective employees may experience uncertainty about their future
roles with the combined entity, which might adversely affect PartnerRe’s
and Paris Re’s ability to retain or attract key managers and other
employees;
|
|
·
|
subject
to the terms of their contracts, current and prospective customers of
PartnerRe or Paris Re may choose to discontinue purchasing from either
company or choose another supplier;
and
|
|
·
|
the
attention of management of each of PartnerRe and Paris Re may be diverted
from the operation of the businesses toward the completion of the
transactions.
|
|
·
|
to
consider and vote upon the proposal to issue PartnerRe common shares and
securities exercisable or exchangeable for PartnerRe common shares to the
holders of Paris Re securities in connection with the transactions, which
proposal we refer to as the “share issuance
proposal;”
|
|
·
|
to
consider and vote upon the proposal to increase the size of the board of
directors of PartnerRe from 11 to 12 which proposal we refer to as the
“board size proposal;”
|
|
·
|
to
consider and vote upon the proposal to amend the 2005 employee
equity plan to increase the shares available for issuance and to increase
the number of shares that may be awarded as restricted shares or
restricted share units, which proposal we refer to as the “equity plan
proposal;” and
|
|
·
|
to
transact such other business as may properly come before the meeting or
any properly reconvened meeting following an adjournment or postponement
thereof.
|
|
·
|
Share Issuance Proposal and
Equity Plan Proposal. New York Stock Exchange rules
impose special requirements that must be met for PartnerRe’s shareholders
to approve the share issuance proposal and the equity plan
proposal. The total number of votes cast at the special general
meeting must represent over 50% of the PartnerRe common shares entitled to
vote as of the record date, which requirement we refer to as the “‘vote
cast’ quorum requirement.” The failure of a shareholder to
submit a proxy or to attend the special general meeting will result in
that shareholder’s vote not being “cast,” making it less likely that the
“vote cast” quorum requirement will be met. If a shareholder
who has submitted a proxy or attended the meeting abstains from voting,
this will be treated as a “vote cast,” making it more likely that the
“vote cast” quorum requirement will be met. Assuming that the
“vote cast” quorum requirement is met, the share issuance proposal and the
equity plan proposal will each pass only if a majority of votes cast are
in favor of that proposal. If a shareholder who has submitted a
proxy or attended the meeting abstains from voting, this will be treated
as a “vote cast,” but not in favor of the proposal, making it less likely
that the required majority will be achieved. If on the other
hand a shareholder fails to submit a proxy or to attend the special
|
|
·
|
Board Size
Proposal. In order for PartnerRe’s shareholders to
approve the board size proposal, the holders of at least 25% of the
outstanding common shares as of the record date must be present at the
special general meeting, in person or by proxy. This
constitutes a quorum for the purposes of the board size
proposal. The failure of a shareholder to submit a proxy or to
attend the special general meeting will result in that shareholder not
being counted toward the quorum, making it less likely that the board size
proposal can be approved. If a shareholder who has properly
submitted a proxy or attended the meeting abstains from voting, the
shareholder will still be treated as present for the purposes of counting
the quorum. Assuming that the quorum requirement is met, the
board size proposal will be decided by a simple majority of votes
cast. If a shareholder fails to submit a proxy or attend the
special general meeting, or abstains from voting, this will result in the
shareholders’ vote not being “cast” and so will not affect the
determination of whether a majority has voted for the
proposals.
|
|
·
|
each
block seller and each post-announcement seller will receive the remaining
per share portion of the share capital repayment in the form of a
promissory note issued by PartnerRe at the closing of the block purchase
(for an explanation of the terms of the promissory notes, see “The Block
Purchase Agreement—Purchase and Sale” and “The Post-Announcement Purchase
Agreements—Purchase and Sale”); and
|
|
·
|
each
other holder of Paris Re common shares that holds Paris Re common shares
on the relevant record date occurring shortly prior to the settlement of
the exchange offer (including PartnerRe with respect to the Paris Re
common shares owned by PartnerRe and its subsidiaries at that time) will
receive the remaining per share portion in the form of cash by way of a
capital distribution from Paris Re immediately prior to the settlement of
the exchange offer. The cash payment, however, will only be
paid if the exchange offer is settled. See “The Transaction
Agreement—Certain Covenants—Share Capital
Repayment.”
|
|
·
|
upwards
if the percentage decline in PartnerRe’s tangible book value per share
from March 31, 2009 to the measurement date is greater than that of Paris
Re’s; or
|
|
·
|
downwards
if the percentage decline in Paris Re’s tangible book value per share from
March 31, 2009 to the measurement date is greater than that of
PartnerRe’s.
|
|
·
|
from
July 4, 2009, when there were 80.6 million Paris Re common shares
outstanding (net of treasury shares), until the completion of the
transactions, no additional Paris Re common shares will be issued
(including upon the exercise or conversion of options, restricted share
units, warrants or other securities exercisable, convertible or
exchangeable for Paris Re common
shares);
|
|
·
|
from
July 4, 2009, when there were 56.7 million PartnerRe common shares
outstanding (net of treasury shares), until the completion of the
transactions, except for issuances in connection with the transactions, no
additional PartnerRe common shares will be issued (including upon the
exercise or conversion of options, restricted share units, warrants or
other securities exercisable, convertible or exchangeable for PartnerRe
common shares);
|
|
·
|
PartnerRe
will acquire 100% of the outstanding Paris Re common shares and Paris Re
warrants in the transactions;
|
|
·
|
no
adjustment will be made to the per share consideration and per warrant
consideration pursuant to the tangible book value adjustment;
and
|
|
·
|
PartnerRe
will not declare any dividends on the PartnerRe common shares with a
record date between the closing of the block purchase and the exchange
offer and, as a result, no adjustment will be made to the per share
consideration pursuant to the post-block purchase closing dividend
adjustment.
|
|
·
|
in
addition to the PartnerRe common shares issued in connection with the
transactions, additional Paris Re common shares or PartnerRe common shares
are issued prior to the completion of the transactions (including upon the
exercise or conversion of options, restricted share units, warrants or
other securities exercisable, convertible or exchangeable for Paris Re
common shares or PartnerRe common shares), in each case, in accordance
with the limitations set forth in the transaction
agreement;
|
|
·
|
PartnerRe
acquires less than all of the outstanding Paris Re warrants in the
transactions;
|
|
·
|
the
per share consideration and per warrant consideration are adjusted upwards
or downwards pursuant to the tangible book value per share adjustment;
or
|
|
·
|
for
purposes of the post-block purchase closing dividend adjustment, PartnerRe
declares one or more dividends on the PartnerRe common shares with a
record date between the closing of the block purchase and the exchange
offer, in which case the increase in the number of PartnerRe common shares
issued will be determined based on the formula described under “The
Transactions—Post-Block Purchase Closing
|
|
·
|
a
three-step transaction, beginning with the initial purchase of 57.5% of
the outstanding Paris Re common shares from certain private equity
shareholders, followed by an exchange offer and a compulsory
merger;
|
|
·
|
a
purchase price of 0.300 PartnerRe common shares for each Paris Re common
share;
|
|
·
|
a
purchase price of 0.167 PartnerRe common shares for each Paris Re
warrant;
|
|
·
|
a
$3.85 per share extraordinary cash distribution to be paid to all Paris Re
shareholders immediately prior to the initial
purchase;
|
|
·
|
investor
agreements that would, among other things, restrict the purchase and sale
of PartnerRe common shares by the private equity shareholders
participating in the initial purchase;
and
|
|
·
|
the
possibility that the private equity shareholders participating in the
initial purchase would be granted registration rights should sales under
Rule 144 of the Securities Act of 1933 be unavailable to
them.
|
|
·
|
The
opportunity to acquire a high quality balance sheet at approximately book
value, together with Paris Re’s seasoned book of business and experienced
staff.
|
|
·
|
The
enhanced size and scope of the combined entity (with the acquisition
adding approximately $1.7 billion to PartnerRe’s shareholders’ equity),
which, while not a necessity to PartnerRe’s business or the effective
execution of its strategy, should lead to improved financial strength, an
improved ability to manage capital across its portfolio and flexibility in
deploying capital.
|
|
·
|
The
expectation that the larger capital base of the combined entity will give
PartnerRe the ability to provide clients with greater capacity, larger
lines and a broader range of products and services and that the combined
entity’s enhanced stability will give PartnerRe the ability to more
consistently make capacity available to its
clients.
|
|
·
|
The
fact that the acquisition is expected to diversify risk and provide more
balance and stability to, and opportunities for, PartnerRe at a critical
time when financial and reinsurance markets are uncertain and
volatile. In particular, the integration of Paris Re should
enhance PartnerRe’s market presence, capital base and financial
flexibility, risk diversification, capital strength and scale, and should
reduce volatility of earnings, all of which should permit PartnerRe to
deliver more stable results under a wider range of market conditions and
economic environments.
|
|
·
|
The
complementary nature of PartnerRe’s and Paris Re’s businesses, in
particular the increased market position of the combined operations from
emerging markets and non-proportional and facultative risk
segments.
|
|
·
|
In
the view of PartnerRe’s board of directors, while the combined entity will
be larger, the acquisition will not be so large as to change the PartnerRe
strategy, philosophy and culture, stability in executive management, risk
management culture and enterprise risk management
framework.
|
|
·
|
The
due diligence reviews of Paris Re’s assets, liabilities, book of business,
staff, operating structure and other commitments and contingencies
performed by PartnerRe, with the assistance of its advisors and with the
full engagement of Paris Re’s senior management as well as its financial,
legal, accounting, tax and human resource professionals. The
due diligence culminated in the determination that the acquisition of
Paris Re satisfies PartnerRe’s acquisition criteria, given
that:
|
|
–
|
Paris
Re represents the appropriate size in terms of capital, business and staff
to present a manageable integration process with low to moderate
risk;
|
|
–
|
Paris
Re and PartnerRe have compatible cultures, which will help ease the
process of integrating the two
companies;
|
|
–
|
Paris
Re has a high quality and liquid asset portfolio, comprised of tradable
fixed income securities with an average overall Standard & Poor’s
rating of AA-;
|
|
–
|
Paris
Re’s book of business is almost entirely reinsurance—a business that
PartnerRe understands thoroughly, since it is also PartnerRe’s
business—and does not contain material amounts of direct insurance or
other business lines; and
|
|
–
|
Paris
Re has a generally short tail book of business, large book of facultative
business, high concentration of non-proportional business and meaningful
business in emerging markets, all of which should enhance PartnerRe’s
business mix and create a more stable book of
business.
|
|
·
|
The
PartnerRe board of directors’ assessment that Paris Re has a high-quality
balance sheet and no debt.
|
|
·
|
The
fact that Paris Re’s reserves are guaranteed by AXA and
Colisée Re for losses incurred before January 1, 2006 in connection
with the 2006 acquisition.
|
|
·
|
The
scope, experience and expertise of the Paris Re employees and the finding
by PartnerRe’s senior management that they will bring long-standing
industry knowledge and relationships to the combined
organization.
|
|
·
|
The
agreement of Mr. Hans-Peter Gerhardt, the chief executive officer of Paris
Re, to remain employed with PartnerRe through June
2010.
|
|
·
|
The
fact that the exchange ratio of 0.30 PartnerRe common shares for each
outstanding Paris Re common share was the result of negotiations between
PartnerRe, on the one hand, and Paris Re and the block sellers, on the
other hand, as described under “Background to the
Transactions.”
|
|
·
|
The
opinion of UBS, dated July 4, 2009, to PartnerRe’s board of directors as
to the fairness, from a financial point of view to PartnerRe and based
upon and subject to various assumptions, matters considered and
limitations described in the opinion, of the aggregate consideration to be
paid by PartnerRe in the block purchase, the exchange offer and the merger
(taken together as integrated transactions), as more fully described in
“The Transactions—Opinion of UBS Securities
LLC.”
|
|
·
|
The
PartnerRe board of directors’ view that the tangible book value per share
adjustment described under “The Transactions—Tangible Book Value Per Share
Adjustment and Termination Right,” including
the
|
|
·
|
The
fact that the block sellers may not terminate the block purchase agreement
in the face of a competing proposal, Paris Re must present matters
requiring Paris Re shareholder approval for consideration to its
shareholders, the block sellers must vote in favor of such matters and
Paris Re is restricted from soliciting third-party acquisition proposals,
all of which reduce the risks associated with completing the acquisition,
including interloper risk (i.e., the risk that a
competitor would emerge seeking to acquire Paris Re and/or interfere with
the transactions between Paris Re and
PartnerRe).
|
|
·
|
The
fact that the acquisition of Paris Re is subject to the approval of
PartnerRe’s shareholders and that the transaction documents allow the
PartnerRe board of directors to change or withdraw its recommendation in
favor of the transactions, subject to certain limitations, and, in certain
circumstances, the payment of a termination
fee.
|
|
·
|
The
PartnerRe board of directors’ determination that the $75 million
termination fee payable upon either the PartnerRe board of directors
withdrawing or changing its recommendation or the PartnerRe shareholders
failing to approve the transactions is reasonable in light of the
uncertainties posed to Paris Re and its shareholders by the PartnerRe
shareholder approval condition.
|
|
·
|
The
covenants to the transaction agreement requiring PartnerRe to use
reasonable best efforts to obtain certain regulatory approvals and
clearances, provided that such approvals and clearances do not impose a
“burdensome condition” (for an explanation of the term “burdensome
condition,” see “The Transaction Agreement—Certain Covenants—Reasonable
Best Efforts Covenant”).
|
|
·
|
The
requirement that Paris Re operate its business pending the effective time
of the merger in the ordinary course of business consistent with past
practices and within previously established and communicated risk
management guidelines, which should provide PartnerRe protection during
this interim period, while at the same time providing Paris Re sufficient
operating latitude to conduct its
business.
|
|
·
|
The
fact that no financing is required for the transaction, which increases
the likelihood that the transactions will be
consummated.
|
|
·
|
PartnerRe’s
board of directors’ belief, after consultation with its internal and
outside legal counsel, that the transactions are likely to receive
necessary regulatory approvals in a relatively timely manner without
material adverse conditions, which increases the likelihood the
transactions will be consummated.
|
|
·
|
The
expectation of PartnerRe’s board of directors that the integration will be
completed in a timely and efficient manner with minimal disruption to
clients and employees in accordance with PartnerRe’s history of successful
European acquisitions.
|
|
·
|
The
fact that current PartnerRe shareholders will hold approximately 68.9% of
the outstanding PartnerRe common shares upon completion of the
transactions in their entirety based on the base case assumptions
described under “The Transactions—Ownership of PartnerRe Following the
Transactions.”
|
|
·
|
The
fact that steps were taken in the transaction to ensure that no
shareholder constituency will have undue influence over the combined
entity after the consummation of the transactions, including by requiring
that the block sellers abide by certain transfer restrictions, vote
neutralization provisions and standstill limitations following the closing
of the block purchase.
|
|
·
|
The
possibility that the AMF may not approve the exchange offer or may impose
conditions upon PartnerRe, such as a requirement that PartnerRe provide
Paris Re shareholders with an all-cash alternative to the exchange
offer.
|
|
·
|
The
risk that the French independent expert may not render an opinion that the
exchange offer is fair to Paris Re’s
shareholders.
|
|
·
|
The
possibility that PartnerRe may not be able to obtain a listing on Euronext
Paris in a timely manner, or at
all.
|
|
·
|
If
PartnerRe does not own at least 90% of the outstanding Paris Re shares
following the settlement of the exchange offer, there can be no assurance
if or when the merger will occur. This risk is heightened by
the fact that, subject to compliance with certain obligations under the
transaction documents, the Paris Re board of directors may change its
recommendation to the Paris Re shareholders, which could discourage Paris
Re shareholders from tendering in the exchange
offer.
|
|
·
|
The
risk that if the share capital repayment is not paid in full immediately
prior to the closing of the block purchase due to, among other things, the
failure of Paris Re to obtain the required regulatory approvals, PartnerRe
may be obligated to fund the payment by Paris Re of the share capital
repayment (or remaining portion thereof) through the use of its (as
opposed to Paris Re’s) available
cash.
|
|
·
|
The
facts that (i) the number of PartnerRe common shares to be issued in the
transactions is uncertain because the transaction documents provide for
certain adjustments to per share consideration and per warrant
consideration as described under “The Transactions—Ownership of PartnerRe
Following the Transactions,” and (ii) the per share or warrant value of
the consideration to be paid to Paris Re shareholders in connection with
the transactions could be significantly more than the per share or warrant
value of the consideration immediately prior to the announcement of the
transactions.
|
|
·
|
The
risks and costs to PartnerRe if any or all of the transactions are not
completed (other than due to a significant disproportionate decline in
Paris Re’s tangible book value per share), including the potential effect of the
resulting public announcement of termination of the transaction documents
on, among other things, the market price for PartnerRe common shares, its
operating results, its ability to attract and retain key personnel and its
ability to complete an alternative
transaction.
|
|
·
|
The
fact that if the block purchase is not consummated, there might not be an
active or liquid public trading market for the approximately 6.1% of the
outstanding Paris Re common shares that PartnerRe acquired at a premium to
the then-current market price in anticipation of completing the
transactions, which could have an adverse effect on the market price for
or ability of PartnerRe to sell such common
shares.
|
|
·
|
The
challenges of combining Paris Re’s business with PartnerRe’s, including
technical, accounting and other challenges, and the risk of diverting
management resources for an extended period of time to accomplish this
combination.
|
|
·
|
The
loss of service of key members of Paris Re’s senior management or other
key personnel could delay or prevent the combined entity from fully
implementing its business strategy and, consequently, significantly and
negatively affect its business.
|
|
·
|
If
the transactions take longer to complete than anticipated or, if the block
purchase closes but PartnerRe does not complete the remaining
transactions, PartnerRe may not be able to fully integrate Paris Re’s
operations as quickly as expected or at
all.
|
|
·
|
In
analyzing the value of Paris Re’s business, PartnerRe has ascribed
significant value to the continued effectiveness of a number of Paris Re’s
existing contractual arrangements, including certain commutation
agreements and guarantees, and if the benefits from these arrangements are
less than expected (including as a result of these arrangements being
determined to be unenforceable in whole or in part), the benefits of the
transaction to PartnerRe may be significantly less than
anticipated.
|
|
·
|
Notwithstanding
the standstill restrictions and vote neutralization provisions contained
in the investor agreements, the block sellers may have the ability, with
their approximately 18.6% ownership interest in PartnerRe following the
completion of the transactions, to influence matters requiring PartnerRe
shareholder approvals, including the election of directors and approval of
significant corporate transactions.
|
|
·
|
The
fact that two of the four major ratings agencies, while affirming
PartnerRe’s financial strength ratings, revised PartnerRe’s rating outlook
to negative from stable due to, among other things, some concern regarding
integration risks (including PartnerRe’s ability to integrate the culture
and risk management cultures of both organizations) as well as potential
earnings dilution and treaty overlap risks. While it is
expected that PartnerRe’s ratings would remain comparable to many of its
peers notwithstanding any rating downgrade, a future significant ratings
downgrade could lead to modification of certain contracts or make it more
difficult for PartnerRe to obtain new
business.
|
|
·
|
The
block sellers or other significant shareholders who obtained PartnerRe
common shares through the transactions may liquidate their shares in such
a manner as to temporarily depress PartnerRe’s share
price.
|
|
·
|
Until
the closing of the block purchase, Paris Re will operate in accordance
with its own distinct business practices. As a result, Paris Re
may assume risks or make decisions that, while consistent with its own
past practice, may not be the same as PartnerRe’s approach to its
business. While the specifically negotiated contractual
provisions requiring that Paris Re operate its business during the interim
period in the ordinary course of business consistent with past practices
and the tangible book value per share adjustment mitigate PartnerRe’s
exposure to some degree, these risks are not eliminated and will only
become more acute the more prolonged the delay in closing the block
purchase.
|
|
·
|
Opportunities
for a business combination could become available in the future that might
permit PartnerRe to increase its scale on more favorable terms than the
terms of the transactions.
|
|
·
|
The
risks described in this proxy statement under “Risk
Factors.”
|
|
·
|
reviewed
certain publicly available business and financial information relating to
PartnerRe and
Paris Re;
|
|
·
|
reviewed
certain internal financial information and other data relating to the
business and financial prospects of Paris Re that were not publicly
available, including financial forecasts and estimates prepared by Paris
Re’s management as adjusted by PartnerRe’s management that PartnerRe’s
board of directors directed UBS to utilize for purposes of its
analysis;
|
|
·
|
reviewed
certain internal financial information and other data relating to the
business and financial prospects of PartnerRe that were not publicly
available, including financial forecasts and estimates, both with and
without giving effect to the block purchase, the exchange offer and the
merger, prepared by PartnerRe’s management that PartnerRe’s board of
directors directed UBS to utilize for purposes of its analysis, which, in
the case of forecasts and estimates giving effect to the block purchase,
the exchange offer and the merger, reflect certain estimates of net
synergies;
|
|
·
|
conducted
discussions with members of the senior managements of PartnerRe and Paris
Re concerning the businesses and financial prospects of PartnerRe and
Paris Re;
|
|
·
|
reviewed
publicly available financial and stock market data with respect to certain
other companies UBS believed to be generally
relevant;
|
|
·
|
compared
the financial terms of the block purchase, the exchange offer and the
merger with the publicly available financial terms of certain other
transactions UBS believed to be generally
relevant;
|
|
·
|
reviewed
current and historical market prices of PartnerRe common shares and Paris
Re common shares;
|
|
·
|
considered
certain pro forma effects of the block purchase, the exchange offer and
the merger on PartnerRe’s financial
statements;
|
|
·
|
reviewed
drafts, each dated July 3, 2009, of the block purchase agreement and the
transaction agreement; and
|
|
·
|
conducted
such other financial studies, analyses and investigations, and considered
such other information, as UBS deemed necessary or
appropriate.
|
· Allied World Assurance Company Holdings,
Ltd
|
· Arch Capital Group
Ltd.
|
· Aspen Insurance Holdings
Limited
|
· Axis Capital Holdings
Limited
|
· Endurance Specialty Holdings
Ltd.
|
· Everest Re Group, Ltd.
|
· Flagstone Reinsurance Holdings
Limited
|
· Greenlight Capital Re,
Ltd.
|
· IPC Holdings, Ltd.
|
· Max Capital Group Ltd.
|
· Montpelier Re Holdings
Ltd.
|
· PartnerRe Ltd.
|
· Platinum Underwriters Holdings,
Ltd.
|
· RenaissanceRe Holdings
Ltd.
|
· SCOR SE
|
· Transatlantic Holdings,
Inc.
|
· Validus Holdings,
Ltd.
|
Implied
Multiples for Selected Companies
|
Implied
Multiples for Paris Re Based on Closing Share Price on July 2,
2009
|
Implied
Multiples for Paris Re Based on Implied Per Share Transaction
Value
|
|||||||||||||
Low
|
Mean
|
Median
|
High
|
Wall
Street Consensus
|
Management
|
Wall
Street Consensus
|
Management
|
||||||||
Share
Price as Multiple of:
|
|||||||||||||||
2009E
EPS
|
4.9x
|
6.2x
|
6.1x
|
8.1x
|
6.7x
|
5.9x
|
10.2x
|
9.0x
|
|||||||
2010E
EPS
|
4.3x
|
5.8x
|
5.8x
|
6.8x
|
6.8x
|
5.3x
|
10.8x
|
8.0x
|
|||||||
2011E
EPS
|
3.2x
|
5.5x
|
5.9x
|
6.7x
|
7.2x
|
4.8x
|
10.7x
|
7.3x
|
|||||||
Diluted
Book Value Per Share
|
0.77x
|
0.90x
|
0.84x
|
1.23x
|
0.65x
|
0.65x
|
0.97x
|
0.97x
|
|||||||
Diluted
Tangible Book Value Per Share
|
0.78x
|
0.95x
|
0.89x
|
1.23x
|
0.70x
|
0.70x
|
1.04x
|
1.04x
|
Announcement
Date
|
Acquiror
|
Target
|
||
·
03/31/09
|
·
Validus Holdings, Ltd.
|
·
IPC Holdings, Ltd.
|
||
·
08/05/08
|
·
Tower Group, Inc.
|
·
CastlePoint Holdings, Ltd.
|
||
·
12/14/07
|
·
Tokio Marine & Nichido Fire Insurance Co., Ltd.
|
·
Kiln Ltd.
|
||
·
05/24/07
|
·
RSA Overseas Holdings B.V.
|
·
Codan A/S
|
||
·
02/19/07
|
·
SCOR SE
|
·
Converium Holding AG
|
||
·
06/25/06
|
·
Assicurazioni Generali S.p.A.
|
·
Toro Assicurazioni S.p.A.
|
||
·
01/31/00
|
·
Markel Corporation
|
·
Terra Nova (Bermuda) Holdings Ltd.
|
||
·
12/19/99
|
·
Trenwick Group Inc.
|
·
LaSalle Re Holdings Limited
|
||
·
06/21/99
|
·
Trenwick Group Inc.
|
·
Chartwell Re Corporation
|
||
·
05/27/99
|
·
Ace Limited
|
·
Capital Re Corporation
|
||
·
02/15/99
|
·
XL Capital Ltd
|
·
NAC Re Corp.
|
Implied
Multiples
for
Selected Transactions
|
Implied
Multiples for Paris Re Based on Implied Transaction
Value
|
||||||||
Transaction
Value as Multiple of:
|
Low
|
Mean
|
Median
|
High
|
|||||
Latest
12 Months Operating Earnings
|
8.4x
|
11.5x
|
10.8x
|
17.4x
|
13.3x
|
||||
Book
Value
|
0.80x
|
1.31x
|
1.36x
|
2.55x
|
0.97x
|
||||
Tangible
Book Value
|
0.87x
|
1.52x
|
1.37x
|
3.10x
|
1.04x
|
Implied
Multiples for Selected Companies
|
Implied
Multiples for PartnerRe Based on Closing Share Price on July 2,
2009
|
|||||||||||
Low
|
Mean
|
Median
|
High
|
Wall
Street Consensus
|
Management
|
|||||||
Share
Price as Multiple of:
|
||||||||||||
2009E
EPS
|
4.9x
|
6.2x
|
6.1x
|
8.1x
|
6.6x
|
7.0x
|
||||||
2010E
EPS
|
4.3x
|
5.8x
|
5.8x
|
6.8x
|
6.6x
|
6.4x
|
||||||
2011E
EPS
|
3.2x
|
5.5x
|
5.9x
|
6.7x
|
6.7x
|
6.0x
|
||||||
Diluted
Book Value Per Share
|
0.77x
|
0.90x
|
0.84x
|
1.23x
|
1.00x
|
1.00x
|
||||||
Diluted
Tangible Book Value Per Share
|
0.78x
|
0.95x
|
0.89x
|
1.23x
|
1.13x
|
1.13x
|
|
·
|
approximately
$ in financial, legal, accounting and tax
advisory fees;
|
|
·
|
approximately
$ in SEC filing
fees;
|
|
·
|
approximately
$ in printing, solicitation and mailing
expenses associated with this proxy statement;
and
|
|
·
|
approximately
$ in miscellaneous
expenses.
|
|
·
|
the
approval and adoption of the share capital repayment by Paris Re’s
shareholders and the payment of the share capital repayment immediately
prior to the block purchase (See “The Transaction Agreement—Certain
Covenants—Share Capital Repayment”);
and
|
|
·
|
the
approval and declared effectiveness of the amendment to Paris Re’s
articles of incorporation to remove a provision thereof purporting to
require a cash takeover bid for any acquisition of more than one-third of
the Paris Re voting rights and to reduce the minimum number of the
directors on the Paris Re board of directors from 10 to
six.
|
|
·
|
enter
into an agreement with any third party for the purchase and sale of any
Paris Re common shares and Paris Re warrants that are the subject of the
block purchase agreement;
|
|
·
|
vote
in favor of any proposal presented to the Paris Re shareholders that, if
approved, would be inconsistent with, or could otherwise be expected to
impede, interfere with, prevent or materially delay, or dilute materially
the benefits to PartnerRe of, the transactions contemplated by the block
purchase agreement and the transaction
agreement;
|
|
·
|
solicit,
initiate or take any action to facilitate or encourage the submission of
any acquisition proposal relating to Paris Re (for an explanation of the
term “acquisition proposal” as it relates to Paris Re, see “The
Transaction Agreement—Certain Covenants—No
Solicitation”);
|
|
·
|
enter
into or participate in any discussions or negotiations with or furnish any
information relating to Paris Re or any of its subsidiaries or knowingly
assist or encourage any third party seeking to make or who has made an
“acquisition proposal” relating to Paris Re;
or
|
|
·
|
enter
into any agreement in principle, letter of intent, term sheet or other
similar instrument relating to an “acquisition proposal” relating to Paris
Re.
|
|
·
|
absence
of any law, rule, order, injunction or judgment prohibiting or preventing
the completion of the block purchase, the exchange offer or the
merger;
|
|
·
|
expiration
or termination of the waiting period (or extensions thereof) under the HSR
Act and expiration, termination or receipt of any applicable waiting
period (or extensions thereof) or approval under applicable foreign
antitrust law, in each case, without the imposition of a “burdensome
condition.” (For an explanation of the term “burdensome condition,” see
“The Transaction Agreement—Certain Covenants—Reasonable Best Efforts
Covenant”);
|
|
·
|
receipt
of all approvals from, making all filings and notifications to and taking
all other actions by or in respect of any insurance authority required in
connection with the block purchase, the exchange offer and the merger
without the imposition of any “burdensome
condition;”
|
|
·
|
receipt
of all approvals from, making all filings and notifications to and taking
all other actions by or in respect of any governmental authority (other
than those referred to in the two immediately preceding bullet points)
without the imposition of a “burdensome
condition;”
|
|
·
|
approval
for the listing of the PartnerRe common shares on a European Union stock
exchange selected by PartnerRe in accordance with the transaction
agreement or, in PartnerRe’s reasonable judgment, such listing is
reasonably expected to occur prior to the settlement of the exchange
offer;
|
|
·
|
approval
for the listing on the New York Stock Exchange of the PartnerRe common
shares to be issued in the block
purchase;
|
|
·
|
PartnerRe’s
registration statement on Form S-4, if required, to be filed in connection
with the exchange offer being declared effective (or, in PartnerRe’s
reasonable judgment, no reasonable basis to believe that the Form S-4 will
not be declared effective prior to the settlement of the exchange offer),
and absence of any SEC stop order suspending (or threatening to suspend)
the effectiveness;
|
|
·
|
approval
by the Paris Re shareholders of the “Paris Re shareholder proposals”
described under “Transaction Agreement— Certain Covenants—Paris Re
Covenant to Recommend and Call Shareholders Meetings” and approval by the
PartnerRe shareholders of the “PartnerRe shareholder proposals” described
under “Transaction Agreement— Certain Covenants—PartnerRe Covenant to
Recommend and Call Shareholders Meeting;”
and
|
|
·
|
receipt
of exemptive and no-action relief from the SEC, if necessary, permitting
PartnerRe to settle the exchange offer in accordance with the French
tender offer rules.
|
|
·
|
the
performance in all material respects by each block seller and Paris Re of
their obligations under the block purchase agreement and transaction
agreement required to be performed by it prior to the closing of the block
purchase;
|
|
·
|
the
representations and warranties made by each block seller and Paris Re in
the block purchase agreement and the transaction agreement (disregarding
all materiality and material adverse effect qualifications) being true and
correct as of the date of the block purchase closing as if made at and as
of such time (other than representations and warranties that by their
terms address matters only as of another specified time, which must be
true only as of such time), except where the failure of any of the
representations and warranties (other than those pertaining to existence
and power, authorization, ownership of Paris Re shares, investment
purpose, capitalization, subsidiaries and the effectiveness of the AXA
and
Colisée Re guarantee of
Paris
|
|
·
|
the
delivery by each block seller and Paris Re of an officer’s certificate
certifying that the two immediately preceding conditions applicable to it
have been satisfied;
|
|
·
|
execution
and delivery by each block seller of an investor agreement and a block
seller registration rights
agreement;
|
|
·
|
receipt
of evidence that, immediately following the closing of the block purchase,
the individuals designated by PartnerRe to Paris Re’s board of directors
will comprise a majority of Paris Re’s board of directors;
and
|
|
·
|
effectiveness
of the amendments to Paris Re’s articles of incorporation described under
“The Transaction Agreement— Certain Covenants—Paris Re Covenant to
Recommend and Call Shareholder
Meetings.”
|
|
·
|
the
performance in all material respects by PartnerRe of its obligations under
the block purchase agreement and the transaction agreement required to be
performed by it prior to the closing of the block
purchase;
|
|
·
|
the
representations and warranties made by PartnerRe in the block purchase
agreement and the transaction agreement (disregarding all materiality and
material adverse effect qualifications) must be true and correct as of the
date of the block purchase closing as if made at and as of such time
(other than representations and warranties that by their terms address
matters only as of another specified time, which must be true only as of
such time), except where the failure of any of the representations and
warranties (other than those pertaining to existence and power,
authorization, valid issuance of PartnerRe common shares, investment
purpose, capitalization and subsidiaries) to be so true and correct would
not reasonably be expected to have a material adverse effect on
PartnerRe;
|
|
·
|
the
delivery by PartnerRe of an officer’s certificate certifying that the two
immediately preceding conditions have been satisfied;
and
|
|
·
|
execution
and delivery by PartnerRe to each block seller of an investor agreement
and a block seller registration rights
agreement.
|
|
·
|
by
mutual written agreement of the block sellers and
PartnerRe;
|
|
·
|
by
either any block seller or PartnerRe if the closing of the block purchase
has not occurred on or before March 15, 2010, subject to automatic
extension until 10 business days after the date on which the “adjustment
amount” is finally determined if Paris Re or PartnerRe exercises its right
to designate a “deferred delivery date” and the date on which the
“adjustment amount” is finally determined does not occur at least 10
business days prior to March 15, 2010 (except that this right to terminate
the block purchase agreement will not be available to any party whose
breach of any provision of the block purchase agreement results in the
failure of the closing of the block purchase to occur by such
time). See “The Transaction Agreement—Tangible Book Value Per
Share Adjustment” for an explanation of the “adjustment amount,” the
“deferred date” and the related tangible book value adjustment per share
more generally;
|
|
·
|
by
either any block seller or PartnerRe if the transaction agreement has been
terminated;
|
|
·
|
by
either any block seller or PartnerRe if there is any applicable law that
makes consummation of the transactions illegal or otherwise prohibited or
if consummation of the transactions would violate any nonappealable final
order, decree or judgment of any governmental authority having competent
jurisdiction (except that this right to terminate the block purchase
agreement will not be available to any party whose failure to comply in
any material respect with any provision of the block purchase agreement
has been the direct cause of, or resulted directly in, such action);
and
|
|
·
|
by
either any block seller or PartnerRe if the other party (including in the
case of PartnerRe, the acquisition subsidiary) has breached any of its
covenants or agreements or any of its representations and warranties set
forth in the block purchase agreement or transaction agreement which
would, if occurring at the closing of the block purchase, result in the
failure of a closing condition to the terminating party’s obligations and
which breach is not cured within 30 days following written notice thereof
or, by its nature, cannot be cured within 30 days (except that this right
to terminate the block purchase agreement will not be available to any
party who is then in material breach of its obligations under the block
purchase agreement or the transaction
agreement).
|
|
·
|
the
transaction agreement having not been previously
terminated;
|
|
·
|
the
absence of any law, rule, order, injunction or judgment prohibiting or
preventing the completion of the exchange offer or the
merger;
|
|
·
|
the
approval for listing of the PartnerRe common shares on a European Union
stock exchange selected by
PartnerRe;
|
|
·
|
the
approval for listing of the PartnerRe common shares to be issued in the
exchange offer and the merger on the New York Stock
Exchange;
|
|
·
|
PartnerRe’s
registration statement on Form S-4, if required, to be filed in connection
with the exchange offer having been declared effective (or, in PartnerRe’s
reasonable judgment, there being no reasonable basis to believe that the
Form S-4 will not be declared effective prior to the settlement of the
exchange offer), and the absence of any SEC stop order suspending (or
threatening to suspend) the
effectiveness;
|
|
·
|
receipt
of exemptive and no-action relief from the SEC, if necessary, permitting
PartnerRe to settle the exchange offer in accordance with the French
tender offer rules;
|
|
·
|
the
absence of PartnerRe having a reasonable basis to believe that the
independent expert appointed in accordance with the regulations of the
AMF, would render an opinion that the exchange offer on the terms proposed
that would not satisfy the regulations of the AMF;
and
|
|
·
|
the
exchange offer on the terms proposed being declared compliant by the AMF
without imposing any requirement that if not satisfied would require a
cash alternative in accordance with the French tender offer rules (other
than certain requirements accepted by PartnerRe as of the execution date
of the transaction agreement).
|
|
·
|
decrease
the per share consideration or per warrant
consideration;
|
|
·
|
change
the form of consideration to be paid in the exchange
offer;
|
|
·
|
decrease
the number of Paris Re shares or Paris Re warrants sought in the exchange
offer;
|
|
·
|
extend
or otherwise change the expiration date of the exchange offer, except the
acquisition subsidiary may in accordance with the regulations of the
AMF extend
the exchange offer:
|
|
–
|
from
time to time if, at the scheduled or extended expiration date of the
exchange offer, either (A) the registration statement on Form S-4, if
required, to be filed in connection with the exchange offer has not been
declared effective by the SEC upon a request, there is a stop order
suspending the effectiveness of the Form S-4 or proceedings for that
purpose have been initiated or threatened by the SEC or (B) the PartnerRe
common shares have not been approved for listing on a European Union stock
exchange selected by PartnerRe;
|
|
–
|
for
any period required by any rule, regulation, interpretation or position of
the AMF or the staff thereof applicable to the exchange offer;
or
|
|
–
|
any
period otherwise required by applicable law;
or
|
|
·
|
otherwise
amend, modify or supplement any terms of the exchange offer in a manner
adverse to the holders of the Paris Re common shares or Paris Re
warrants.
|
|
·
|
the
excess (if any) of:
|
|
–
|
PartnerRe’s
or Paris Re’s consolidated assets, as applicable, as of the measurement
date (excluding goodwill, trademarks and other intangible assets, after
consideration of applicable taxes, if any);
over
|
|
–
|
PartnerRe’s
or Paris Re’s consolidated liabilities, as applicable, as of the
measurement date (after consideration of applicable taxes, if
any);
|
|
·
|
the
number of PartnerRe’s or Paris Re’s common shares, as applicable,
outstanding as of the measurement
date.
|
|
·
|
if
the parties agree that an adjustment to the per share consideration is
required and the only issue in dispute is the amount of such adjustment,
by the party whose calculation of the amount of such adjustment based on
its final proposal or proposals is further from the adjustment amount
finally determined as compared with the other party;
and
|
|
·
|
if
the parties disagree as to whether an adjustment to the per share
consideration is required, by the party whose position is not supported by
accounting referee’s
determinations.
|
|
·
|
if
the percentage decline in PartnerRe’s tangible book value per share from
March 31, 2009 to the measurement date is greater than that of Paris Re’s,
the per share consideration and per warrant consideration will be
increased by the adjustment amount described below;
and
|
|
·
|
if
the percentage decline in Paris Re’s tangible book value per share from
March 31, 2009 to the measurement date is greater than that of
PartnerRe’s, the per share consideration and per warrant consideration
will be decreased by the adjustment amount described
below.
|
|
·
|
due
organization, valid existence and good
standing;
|
|
·
|
authority
to enter into, and enforceability of, the transaction agreement and
authority to consummate the exchange offer and the
merger;
|
|
·
|
required
shareholder approvals to consummate the block purchase, the exchange offer
and the merger;
|
|
·
|
approvals
of the boards of directors of PartnerRe and Paris Re in connection with
the exchange offer and the merger;
|
|
·
|
required
consents and filings with government
entities;
|
|
·
|
the
absence of conflicts with organizational documents, laws and material
agreements, in each case as a result of the consummation of the block
purchase, the exchange offer and the
merger;
|
|
·
|
capitalization;
|
|
·
|
ownership
of subsidiaries;
|
|
·
|
conformity
of the financial statements with applicable accounting principles and fair
presentation of the consolidated financial
position;
|
|
·
|
accuracy
of PartnerRe’s and Paris Re’s respective tangible book value per share
calculations as of March 31, 2009;
|
|
·
|
accuracy
and sufficiency of documents to be filed with the SEC and the
AMF;
|
|
·
|
absence
of material changes or events in the business or condition of PartnerRe
and Paris Re;
|
|
·
|
absence
of undisclosed liabilities;
|
|
·
|
compliance
with laws and court orders;
|
|
·
|
absence
of material pending or threatened legal
proceedings;
|
|
·
|
real
and leased properties;
|
|
·
|
intellectual
property matters;
|
|
·
|
tax
matters and tax treatment;
|
|
·
|
environmental
matters;
|
|
·
|
validity
and enforceability of material
contracts;
|
|
·
|
agreements
with regulatory agencies or governmental
authorities;
|
|
·
|
computation
and sufficiency of reserves;
|
|
·
|
insurance
coverage;
|
|
·
|
investments
and derivatives;
|
|
·
|
insurance
matters, including statements and reports filed with applicable insurance
regulatory authorities; and
|
|
·
|
finders’
fees payable in connection with the block purchase, the exchange offer and
the merger.
|
|
·
|
Paris
Re’s status as a foreign private issuer and the eligibility of the
exchange offer for “Tier I” exemptive relief under the Securities and
Exchange Act of 1934, as amended, which we refer to as the “Exchange
Act;”
|
|
·
|
employee
benefit plans, key employees and labor
matters;
|
|
·
|
the
inapplicability of French and Swiss takeover statutes to the transactions;
and
|
|
·
|
the
effectiveness of the AXA and Colisée Re guarantee, financial guaranty
contracts and contracts ceded through the quota share retrocession
arrangement.
|
|
·
|
Paris
Re and PartnerRe’s ability to close the block purchase;
or
|
|
·
|
the
financial condition, business, assets or results of operations of Paris Re
or PartnerRe, as the case may be, and its subsidiaries, taken as a whole,
excluding any effect resulting
from:
|
|
–
|
changes
in the financial or securities markets or general economic, regulatory or
political conditions in the United States, France, Switzerland, Bermuda or
any other market in which Paris Re or PartnerRe, as the case may be, or
its subsidiary operates not having a materially disproportionate effect on
Paris Re or PartnerRe, as the case may be, and its subsidiaries, taken as
a whole, relative to other participants primarily in the reinsurance
industry;
|
|
–
|
changes
or conditions generally affecting the reinsurance industry not having a
materially disproportionate effect on Paris Re or PartnerRe, as the case
may be, and its subsidiaries, taken as a whole, relative to other
participants primarily in the reinsurance
industry;
|
|
–
|
acts
of war, sabotage or terrorism not having a materially disproportionate
effect on Paris Re or PartnerRe, as the case may be, and its subsidiaries,
taken as a whole, relative to other participants primarily in the
reinsurance industry;
|
|
–
|
any
failure by Paris Re or PartnerRe, as the case may be, and its subsidiaries
to meet any internal or published budgets, projections, forecasts or
predictions of financial performance for any period (excluding any fact,
change, event, occurrence, circumstance or effect that may have
contributed to such failure);
|
|
–
|
changes
or conditions resulting in liabilities under reinsurance contracts,
including any effects resulting from any earthquake, hurricane, tornado,
windstorm, terrorist act, act of war or other natural or man-made
disaster;
|
|
–
|
any
change or announcement of a potential change in Paris Re’s or PartnerRe’s,
as the case may be, or any of its subsidiaries’ credit or claims paying
rating or the ratings of any of its or its subsidiaries’ businesses or
securities (excluding any fact, change, event, occurrence, circumstance or
effect that may have contributed to the change or potential
change);
|
|
–
|
a
change in the trading prices or volume of capital stock of Paris Re or
PartnerRe, as the case may be (excluding any fact, change, event,
occurrence, circumstance or effect that may have contributed to the
change);
|
|
–
|
the
execution, delivery and announcement of the block purchase agreement, the
transaction agreement and the transactions, including any loss or adverse
change in, the relationship of Paris Re or PartnerRe, as the case may be,
or any of its subsidiaries with its customers, officers, employees,
agents, suppliers, financing sources, business partners or
regulators;
|
|
–
|
changes
of applicable law, generally accepted accounting principles or of
statutory accounting principles, including accounting and financial
reporting pronouncements by the International Accounting Standards Board,
the SEC, the National Association of Insurance Commissioners and the
Financial Accounting Standards Board not having a materially
disproportionate effect on Paris Re or
|
|
–
|
any
action or failure to act required to be taken by Paris Re or PartnerRe, as
the case may be, pursuant to the terms of the transaction
agreement.
|
|
·
|
PartnerRe
will use its reasonable best efforts, subject to certain limitations, to
cause Paris Re’s subsidiaries to pay, transfer or otherwise distribute to
Paris Re prior to the settlement of the exchange offer the maximum amount
of funds that can reasonably be so paid, transferred or distributed to
Paris Re by its subsidiaries to fund the share capital
repayment;
|
|
·
|
PartnerRe
will lend the amount of the shortfall for which funding is still required
(after applying the funds received pursuant to the immediately preceding
bullet point) to Paris Re Holdings France S.A., a wholly-owned subsidiary
of Paris Re, to enable Paris Re to pay the share capital
repayment;
|
|
·
|
The
proceeds from such loan will be applied to cancel certain outstanding
intercompany obligations owed by Paris Re Holdings France S.A. to Paris
Re; and
|
|
·
|
Paris
Re will thereafter distribute the remaining portion of the share capital
repayment to holders of Paris Re common
shares.
|
|
·
|
not
amend its articles of incorporation or other organizational
documents;
|
|
·
|
not
split, combine or reclassify its shares of capital stock or those of its
subsidiaries;
|
|
·
|
not
set aside or pay any dividends (other than the share capital repayment or
dividends paid by a wholly-owned subsidiary of Paris Re to Paris Re or
another wholly-owned subsidiary) provided that no dividends shall be paid
to Paris Re or to fund the share capital repayment except in accordance
with a pre-agreed plan (or such alternative method of funding the share
capital repayment as the parties may
agree);
|
|
·
|
not
redeem, repurchase or otherwise acquire any shares of its or any of its
subsidiaries’ share capital or any securities convertible into or
exercisable for any such shares (other than repurchases, redemptions or
acquisitions by a wholly-owned subsidiary of share capital or such other
securities, as the case may be, of another of its wholly-owned
subsidiaries);
|
|
·
|
not
issue, deliver or sell equity securities, options or other securities
convertible into or exercisable for equity securities (other than upon the
exercise of any outstanding options, warrants or RSUs or issuances of
securities of any Paris Re subsidiary to Paris Re or to any other Paris Re
subsidiary);
|
|
·
|
not
amend any term of any security of Paris Re or any of its
subsidiaries;
|
|
·
|
not
incur any capital expenditures or any obligations or liabilities in
respect thereof (other than those already contemplated by a capital
expenditure budget made available to PartnerRe and below certain U.S.
dollar thresholds);
|
|
·
|
not
acquire or dispose of any assets (other than certain types of assets in
the ordinary course of business consistent with past practice and/or below
certain U.S. dollar thresholds);
|
|
·
|
not
sell, lease or otherwise transfer, or create or incur certain liens on any
of its or its subsidiaries’ assets, securities, properties, interests or
businesses (other than certain types of assets in the ordinary course of
business consistent with past practice and/or below certain U.S. dollar
thresholds);
|
|
·
|
not
make any loans, advances or capital contributions to, or investments in,
any other person (other than in the ordinary course consistent with past
practice or to wholly-owned Paris Re
subsidiaries);
|
|
·
|
not
create, incur or assume any indebtedness (other than in replacement of
existing or maturing debt, guarantees relating to business written by any
wholly-owned subsidiary in the ordinary course of business consistent with
past practice and below certain U.S. dollar thresholds and draw-downs
pursuant to existing credit facilities and letters of credit in the
ordinary course of business consistent with past
practice);
|
|
·
|
not
increase the compensation of or enter into any new agreements with any
officers, directors or employees or adopt any additional benefit plans,
subject to certain exceptions;
|
|
·
|
not
change its accounting methods (other than to comply with changes in
accounting principles);
|
|
·
|
not
settle or offer or propose to settle any material legal proceedings (other
than those below certain U.S. dollar thresholds or arising from ordinary
course claims for insurance or reinsurance that are handled pursuant to
Paris Re’s normal claims handling process consistent with past practice),
any shareholder litigation or dispute against Paris Re or any of its
officers or directors or any legal proceedings that relate to the
transactions;
|
|
·
|
not
make or change any material tax election, change any annual tax accounting
period, adopt or change any method of tax accounting (except as required
by law), materially amend any tax returns, enter into any material closing
agreement, settle any material tax claim, audit or assessment or surrender
any right to claim a material tax refund, offset or other reduction in tax
liability;
|
|
·
|
subject
to certain limited exceptions, comply in all material respects with, and
not alter or amend, Paris Re’s or any of its subsidiaries’ existing
underwriting guidelines, referral processes, authority levels, risk
limitations, pricing policies and
practices;
|
|
·
|
comply
in all material respects with Paris Re’s and its subsidiaries’ existing
risk management policies and
practices;
|
|
·
|
not
enter into any new material risk segments, classes or
markets;
|
|
·
|
not
permit the aggregate premium volumes of new business in certain classes to
exceed specified thresholds of the in-force aggregate premium volumes as
of the first day of the current calendar
quarter;
|
|
·
|
not
make any material change to the methodology used in the calculation of
reserves for future payment of benefits, losses, claims, expenses and
other similar purposes;
|
|
·
|
use
its commercially reasonable efforts consistent with past practice to enter
into or renew any retrocession treaties involving cession of risk on terms
and conditions consistent with those entered into by Paris Re and its
subsidiaries in the ordinary course of business consistent with past
practice to the extent available on commercially reasonable
terms;
|
|
·
|
not
amend or modify in any material respect or terminate any material
contract, or enter into any new material
contracts;
|
|
·
|
not
enter into, amend or modify in any material respect any agreement relating
to the commutation of any reinsurance program or reinsurance agreement
having commutation amounts in excess of certain U.S. dollar
thresholds;
|
|
·
|
not
enter into any new agreement appointing any managing general agent or any
person performing similar
functions;
|
|
·
|
comply
with and take reasonable action to ensure that each investment manager,
adviser, agent or administrator complies with, and not alter or amend in
any material respect, Paris Re’s investment policy and guidelines, except
as required by or advisable under certain accounting rules or
law;
|
|
·
|
not
enter into, purchase, sell, amend or modify derivative contracts other
than for certain derivative contracts in the ordinary course of business
consistent with past practice or below certain U.S. dollar
thresholds;
|
|
·
|
not
underwrite sport, leisure and entertainment business in excess of certain
U.S. dollar or euro thresholds;
|
|
·
|
commit
to continue Paris Re’s existing investment practices to not incur exposure
to equities or to not acquire additional non-guaranteed asset-backed
securities and to seek, subject to certain exceptions, to maintain an
average credit rating of AA- or better for its investment
portfolio;
|
|
·
|
not
voluntarily forfeit, abandon or otherwise change any of its material
governmental licenses, authorizations or permits;
and
|
|
·
|
use
its reasonable best efforts to maintain in existence its material rights
to third-party intellectual
property.
|
|
·
|
not
change its accounting methods (other than to comply with changes in
accounting principles);
|
|
·
|
comply
in all material respects with PartnerRe’s and its subsidiaries’ existing
risk management policies and practices;
and
|
|
·
|
not
make any material change to the methodology used in the calculation of
reserves for future payment of benefits, losses, claims, expenses and
similar purposes.
|
|
·
|
since
the execution date of the transaction agreement, PartnerRe has issued, or
committed to issue, PartnerRe common shares (in one or more transactions)
having an aggregate market value in excess of $500 million in connection
with the acquisition, directly or indirectly, of any assets, securities,
properties, interests or businesses;
or
|
|
·
|
PartnerRe
has entered into a definitive agreement with respect to or consummated any
transaction (including the consolidation of PartnerRe with, or the merger
or amalgamation of PartnerRe with or into any person) pursuant to which
the outstanding PartnerRe common shares have or will be converted into or
exchanged for securities of any other person, cash or other
property.
|
|
·
|
solicit,
initiate or take any action to facilitate or encourage the submission of
any “acquisition proposal” relating to itself of the type described
below;
|
|
·
|
enter
into or participate in any discussions or negotiations with or furnish any
non-public information relating to itself or any of its subsidiaries or
otherwise cooperate in any way with, or knowingly assist or encourage any
third party seeking to make or who has made an acquisition
proposal;
|
|
·
|
grant
any waiver or release under any standstill or similar agreement with
respect to any class of equity securities of itself or any of its
subsidiaries to the extent such waiver or release would permit any party
to make an acquisition proposal;
and
|
|
·
|
enter
into any agreement in principle, letter of intent, term sheet or other
similar instrument relating to an acquisition
proposal.
|
|
·
|
solely
in the case of Paris Re, the Paris Re board of directors reasonably
believes such acquisition proposal will lead to a “superior proposal” of
the type described below;
|
|
·
|
its
board of directors determines in good faith, after consultation with
outside legal counsel, that such action is required by its fiduciary
duties under, in the case of PartnerRe, Bermuda law and, in the case of
Paris Re, Swiss law; and
|
|
·
|
it
receives from such person an executed confidentiality agreement with terms
no less favorable than those contained in the existing confidentiality
agreements between Paris Re and
PartnerRe.
|
|
·
|
any
acquisition or purchase of 5% or more of the Paris Re consolidated
assets;
|
|
·
|
any
acquisition or purchase of, or tender offer (including a self-tender
offer) or exchange offer for, its voting securities, that, if consummated,
would result in such third party beneficially owning securities
representing 5% or more of its total voting power (or of the surviving
Paris Re entity in such transaction) or 5% or more of the voting power of
any of its subsidiaries whose assets, individually or in the aggregate,
constitute 5% or more of the Paris Re consolidated
assets;
|
|
·
|
a
merger, amalgamation, consolidation, share exchange, business combination,
sale of substantially all the assets, reorganization, recapitalization,
liquidation, dissolution or other similar transaction involving Paris Re
or any of its subsidiaries whose assets, individually or in the aggregate,
constitute 5% or more of the Paris Re consolidated assets;
or
|
|
·
|
any
other transaction, the consummation of which could reasonably be expected
to impede, interfere with, prevent or materially delay the transactions
contemplated by the transaction agreement and the block purchase
agreement, or that could reasonably be expected to dilute materially the
benefits to PartnerRe of the
transactions.
|
|
·
|
any
acquisition or purchase of 50% or more of the PartnerRe consolidated
assets;
|
|
·
|
any
acquisition or purchase of, or, tender offer (including a self-tender
offer) or exchange offer for, its voting securities, that, if consummated,
would result in such third party beneficially owning securities
representing 50% or more of its total voting power (or of the surviving
PartnerRe entity in such
transaction);
|
|
·
|
a
merger, amalgamation, consolidation, share exchange, business combination,
sale of substantially all the assets, reorganization, recapitalization,
liquidation, dissolution or other similar transaction involving PartnerRe
or any of its subsidiaries whose assets, individually or in the aggregate,
constitute 50% or more of the PartnerRe consolidated assets;
or
|
|
·
|
any
other transaction, the consummation of which could reasonably be expected
to impede, interfere with, prevent or materially delay the transactions
contemplated by the transaction agreement and the block purchase
agreement.
|
|
·
|
the
payment of the share capital repayment, subject to the closing of the
block purchase;
|
|
·
|
the
appointment of individuals designated by PartnerRe to the Paris Re board
of directors comprising a majority of the Paris Re board of directors,
subject to and effective upon the closing of the block purchase;
and
|
|
·
|
amendments
to Paris Re’s articles of incorporation (i) to remove a provision thereof
purporting to require a cash takeover bid for any acquisition of more than
one-third of the Paris Re voting rights and (ii) to reduce the minimum
number of the directors on the Paris Re board of directors from 10 to six,
which amendment would become effective immediately prior to the block
purchase.
|
|
·
|
the
issuance of PartnerRe common shares and securities exercisable or
exchangeable for PartnerRe common shares in connection with the
transactions contemplated by the transaction agreement and the block
purchase agreement;
|
|
·
|
an
increase in the number of directors constituting the PartnerRe board of
directors from 11 to 12; and
|
|
·
|
any
amendment to PartnerRe’s 2005 employee equity plan to the extent required
to give effect to provisions of the transaction agreement relating to the
treatment of Paris Re options held by French employees and RSUs held by
all employees described under “The Transaction Agreement—Treatment of
Paris Re Share Options, Restricted Share Units and
Warrants.”
|
|
·
|
any
obligation to license, divest, dispose of or hold separate any portion of
its or any of its affiliates’ assets that would reasonably be expected to
be material to PartnerRe and its subsidiaries, taken as a
whole;
|
|
·
|
any
condition, limitation, obligation, commitment, requirement or other action
imposed or proposed by any governmental authority
that:
|
|
–
|
restricts
or limits PartnerRe’s, Paris Re’s or any of their respective affiliates’
freedom of action or requires PartnerRe, Paris Re or any of their
respective affiliates to take any action, with respect to any of its or
their assets or any portion of its or their businesses that would, in each
case, reasonably be expected to be material to PartnerRe and its
subsidiaries, taken as a whole; or
|
|
–
|
limits
in any material respect its or any of its subsidiaries’ ability
effectively to exercise full rights of ownership of any Paris Re common
shares and Paris Re warrants;
|
|
·
|
a
requirement that PartnerRe pay an aggregate amount reasonably expected to
be material to PartnerRe and its subsidiaries, taken as a whole, in
connection with seeking or obtaining any required actions, consents or
waivers as are required to complete the transactions (excluding any
mandatory filing fees and reasonable and customary costs and expenses
associated with making applications for, and responding to requests for
information from, governmental authorities);
or
|
|
·
|
a
requirement that PartnerRe commit or agree to any of the
foregoing.
|
|
·
|
may
not take or agree to take any of the foregoing actions that would
reasonably be expected to materially reduce or materially and negatively
interfere with the benefits to be recognized by PartnerRe and its
subsidiaries in the transactions contemplated by the transaction agreement
and the block purchase agreement without the prior written consent of
PartnerRe; and
|
|
·
|
if
so requested by PartnerRe, will use reasonable best efforts to take any of
the foregoing actions reasonably necessary to obtain clearances or
approvals required to give effect to the transactions contemplated by the
transaction agreement and the block purchase agreement, provided that such
action is conditioned on the closing of the block purchase and does not
reduce the amount or delay the payment of the per share consideration or
the per warrant consideration.
|
|
·
|
PartnerRe
will cause Paris Re or the surviving company, as applicable, to indemnify,
defend and hold harmless and (subject to certain limitations) provide
advancement of expenses to, the Paris Re present
and
|
|
·
|
PartnerRe
has agreed to cause to be maintained in effect provisions in Paris Re’s or
the surviving company’s, as applicable, articles of incorporation and
bylaws regarding elimination of liability of directors, indemnification of
officers, directors and employees and advancement of expenses that are no
less advantageous to the intended beneficiaries than the corresponding
provisions in existence on the date of the transaction agreement, to the
fullest extent permitted by Swiss law or any other applicable
law.
|
|
·
|
to
be listed on such European Union stock exchange as may be reasonably
determined by PartnerRe, provided that the choice of such exchange does
not result in a material delay in the consummation of the transactions
contemplated by the transaction agreement;
and
|
|
·
|
to
be issued in the block purchase, the exchange offer and the merger to be
approved for listing on the New York Stock Exchange, subject to official
notice of issuance, prior to the closing of the block
purchase.
|
|
·
|
by
mutual written agreement of Paris Re and
PartnerRe;
|
|
·
|
by
either of Paris Re or PartnerRe,
if:
|
|
–
|
the
block purchase agreement has terminated prior to the closing of the block
purchase;
|
|
–
|
either
(i) the settlement of the exchange offer has not occurred within five
months after the closing of the block purchase or (ii) the effective time
of the merger has not occurred within three months
after
|
|
–
|
there
is any applicable law that makes consummation of the transactions illegal
or otherwise prohibited or if consummation of the transactions would
violate any nonappealable final order, decree or judgment of any
governmental authority having competent jurisdiction (except that this
right to terminate the transaction agreement will not be available to any
party whose failure to comply in any material respect with any provision
of the transaction agreement has been the direct cause of, or resulted
directly in, such action);
|
|
–
|
prior
to the closing of the block purchase, the PartnerRe shareholders have not
approved the PartnerRe shareholder proposals upon a vote taken thereon at
a duly convened PartnerRe shareholder meeting, or any adjournment or
postponement thereof at which the applicable vote was taken (except that
this right to terminate the transaction agreement will not be available to
PartnerRe where the failure to obtain such approvals has been caused by
PartnerRe’s action or failure to act, and such action or failure to act
constitutes a breach by PartnerRe under the transaction
agreement);
|
|
·
|
by
PartnerRe, if:
|
|
–
|
prior
to the closing of the block purchase, it is determined that the tangible
book value per share differential is in excess of 40% as described under
“The Transaction Agreement—Tangible Book Value Per Share Adjustment” and
Paris Re’s decline in its tangible book value per share from March 31,
2009 to the measurement date is greater than that of PartnerRe’s over the
same period;
|
|
–
|
prior
to the closing of the block purchase, Paris Re has breached any of its
covenants or agreements or any of its representations and warranties set
forth in the transaction agreement which would, if occurring at the
closing of the block purchase, result in the failure of a closing
condition to PartnerRe’s obligations to close the block purchase as set
forth in the block purchase agreement (for an explanation of the
conditions to the closing of the block purchase, see “The Block Purchase
Agreement—Conditions to the Closing of the Block Purchase”) and which
breach is not cured within 30 days following written notice thereof or, by
its nature, cannot be cured within 30 days (except that this right to
terminate the transaction agreement will not be available to PartnerRe if
PartnerRe is then in material breach of its obligations under the block
purchase agreement or the transaction agreement);
and
|
|
–
|
prior
to the closing of the block purchase, the Paris Re shareholders have not
approved the Paris Re shareholder proposals upon a vote taken thereon at a
duly convened Paris Re shareholder meeting, or any adjournment or
postponement thereof at which the applicable vote was
taken;
|
|
·
|
by
Paris Re, if:
|
|
–
|
prior
to the closing of the block purchase, PartnerRe’s board of directors has
withdrawn or modified its recommendations relating to the PartnerRe
shareholder proposals or at any time after receipt or public announcement
of an acquisition proposal with respect to PartnerRe, the PartnerRe board
of directors has failed to reaffirm its recommendation of the PartnerRe
shareholder proposals as promptly as practicable (but in any event within
five business days) after receipt of any written request to do so from
Paris Re;
|
|
–
|
prior
to the approval by the PartnerRe shareholders of the PartnerRe shareholder
proposals, there has been a breach of PartnerRe’s non-solicitation
obligations described under “The Transaction Agreement—Certain
Covenants—No Solicitation;”
|
|
–
|
prior
to the closing of the block purchase, it is determined that the tangible
book value per share differential is in excess of 40% as described under
“The Transaction Agreement—Tangible Book
|
|
–
|
prior
to the closing of the block purchase, PartnerRe or the acquisition
subsidiary has breached any of its covenants or agreements or any of its
representations and warranties set forth in the transaction agreement
which would, if occurring at the closing of the block purchase, result in
the failure of a closing condition to the block sellers’ obligations to
close the block purchase as set forth in the block purchase agreement (for
an explanation of the conditions to the closing of the block purchase, see
“The Block Purchase Agreement—Conditions to the Closing of the Block
Purchase”) and which breach is not cured within 30 days following written
notice thereof or, by its nature, cannot be cured within 30 days (except
that this right to terminate the transaction agreement will not be
available to Paris Re if Paris Re or any block seller is then in material
breach of its obligations under the block purchase agreement or the
transaction agreement).
|
|
·
|
PartnerRe’s
board of directors has withdrawn or modified its recommendations relating
to the PartnerRe shareholder proposals in a manner adverse to Paris Re or
at any time after receipt or public announcement of an acquisition
proposal with respect to PartnerRe, the PartnerRe board of directors has
failed to reaffirm its recommendation of the PartnerRe shareholder
proposals as promptly as practicable (but in any event within five
business days) after receipt of any written request to do so from Paris
Re; or
|
|
·
|
the
approvals of the PartnerRe shareholder proposals by the PartnerRe
shareholders have not been obtained upon a vote taken thereon at a duly
convened PartnerRe shareholder meeting, or any adjournment or postponement
thereof at which the applicable vote was
taken.
|
|
·
|
after
the closing of the block purchase, no amendment may be made to the
transaction agreement that:
|
|
–
|
decreases
the per share consideration or the per warrant consideration or the share
capital repayment, or
|
|
–
|
amends
the provisions described under “The Transaction Agreement—Certain
Covenants—Paris Re Director and Officer Liability,” “The Transaction
Agreement—Certain Covenants—Protection of Paris Re Directors and
Management,” “The Transaction Agreement—Employee Matters” and “The
Transaction Agreement—Certain Covenants—Share Capital
Repayment;”
|
|
·
|
after
the closing of the block purchase, any amendment to the transaction
agreement will require the approval of Paris Re directors who are not
affiliated with or associates of the block sellers;
and
|
|
·
|
after
the earlier of either the receipt of approval by the Paris Re shareholders
of any Paris Re shareholder proposal or the receipt of approval by the
PartnerRe shareholders of the PartnerRe shareholder proposals, there may
be no amendment or waiver that would require further approval of the
relevant shareholders under applicable law without such approval having
first been obtained.
|
|
·
|
enter
into an agreement with any third party for the purchase and sale of any
Paris Re common shares that are the subject of its post-announcement
purchase agreement; and
|
|
·
|
vote
in favor of any proposal presented to the Paris Re shareholders that, if
approved, would be inconsistent with, or could otherwise be expected to
impede, interfere with, prevent or materially delay, or dilute materially
the benefits to PartnerRe of, the transactions contemplated by the
post-announcement purchase agreements, the block purchase agreement and
the transaction agreement.
|
|
·
|
the
closing of the block purchase occurring simultaneously with the closing of
the post-announcement purchase; and
|
|
·
|
approval
for the listing on the New York Stock Exchange of the PartnerRe common
shares to be issued in the post-announcement
purchases.
|
|
·
|
the
performance in all material respects by such post-announcement seller of
its obligations under the post-announcement purchase agreements required
to be performed by it prior to the closing of the post-announcement
purchases; and
|
|
·
|
the
representations and warranties made by such post-announcement seller in
its post-announcement purchase agreement (disregarding all materiality and
material adverse effect qualifications) being true and correct as of the
date of the closing of the post-announcement purchases as if made at and
as of such time (other than representations and warranties that by their
terms address matters only as of another specified time, which must be
true only as of such time), except where the failure of any of the
representations and warranties (other than those pertaining to existence
and power, authorization, ownership of Paris Re shares and eligibility to
participate in a post-announcement purchase) to be so true and correct
would not reasonably be expected to have a material adverse effect on such
post-announcement seller’s ability to consummate the transactions
contemplated by the post-announcement purchase agreements to be
consummated by it.
|
|
·
|
the
performance in all material respects by PartnerRe of its obligations under
the post-announcement purchase agreements required to be performed by it
prior to the closing of the post-announcement purchases;
and
|
|
·
|
the
representations and warranties made by PartnerRe in the post-announcement
purchase agreements (disregarding all materiality and material adverse
effect qualifications) must be true and correct as of the date of the
closing of the post-announcement purchases as if made at and as of such
time (other than representations and warranties that by their terms
address matters only as of another specified time, which must be true only
as of such time), except where the failure of any of the representations
and warranties (other than those pertaining to existence and power,
authorization, valid issuance of PartnerRe common shares and investment
purpose) to be so true and correct would not reasonably be expected to
have a material adverse effect on
PartnerRe.
|
|
·
|
by
mutual written agreement of such post-announcement seller and
PartnerRe;
|
|
·
|
by
either such post-announcement seller or PartnerRe if the block purchase
agreement or the transaction agreement has been
terminated;
|
|
·
|
by
either such post-announcement seller or PartnerRe if there is any
applicable law that makes consummation of the transactions illegal or
otherwise prohibited or if consummation of the transactions would violate
any nonappealable final order, decree or judgment of any governmental
authority having competent jurisdiction (except that this right to
terminate the post-announcement purchase agreement will not be available
to any party whose failure to comply in any material respect with any
provision of the post-announcement purchase agreement has been the direct
cause of, or resulted directly in, such action);
and
|
|
·
|
by
either such post-announcement seller or PartnerRe if the other party
(including in the case of PartnerRe, the acquisition subsidiary) has
breached any of its covenants or agreements or any of its representations
and warranties set forth in the post-announcement purchase agreement which
would, if occurring at the closing of the post-announcement purchases,
result in the failure of a closing condition to the terminating party’s
obligations and which breach is not cured within 30 days following written
notice thereof or, by its nature, cannot be cured within 30 days (except
that this right to terminate the post-announcement purchase agreement will
not be available to any party who is then in material breach of its
obligations under the post-announcement purchase agreement, the block
purchase agreement or the transaction
agreement).
|
|
·
|
transfers
to an affiliate or portfolio company of such block purchase shareholder,
so long as such affiliate or portfolio company agrees to be bound by the
terms of the investor agreement; or
|
|
·
|
if
all applicable conditions of Rule 144 under the Securities Act of 1933, as
amended, are satisfied with respect to a transfer of such PartnerRe
securities, transfers to such block purchase shareholder’s limited
partners or other investors as a distribution in-kind, subject to certain
limitations on transfers of more than 1% of PartnerRe’s outstanding voting
power to any limited partner or investor and on transfers to affiliated
entities of such block purchase
seller.
|
|
·
|
transfers
to a broker-dealer in a block sale (either as an unregistered block sale
or as a registered sale pursuant to a block seller registration rights
agreement) so long as such broker-dealer is instructed not to transfer to
any person who (i) has filed a Statement on Schedule 13D with respect to
PartnerRe’s voting securities indicating as of the last filing thereof
that it beneficially owns (or is a member of a group that beneficially
owns) at least 5% of PartnerRe’s total outstanding voting power or (ii)
would acquire in such sale beneficial ownership of PartnerRe securities
greater than or equal to 4.5% of PartnerRe’s market
capitalization;
|
|
·
|
transfers
to a mutual fund which, to such block purchase shareholder’s knowledge,
typically makes investments in parties in the ordinary course of its
business for investment purposes only and not with the purpose or effect
of changing or influencing the control of such party and that, to such
block purchase shareholder’s knowledge, has not filed a Statement on
Schedule 13D with respect to PartnerRe’s voting securities during the
prior three years;
|
|
·
|
transfers
structured as regular sales made over the New York Stock Exchange or such
European Union stock exchange selected by PartnerRe in accordance with the
transaction agreement;
|
|
·
|
transfers
to any other block purchase shareholder or an affiliate of any other block
purchase shareholder so long as any such person who is not already bound
by an investor agreement agrees to be bound thereby (subject in all cases
to the compliance with the standstill provisions described
below);
|
|
·
|
transfers
pursuant to any tender offer, exchange offer, share exchange, merger,
consolidation or amalgamation pursuant to which PartnerRe voting
securities would be acquired or received by PartnerRe or any other party,
so long as PartnerRe’s board of directors has approved such transaction
and recommended it to its shareholders (and has not withdrawn such
recommendation); and
|
|
·
|
transfers
permitted prior to the end of the lock-up
period.
|
|
·
|
acquire
or knowingly facilitate the acquisition of any PartnerRe securities if
after such acquisition, such block purchase shareholder (together with its
affiliates and certain controlled portfolio companies) would beneficially
own PartnerRe voting securities representing in the aggregate more than
9.9% of PartnerRe’s total outstanding voting
power;
|
|
·
|
publicly
announce or submit to the PartnerRe board of directors a proposal for or
seek to effect or knowingly facilitate any merger, tender offer or other
extraordinary transaction, an acquisition of a material portion of
PartnerRe’s assets or any transaction that would result in any person or
group beneficially owning voting securities representing more than 9.9% of
PartnerRe’s total outstanding voting power (except the foregoing will not
restrict any block purchase shareholder from obtaining financing for or
guaranteeing any financing for any such transaction that has previously
been approved by the PartnerRe board of directors and that continues to be
supported by the PartnerRe board of
directors);
|
|
·
|
take
any action that would have a reasonable possibility of requiring PartnerRe
to make a public announcement under applicable law or the rules of any
exchange regarding the possibility of any of the transactions described in
the immediately preceding bullet
point;
|
|
·
|
make,
or in any way participate or engage in, any solicitation of proxies to
vote or seek to advise or influence any third party with respect to the
voting of, any PartnerRe voting
securities;
|
|
·
|
make
any proposal, or knowingly facilitate or encourage any third party, to
seek representation on the PartnerRe board of directors or to otherwise
control the management or policies of PartnerRe or any of its
subsidiaries;
|
|
·
|
form,
join or participate in a 13D group, including a group consisting of other
block purchase shareholders, with respect to the PartnerRe voting
securities or otherwise acting in concert with any person for taking any
action prohibited above;
|
|
·
|
advise,
knowingly facilitate or knowingly encourage any discussions, negotiations,
agreements or arrangements with any person regarding the foregoing;
and
|
|
·
|
disclose
any intention, indication of interest or proposal or plan or arrangement
inconsistent with the foregoing.
|
|
·
|
selections
of PartnerRe’s board and committee books relating to PartnerRe’s
operations and risk management framework provided to the PartnerRe board
of directors, audit committee and risk management and finance committee at
their most recent quarterly
meetings;
|
|
·
|
PartnerRe’s
quarterly operations review summaries for PartnerRe’s U.S., global and
capital markets groups prepared for PartnerRe’s chief executive officer;
and
|
|
·
|
certain
information regarding reserve
development.
|
|
·
|
except
as described below, with respect to all block purchase shareholders at
such time that the block purchase shareholders’ collectively own PartnerRe
voting securities representing less than 10% of PartnerRe’s total
outstanding voting power (continuously for a three month period);
and
|
|
·
|
with
respect to any individual block purchase shareholder, at such time that
such block purchase shareholder ceases to beneficially own PartnerRe
voting securities representing a percentage of PartnerRe’s total
outstanding voting power that is at least equal to 50% of such block
purchase shareholder’s voting limitation percentage (continuously for a
three month period).
|
|
·
|
allocate
a further PartnerRe common shares to
the 2005 employee equity plan; and
|
|
·
|
allocate
a further PartnerRe common shares to
the 2005 employee equity plan that may be awarded as either restricted
shares or restricted share units.
|
|
·
|
The
compensation committee, which consists solely of independent directors on
our board, administers the 2005 employee equity
plan.
|
|
·
|
Awards
under the 2005 employee equity plan may be made in the form of options
(non-qualified and incentive share options), restricted shares, restricted
share units and share-settled share appreciation
rights.
|
|
·
|
No
counting of PartnerRe common shares tendered in payment of the exercise
price of an option for the purposes of determining the shares available
under the 2005 employee equity
plan.
|
|
·
|
No
counting of PartnerRe common shares withheld for payment of taxes for the
purposes of determining the PartnerRe common shares available under the
2005 employee equity plan.
|
|
·
|
No
net share counting.
|
|
·
|
The
number of PartnerRe common shares that may be awarded under the 2005
employee equity plan is capped at
PartnerRe common shares. This number represents the
original cap of 1,531,764 plus the additional amount
of PartnerRe common shares being
requested pursuant to this
proposal.
|
|
·
|
The
number of PartnerRe common shares that may be awarded under the 2005
employee equity plan as either restricted shares or restricted share units
is capped at PartnerRe common
shares. This number represents the original cap of 1,343,325
plus the additional amount of
PartnerRe common shares being requested pursuant to this
proposal.
|
|
·
|
Restricted
shares and restricted share units will not vest prior to three years from
the date of grant unless: (i) the vesting is performance based, (ii) they
are awarded in lieu of a company obligation to pay cash or (iii) they are
issued in connection with the exercise of an option or other award made
under the 2005 employee equity
plan.
|
|
·
|
The
exercise price of options and share appreciation rights awarded under the
plan will not be less than fair market value at the time of
grant. As
of
, 2009 the per share closing price of PartnerRe common shares
is .
|
|
·
|
Repricing
of options and share appreciation rights is
prohibited.
|
|
·
|
Options
and share appreciation rights will generally vest ratably over three years
on the first, second and third anniversaries of the date of grant and
expire 10 years from the date of
grant.
|
|
·
|
Accelerated
vesting of any grant may only be made at the discretion of the
compensation committee.
|
|
·
|
Unless
specifically provided to the contrary in any award agreement under the
2005 employee equity plan, upon a change in control (as defined in the
2005 employee equity plan), all outstanding awards will become fully
exercisable, will vest and will be settled, as applicable, and any
restrictions applicable to any award shall automatically
lapse.
|
|
·
|
The
2005 employee equity plan will expire on the date of the annual meeting of
shareholders in 2015.
|
|
·
|
Certain
awards to certain senior executives will, if the compensation committee
intends any such award to qualify as “qualified performance based
compensation” under Section 162(m) of the Internal Revenue Code, become
earned and payable only if pre-established targets relating to one or more
of the following performance measures are achieved: (i) earnings per
share, (ii) financial year return on common equity, (iii) underwriting
year return on equity, (iv) return on net assets, (v) organizational
objectives and (vi) premium growth. The individual maximum
number of PartnerRe common shares underlying any such share-denominated
award granted in any year will be 800,000 PartnerRe common shares, and the
individual maximum amount earned with respect to any such non-share
denominated award granted in any year will be
$5,000,000.
|
A
|
B
|
C | |||||||
Plan
Category
|
Number
of Securities To be Issued upon Exercise of Outstanding Options, Warrants
& Rights(1)
|
Weighted-Average
Exercise Price of Outstanding Options, Warrants &
Rights($)(2)
|
Number
of Securities Remaining Available for Future Issuance under Equity
Compensation Plans (Excluding Securities Reflected in Column
A)(3)
|
||||||
Equity
compensation plans approved by shareholders
|
3,965,153
|
57.09
|
1,490,412
|
||||||
Equity
compensation plans not approved by shareholders
|
—
|
|
—
|
|
72,890
|
||||
Total
|
3,965,153
|
57.09
|
1,563,302
|
(1)
|
Includes
69,790 shares that relate to the 1993 Non-Employee Director Stock Plan,
382,634 shares that relate to the 2003 Non-Employee Director Stock Plan,
45,502 shares that relate to the 1993 Stock Option Plan, 1,981,813 shares
that relate to the Employee Incentive Plan, and 894,022 shares and 591,392
restricted share unit awards that relate to the 2005 employee equity plan.
Column A includes restricted share unit awards but does not include the
estimated number of shares to be purchased pursuant to the Employee Share
Purchase Plan, which we refer to as the “ESPP,” or the SSPP during the
current offering period, which commenced on December 1, 2008, and will
close on May 31, 2009.
|
(2)
|
The
weighted average exercise price of outstanding options is $50.31 per share
under the 1993 Non-Employee Director Stock Plan, $65.97 per
share under the 2003 Non-Employee Director Stock Plan, $44.42 per share
under the 1993 Stock Option Plan, $52.73 per share under the Employee
Incentive Plan, and $72.00 per share under the 2005 employee equity plan.
The weighted average exercise price does not take into account any
restricted share unit awards or the estimated number of shares to be
purchased pursuant to the ESPP or SSPP during the current offering
period.
|
(3)
|
Includes
94,377 shares remaining available for grant under the 2003 Non-Employee
Director Stock Plan, 629,174 shares and 751,933 restricted share unit
awards remaining available for issue under the 2005 employee equity plan.
Also includes 14,928 shares remaining available for issue under the ESPP
and 72,890 shares remaining available for issue under the SSPP. Both
figures exclude the estimated number of shares to be purchased in the
current offering period. The 1993 Non-Employee Director Stock Plan, the
1993 Stock Option Plan, and the Employee Incentive Plan have
expired.
|
|
·
|
PartnerRe’s
separate historical audited financial statements as of and for the year
ended December 31, 2008, included in PartnerRe’s Annual Report on Form
10-K for the year ended December 31,
2008;
|
|
·
|
Paris
Re’s separate historical audited financial statements as of and for the
year ended December 31, 2008, included
herein;
|
|
·
|
PartnerRe’s
separate historical interim financial information as of and for the three
months ended March 31, 2009, included in PartnerRe’s Form 10-Q for the
three months ended March 31, 2009;
|
|
·
|
Paris
Re’s separate historical interim financial information as of and for the
three months ended March 31, 2009, included
herein;
|
|
·
|
the
accompanying notes to the unaudited pro forma condensed combined financial
information; and
|
|
·
|
unaudited
reconciliation of Paris Re’s separate historical financial information
from IFRS to U.S. GAAP as provided by Paris
Re.
|
Historical
PartnerRe
|
Historical
Paris
Re
|
Pro
Forma Purchase adjustments
|
Notes
|
Pro
Forma Combined
|
||||||||||||||||
Assets
|
||||||||||||||||||||
Fixed
maturities, at fair value
|
$ | 10,280,043 | $ | 2,194,370 | $ | — | $ | 12,474,413 | ||||||||||||
Short-term
investments, at fair value
|
69,024 | 23,588 | — | 92,612 | ||||||||||||||||
Equities,
at fair value
|
426,416 | 1,756 | — | 428,172 | ||||||||||||||||
Other
invested assets
|
54,769 | 1,799 | — | 56,568 | ||||||||||||||||
Total
investments
|
10,830,252 | 2,221,513 | — | 13,051,765 | ||||||||||||||||
Cash
and cash equivalents
|
571,638 | 502,398 | (345,390 | ) |
3(a)
|
728,646 | ||||||||||||||
Reinsurance
balances receivable
|
2,125,796 | 872,880 | — | 2,998,676 | ||||||||||||||||
Reinsurance
recoverable on paid and unpaid losses
|
161,753 | 342,748 | — | 504,501 | ||||||||||||||||
Funds
held by reinsured companies
|
753,187 | 2,340,190 | — | 3,093,377 | ||||||||||||||||
Deferred
acquisition costs
|
659,012 | 153,985 | (153,985 | ) |
3(b)
|
659,012 | ||||||||||||||
Deposit
assets
|
328,552 | 26,864 | — | 355,416 | ||||||||||||||||
Net
tax assets
|
168,264 | 71,282 | — | 239,546 | ||||||||||||||||
Intangible
assets
|
— | 2,503 | 234,830 |
3(c)
|
237,333 | |||||||||||||||
Goodwill
|
429,519 | — | 121,640 |
3(d)
|
551,159 | |||||||||||||||
Other
assets
|
246,801 | 19,045 | — | 265,846 | ||||||||||||||||
Total
assets
|
$ | 16,274,774 | $ | 6,553,408 | $ | (142,905 | ) | $ | 22,685,277 | |||||||||||
Liabilities
|
||||||||||||||||||||
Unpaid
losses and loss expense
|
$ | 7,393,205 | $ | 3,222,199 | $ | — | $ | 10,615,404 | ||||||||||||
Policy
benefits for life and annuity contracts
|
1,421,420 | — | — | 1,421,420 | ||||||||||||||||
Unearned
premiums
|
1,706,598 | 837,328 | — | 2,543,926 | ||||||||||||||||
Other
reinsurance balances payable
|
217,335 | 283,883 | — | 501,218 | ||||||||||||||||
Deposit
liabilities
|
353,726 | 27,096 | — | 380,822 | ||||||||||||||||
Net
tax liabilities
|
195,663 | 61,096 | 11,461 |
3(e)
|
268,220 | |||||||||||||||
Accounts
payable, accrued expenses and other
|
183,771 | 207,845 | — | 391,616 | ||||||||||||||||
Debt
obligations
|
520,989 | — | — | 520,989 | ||||||||||||||||
Total
liabilities
|
11,992,707 | 4,639,447 | 11,461 | 16,643,615 | ||||||||||||||||
Shareholders’
equity
|
||||||||||||||||||||
Common
shares
|
57,874 | 248,524 | (222,920 | ) |
3(f)
|
83,478 | ||||||||||||||
Preferred
shares
|
20,800 | — | — | 20,800 | ||||||||||||||||
Additional
paid-in capital
|
1,471,062 | 927,145 | 821,846 |
3(g)
|
3,220,053 | |||||||||||||||
Accumulated
other comprehensive (loss) income
|
(6,068 | ) | 109,972 | (109,972 | ) |
3(h)
|
(6,068 | ) | ||||||||||||
Retained
earnings
|
2,835,998 | 628,320 | (643,320 | ) |
3(i)
|
2,820,998 | ||||||||||||||
Treasury
shares
|
(97,599 | ) | — | — | (97,599 | ) | ||||||||||||||
Total
shareholders’ equity
|
4,282,067 | 1,913,961 | (154,366 | ) | 6,041,662 | |||||||||||||||
Total
liabilities and shareholders’ equity
|
$ | 16,274,774 | $ | 6,553,408 | $ | (142,905 | ) | $ | 22,685,277 | |||||||||||
Common
shares outstanding
|
56,579,095 | 80,627,000 |
4
|
82,292,460 |
Historical
PartnerRe
|
Historical
Paris
Re
|
Pro
Forma Purchase adjustments
|
Notes
|
Pro
Forma Combined
|
||||||||||||||||
Common
shares and common share equivalents outstanding
|
57,388,190 | 81,017,000 |
4
|
83,150,520 | ||||||||||||||||
Book
value per share
|
$ | 66.49 | $ | 23.74 |
4
|
$ | 67.10 | |||||||||||||
Diluted
book value per share
|
$ | 65.55 | $ | 23.62 |
4
|
$ | 66.41 |
Historical
PartnerRe
|
Historical
Paris
Re
|
Pro
Forma Purchase adjustments
|
Notes
|
Pro
Forma Combined
|
||||||||||||||||
Revenues
|
||||||||||||||||||||
Gross
premiums written
|
$ | 4,028,248 | $ | 1,402,612 | $ | — | $ | 5,430,860 | ||||||||||||
Net
premiums written
|
3,989,435 | 1,196,617 | — | 5,186,052 | ||||||||||||||||
(Increase)
decrease in unearned premiums
|
(61,411 | ) | 14,287 | — | (47,124 | ) | ||||||||||||||
Net
premiums earned
|
3,928,024 | 1,210,904 | — | 5,138,928 | ||||||||||||||||
Net
investment income
|
572,964 | 225,760 | (16,579 | ) |
3(j)
|
782,145 | ||||||||||||||
Net
realized and unrealized investment (losses) gains
|
(531,360 | ) | 18,781 | — | (512,579 | ) | ||||||||||||||
Other
income (loss)
|
10,335 | (1,199 | ) | — | 9,136 | |||||||||||||||
Total
revenues
|
3,979,963 | 1,454,246 | (16,579 | ) | 5,417,630 | |||||||||||||||
Expenses
|
||||||||||||||||||||
Losses
and loss expense and life policy benefits
|
2,609,220 | 891,578 | — | 3,500,798 | ||||||||||||||||
Acquisition
costs
|
898,882 | 203,364 | — | 1,102,246 | ||||||||||||||||
Other
operating expenses
|
365,009 | 151,343 | — | 516,352 | ||||||||||||||||
Amortization
of intangibles
|
— | 9,665 | (3,215 | ) |
|
3(k)
|
6,450 | |||||||||||||
Interest
expense
|
51,228 | — | — | 51,228 | ||||||||||||||||
Net
foreign exchange (gains) losses
|
(6,221 | ) | 161,004 | — | 154,783 | |||||||||||||||
Total
expenses
|
3,918,118 | 1,416,954 | (3,215 | ) | 5,331,857 | |||||||||||||||
Income
before taxes and interest in losses of equity investments
|
61,845 | 37,292 | (13,364 | ) | 85,773 | |||||||||||||||
Income
tax expense
|
9,705 | 15,688 | (3,341 | ) |
|
3(l)
|
22,052 | |||||||||||||
Interest
in losses of equity investments
|
(5,573 | ) | — | — | (5,573 | ) | ||||||||||||||
Net
income
|
46,567 | 21,604 | (10,023 | ) | 58,148 | |||||||||||||||
Preferred
dividends
|
34,525 | — | — | 34,525 | ||||||||||||||||
Net
income available to common shareholders
|
$ | 12,042 | $ | 21,604 | $ | (10,023 | ) | $ | 23,623 | |||||||||||
Per
share data
|
||||||||||||||||||||
Net
income per common share:
|
||||||||||||||||||||
Basic
net income
|
$ | 0.22 | $ | 0.26 |
4
|
$ | 0.30 | |||||||||||||
Diluted
net income
|
$ | 0.22 | $ | 0.26 |
4
|
|
$ | 0.29 | ||||||||||||
Weighted
average number of common shares outstanding
|
54,347,052 | 82,703,000 |
4
|
80,060,417 |
Historical
PartnerRe
|
Historical
Paris
Re
|
Pro
Forma Purchase adjustments
|
Notes
|
Pro
Forma Combined
|
||||||||||||||||
Weighted
average number of common and common share equivalents
outstanding
|
55,639,600 | 83,977,000 |
4
|
81,401,928 |
Historical
PartnerRe
|
Historical
Paris
Re
|
Pro
Forma Purchase adjustments
|
Notes
|
Pro
Forma Combined
|
||||||||||||||||
Revenues
|
||||||||||||||||||||
Gross
premiums written
|
$ | 1,340,380 | $ | 667,223 | $ | — | $ | 2,007,603 | ||||||||||||
Net
premiums written
|
1,308,058 | 575,208 | — | 1,883,266 | ||||||||||||||||
Increase
in unearned premiums
|
(441,608 | ) | (275,712 | ) | — | (717,320 | ) | |||||||||||||
Net
premiums earned
|
866,450 | 299,496 | — | 1,165,946 | ||||||||||||||||
Net
investment income
|
133,127 | 43,607 | (4,058 | ) |
3(j)
|
172,676 | ||||||||||||||
Net
realized and unrealized investment losses
|
(70,120 | ) | (11,874 | ) | — | (81,994 | ) | |||||||||||||
Net
realized gain on purchase of capital efficient notes
|
88,427 | — | — | 88,427 | ||||||||||||||||
Other
income (loss)
|
4,582 | (182 | ) | — | 4,400 | |||||||||||||||
Total
revenues
|
1,022,466 | 331,047 | (4,058 | ) | 1,349,455 | |||||||||||||||
Expenses
|
||||||||||||||||||||
Losses
and loss expense and life policy benefits
|
518,899 | 201,888 | — | 720,787 | ||||||||||||||||
Acquisition
costs
|
199,968 | 46,450 | — | 246,418 | ||||||||||||||||
Other
operating expenses
|
83,594 | 27,302 | — | 110,896 | ||||||||||||||||
Amortization
of intangibles
|
— | 31 | (804 | ) |
3(k)
|
(773 | ) | |||||||||||||
Interest
expense
|
9,146 | — | — | 9,146 | ||||||||||||||||
Net
foreign exchange losses (gains)
|
3,349 | (75,401 | ) | — | (72,052 | ) | ||||||||||||||
Total
expenses
|
814,956 | 200,270 | (804 | ) | 1,014,422 | |||||||||||||||
Income
before taxes and interest in losses of equity investments
|
207,510 | 130,777 | (3,254 | ) | 335,444 | |||||||||||||||
Income
tax expense
|
59,812 | 4,839 | (814 | ) |
3(l)
|
63,837 | ||||||||||||||
Interest
in losses of equity investments
|
(6,177 | ) | — | — | (6,177 | ) | ||||||||||||||
Net
income
|
141,521 | 125,938 | (2,440 | ) | 265,019 | |||||||||||||||
Preferred
dividends
|
8,631 | — | — | 8,631 | ||||||||||||||||
Net
income available to common shareholders
|
$ | 132,890 | $ | 125,938 | $ | (2,440 | ) | $ | 256,388 | |||||||||||
Per
share data
|
||||||||||||||||||||
Net
income per common share:
|
||||||||||||||||||||
Basic
net income
|
$ | 2.35 | $ | 1.56 |
4
|
$ | 3.12 | |||||||||||||
Diluted
net income
|
$ | 2.32 | $ | 1.55 |
4
|
$ | 3.09 | |||||||||||||
Weighted
average number of common shares outstanding
|
56,511,201 | 80,627,000 |
4
|
82,224,556 | ||||||||||||||||
Weighted
average number of common and common share equivalents
outstanding
|
57,320,296 | 81,017,000 |
4
|
83,082,626 |
Number
of Paris Re common shares outstanding, net of treasury shares,
as
of March 31, 2009 (in thousands)
|
80,620.9 | |||
Exchange
ratio
|
0.300 | |||
PartnerRe
common shares issued for Paris Re common shares (in
thousands)
|
24,186.3 | |||
Number
of Paris Re warrants outstanding as of March 31, 2009 (in
thousands)
|
8,487.8 | |||
Exchange
ratio
|
0.167 | |||
PartnerRe
common shares issued for Paris Re warrants (in thousands)
|
1,417.5 | |||
Total
PartnerRe common shares issued for Paris Re common shares and
warrants (in thousands)
|
25,603.8 | |||
PartnerRe’s
closing share price on August 3, 2009
|
$ | 68.57 | ||
Estimated
purchase price before adjustments for stock based compensation (in
millions)
|
$ | 1,755.6 | ||
Estimated
fair value of Paris Re’s
stock-based awards outstanding (in millions)
|
45.0 | |||
Unrecognized
compensation on unvested Paris Re restricted share units (in
millions)
|
(26.0 | ) | ||
Estimated
purchase price (in millions)
|
$ | 1,774.6 | ||
Net
book value of net assets acquired prior to fair value adjustments
(a)
|
$ | 1,914.0 | ||
Preliminary
adjustments for fair value
|
||||
Adjustment
for pre-close return of capital (b)
|
(310.4 | ) | ||
Adjustment
to record Paris Re’s estimated transaction costs (c)
|
(15.0 | ) | ||
Adjustment
to deferred acquisition costs (d)
|
(154.0 | ) | ||
Adjustment
to intangible assets (e)
|
234.8 | |||
Adjustment
to income taxes (f)
|
(16.4 | ) | ||
Preliminary
fair value of net assets acquired
|
1,653.0 | |||
Estimated
purchase price
|
1,774.6 | |||
Preliminary
estimate of goodwill
|
$ | 121.6 |
(a)
|
Represents
historical net book value of Paris Re as of March 31,
2009.
|
(b)
|
Represents
adjustment to reflect the pre-close return of capital to Paris Re
shareholders, paid by Paris Re.
|
(c)
|
In
connection with the transactions, transaction costs currently estimated at
$35 million will be incurred and expensed. Of this amount, $20
million relates to PartnerRe expenses as set forth in “The Transactions —
Sources of Funds, Fees and Expenses” and $15 million is our estimate of
Paris Re’s expenses. Actual transaction costs may vary from
such estimates, which are based on the best information available at the
time the unaudited pro forma condensed combined financial information was
prepared.
|
(d)
|
Represents
adjustment to reduce deferred acquisition costs of Paris Re to their
estimated fair value at March 31,
2009.
|
(e)
|
The
intangible assets arise from unpaid loses and loss expense reserves ($160
million), unearned premium reserves ($64 million), and licenses and
renewal rights ($13 million). The purchase accounting
adjustments mainly reflect the discount rates applied to the underlying
cash flows and an estimated risk premium associated with such reserves in
order to determine their fair values, less Paris Re’s intangible assets at
March 31, 2009 ($2 million).
|
(f)
|
Represents
the tax impact of the transaction costs, deferred acquisition costs and
intangible assets, assuming a 25% tax rate. This tax rate is a
blended rate based on the local statutory tax rates for Paris Re’s
operations.
|
|
·
|
from
July 4, 2009, when there were 80.6 million Paris Re common shares
outstanding (net of treasury shares), until the completion of the
transactions, no additional Paris Re common shares will be issued
(including upon the exercise or conversion of options, restricted share
units, warrants or other securities exercisable, convertible or
exchangeable for Paris Re common
shares);
|
|
·
|
from
July 4, 2009, when there were 56.7 million PartnerRe common shares
outstanding (net of treasury shares), until the completion of the
transactions, except for issuances in connection with the transactions, no
additional PartnerRe common shares will be issued (including upon the
exercise or conversion of options, restricted share units, warrants or
other securities exercisable, convertible or exchangeable for PartnerRe
common shares);
|
|
·
|
PartnerRe
will acquire 100% of the outstanding Paris Re common shares and Paris Re
warrants in the transactions;
|
|
·
|
no
adjustment will be made to the per share consideration and per warrant
consideration pursuant to the tangible book value adjustment;
and
|
|
·
|
PartnerRe
will not declare any dividends on the PartnerRe common shares with a
record date between the closing of the block purchase and the exchange
offer and, as a result, no adjustment will be made to the per share
consideration pursuant to the post-block purchase closing dividend
adjustment.
|
|
·
|
in
addition to the PartnerRe common shares issued in connection with the
transactions, additional Paris Re common shares or PartnerRe common shares
are issued prior to the completion of the transactions (including upon the
exercise or conversion of options, restricted share units, warrants or
other securities exercisable, convertible or exchangeable for Paris Re
common shares or PartnerRe common shares), in each case, in accordance
with the limitations set forth in the transaction
agreement;
|
|
·
|
PartnerRe
acquires less than all of the outstanding Paris Re common shares or Paris
Re warrants in the transactions;
|
|
·
|
the
per share consideration and per warrant consideration are adjusted upwards
or downwards pursuant to the tangible book value per share adjustment;
or
|
|
·
|
for
purposes of the post-block purchase closing dividend adjustment, PartnerRe
declares one or more dividends on the PartnerRe common shares with a
record date between the closing of the block purchase and the exchange
offer, in which case the increase in the number of PartnerRe common shares
issued will be determined based on the formula described above under
“Summary—Post-Block Purchase Closing Dividend Adjustment” and would be
dependent on both the aggregate amount of dividends so declared as well as
the average price per PartnerRe common share during the applicable
measurement period.
|
Historical
Paris
Re
IFRS
(1)
|
U.S.
GAAP
Adjustments
(2)
|
Reclassification
Adjustments
(3)
|
Notes
|
Historical
Paris
Re
U.S.
GAAP
|
|||||||||||||
Assets
|
|||||||||||||||||
Fixed
maturities, at fair value
|
$ | 2,194,370 | $ | — | $ | — | $ | 2,194,370 | |||||||||
Short-term
investments, at fair value
|
23,588 | — | — | 23,588 | |||||||||||||
Equities,
at fair value
|
1,756 | — | — | 1,756 | |||||||||||||
Other
invested assets
|
5,864 | — | (4,065 | ) | 1,799 | ||||||||||||
Total
investments
|
2,225,578 | — | (4,065 | ) | 2,221,513 | ||||||||||||
Cash
and cash equivalents
|
502,398 | — | — | 502,398 | |||||||||||||
Reinsurance
balances receivable
|
1,092,836 | — | (219,956 | ) | 872,880 | ||||||||||||
Reinsurance
recoverable on paid and unpaid losses
|
318,998 | — | 23,750 | 342,748 | |||||||||||||
Funds
withheld asset
|
2,330,021 | 10,169 | — |
(a)
|
2,340,190 | ||||||||||||
Deferred
acquisition costs
|
— | — | 153,985 | 153,985 | |||||||||||||
Deposit
assets
|
— | — | 26,864 | 26,864 | |||||||||||||
Net
tax assets
|
31,582 | — | 39,700 | 71,282 | |||||||||||||
Intangible
assets
|
193,824 | (191,321 | ) | — |
(b)
|
2,503 | |||||||||||
Other
assets
|
58,745 | — | (39,700 | ) | 19,045 | ||||||||||||
Total
assets
|
$ | 6,753,982 | $ | (181,152 | ) | $ | (19,422 | ) | $ | 6,553,408 | |||||||
Liabilities
|
|||||||||||||||||
Unpaid
losses and loss expense
|
$ | 3,222,199 | $ | — | $ | — | $ | 3,222,199 | |||||||||
Unearned
premiums
|
837,328 | — | — | 837,328 | |||||||||||||
Other
reinsurance balances payable
|
326,336 | — | (42,453 | ) | 283,883 | ||||||||||||
Deposit
liabilities
|
— | — | 27,096 | 27,096 | |||||||||||||
Net
tax liabilities
|
111,038 | (49,942 | ) | — |
(c)
|
61,096 | |||||||||||
Accounts
payable, accrued expenses and other
|
211,910 | — | (4,065 | ) | 207,845 | ||||||||||||
Total
liabilities
|
4,708,811 | (49,942 | ) | (19,422 | ) | 4,639,447 | |||||||||||
Shareholders’
equity
|
|||||||||||||||||
Common
shares
|
248,524 | — | — | 248,524 | |||||||||||||
Additional
paid-in capital
|
927,145 | — | — | 927,145 | |||||||||||||
Currency
translation reserves
|
122,998 | (13,026 | ) | — |
(d)
|
109,972 | |||||||||||
Retained
earnings and other reserves
|
746,504 | (118,184 | ) | — |
(e)
|
628,320 |
Historical
Paris
Re
IFRS
(1)
|
U.S.
GAAP
Adjustments
(2)
|
Reclassification
Adjustments
(3)
|
Notes
|
Historical
Paris
Re
U.S.
GAAP
|
|||||||||||||
Total
shareholders’ equity
|
2,045,171 | (131,210 | ) | — | 1,913,961 | ||||||||||||
Total
liabilities and shareholders’ equity
|
$ | 6,753,982 | $ | (181,152 | ) | $ | (19,422 | ) | $ | 6,553,408 | |||||||
(1)
|
Derived
from Paris Re’s financial statements. Certain amounts have been
combined to conform to PartnerRe’s
presentation.
|
(2)
|
U.S.
GAAP adjustments have been provided to PartnerRe by Paris Re and have not
been audited.
|
(3)
|
Reclassification
adjustments have been prepared by PartnerRe to conform to PartnerRe’s
financial statement presentation.
|
Historical
Paris
Re
IFRS
(1)
|
U.S.
GAAP
Adjustments
(2)
|
Notes
|
Historical
Paris
Re
U.S.
GAAP
|
||||||||||
Revenues
|
|||||||||||||
Gross
premiums written
|
$ | 1,402,612 | $ | — | $ | 1,402,612 | |||||||
Net
premiums written
|
1,196,617 | — | 1,196,617 | ||||||||||
Decrease
in unearned premiums
|
14,287 | — | 14,287 | ||||||||||
Net
premiums earned
|
1,210,904 | — | 1,210,904 | ||||||||||
Net
investment income
|
225,760 | — | 225,760 | ||||||||||
Net
realized and unrealized investment (losses) gains
|
(1,138 | ) | 19,919 |
(f)
|
18,781 | ||||||||
Other
loss
|
(1,199 | ) | — | (1,199 | ) | ||||||||
Total
revenues
|
1,434,327 | 19,919 | 1,454,246 | ||||||||||
Expenses
|
|||||||||||||
Losses
and loss expense
|
891,578 | — | 891,578 | ||||||||||
Acquisition
costs
|
196,755 | 6,609 |
(g)
|
203,364 | |||||||||
Other
operating expenses
|
154,746 | (3,403 | ) |
(h)
|
151,343 | ||||||||
Amortization
of intangibles
|
61,848 | (52,183 | ) |
(i)
|
9,665 | ||||||||
Net
foreign exchange losses
|
161,004 | — | 161,004 | ||||||||||
Total
expenses
|
1,465,931 | (48,977 | ) | 1,416,954 | |||||||||
(Loss)
income before taxes
|
(31,604 | ) | 68,896 | 37,292 | |||||||||
Income
tax expense
|
2,601 | 13,087 |
(j)
|
15,688 | |||||||||
Net
(loss) income
|
$ | (34,205 | ) | $ | 55,809 | $ | 21,604 |
Historical
Paris
Re
IFRS
(1)
|
U.S.
GAAP
Adjustments
(2)
|
Notes
|
Historical
Paris
Re
U.S.
GAAP
|
||||||||||
Revenues
|
|||||||||||||
Gross
premiums written
|
$ | 667,223 | $ | — | $ | 667,223 | |||||||
Net
premiums written
|
575,208 | — | 575,208 | ||||||||||
Increase
in unearned premiums
|
(275,712 | ) | — | (275,712 | ) | ||||||||
Net
premiums earned
|
299,496 | — | 299,496 | ||||||||||
Net
investment income
|
43,607 | — | 43,607 | ||||||||||
Net
realized and unrealized investment gains (losses)
|
1,488 | (13,362 | ) |
(f)
|
(11,874 | ) | |||||||
Other
loss
|
(182 | ) | — | (182 | ) | ||||||||
Total
revenues
|
344,409 | (13,362 | ) | 331,047 | |||||||||
Expenses
|
Historical
Paris
Re
IFRS
(1)
|
U.S.
GAAP Adjustments (2)
|
Notes
|
Historical
Paris
Re
U.S.
GAAP
|
||||||||||
Losses
and loss expense
|
201,888 | — | 201,888 | ||||||||||
Acquisition
costs
|
46,450 | — | 46,450 | ||||||||||
Other
operating expenses
|
27,792 | (490 | ) |
(h)
|
27,302 | ||||||||
Amortization
of intangibles
|
21,638 | (21,607 | ) |
(i)
|
31 | ||||||||
Net
foreign exchange gains
|
(75,401 | ) | — | (75,401 | ) | ||||||||
Total
expenses
|
222,367 | (22,097 | ) | 200,270 | |||||||||
Income
before taxes
|
122,042 | 8,735 | 130,777 | ||||||||||
Income
tax expense
|
3,447 | 1,392 |
(j)
|
4,839 | |||||||||
Net
income
|
$ | 118,595 | $ | 7,343 | $ | 125,938 | |||||||
Increase
(decrease) as of March 31, 2009
|
||||||
(dollars
in thousands)
|
||||||
Assets | ||||||
(a) | Adjustment to reflect the fair value of assets underlying the funds withheld asset | $ | 10,169 | |||
(b) | Adjustment to reflect the elimination of intangible assets related to the 2006 bargain purchase | (191,321 | ) | |||
Liabilities | ||||||
(c) | Net tax liabilities | |||||
i. |
Tax
adjustment related to the adjustment on intangible assets
|
(53,348 | ) | |||
ii. |
Tax
adjustment related to the adjustment on the funds withheld
asset
|
3,406 | ||||
(49,942 | ) | |||||
Shareholders’ equity | ||||||
(d) | Currency translation reserves | |||||
i. |
Currency
translation related to the elimination of intangible
assets
|
(14,097 | ) | |||
ii. |
Currency
translation related to the funds withheld asset
|
631 | ||||
iii |
Other
|
440 | ||||
(13,026 | ) | |||||
(e) | Retained earnings and other reserves | |||||
i. |
Cumulative
adjustment related to the elimination of intangible assets, net of tax and
currency translation
|
(123,876 | ) | |||
ii. |
Cumulative
adjustment related to the fair value adjustment on the funds withheld
asset, net of tax and currency translation
|
6,132 | ||||
iii |
Other
|
(440 | ) | |||
(118,184 | ) |
Increase
(decrease)
|
||||||||||
Three
Months Ended March 31, 2009
|
Year
Ended December 31, 2008
|
|||||||||
(dollars
in thousands)
|
||||||||||
Revenues | ||||||||||
(f) | Net realized and unrealized investment (losses) gains | |||||||||
i. |
Adjustment
to reflect the fair value option for invested assets
|
$ | 5,226 | $ | 31,113 | |||||
ii. |
Adjustment
to reflect the fair value of the funds withheld asset
|
(18,588 | ) | (11,330 | ) | |||||
iii. |
Adjustment
related to the amortization of intangible assets
|
— | 136 | |||||||
(13,362 | ) | 19,919 |
Increase
(decrease)
|
||||||||||
Three
Months Ended March 31, 2009
|
Year
Ended December 31, 2008
|
|||||||||
(dollars
in thousands)
|
||||||||||
Expenses | ||||||||||
(g) | Adjustment to record accrued profit commissions | — | 6,609 | |||||||
(h) | Adjustment related to the amortization of intangible assets | (490 | ) | (3,403 | ) | |||||
(i) | Adjustment to reverse the amortization of intangible assets | (21,607 | ) | (52,183 | ) | |||||
Income tax expense | ||||||||||
(j) | Tax impact of foregoing adjustments | 1,392 | 13,087 |
Increase
(decrease) as of March 31, 2009
|
||||||
(dollars
in millions)
|
||||||
Unaudited Pro Forma Condensed Combined Balance Sheet | ||||||
Assets | ||||||
(a) | Cash | |||||
i. |
Adjustment
to reflect the pre-closing return of capital
|
$ | (310.4 | ) | ||
ii. |
Adjustment
to record Paris Re’s estimated transaction costs
|
(15.0 | ) | |||
iii. |
Adjustment
to record PartnerRe’s estimated transaction costs
|
(20.0 | ) | |||
(345.4 | ) | |||||
(b) |
Adjustment
to reduce deferred acquisition costs to their estimated fair
value
|
(154.0 | ) | |||
(c) |
Adjustment
to reflect intangible assets at their estimated fair value (Note
1)
|
234.8 | ||||
(d) |
Adjustment
to reflect the goodwill recognized on the transactions (Note
1)
|
121.6 | ||||
Liabilities | ||||||
(e) | Adjustment to reflect the tax impact of adjustments | 11.5 | ||||
Shareholders’ Equity | ||||||
(f) | Common shares | |||||
i. |
Adjustment
to reflect the elimination of Paris Re common shares
|
(248.5 | ) | |||
ii. |
Adjustment
to reflect the issuance of PartnerRe common shares
|
25.6 | ||||
(222.9 | ) | |||||
(g) | Additional paid-in capital | |||||
i. |
Adjustment
to reflect the elimination of Paris Re’s additional paid-in
capital
|
(927.2 | ) | |||
ii. |
Adjustment
to reflect the issuance of PartnerRe common shares
|
1,730.0 | ||||
iii. |
Adjustment
to reflect the fair value of Paris Re’s stock-based awards
outstanding
|
45.0 | ||||
iv. |
Unrecognized
compensation on unvested Paris Re restricted share units
|
(26.0 | ) | |||
821.8 |
Increase
(decrease) as of March 31, 2009
|
||||||
(h) | Adjustment to reflect the elimination of Paris Re’s accumulated other comprehensive income | (110.0 | ) | |||
(i) | Retained earnings | |||||
i. |
Adjustment
to reflect the pre-closing return of capital
|
(310.4 | ) | |||
ii. |
Adjustment
to record PartnerRe’s and Paris Re’s estimated transaction
costs
|
(26.2 | ) | |||
iii. |
Adjustment
to reflect the elimination of Paris Re’s retained earnings
|
(306.7 | ) | |||
(643.3 | ) |
Increase
(decrease)
|
|||||||||
Three
Months Ended March 31, 2009
|
Year
Ended December 31, 2008
|
||||||||
(dollars
in millions)
|
|||||||||
Unaudited Pro Forma Condensed Combined Income Statement | |||||||||
Revenues | |||||||||
(j) |
Adjustment
to reduce net investment income for the impact of the pre-close return of
capital of $310.4 million and transaction costs of $35 million, assuming a
4.8% investment yield for 2008 and 4.7% for 2009.
|
$ | (4.1 | ) | $ | (16.6 | ) | ||
Expenses | |||||||||
(k) |
Adjustment
to amortize the intangible assets. Amortization periods were
based on the estimated duration of the underlying cash flows and are
assumed to be four years related to unpaid losses and loss expense, two
years related to unearned premiums and three years related to renewal
rights.
|
(0.8 | ) | (3.2 | ) | ||||
Income tax expense | |||||||||
(l) |
Represents
the tax impact of the foregoing adjustments assuming a 25% tax rate. This
tax rate is a blended rate based on the local statutory tax rates for
Paris Re’s operations.
|
(0.8 | ) | (3.3 | ) |
Historical
PartnerRe
|
Pro
Forma Adjustments
|
Pro
Forma Combined
|
||||||||||
Total
shareholders’ equity
|
$ | 4,282,067 | $ | 1,759,595 | $ | 6,041,662 | ||||||
Less:
preferred shares
|
(520,000 | ) | — | (520,000 | ) | |||||||
Common
shareholders’ equity
|
$ | 3,762,067 | $ | 1,759,595 | $ | 5,521,662 | ||||||
Basic
common shares outstanding
|
56,579.1 | 25,713.3 | 82,292.4 | |||||||||
Diluted
common and common share equivalents outstanding
|
57,388.2 | 25,762.3 | 83,150.5 | |||||||||
Basic
book value per common share
|
$ | 66.49 | $ | 67.10 | ||||||||
Diluted
book value per common share
|
$ | 65.55 | $ | 66.41 | ||||||||
Historical
PartnerRe
|
Pro
Forma Adjustments
|
Pro
Forma Combined
|
||||||||||
Numerator:
|
||||||||||||
Net
income
|
$ | 46,567 | $ | 11,581 | $ | 58,148 | ||||||
Less:
preferred dividends
|
(34,525 | ) | — | (34,525 | ) | |||||||
Net
income available to common shareholders
|
$ | 12,042 | $ | 11,581 | $ | 23,623 | ||||||
Denominator:
|
||||||||||||
Weighted
average number of common shares outstanding – basic
|
54,347.1 | 25,713.3 | 80,060.4 | |||||||||
Weighted
average number of common and common share equivalents outstanding –
diluted
|
55,639.6 | 25,762.3 | 81,401.9 | |||||||||
Basic
net income per share
|
$ | 0.22 | $ | 0.30 | ||||||||
Diluted
net income per share
|
$ | 0.22 | $ | 0.29 |
Historical
PartnerRe
|
Pro
Forma Adjustments
|
Pro
Forma Combined
|
||||||||||
Numerator:
|
||||||||||||
Net
income
|
$ | 141,521 | $ | 123,498 | $ | 265,019 | ||||||
Less:
preferred dividends
|
(8,631 | ) | — | (8,631 | ) | |||||||
Net
income available to common shareholders
|
$ | 132,890 | $ | 123,498 | $ | 256,388 | ||||||
Denominator:
|
||||||||||||
Weighted
average number of common shares outstanding – basic
|
56,511.2 | 25,713.3 | 82,224.5 | |||||||||
Weighted
average number of common and common share equivalents outstanding –
diluted
|
57,320.3 | 25,762.3 | 83,082.6 | |||||||||
Basic
net income per share
|
$ | 2.35 | $ | 3.12 | ||||||||
Diluted
net income per share
|
$ | 2.32 | $ | 3.09 |
Name
of Beneficial Owner
|
Amount and
Nature of Beneficial
Ownership
|
Percentage
of
Outstanding
Common
Shares
|
||||||
Patrick
A. Thiele
|
542,748 | (1) | * | |||||
Albert
A. Benchimol
|
286,684 | (2) | * | |||||
Bruno
Meyenhofer
|
267,794 | (3) | * | |||||
Costas
Miranthis
|
73,091 | (4) | * | |||||
Scott
D. Moore
|
197,877 | (5) | * | |||||
Theodore
C. Walker
|
46,929 | (6) | * | |||||
John
A. Rollwagen
|
77,274 | (7) | * | |||||
Vito
H. Baumgartner
|
44,778 | (8) | * | |||||
Robert
M. Baylis
|
51,255 | (9) | * | |||||
Judith
Hanratty
|
36,346 | (10) | * | |||||
Jan
H. Holsboer
|
73,719 | (11) | * | |||||
Jean-Paul
L. Montupet
|
41,441 | (12) | * | |||||
Rémy
Sautter
|
38,182 | (13) | * | |||||
Lucio
Stanca
|
16,180 | (14) | * | |||||
Kevin
M. Twomey
|
36,689 | (15) | * | |||||
Jürgen
Zech
|
56,509 | (16) | * | |||||
All
directors and executive officers (16 total)
|
1,887,496 | 3.3 | % |
*
|
Denotes
beneficial ownership of less than
1%
|
(1)
|
Mr.
Thiele held 451,670 exercisable options to purchase common shares and
56,700 restricted share units that were vested. In addition, Mr. Thiele
has acquired 3,478 common shares under the Employee Share Purchase Plan,
and held an additional 30,900 common shares, 15,900 of which were
purchased on the open market.
|
(2)
|
Mr.
Benchimol held 268,781 exercisable options to purchase common shares and
15,623 restricted share units that were vested. In addition, Mr. Benchimol
has acquired 2,280 common shares under the Employee Share Purchase Plan.
Mr. Benchimol holds 17,903 shares in a margin
account.
|
(3)
|
Mr.
Meyenhofer held 247,015 exercisable options to purchase common shares and
17,589 restricted share units that were vested. In addition, Mr.
Meyenhofer has acquired 3,190 common shares under the Employee Share
Purchase Plan and the Swiss Share Purchase
Plan.
|
(4)
|
Mr.
Miranthis held 69,534 exercisable options to purchase common shares and
2,540 restricted share units that were vested. In addition, Mr. Miranthis
has acquired 1,017 common shares under the Employee Share Purchase
Plan.
|
(5)
|
Mr.
Moore held 182,250 exercisable options to purchase common shares and
15,627 restricted share units that were
vested.
|
(6)
|
Mr.
Walker held 44,365 exercisable options to purchase common shares and 1,719
restricted share units that were vested. In addition, Mr. Walker has
acquired 845 common shares under the Employee Share Purchase
Plan.
|
(7)
|
Mr.
Rollwagen held exercisable options to purchase 49,413 common shares. In
addition, Mr. Rollwagen has 23,861 restricted share units, which vested
immediately with a delivery date restriction of five years from date of
grant. Mr. Rollwagen also held 4,000 common shares that he purchased on
the open market.
|
(8)
|
Mr.
Baumgartner held exercisable options to purchase 34,991 common shares. Mr.
Baumgartner has been granted 9,787 restricted share units, which vested
immediately with a delivery date restriction of five years from date of
grant.
|
(9)
|
Mr.
Baylis held exercisable options to purchase 36,124 common shares. In
addition, Mr. Baylis has been granted 12,458 restricted share units, which
vested immediately with a delivery date restriction of five years from
date of grant and 673 common shares. Mr. Baylis also held 2,000 common
shares that he purchased on the open
market.
|
(10)
|
Ms.
Hanratty held exercisable options to purchase 29,741 common shares. In
addition, Ms. Hanratty has been granted 6,605 restricted share units,
which vested immediately with a delivery date restriction of five years
from date of grant.
|
(11)
|
Mr.
Holsboer held exercisable options to purchase 60,866 common shares. In
addition, Mr. Holsboer has been granted 11,656 restricted share units,
which vested immediately with a delivery date restriction of five years
from date of grant, and 1,197 common
shares.
|
(12)
|
Mr.
Montupet held exercisable options to purchase 32,366 common shares. In
addition, Mr. Montupet has been granted 7,659 restricted share units,
which vested immediately with a delivery date restriction of five years
from date of grant, and 1,416 common
shares.
|
(13)
|
Mr.
Sautter held exercisable options to purchase 28,124 common shares. In
addition, Mr. Sautter has been granted 10,058 restricted share units,
which vested immediately with a delivery date restriction of five years
from date of grant.
|
(14)
|
Mr.
Stanca held exercisable options to purchase 9,569 common shares. In
addition, Mr. Stanca has been granted 6,611 restricted share units, which
vested immediately with a delivery date restriction of five years from
date of grant.
|
(15)
|
Mr.
Twomey held exercisable options to purchase 27,866 common shares. In
addition, Mr. Twomey has 8,823 restricted share units, which vested
immediately with a delivery date restriction of five years from date of
grant.
|
(16)
|
Dr.
Zech held exercisable options to purchase 43,691 common shares. In
addition, Dr. Zech has been granted 12,143 restricted share units, which
vested immediately with a delivery date restriction of five years from
date of grant. Dr. Zech also held 675 common shares that he purchased on
the open market.
|
Name
and Address of Beneficial Owner
|
Amount
and Nature of Beneficial Ownership
|
Percent
of Class
|
||||||
FMR
LLC
82
Devonshire Street
Boston,
MA, 02109, U.S.A.
|
5,497,856 | (1) | 9.45 | % | ||||
Wellington
Management Company, LLP
75
State Street
Boston,
MA, 02109, U.S.A.
|
2,928,404 | (2) | 5.03 | % |
(1)
|
As
of December 31, 2008, based on a joint report on Schedule 13G/A filed on
February 17, 2009, FMR LLC, Edward C. Johnson 3rd and Fidelity Management
& Research Company are together deemed to be the beneficial owners and
have sole dispositive power over 5,497,856 common shares. The Schedule
13G/A states that no one person’s interest exceeds 5% of PartnerRe’s total
outstanding common shares.
|
(2)
|
As
of December 31, 2008, based on a report on Schedule 13G filed on February
17, 2009, Wellington Management Company, LLP beneficially owns 2,928,404
common shares.
|
Name
and Address of Beneficial Owner
|
Amount
and Nature of Beneficial Ownership
|
Percent
of Class*
|
||||||
FMR
LLC
82
Devonshire Street
Boston,
MA, 02109, U.S.A.
|
5,497,856 | (1) | 6.68 | % | ||||
Stone
Point Capital LLC
20
Horseneck Lane
Greenwich,
CT, 06830, U.S.A.
|
4,877,887 | (2) | 5.93 | % | ||||
Hellman
& Friedman LLC
One
Maritime Plaza, 12th Floor
San
Francisco, CA, 94111, U.S.A.
|
4,130,357 | 5.02 | % |
*
|
Based
on the “base case assumptions” described under “The Transactions—Ownership
of PartnerRe Following the Transactions,” the respective beneficial
ownership percentages are computed assuming there will be outstanding
approximately 82.3 million PartnerRe common shares (net of treasury
shares) at the completion of the
transactions.
|
(1)
|
As
of December 31, 2008, based on a joint report on Schedule 13G/A filed on
February 17, 2009, FMR LLC, Edward C. Johnson 3rd and Fidelity Management
& Research Company are together deemed to be the beneficial owners and
have sole dispositive power over 5,497,856 common shares. The Schedule
13G/A states that no one person’s interest exceeds 5% of PartnerRe’s total
outstanding common shares.
|
(2)
|
Includes
757,232 shares over which Procific has granted Stone Point Capital LLC
sole voting and dispositive power.
|
|
·
|
property;
|
|
·
|
casualty
(including general liability and motor
liability);
|
|
·
|
facultative;
|
|
·
|
credit
and surety;
|
|
·
|
marine,
aviation and space; and
|
|
·
|
life,
accident and health.
|
|
·
|
property;
|
|
·
|
casualty
(including general liability and motor
liability);
|
|
·
|
facultative;
|
|
·
|
credit
and surety;
|
|
·
|
marine,
aviation and space, which is referred to herein as “MAS;”
and
|
|
·
|
life,
accident and health.
|
|
·
|
premiums
from its reinsurance business;
|
|
·
|
investment
income and gains from its portfolio of invested assets including those
underlying the funds withheld asset (see “Liquidity and Capital
Resources—Investments—Funds Withheld Asset” below), net of investment
expenses; and
|
|
·
|
interest
on premium and loss deposits withheld by Paris Re’s
clients.
|
|
·
|
losses
and loss adjustment expenses as offset by recoveries from the
retrocessional reinsurance it
purchases;
|
|
·
|
operating
and administration costs, which
include:
|
|
·
|
treaty
and facultative underwriting acquisition costs, commonly referred to as
commissions and brokerage;
|
|
·
|
overhead
costs, predominantly consisting of salaries and related
costs;
|
|
·
|
interest
expenses;
|
|
·
|
income
taxes; and
|
|
·
|
costs
of retrocessional reinsurance it
purchases.
|
|
·
|
the
quality of its underwriting and
pricing;
|
|
·
|
the
frequency and severity of incurred losses, including losses from
catastrophes, and the timing of related loss and benefit
payments;
|
|
·
|
its
ability to earn appropriate yields on its investment
portfolio;
|
|
·
|
its
ability to manage operating and administration
costs;
|
|
·
|
its
ability to manage foreign exchange currency
risk;
|
|
·
|
its
ability to maintain an adequate capitalization and financial strength
rating;
|
|
·
|
its
ability to manage claims effectively;
and
|
|
·
|
its
ability to efficiently and effectively manage risk, including through
retrocessions.
|
|
·
|
AXA,
Colisée Re and Paris Re entered into a reserve agreement, which is
referred to herein as the “reserve agreement,” pursuant to which AXA and
Colisée Re agreed to guarantee reserves relating to losses incurred
prior to January 1, 2006. The reserve guarantee provided by AXA
is conditioned upon, among other things, the guaranteed business,
including all related ceded reinsurance, being managed by an affiliate of
AXA.
|
|
·
|
Colisée
Re and affiliates of Paris Re entered into two quota share retrocession
agreements to reinsure substantially all of the business of Colisée Re:
one between Paris Re (France) and Colisée Re and the other between the
Canadian branch of Paris Re (France) and the Canadian branch of Colisée
Re. The two quota share retrocession agreements are
collectively referred to herein as the “quota share retrocession
arrangement.”
|
|
·
|
Colisée
Re and Paris Re (France) entered into an issuance agreement, which is
referred to herein as the “issuance agreement,” pursuant to which Colisée
Re wrote certain business on behalf of Paris Re (France) for a specified
period that ended on September 30, 2007. The issuance agreement
enabled Paris Re (France) to write business, through Colisée Re, during a
period after the closing of the 2006 acquisition when Paris re (France)
had not yet obtained a standalone financial strength
rating.
|
|
·
|
Paris
Re (France) and Colisée Re entered into a claims management and services
agreement, pursuant to which Paris Re (France) agreed to provide certain
services, including claims management, in respect of the business that is
covered by the quota share retrocession arrangement but not subject to the
reserve guarantee of AXA and
Colisée Re.
|
|
·
|
in
net income for the exchange difference applicable to the amortized cost of
an asset; and
|
|
·
|
in
shareholders’ equity for the remaining foreign exchange
difference.
|
|
·
|
significant
financial difficulty of the issuer;
|
|
·
|
the
risk of non-performance of a contract due to non-payment or to a delay in
the payment of principal or of
interest;
|
|
·
|
the
grant by a lender, for economic or legal reasons, of a concession it would
not otherwise grant;
|
|
·
|
the
risk of bankruptcy or of financial restructuring of the
issuer;
|
|
·
|
the
risk of deterioration of equity markets following a financial
crisis;
|
|
·
|
the
existence of objective data indicating a measurable decrease in the
estimated future cash flow of the financial asset, or an adverse
development of the payment status of borrowers indicating the risk of
asset default; or
|
|
·
|
a
significant or continuous decline in fair value below its amortized
cost.
|
|
·
|
for
unrealized loss in excess of 50%, Paris Re reports an impairment charge of
100% of the unrealized loss; and
|
|
·
|
for
unrealized losses below 50%, Paris Re reports an impairment charge in the
income statement which corresponds to 100% of the unrealized loss, if two
of the three following criteria are
met:
|
|
·
|
consistent
unrealized loss greater than 20% for a period of six consecutive months,
as measured on the final date of applicable reporting
period;
|
|
·
|
a
rating of less than A-; or
|
|
·
|
a
solvency ratio below 100% (where the value of the underlying collateral
less the delinquency rate falls below
100%).
|
|
·
|
a
discount rate between 3.5% and 5%, depending on currency;
and
|
|
·
|
the
anticipated payout pattern of such
reserves.
|
December
31, 2008
|
December
31, 2007
|
|||||||
(in
thousands of U.S. dollars, except for percentage
points)
|
||||||||
Income
statement
|
||||||||
Gross
written premiums
|
1,402,612 | 1,276,994 | ||||||
Net
written premiums
|
1,196,617 | 1,150,257 | ||||||
Net
earned premiums
|
1,210,903 | 1,168,017 | ||||||
Claims
net of retrocession(1)
|
(891,578 | ) | (722,401 | ) | ||||
Commissions
and brokerage net of retrocession
|
(196,755 | ) | (202,649 | ) | ||||
Net
underwriting income
|
122,570 | 242,967 | ||||||
Net
investment income
|
225,760 | 231,040 | ||||||
Net
capital gains and losses
|
(553 | ) | 7,092 | |||||
Valuation
of derivative instruments
|
383 | (6,153 | ) | |||||
Variations
in investment impairment
|
(968 | ) | - | |||||
Other
financial items(2)
|
(162,203 | ) | (120,277 | ) | ||||
Net
financial income including debt expense
|
62,419 | 111,702 | ||||||
Net
income from investments in associates using the equity
method
|
- | 608 | ||||||
General
expenses
|
(154,745 | ) | (139,468 | ) | ||||
Net
income before amortization of intangibles
|
30,244 | 215,810 | ||||||
Amortization
of intangibles
|
(61,848 | ) | (127,735 | ) | ||||
Net
income before tax
|
(31,604 | ) | 88,075 | |||||
Income
tax
|
(2,601 | ) | (1,037 | ) | ||||
Total
net income
|
(34,205 | ) | 87,038 | |||||
Balance
sheet data (at end of period)
|
||||||||
Total
intangible assets
|
224,942 | 306,533 | ||||||
Total
financial invested assets
|
4,679,776 | 5,156,781 | ||||||
Ceded
technical reserves
|
230,367 | 126,219 | ||||||
Deferred
tax assets
|
18,825 | 3,479 | ||||||
Total
other assets
|
857,082 | 821,029 | ||||||
Cash
and cash equivalents
|
380,690 | 451,594 | ||||||
Total
assets
|
6,391,681 | 6,865,635 | ||||||
Total
shareholders’ equity
|
2,171,759 | 2,474,115 | ||||||
Total
liabilities relating to reinsurance and investment
contracts
|
3,787,792 | 3,988,812 | ||||||
Provisions
for risks and charges
|
11,947 | 13,368 | ||||||
Deferred
tax liabilities
|
92,498 | 81,798 | ||||||
Total
other payables(3)
|
327,686 | 307,542 | ||||||
Total
liabilities
|
6,391,681 | 6,865,635 | ||||||
Ratios
|
||||||||
Total
loss ratio net of reinsurance(4)
|
73.6 | % | 61.8 | % |
December
31, 2008
|
December
31, 2007
|
|||||||
(in
thousands of U.S. dollars, except for percentage
points)
|
||||||||
Total
net expense ratio(5)
|
29.0 | % | 29.3 | % | ||||
General
and administrative expense ratio(6)
|
12.8 | % | 11.9 | % | ||||
Net
commissions and brokerage expense ratio(7)
|
16.2 | % | 17.3 | % | ||||
Combined
ratio(8)
|
102.7 | % | 91.1 | % |
(1)
|
Claims
net of retrocession, which is sometimes referred to as a “claims charge,”
consists of major losses and attritional losses. A “major” loss
is defined as any event involving multiple insured risks causing a pre-tax
loss to Paris Re, gross of reinsurance, in excess of U.S. $30 million, to
all operating lines combined. All other losses are referred to
as “attritional” or “non-major”
losses.
|
(2)
|
Other
financial items include “exchange rate impact” and “financial
results—other” in Paris Re’s consolidated financial statements included
elsewhere in this proxy statement.
|
(3)
|
Total
other payables consist in payables arising from reinsurance operations,
technical accruals on ceded reinsurance and other
payables.
|
(4)
|
Claims
net of retrocession, divided by net earned premiums. The total
loss ratio net of reinsurance is net of any positive or negative
development on prior years.
|
(5)
|
Sum
of commissions and brokerage net of retrocession including acquisition and
operational expenses and general and administrative expenses, divided by
net earned premiums.
|
(6)
|
Sum
of general expenses, divided by net earned
premiums.
|
(7)
|
Sum
of commissions and brokerage net of retrocession, including acquisition
and operational expenses, divided by net earned
premiums.
|
(8)
|
Sum
of the total loss ratio net of reinsurance and the total net expense
ratio.
|
December
31,
2008
|
December
31,
2007
|
Variance
|
||||||||||
(In
thousands of U.S. dollars)
|
(%)
|
|||||||||||
Bonds
|
65,342 | 22,831 | 186 | % | ||||||||
Equities
|
- | 599 | (100 | )% | ||||||||
Other
financial assets available for sale
|
11,519 | 48,190 | (76 | )% | ||||||||
Other
assets held by non consolidated investment funds
|
402 | 15,184 | (97 | )% | ||||||||
Loans
and other loans
|
155 | (5 | ) | - | ||||||||
Other
investment income
|
217 | (1,304 | ) | (117 | )% | |||||||
Income
from funds withheld asset
|
133,742 | 147,513 | (9 | )% | ||||||||
Income
from cash equivalent
|
17,106 | - | - | |||||||||
Debt
expense
|
||||||||||||
Expenses
on investments and loans
|
(2,723 | ) | (1,967 | ) | 38 | % | ||||||
Total
net investment income
|
225,760 | 231,040 | (2 | )% | ||||||||
Realized
capital gains and losses
|
||||||||||||
Bonds
|
2,485 | 2,009 | 24 | % | ||||||||
Equities
|
(3,040 | ) | 3,931 | (177 | )% | |||||||
Non
consolidated mutual funds invested in other assets (mainly money market
funds)
|
- | 1,152 | (100 | )% | ||||||||
Cash
equivalent
|
3 | - | - | |||||||||
Net
capital gains and losses
|
(553 | ) | 7,092 | (108 | )% | |||||||
Valuation
of derivative instruments
|
383 | (6,153 | ) | (106 | )% | |||||||
Variations
in investment impairment
|
(968 | ) | - | - | ||||||||
Exchange
Rate impact
|
(161,004 | ) | (107,668 | ) | 50 | % | ||||||
Financial
Results—Other
|
(1,199 | ) | (12,609 | ) | (90 | )% | ||||||
Net
financial income including debt expense
|
62,419 | 111,702 | (44 | )% |
Year
ended December 31
|
Property
|
Facultative
|
Casualty
|
Credit/Surety
|
Marine,
Aviation and Space
|
Life,
Accident and Health
|
TOTAL
|
|||||||||||||||||||||||||||||||||||||||||||||||||
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
|||||||||||||||||||||||||||||||||||||||||||
(In
millions of U.S. dollars, except for percentage
points)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gross
written premiums
|
605 | 488 | 243 | 224 | 222 | 242 | 131 | 134 | 102 | 114 | 99 | 76 | 1,403 | 1,277 | ||||||||||||||||||||||||||||||||||||||||||
Net
written premiums
|
476 | 377 | 183 | 208 | 221 | 242 | 119 | 134 | 100 | 114 | 97 | 76 | 1,197 | 1,150 | ||||||||||||||||||||||||||||||||||||||||||
Net
earned premiums
|
474 | 397 | 201 | 198 | 229 | 253 | 119 | 144 | 108 | 110 | 80 | 66 | 1,211 | 1,168 | ||||||||||||||||||||||||||||||||||||||||||
Claims
net of retrocession
|
(287 | ) | (177 | ) | (195 | ) | (149 | ) | (173 | ) | (179 | ) | (80 | ) | (73 | ) | (91 | ) | (99 | ) | (65 | ) | (47 | ) | (892 | ) | (722 | ) | ||||||||||||||||||||||||||||
Commissions
and brokerage net of retrocession
|
(55 | ) | (43 | ) | (27 | ) | (32 | ) | (48 | ) | (53 | ) | (42 | ) | (49 | ) | (13 | ) | (16 | ) | (12 | ) | (9 | ) | (197 | ) | (203 | ) |
Year
ended December 31
|
Property
|
Facultative
|
Casualty
|
Credit/Surety
|
Marine,
Aviation and Space
|
Life,
Accident and Health
|
TOTAL
|
|||||||||||||||||||||||||||||||||||||||||||||||||
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
2008
|
2007
|
|||||||||||||||||||||||||||||||||||||||||||
(In
millions of U.S. dollars, except for percentage
points)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net
underwriting income
|
132 | 177 | (21 | ) | 17 | 8 | 21 | (3 | ) | 23 | 4 | (5 | ) | 3 | 11 | 123 | 243 | |||||||||||||||||||||||||||||||||||||||
General
expenses(1)
|
(66 | ) | (65 | ) | (33 | ) | (29 | ) | (25 | ) | (23 | ) | (10 | ) | (6 | ) | (12 | ) | (10 | ) | (9 | ) | (7 | ) | (155 | ) | (139 | ) | ||||||||||||||||||||||||||||
Total
loss ratio net of reinsurance
|
60.6 | % | 44.6 | % | 97.2 | % | 75.1 | % | 75.7 | % | 70.8 | % | 66.8 | % | 50.4 | % | 84.5 | % | 89.9 | % | 81.2 | % | 70.2 | % | 73.6 | % | 61.8 | % | ||||||||||||||||||||||||||||
Net
commissions and brokerage expense ratio
|
11.6 | % | 10.9 | % | 13.4 | % | 16.3 | % | 21.0 | % | 21.1 | % | 35.3 | % | 33.9 | % | 12.2 | % | 14.2 | % | 14.5 | % | 13.7 | % | 16.2 | % | 17.3 | % | ||||||||||||||||||||||||||||
General
and administrative expense ratio
|
13.8 | % | 16.3 | % | 16.3 | % | 14.5 | % | 11.0 | % | 8.9 | % | 8.7 | % | 4.4 | % | 10.9 | % | 9.3 | % | 11.3 | % | 10.4 | % | 12.8 | % | 11.9 | % | ||||||||||||||||||||||||||||
Combined
Ratio
|
86.0 | % | 71.8 | % | 126.9 | % | 105.9 | % | 107.7 | % | 100.8 | % | 110.8 | % | 88.8 | % | 107.6 | % | 113.4 | % | 107.0 | % | 94.2 | % | 102.7 | % | 91.1 | % |
(1)
|
General
expenses by line of business results from the application of an allocation
key by line of business to the total amount of general
expenses. This allocation key is based on a yearly in-depth
study by entity and by budgetary section. For each entity or
budgetary section, an allocation by line of business is performed using
indicators chosen by Paris Re’s management control department and the
managers of the relevant budgetary sections. These indicators include
headcounts, timesheets, amounts of premiums, and amounts of
claims.
|
Year
Ended December 31,
|
||||||||||||
2008
|
2007
|
Variation
|
||||||||||
(in
millions of U.S. dollars, except for percentage
points)
|
||||||||||||
Gross
written
premiums
|
605 | 488 | 117 | |||||||||
Net
written
premiums
|
476 | 377 | 99 | |||||||||
Net
earned
premiums
|
474 | 397 | 77 | |||||||||
Claims
net of
retrocession
|
(287 | ) | (177 | ) | (110 | ) | ||||||
Commissions
and brokerage net of
retrocession
|
(55 | ) | (43 | ) | (12 | ) | ||||||
Net
underwriting
income
|
132 | 177 | (45 | ) | ||||||||
General
expenses
|
(66 | ) | (65 | ) | (1 | ) | ||||||
Total
loss ratio net of
reinsurance
|
60.6 | % | 44.6 | % |
16.0
|
pts. | ||||||
Net
commissions and brokerage expense
ratio
|
11.6 | % | 10.9 | % |
0.7
|
pts. | ||||||
General
and administrative expense
ratio
|
13.8 | % | 16.3 | % |
(2.5
|
) pts. | ||||||
Combined
ratio
|
86.0 | % | 71.8 | % |
14.2
|
pts. |
Year
Ended December 31,
|
||||||||||||
2008
|
2007
|
Variation
|
||||||||||
(in
millions of U.S. dollars, except for percentage
points)
|
||||||||||||
Gross
written
premiums
|
243 | 224 | 19 | |||||||||
Net
written
premiums
|
183 | 208 | (24 | ) | ||||||||
Net
earned
premiums
|
201 | 198 | 3 | |||||||||
Claims
net of
retrocession
|
(195 | ) | (149 | ) | (47 | ) | ||||||
Commissions
and brokerage net of
retrocession
|
(27 | ) | (32 | ) | 5 | |||||||
Net
underwriting
income
|
(21 | ) | 17 | (38 | ) | |||||||
General
expenses
|
(33 | ) | (29 | ) | (4 | ) | ||||||
Total
loss ratio net of
reinsurance
|
97.2 | % | 75.1 | % |
22.1
|
pts. | ||||||
Net
commissions and brokerage expense
ratio
|
13.4 | % | 16.3 | % |
(2.9
|
) pts. | ||||||
General
and administrative expense
ratio
|
16.3 | % | 14.5 | % |
1.8
|
pts. | ||||||
Combined
ratio
|
126.9 | % | 105.9 | % |
21.0
|
pts. |
Year
Ended December 31,
|
||||||||||||
2008
|
2007
|
Variation
|
||||||||||
(in
millions of U.S. dollars, except for percentage
points)
|
||||||||||||
Gross
written
premiums
|
222 | 242 | (20 | ) | ||||||||
Net
written
premiums
|
221 | 242 | (21 | ) | ||||||||
Net
earned
premiums
|
229 | 253 | (24 | ) | ||||||||
Claims
net of
retrocession
|
(173 | ) | (179 | ) | 6 | |||||||
Commissions
and brokerage net of
retrocession
|
(48 | ) | (53 | ) | 5 | |||||||
Net
underwriting
income
|
8 | 21 | (13 | ) | ||||||||
General
expenses
|
(25 | ) | (23 | ) | (2 | ) | ||||||
Total
loss ratio net of
reinsurance
|
75.7 | % | 70.8 | % |
4.9
|
pts. | ||||||
Net
commissions and brokerage expense
ratio
|
21.0 | % | 21.1 | % |
(0.1
|
) pts. | ||||||
General
and administrative expense
ratio
|
11.0 | % | 8.9 | % |
2.1
|
pts. | ||||||
Combined
ratio
|
107.7 | % | 100.8 | % |
6.9
|
pts. |
Year
Ended December 31,
|
||||||||||||
2008
|
2007
|
Variation
|
||||||||||
(in
millions of U.S. dollars, except for percentage
points)
|
||||||||||||
Gross
written
premiums
|
131 | 134 | (3 | ) | ||||||||
Net
written
premiums
|
119 | 134 | (15 | ) | ||||||||
Net
earned
premiums
|
119 | 144 | (25 | ) | ||||||||
Claims
net of
retrocession
|
(80 | ) | (73 | ) | (7 | ) | ||||||
Commissions
and brokerage net of
retrocession
|
(42 | ) | (49 | ) | 7 | |||||||
Net
underwriting
income
|
(3 | ) | 23 | (26 | ) | |||||||
General
expenses
|
(10 | ) | (6 | ) | (4 | ) | ||||||
Total
loss ratio net of
reinsurance
|
66.8 | % | 50.4 | % |
16.4
|
pts. | ||||||
Net
commissions and brokerage expense
ratio
|
35.3 | % | 33.9 | % |
1.4
|
pts. | ||||||
General
and administrative expense
ratio
|
8.7 | % | 4.4 | % |
4.3
|
pts. | ||||||
Combined
ratio
|
110.8 | % | 88.8 | % |
22.0
|
pts. |
Year
Ended December 31,
|
||||||||||||
2008
|
2007
|
Variation
|
||||||||||
(in
millions of U.S. dollars, except for percentage
points)
|
||||||||||||
Gross
written
premiums
|
102 | 114 | (12 | ) | ||||||||
Net
written
premiums
|
100 | 114 | (14 | ) | ||||||||
Net
earned
premiums
|
108 | 110 | (2 | ) | ||||||||
Claims
net of
retrocession
|
(91 | ) | (99 | ) | 8 | |||||||
Commissions
and brokerage net of
retrocession
|
(13 | ) | (16 | ) | 3 | |||||||
Net
underwriting
income
|
4 | (5 | ) | 9 |
Year
Ended December 31,
|
||||||||||||
2008
|
2007
|
Variation
|
||||||||||
(in
millions of U.S. dollars, except for percentage
points)
|
||||||||||||
General
expenses
|
(12 | ) | (10 | ) | (2 | ) | ||||||
Total
loss ratio net of
reinsurance
|
84.5 | % | 89.9 | % |
(5.4
|
) pts. | ||||||
Net
commissions and brokerage expense
ratio
|
12.2 | % | 14.2 | % |
(2.0
|
) pts. | ||||||
General
and administrative expense
ratio
|
10.9 | % | 9.3 | % |
1.6
|
pts. | ||||||
Combined
ratio
|
107.6 | % | 113.4 | % |
(5.8
|
) pts. |
Year
Ended December 31,
|
||||||||||||
2008
|
2007
|
Variation
|
||||||||||
(in
millions of U.S. dollars, except for percentage
points)
|
||||||||||||
Gross
written
premiums
|
99 | 76 | 23 | |||||||||
Net
written
premiums
|
97 | 76 | 21 | |||||||||
Net
earned
premiums
|
80 | 66 | 14 | |||||||||
Claims
net of
retrocession
|
(65 | ) | (47 | ) | (18 | ) | ||||||
Commissions
and brokerage net of
retrocession
|
(12 | ) | (9 | ) | (3 | ) | ||||||
Net
underwriting
income
|
3 | 11 | (8 | ) | ||||||||
General
expenses
|
(9 | ) | (7 | ) | (2 | ) | ||||||
Total
loss ratio net of
reinsurance
|
81.2 | % | 70.2 | % |
11.0
|
pts. | ||||||
Net
commissions and brokerage expense
ratio
|
14.5 | % | 13.7 | % |
0.8
|
pts. | ||||||
General
and administrative expense
ratio
|
11.3 | % | 10.4 | % |
0.9
|
pts. | ||||||
Combined
ratio
|
107.0 | % | 94.2 | % |
12.8
|
pts. |
Period
from incorporation to December 31, 2006
|
||||
(in
thousands of U.S. dollars)
|
||||
Income
statement
|
||||
Gross
written premiums
|
722,884 | |||
Net
written premiums
|
707,286 | |||
Net
earned premiums
|
586,527 | |||
Claims
net of retrocession(1)
|
(253,501
|
) | ||
Commissions
and brokerage net of retrocession
|
(121,909
|
) | ||
Net
underwriting income
|
211,118 | |||
Net
investment income
|
141,008 | |||
Net
capital gains and losses
|
(1,000
|
) | ||
Other
financial items(2)
|
(1,165
|
) | ||
Net
financial income including debt expense
|
138,842 | |||
Net
income from investments in associates using the equity
method
|
1,213 | |||
General
expenses
|
(97,055
|
) | ||
Net
income before amortization of intangibles
|
254,118 | |||
Amortization
of intangibles
|
(100,714
|
) | ||
Recognition
of negative goodwill
|
341,434 | |||
Net
income before tax
|
494,837 | |||
Income
tax
|
(57,825
|
) | ||
Total
net income
|
437,013 | |||
|
||||
Ratios
|
Period
from incorporation to December 31, 2006
|
||||
(in
thousands of U.S. dollars)
|
||||
Total
loss ratio net of reinsurance(3)
|
43.2%
|
|||
Total
net expense ratio(4)
|
37.3%
|
|||
General
and administrative expense ratio(5)
|
16.5%
|
|||
Net
commissions and brokerage expense ratio(6)
|
20.8%
|
|||
Combined
ratio(7)
|
80.6%
|
(1)
|
Claims
net of retrocession, which is sometimes referred to as a “claims charge”,
consists of major losses and attritional losses. A “major” loss
is defined as any event involving multiple insured risks causing a pre-tax
loss to Paris Re, gross of reinsurance, in excess of U.S. $30 million, to
all operating lines combined. All other losses are referred to
as “attritional” or “non-major”
losses.
|
(2)
|
Other
financial items include “exchange rate impact” and “financial
results—other” in Paris Re’s consolidated financial statements included
elsewhere in this proxy statement.
|
(3)
|
Claims
net of retrocession divided by net earned
premiums.
|
(4)
|
Sum
of commissions and brokerage net of retrocession, including acquisition
and operational expenses, and general and administrative expenses, divided
by net earned premiums.
|
(5)
|
Sum
of general expenses, divided by net earned
premiums.
|
(6)
|
Sum
of commissions and brokerage net of retrocession, including acquisition
and operational expenses, divided by net earned
premiums.
|
(7)
|
Sum
of the total loss ratio net of reinsurance and the total net expense
ratio.
|
Period
from
incorporation
to
December 31,
2006
|
||||
(in
thousands of U.S. dollars)
|
||||
Bonds
|
7,191 | |||
Equities
|
393 | |||
Loans
and other
loans
|
535 | |||
Other
investment
income
|
3,938 | |||
Income
from funds withheld
asset
|
129,534 | |||
Debt
expense
|
||||
Expenses
on investments and
loans
|
(583 | ) | ||
Net
investment
income
|
141,008 | |||
Realized
capital gains and losses
|
||||
Bonds
|
(639 | ) | ||
Equities
|
(361 | ) | ||
Net
capital gains and
losses
|
(1,000 | ) | ||
Exchange
Rate impact
|
(1,881 | ) | ||
Financial
results — Other
|
716 | |||
Net
financial income including debt expense
|
138,842 |
December
31, 2008
|
December
31, 2007
|
||||||
(In
thousands of U.S. dollars)
|
|||||||
Cash
flows from operating
activities
|
820,124
|
68,837 | |||||
Cash
flows used in investing
activities
|
(495,264 | ) | (1,193,518 | ) | |||
Cash
flows (used in) from financing
activities
|
(363,129 | ) | 126,590 | ||||
Effects
of exchange rate
changes
|
(32,635 | ) | 6,061 | ||||
Decrease
in cash and cash
equivalents
|
(70,904 | ) | (992,030 | ) | |||
Cash
position at
opening
|
451,594 | 1,443,624 | |||||
Cash
position at
closing
|
380,690 | 451,594 |
Directly
Held Assets
|
funds
withheld asset
|
Total
|
||||||||||||||||||||||||||||||||||
Net
book value
|
Market
value
|
Unrealized
gain/(loss)
|
Net
book value
|
Market
value(1)
|
Unrealized
gain/(loss)(2)
|
Net
book value
|
Market
value
|
Unrealized
gain/(loss)
|
||||||||||||||||||||||||||||
(in
millions of U.S. dollars)
|
||||||||||||||||||||||||||||||||||||
Cash
and cash equivalents
|
381 | 381 | - | 244 | 244 |
-
|
625 | 625 | - | |||||||||||||||||||||||||||
Fixed
maturities available for sale
|
2,039 | 2,078 | 39 | 1,928 | 1,957 | 29 | 3,967 | 4,035 | 68 | |||||||||||||||||||||||||||
Short
term investment available for sale
|
38 | 38 | - | 14 | 14 | - | 52 | 52 | - | |||||||||||||||||||||||||||
Equities
available for sale and Non-consolidated affiliates(3)
|
2 | 2 | - | - | - | - | 2 | 2 | - | |||||||||||||||||||||||||||
Non-consolidated
mutual funds available for sale(4)
|
85 | (5) | 85 | (5) | - | 57 | 58 | 1 | 142 | 143 | 1 | |||||||||||||||||||||||||
Other
assets held at fair value
|
4 | 4 | - | 33 | 33 | - | 38 | 38 | - | |||||||||||||||||||||||||||
Total
Investments
|
2,548 | 2,588 | 39 | 2,276 | 2,306 | 30 | 4,825 | 4,894 | 69 |
(1)
|
The
market value of the assets forming the funds withheld asset is based on
the market value of the assets held by Colisée Re pursuant to the quota
share retrocession arrangement.
|
(2)
|
In
respect of the funds withheld asset account, unrealized gains or losses do
not appear in Paris Re’s consolidated financial
statements.
|
(3)
|
Includes both
equities available for sale and non-consolidated affiliates. See Note 6.2
to the Paris Re financial statements included elsewhere in this proxy
statement.
|
(4)
|
Paris
Re consolidates money-market funds when its share of ownership exceeds
20%. As of December 31, 2008, Paris Re does not own 20% or more of any
money-market funds.
|
(5)
|
Corresponds
principally to cash and cash equivalents awaiting investment in accordance
with Paris Re’s investment
policies.
|
Market
value
|
%
of total
|
|||||||
(in
millions of U.S. dollars)
|
(%)
|
|||||||
Maturity
within twelve
months
|
659 | 16 | % | |||||
Maturity
between one and five
years
|
2,310 | 57 | % | |||||
Maturity
between five and ten
years
|
787 | 20 | % | |||||
Maturity
greater than ten
years
|
280 | 7 | % | |||||
Total
|
4,035 | (1) | 100 | % |
(1)
|
U.S.
$ 1,957 million relates to the funds withheld asset and U.S. $ 2,078
million relates to the directly invested
assets.
|
Market
value
|
%
of total
|
|||||||
(in
millions of U.S. dollars)
|
(%)
|
|||||||
AAA
|
2,368 | 59 | % | |||||
AA+
|
95 | 2 | % | |||||
AA
|
221 | 6 | % |
Market
value
|
%
of total
|
|||||||
(in
millions of U.S. dollars)
|
(%)
|
|||||||
AA–
|
177 | 4 | % | |||||
A+ | 401 | 10 | % | |||||
A | 357 | 9 | % | |||||
A– | 160 | 4 | % | |||||
BB/BBB
|
217 | 5 | % | |||||
Others
|
39 | 1 | % | |||||
Total
|
4,035 | 100 | % |
(1)
|
Of
which U.S. $ 1,957 million is held in the funds withheld asset and U.S. $
2,078 million for directly invested
assets.
|
Market
value (USD)
|
%
|
Market
value (EUR)
|
%
|
Market
value (CAD)
|
%
|
Market
value (SGD)
|
%
|
Market
value (other currencies)
|
%
|
Total
market value (in USD)
|
%
|
|||||||||||||||||||||||||||||||||||||
(where
applicable, equivalent amount in millions of U.S. dollars as December 31,
2008, except for percentages)
|
||||||||||||||||||||||||||||||||||||||||||||||||
Cash
& cash equivalents(1)
|
415 | 14 | % | 56 | 6 | % | 16 | 3 | % | 33 | 13 | % | 104 | 65 | % | 625 | 13 | % | ||||||||||||||||||||||||||||||
Fixed
maturities available for sale(2)
|
2,593 | 86 | % | 759 | 77 | % | 402 | 89 | % | 234 | 87 | % | 48 | 30 | % | 4,035 | 82 | % | ||||||||||||||||||||||||||||||
Short
term financial assets available for sale
|
11 | - | - | - | 33 | 7 | % | - | - | 8 | 5 | % | 52 | 1 | % | |||||||||||||||||||||||||||||||||
Equities
available for sale and Non-consolidated affiliates(3)
|
- | - | 2 | - | - | - | - | - | - | - | 2 | - | ||||||||||||||||||||||||||||||||||||
Non
consolidated investment funds available for sale
|
8 | - | 134 | 14 | % | - | - | - | - | - | - | 143 | 3 | % | ||||||||||||||||||||||||||||||||||
Other
assets held at fair value(4)
|
- | - | 37 | 4 | % | 1 | - | - | - | - | - | 38 | 1 | % | ||||||||||||||||||||||||||||||||||
Total
invested assets
|
3,028 | 100 | % | 988 | 100 | % | 452 | 100 | % | 267 | 100 | % | 159 | 100 | % | 4,894 | 100 | % | ||||||||||||||||||||||||||||||
Percentage
of total
|
62 | % | 20 | % | 9 | % | 5 | % | 3 | % | 100 | % |
(1)
|
Cash
and cash equivalents comprise all cash funds held by Paris
Re
|
(2)
|
Includes
bonds managed by external investment managers as well as bonds held
directly by Paris Re.
|
(3)
|
Includes both
equities available for sale and non-consolidated affiliates. See Note 6.2
to the Paris Re financial statements included elsewhere in this proxy
statement. Equities include publicly traded
shares.
|
(4)
|
Short
term investments in treasury funds.
|
Net
book value
|
Market
value
|
Amount
shown in balance sheet
|
||||||||||
(in
millions of U.S. dollars)
|
||||||||||||
Directly Held
Assets(1)
|
||||||||||||
Fixed
maturities
|
||||||||||||
Bonds
|
||||||||||||
United
States Government and government agencies and authorities
|
562 | 596 | ||||||||||
States,
municipalities and political subdivisions
|
9 | 9 | ||||||||||
Foreign
governments
|
449 | 528 | ||||||||||
Public
utilities
|
4 | 5 | ||||||||||
All
other corporate bonds
|
1,015 | 939 | ||||||||||
Certificates
of deposit
|
- | - | ||||||||||
Total
fixed
maturities
|
2,039 | 2,078 | ||||||||||
Mortgage
loans on real estate
|
1 | 1 | ||||||||||
Other
long-term investments
|
90 | 90 | ||||||||||
Short
term investment available for sale
|
33 | 33 | ||||||||||
Total
Investments
|
2,163 | 2,203 | 2,203 | |||||||||
Funds Withheld
Asset(2)
|
||||||||||||
Fixed
maturities
|
||||||||||||
Bonds
|
||||||||||||
United
States Government and government agencies and authorities
|
513 | 526 | ||||||||||
States,
municipalities and political subdivisions
|
9 | 9 | ||||||||||
Foreign
governments
|
679 | 717 | ||||||||||
Public
utilities
|
4 | 5 | ||||||||||
All
other corporate bonds
|
723 | 699 | ||||||||||
Certificates
of deposit
|
- | - | ||||||||||
Total
fixed
maturities
|
1,928 | 1,957 | ||||||||||
Mortgage
loans on real estate
|
- | - | ||||||||||
Other
long-term investments
|
104 | 105 | ||||||||||
Short
term investment available for sale
|
- | - | ||||||||||
Cash
and cash
equivalents
|
244 | 244 | ||||||||||
Other
assets and liabilities(3)
|
196 | 196 | ||||||||||
Total
Investments
|
2,473 | 2,502 | 2,473 | |||||||||
Total
|
4,676 |
(1)
|
Excludes
Paris Re’s loans and cash and cash equivalents. See Note 6.2 to
Paris Re’s consolidated financial statements included elsewhere in this
proxy statement.
|
(2)
|
The
funds withheld asset is treated as a reinsurance recoverable in Paris Re’s
accounts and is backed by invested assets held by Colisée
Re. Accordingly, the funds withheld asset is reflected at
book value under applicable accounting
standards.
|
(3)
|
Other
assets and liabilities include income from the funds withheld asset
account (U.S. $19.6 million) and the other assets and
liabilities of the funds withheld asset account (U.S. $176.7
million). These items are detailed in Note 6.1 to Paris Re’s
consolidated financial statements included elsewhere in this proxy
statement.
|
2008
|
2007
|
|||||||||||||||
(in
thousands of U.S. dollars)
|
||||||||||||||||
Given
|
Received
|
Given
|
Received
|
|||||||||||||
Financing
commitments(1)
|
– | 246,886 | – | 146,394 | ||||||||||||
Pledged
assets(2)
|
13,641 | 881 | 13,930 | 883 | ||||||||||||
Letters
of credit(3)
|
111,343 | 194 | 15,046 | – | ||||||||||||
Foreign
currency term operations(4)
|
77,319 | 83,757 | 72,461 | 65,268 | ||||||||||||
Other
off-balance sheet commitments
|
– | – | 1,211 | – | ||||||||||||
Total
off balance sheet commitments
|
202,301 | 331,717 | 102,649 | 212,546 |
(1)
|
Financing
commitments correspond to unused credit facilities required by applicable
law or the terms of the relevant reinsurance agreement. See
“Liquidity and Capital Resources—Liquidity Sources”
above.
|
(2)
|
Guaranteed
assets relate to guarantees given to financial institutions and
cedants.
|
(3)
|
Includes
letters of credit provided by Paris Re to cedants in the context of
relevant reinsurance agreements. See “Liquidity and Capital
Resources—Liquidity Sources” above.
|
(4)
|
Foreign
currency term operations include off-balance sheet commitments related to
foreign exchange coverage. The net impact of U.S. $6.4 million
is discussed in Note 13 to Paris Re’s consolidated financial statements
included elsewhere in this proxy
statement.
|
Total
|
<1
year
|
1-3
years
|
3-5
years
|
>5
years
|
||||||||||||||||
(in
thousands of U.S. dollars)
|
||||||||||||||||||||
Operating
leases
|
37,927 | 8,165 | 17,047 | 9,067 | 3,648 | |||||||||||||||
Other
operating agreements
|
13,329 | 10,226 | 3,103 | - | - | |||||||||||||||
Contract
fees under sale agreement
|
2,400 | 2,400 | - | - | - | |||||||||||||||
Funding
committed on invested assets
|
- | - | - | - | - | |||||||||||||||
Unpaid losses and loss
expenses(1)
|
1,322,000 | 516,000 | 463,000 | 172,000 | 172,000 | |||||||||||||||
Dividends
|
473 | 473 | - | - | - | |||||||||||||||
Total
|
1,376,129 | 536,844 | 482,850 | 180,927 | 175,508 |
(1)
|
Corresponds
to the net claims reserves for which Paris Re is at risk and does not
benefit from a guarantee.
|
|
·
|
PartnerRe’s
Annual Report on Form 10-K for the fiscal year ended December 31, 2008,
filed with the SEC on February 27, 2009 (including those portions of
PartnerRe’s Definitive Proxy Statement for the 2009 annual general meeting
of shareholders that are incorporated by reference into PartnerRe’s Form
10-K);
|
|
·
|
PartnerRe’s
Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2009,
filed with the SEC on May 8, 2009;
|
|
·
|
PartnerRe’s
Current Reports on Form 8-K, filed with the SEC on January 6, 2009,
January 12, 2009, February 11, 2009, March 2, 2009, March 16, 2009, May
14, 2009, May 28, 2009 (relating to the departure of directors or certain
officers), May 28, 2009 (relating to amendments to our bye-laws), July 9,
2009, July 10, 2009, July 23, 2009 and July 27, 2009;
and
|
|
·
|
the
description of PartnerRe’s capital stock contained in our registration
statement on Form S-3/ASR filed with the SEC on April 10,
2009.
|
Audited
Consolidated Financial Statements for the years ended
December 31, 2008 and 2007 and the period from March 27, 2006 to December
31, 2006:
|
|
Unaudited
Interim Consolidated Financial Statements for the three months ended March
31, 2009:
|
|
PARIS
RE Holdings
Limited
Consolidated
Balance Sheets as of
December
31, 2008 and 2007 and
consolidated
statements of income,
Shareholders’
equity and cash
flows
for the years ended
December
31, 2008 and 2007 and
for
the period from incorporation
date
to December 31, 2006
|
Report
of Independent Registered Public Accounting Firm
To
the Board of Directors of PARIS RE Holdings Limited
We have audited the accompanying
consolidated balance sheets of PARIS RE Holdings Limited and its subsidiaries (the
“Company”) as of December 31, 2008 and 2007 and the related consolidated
statements of income, shareholders’ equity and cash flows for the years
ended December 31, 2008, December 31, 2007 and for the period from incorporation date
to December 31, 2006.
These financial statements are the responsibility of the Company’s
management. Our responsibility is to express an opinion on these financial
statements based on our audits.
We
conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material misstatement.
The Company is not required to have, nor were we engaged to perform, an
audit of the Company’s internal control over financial reporting. Our
audits included consideration of internal control over financial reporting
as a basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Company’s internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes examining,
on a test basis, evidence supporting the amounts and disclosures in the
financial statements, assessing the accounting principles used and
significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In
our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of PARIS
RE Holdings Limited and
subsidiaries as of December 31, 2008 and 2007, and the results of their
operations and their cash flows for each of the two years ended December
31, 2008 and 2007 and for the period from incorporation date to December
31, 2006, in conformity with International Financial Reporting Standards
(IFRS), as issued by the International Accounting Standards
Board.
Courbevoie, August 5,
2009
|
/s/ Jean-Claude Pauly | ||
M A Z A R S | ||
Jean-Claude
Pauly
Partner
|
||
US $
thousand
|
||||||||||||
ASSETS
|
Note
|
December
31, 2008
|
December
31, 2007
(As
restated see note 9)
|
|||||||||
Intangible
assets
|
||||||||||||
Value of
Business in Force (VBI)
|
199,178 | 261,673 | ||||||||||
Other
intangible assets
|
25,764 | 44,860 | ||||||||||
TOTAL
INTANGIBLE ASSETS
|
5
|
224,942 | 306,533 | |||||||||
Invested
Assets
|
||||||||||||
Financial
invested assets
|
||||||||||||
Funds
Withheld Asset (FWA)
|
6.1
|
2,472,837 | 3,496,370 | |||||||||
Directly held
assets
|
6.2
|
2,202,580 | 1,650,478 | |||||||||
Loans
|
6.2
|
4,359 | 3,430 | |||||||||
Investments
in associates - equity method
|
6.2
|
0 | 6,503 | |||||||||
TOTAL
FINANCIAL INVESTED ASSETS
|
4,679,776 | 5,156,781 | ||||||||||
CEDED
TECHNICAL RESERVES
|
12
|
230,367 | 126,219 | |||||||||
DEFERRED
TAX ASSETS
|
7
|
18,825 | 3,479 | |||||||||
Other
assets
|
||||||||||||
Fixed
assets
|
3,601 | 3,081 | ||||||||||
Receivables
arising from reinsurance operations
|
8.1
|
151,484 | 58,783 | |||||||||
Reserve
agreement
|
17
|
39,621 | 27,860 | |||||||||
Other
operating receivables
|
8.2
|
58,460 | 106,340 | |||||||||
Technical
accruals - assets
|
8.3
|
603,916 | 624,965 | |||||||||
TOTAL
OTHER ASSETS
|
857,082 | 821,029 | ||||||||||
CASH
AND CASH EQUIVALENTS
|
9
|
380,690 | 451,594 | |||||||||
TOTAL
ASSETS
|
6,391,681 | 6,865,635 |
US $
thousand
|
||||||||||||
LIABILITIES
|
Note
|
December
31, 2008
|
December
31, 2007
|
|||||||||
SHAREHOLDERS'
EQUITY
|
||||||||||||
Capital and
capital in excess of nominal value
|
10.1
|
1,317,236 | 1,773,882 | |||||||||
Retained
earnings and other reserves
|
658,483 | 452,822 | ||||||||||
Currency
translation reserves
|
230,245 | 160,372 | ||||||||||
Consolidated
result
|
(34,205 | ) | 87,038 | |||||||||
TOTAL
SHAREHOLDERS' EQUITY
|
10
|
2,171,759 | 2,474,115 | |||||||||
Liabilities
relating to reinsurance and investment contracts
|
||||||||||||
Gross
technical reserves
|
12
|
3,781,353 | 3,981,619 | |||||||||
Foreign
Exchange natural hedging
|
13
|
6,439 | 7,193 | |||||||||
TOTAL
LIABILITIES RELATING TO REINSURANCE AND INVESTMENT
CONTRACTS
|
3,787,792 | 3,988,812 | ||||||||||
PROVISIONS
FOR RISKS AND CHARGES
|
14
|
11,947 | 13,368 | |||||||||
DEFERRED
TAX LIABILITIES
|
7
|
92,498 | 81,798 | |||||||||
DEBT
|
15
|
- | - | |||||||||
Other
liabilities
|
||||||||||||
Payables
relating to reinsurance operations
|
16.1
|
130,106 | 72,101 | |||||||||
Reserve
agreement
|
17
|
109,552 | 114,105 | |||||||||
Payables -
current tax position
|
8,761 | 47,317 | ||||||||||
Other
operating payables
|
16.2
|
50,637 | 55,541 | |||||||||
Technical
accruals - liabilities
|
16.3
|
28,630 | 18,478 | |||||||||
TOTAL
OTHER PAYABLES
|
327,686 | 307,542 | ||||||||||
TOTAL
LIABILITIES
|
6,391,681 | 6,865,635 |
US $
thousand
|
||||||||||||||||
Note
|
12 month
period ended December 31, 2008
|
12
month period ended December 31, 2007
|
Period from incorporation to
December
31, 2006
|
|||||||||||||
Gross
written premiums
|
1,402,612 | 1,276,994 | 722,884 | |||||||||||||
Total
Premium Revenues
|
1,402,612 | 1,276,994 | 722,884 | |||||||||||||
Premiums
ceded
|
(205,996 | ) | (126,738 | ) | (15,598 | ) | ||||||||||
Net
written premiums
|
1,196,617 | 1,150,257 | 707,286 | |||||||||||||
Net variation
in unearned premium reserves
|
14,287 | 17,761 | (120,758 | ) | ||||||||||||
Net
earned premiums
|
1,210,903 | 1,168,017 | 586,527 | |||||||||||||
Claims net of
retrocession
|
(891,578 | ) | (722,401 | ) | (253,501 | ) | ||||||||||
of which claims paid net of
retrocession
|
(1,013,261 | ) | (625,110 | ) | 2,811,760 | |||||||||||
of
which claims reserves variation net of retrocession
|
121,684 | (97,291 | ) | (3,065,261 | ) | |||||||||||
Commissions
and brokerage net of retrocession
|
(196,755 | ) | (202,649 | ) | (121,909 | ) | ||||||||||
Net
underwriting income
|
122,570 | 242,967 | 211,118 | |||||||||||||
Net
investment income
|
225,760 | 231,040 | 141,008 | |||||||||||||
Net capital
gains and losses
|
(553 | ) | 7,092 | (1,000 | ) | |||||||||||
Valuation of
derivative instruments
|
383 | (6,153 | ) | - | ||||||||||||
Variations in
investment impairment
|
6.1
6.2
|
(968 | ) | - | - | |||||||||||
Exchange rate
impact
|
(161,004 | ) | (107,668 | ) | (1,881 | ) | ||||||||||
Financial
results – other
|
(1,199 | ) | (12,609 | ) | 716 | |||||||||||
Net
financial income excluding debt expense
|
62,419 | 111,702 | 138,842 | |||||||||||||
Net
financial income including debt expense
|
18
|
62,419 | 111,702 | 138,842 | ||||||||||||
Net income
from investments in associates using the equity method
|
- | 608 | 1,213 | |||||||||||||
General
expenses
|
19
|
(154,745 | ) | (139,468 | ) | (97,055 | ) | |||||||||
Net
income before amortization of intangibles
|
30,244 | 215,810 | 254,118 | |||||||||||||
Amortization
of intangibles
|
(61,848 | ) | (127,735 | ) | (100,714 | ) | ||||||||||
Net
income before recognition of negative goodwill
|
(31,604 | ) | 88,075 | 153,404 | ||||||||||||
Recognition
of negative goodwill
|
- | - | 341,434 | |||||||||||||
Net
income before tax
|
(31,604 | ) | 88,075 | 494,837 | ||||||||||||
Income
tax
|
20
|
(2,601 | ) | (1,037 | ) | (57,825 | ) | |||||||||
TOTAL
NET INCOME
|
(34,205 | ) | 87,038 | 437,013 | ||||||||||||
Earnings per
share (US
$) (1)
|
23
|
(0.41 | ) | 1.04 | 187.88 | |||||||||||
Diluted
earning per share (US
$) (1)
|
23
|
(0.41 | ) | 1.00 | 187.88 |
(1)
|
In 2006, the
same average number of shares is used for the computation of the earning
per share and the diluted earning per share, ie 716,081 shares. This is
due to the assumption that the market value of the shares is equal to the
purchase price of the transaction, as the shares are not
listed.
|
US $
thousand
|
||||||||||||
12
month period ended
December
31, 2008
|
12
month period ended
December
31, 2007
|
Period
from incorporation to December 31, 2006
|
||||||||||
Net
income of the period (1)
|
(34,205 | ) | 87,038 | 437,013 | ||||||||
Reserves
relating to changes in fair value through shareholders’ equity (1)
|
19,961 | 7,993 | 5,252 | |||||||||
Translation
reserves
|
69,872 | 163,512 | (3,140 | ) | ||||||||
Net
gains and losses recognized directly through shareholders’
equity (2)
|
89,833 | 171,505 | 2,112 | |||||||||
Total
recognized income and expense for the period (1) +
(2)
|
55,628 | 258,543 | 439,125 |
|
(1)
|
Related
to revaluation of available for sale assets (AFS).
|
|
The
SORIE pension impact amounts to USD 0.5 million as at December 31, 2008
and is classified in consolidated
reserves.
|
US $
thousand
|
||||||||||||
12
month period ended
|
12
month period ended
|
Period
from incorporation to
|
||||||||||
December
31, 2008
|
December
31, 2007
(As
restated see note 9)
|
December
31, 2006
(As
restated see note 9)
|
||||||||||
Net
profit (loss)
|
(34,205 | ) | 87,038 | 437,013 | ||||||||
Adjustments:
|
||||||||||||
Income from
associates
|
- | (608 | ) | (1,050 | ) | |||||||
Depreciation
and provisions
|
69,317 | 133,801 | (238,174 | ) | ||||||||
Change in
reinsurance technical reserves
|
(78,927 | ) | 155,086 | 3,187,650 | ||||||||
Fair value
gains – losses
|
(819 | ) | - | 174 | ||||||||
Profit / loss
on disposal and dilution profit and loss
|
(37,064 | ) | (88,425 | ) | 4,721 | |||||||
Revenues
& expenses with no effect on cash flow (1)
|
174,183 | 8,810 | 11,568 | |||||||||
Income
tax
|
2,601 | 1,037 | 57,825 | |||||||||
Effect of
changes in working capital
|
(55,482 | ) | 8,594 | (237,198 | ) | |||||||
Effect of
changes of current account - Quota share COLISEE RE (2)
|
783,962 | (114,392 | ) | (3,123,925 | ) | |||||||
Tax
paid
|
(3,442 | ) | (122,104 | ) | (88,029 | ) | ||||||
Cash
flows from operating activities
|
820,124 | 68,837 | 10,575 | |||||||||
Effect of
changes in group structure
(3)
(6) (8)
|
13,448 | (190,539 | ) | (68,183 | ) | |||||||
Purchase and
sale of intangible and tangible assets
|
(2,069 | ) | 220 | (4,006 | ) | |||||||
Purchase of
financial invested assets
|
(1,815,020 | ) | (3,990,676 | ) | (234,054 | ) | ||||||
Sale of
financial invested assets
|
1,308,377 | 2,987,477 | 138,789 | |||||||||
Increase
(decrease) in loans and advances made
|
- | - | (24,740 | ) | ||||||||
Dividends
received
|
- | - | - | |||||||||
Cash
flows from (used in) investing activities
|
(495,264 | ) | (1,193,518 | ) | (192,194 | ) | ||||||
Proceeds from
issue of shares (4)
(7)
|
(264,339 | ) | 92,706 | 1,636,194 | ||||||||
Treasury
shares
(5)
|
(81,642 | ) | (538 | ) | ||||||||
Uncalled
subscribed capital
|
7,335 | (7,355 | ) | |||||||||
RSU and
stocks options
|
(17,148 | ) | 27,087 | 16,322 | ||||||||
Net financial
interest paid
|
- | - | (106 | ) | ||||||||
Dividends
paid to group shareholders
|
- | - | - | |||||||||
Cash
flows from (used in) financing activities
|
(363,129 | ) | 126,590 | 1,645,055 | ||||||||
Effects of
exchange rate changes
|
(32,635 | ) | 6,061 | (19,812 | ) | |||||||
Increase
(decrease) in cash and cash equivalents
|
(70,904 | ) | (992,030 | ) | 1,443,624 | |||||||
Cash position at
opening
|
451,594 | 1,443,624 | - | |||||||||
Cash
position at closing
|
380,690 | 451,594 | 1,443,624 | |||||||||
Variation
of cash
|
(70,904 | ) | (992,030 | ) | 1,443,624 |
(1)
|
Mainly
exchange rate impact in local accounts.
|
(2)
|
Decrease in
the current account with COLISEE
RE (Asset position) following payments and end of the issuance agreement
on October 1, 2007.
|
(3)
|
This amount is
due to the reorganization of US entities and corresponds to the treasury
of PARIS RE Latin America for US $147 thousand and AXA Space
for US $13,301 thousand. In 2007, PARIS RE Latin America was not
consolidated and AXA Space was consolidated under equity
method.
|
(4)
|
This amount
corresponds to the repayment of capital of US $264,339 thousand paid on
July 11, 2008.
|
(5)
|
PARIS RE has
repurchased 7 million of its own shares for a total cost of US $81,642
thousand.
|
(6)
|
The “Effect of
changes in group structure” relates to the purchase of the following
companies:
|
(7)
|
The “Proceeds
from issue of shares” include for
2007:
|
(8)
|
Cash inflow
due to the acquisition of subsidiaries for US $85,153 thousand and
purchase price of consolidated securities investments for US $(153,336)
thousand.
|
|
·
|
Ike, a
Hurricane, that occurred in September 2008, a major loss in USA (a loss is
considered a major loss if total related claims exceeds US $30 million
gross of reinsurance): the company’s exposure related to Ike is estimated
at US $130 million net cost(1).
|
|
·
|
Several large
losses such as: Emma Windstorm, (Western Europe, on February 29, 2008) for
a US $8.1 million net cost ; Hilal Storm (Germany, on May 31, 2008) for a
US $9.9 million net cost and Hurricane Gustav (USA, in August 2008) for a
US $7.9 million net cost.
|
|
·
|
Windstorm
Kyrill, a major loss in Western Europe which occurred in the early January
2007: the net cost of this event, estimated at US $27 million as at
December 31, 2007, has increased to US $30 million as at December 31,
2008. The variance between those two periods is due to cedants’
information received and USD/EUR exchange rate.
|
|
·
|
UK Floods
event occurred on June 2007 and was considered as a major loss in 2007:
the net cost of this event, estimated at US $16 million as at December 31,
2007 has decreased to US $3 million as at December 31, 2008. This decrease
comes from the confirmation by many ceding companies that claims will not
reach the attachment point of PARIS RE treaties.
Therefore,
this event is no more considered as a major
loss.
|
|
·
|
Reorganization
of PARIS RE America Insurance Company, PARIS RE Latin America and AXA
Space
|
|
·
|
Merger of
PARIS RE Bermuda and PARIS RE
Switzerland:
|
|
·
|
The company’s
gross exposure related to Kyrill, a windstorm that occurred on January 18,
2007 was estimated at US $45
million.
|
|
·
|
The company’s
gross exposure to the June UK floods that occurred on June 25, 2007 was
estimated at US $30 million. It should be noted that the UK floods that
occurred in July 2007 are not a major loss for PARIS
RE.
|
|
·
|
the
Transfer;
|
|
·
|
the
acquisition of all of the outstanding shares of PARIS RE
(France);
|
|
·
|
the creation
of a branch of PARIS RE (France) in Montreal,
Canada;
|
|
·
|
the
reinsurance of substantially all of the business of COLISEE RE through two
quota share retrocession agreements: one between PARIS RE (France) and
COLISEE RE and the other between the Canadian branch of PARIS RE (France)
and the Canadian branch of COLISEE RE. The two quota share
retrocession agreements are referred to herein as the Quota Share
Retrocession Agreement;
|
|
·
|
the
establishment, pursuant to the Quota Share Retrocession Agreement, of
“funds withheld” balances by COLISEE RE for the benefit of PARIS RE
(France), which is referred to herein as the Funds Withheld Asset, or FWA
with a total balance of US $3.1 billion as of December 31, 2006. The
investment income on the Funds Withheld Asset will inure to the Company’s
benefit;
|
|
·
|
The guarantee
by AXA of PARIS RE (France)’s reserves relating to losses incurred prior
to January 1, 2006;
|
|
·
|
The transfer
of substantially all non-insurance-related assets and liabilities of the
Canadian branch of COLISEE RE to the Canadian branch of PARIS RE
(France).
|
|
·
|
Substantially
all of the reinsurance business historically written under the “COLISEE
RE” brand name, except for reinsurance policies issued by COLISEE RE
entities that were not transferred to PARIS RE (France) as part of the
Acquisition Agreements and mainly all life policies of COLISEE RE;
and
|
|
·
|
Reinsurance
policies issued by COLISEE RE pursuant to the issuance arrangements
entered into with COLISEE RE, as described below under “— Issuance
Agreement and Claims Management and Services
Agreement.”
|
|
·
|
Net unearned
premiums;
|
|
·
|
Net losses
(to the extent not subject to the Reserve Agreement) as defined below;
and
|
|
·
|
Allocated
loss adjustment expenses.
|
|
·
|
Amendments to
IAS 39, Financial Instruments: Recognition and Measurement, and to IFRS 7
Financial Instruments Disclosures: Reclassification of Financial
Assets.
|
|
·
|
IFRIC 11,
Group and Treasury Share
Transactions.
|
|
·
|
IFRIC 12,
Service Concession Arrangements.
|
|
·
|
IFRIC 14, IAS
19 – The Limit on a Defined Benefit Asset Minimum Funding
Requirements ant their Interaction.
|
|
·
|
IFRS 8,
Operating segments.
|
|
·
|
Revised IAS
1, Presentation of financial
statements.
|
|
·
|
Amendment to
IAS 23, Borrowing costs.
|
|
·
|
Revised IFRS
3, Business combinations, and related revisions to IAS 27, Consolidated
and separate financial statements and Accounting for investments in
subsidiaries.
|
|
·
|
Amendment to
IFRS 2, Share-Based payment, makes vesting contingent on service
conditions and performance conditions
only.
|
|
·
|
The impact of
the discount of the claims reserves. No margin of uncertainty
was applied due to the Reserve
Agreement;
|
|
·
|
The value of
renewals rights (customer
intangible);
|
|
·
|
The value of
PARIS RE America Insurance Company’s reinsurance licenses;
and
|
|
·
|
Unrealized
gains on assets backing the Funds Withheld Asset with COLISEE
RE.
|
Classification
|
Foreign
Exchange rate
|
Impacts
|
Examples
|
|
Monetary
items
|
Any
|
Closing
rate
|
P&L
|
Bonds, receivables,
technical reserves
|
Non-monetary
items at fair value
|
Available for
Sale (OCI) (1)
|
Rate on the
date of fair value assessment
|
Equity
|
Listed
shares
|
Available for
Sale (P&L) (2)
|
Rate on the
date of fair value assessment
|
P&L
|
Fair value
option
|
|
Non-monetary
items at cost
|
Any
|
Not
revalued
|
-
|
Value
business in force, operating real
estate
|
(1)
|
Available
for sale with variation of fair value through other comprehensive
income.
|
(2)
|
Available
for sale with variation of fair value through profit and loss
income.
|
12 month
period ended
December 31,
2008
|
12 month
period ended
December 31,
2007
|
Period from
incorporation to
December 31,
2006
|
|||||
Average
rate (1)
|
Closing
rate
|
Average
rate (1)
|
Closing
rate
|
Average
rate(2)
|
Closing
rate
|
||
Swiss
Franc
|
0.927
|
0.937
|
0.834
|
0.890
|
0.809
|
0.819
|
|
Canadian
dollar
|
0.959
|
0.819
|
0.934
|
1.019
|
0.885
|
0.862
|
|
Singaporean
dollar
|
0.710
|
0.694
|
0.664
|
0.696
|
0.637
|
0.652
|
|
Euro
|
1.480
|
1.392
|
1.370
|
1.472
|
1.282
|
1.318
|
|
(1)
|
Average
rate over 12 months from January 1 to December 31, for 2007 and
2008.
|
(2)
|
Average
rate from incorporation to December 31,
2006.
|
|
(i)
|
a discount
rate between 3.5% - 5%, according to the currency
|
|
(ii)
|
the
anticipated payout pattern of such
reserves
|
|
·
|
Assets held to maturity (HTM)
accounted for at amortized
cost;
|
|
·
|
Loans & receivables (including
unquoted debt instruments) accounted for at amortized
cost;
|
|
·
|
Trading assets by nature and
equivalent assets (designated on option) accounted for at fair value, with
changes in fair value through profit or
loss;
|
|
·
|
Assets available for sale
(AFS) accounted for at fair value with
changes in fair value reflected in shareholders’
equity.
|
Accounting
|
|
Available
for sale through OCI
|
Variation of
fair value through equity (OCI) and adjusted for
impairment
|
Fair
value through P&L
|
Variation of
fair value through P&L
|
Held to
maturity
|
Amortized
cost adjusted for impairment
|
Loans
and receivables
|
US $
million
|
December
31, 2008
|
||||
Characteristics
|
Type
of financial assets
|
Fair
value of direct assets
|
Net
historical cost of assets in the FWA
|
TOTAL
|
%
|
Active market
(1)
|
Government
bonds
|
634.5
|
712.9
|
1,347.4
|
32.5%
|
Agency
bonds
|
452.1
|
488.2
|
940.3
|
22.7%
|
|
Other
bonds
|
0.0
|
18.0
|
18.0
|
0.4%
|
|
SUB
TOTAL
|
1,086.6
|
1,219.2
|
2,305.7
|
55.5%
|
|
Technical
valuation using observable inputs / markets with medium liquidity (2)
|
Corporate
bonds with medium liquidity
|
806.3
|
634.2
|
1,440.5
|
34.7%
|
SUB
TOTAL
|
806.3
|
634.2
|
1,440.5
|
34.7%
|
|
Technical
valuation using non observable inputs / Market with low or no liquidity
(3)
|
Corporate
bonds with low liquidity
|
89.0
|
46.2
|
135.2
|
3.3%
|
ABS
|
95.9
|
28.0
|
123.9
|
3.0%
|
|
Non quoted
funds, equities, bonds and real estate funds
|
86.3
|
58.1
|
144.4
|
3.5%
|
|
Non
consolidated affiliates
|
1.9
|
0.0
|
1.9
|
0.0%
|
|
SUB
TOTAL
|
273.1
|
132.3
|
405.3
|
9.8%
|
|
TOTAL
|
2,165.9
|
1,985.6
|
4,151.5
|
100%
|
|
Other
financial assets (4)
|
421.7
|
487.2
|
908.9
|
||
TOTAL
FINANCIAL ASSETS
|
2,587.6
|
2,472.8
|
5,060.5
|
(1)
|
An active
market is a market in which there is a significant volume of
trades and in which financial assets are traded over the counter,
electronically traded, daily priced from external pricing vendors or
priced by brokers.
|
(2)
|
The medium
liquidity market is a less active
market.
|
(3)
|
The low
liquidity market is a market in which the volume of trades is
limited.
|
(4)
|
Other
financial assets include cash, cash equivalent, other assets of FWA,
loans, and deposits.
|
US $
million
|
December
31, 2007
|
||||
Characteristics
|
Type
of financial assets
|
Fair
value of direct assets
|
Net
historical cost
of
assets in the FWA
|
TOTAL
|
%
|
Active market
(1)
|
Fixed
maturities and equities
|
1,939.3
|
2,528.9
|
4,468.3
|
96%
|
Technical
valuation using observable market input
|
ABS
|
78.9
|
63.1
|
142.0
|
3%
|
Internal
technical valuation (2)
|
Non
consolidated affiliates, non quoted funds and equities
|
1.9
|
40.8
|
42.7
|
1%
|
TOTAL
|
2,020.2
|
2,632.9
|
4,653.1
|
100%
|
|
Other
financial assets (Cash and other assets of FWA)
|
91.8
|
863.5
|
955.3
|
||
TOTAL
FINANCIAL ASSETS
|
2,112.0
|
3,496.4
|
5,608.4
|
(1)
|
The fair value
of financial assets is derived using external sources such as exchanges
(Euronext for shares) or data providers (IDC and
Bloomberg).
|
(2)
|
Non
consolidated shares and unquoted funds and securities are valued based on
their net asset value.
|
|
·
|
In net income for the exchange
difference applicable to the amortized cost of the asset,
and
|
|
·
|
In shareholders’ equity for the
remaining foreign exchange difference.
|
|
·
|
Significant financial difficulty
of the issuer;
|
|
·
|
The risk of non-performance of a
contract due to non-payment or to a delay in the payment of principal or
of interest;
|
|
·
|
The lender, for economic or legal
reasons, grants a concession it would not otherwise
grant;
|
|
·
|
The risk of bankruptcy or of
financial restructuring of the
issuer;
|
|
·
|
The risk of deterioration of
equity markets following financial
crisis;
|
|
·
|
The existence of objective data
indicating a measurable decrease in the estimated future cash flow of the
financial asset, or an adverse development of the payment status of
borrowers indicating the risk of asset default;
or
|
|
·
|
A significant or continuous
decline in fair value below its amortized
cost.
|
Nature
|
General
comments
|
Other
|
|
Available for sale
(OCI)
|
Equity
|
Impairment
criteria:
-
loss > 20 %,
or
-
loss for a period more than 6 consecutive months.
|
Irreversible
|
Fixed
maturity
|
Fixed
maturity are impaired in case of credit event.
Criteria
allowing to detect a credit event:
-
BIG (Below
investment grade), investment for which the rating is <
BBB :
Individual
assessment of unrealized losses :
·
loss for a period more than 12 months,
or
· loss
for a period more than 6 months and > 20 % at closing.
-
IG (Investment
grade), investment for which the rating is ≥ BBB :
Individual
assessment of unrealized losses :
·
loss for a period more than 6 months and > 20 % (but
less than 50 %) at closing
or
·
loss > 50 % at closing.
In case where
credit risk can be covered:
no
impairment
|
Reversible
|
|
Debt
|
Risk of recoverability on the
total amount due by the issuer
|
Reversible
|
|
Loans
|
Based on actualized future cash
flow
|
Reversible
|
|
Fair value through
P&L
|
AFS P&L
|
Not
applicable
|
|
·
|
Consistent
unrealized loss for a period of six consecutive months and greater than
20% on December 31, 2007 and 2008,
|
|
·
|
A rating of less than
A-,
|
|
·
|
A solvency ratio below 100 %
(where the value of the underlying collateral less the delinquency rate
falls below 100 %).
|
|
·
|
Unrealized
loss superior to 50%
|
|
·
|
The economic characteristics and
risks of the embedded derivative are not closely related to the economic
characteristics and risks of the host contract;
|
|
·
|
A separate instrument with the
same terms as the embedded derivative would meet the definition of a
derivative; and
|
|
·
|
The hybrid (combined) instrument
is not measured at fair value, any change in fair value being recognized
in profit or loss.
|
|
·
|
Reserves for
unearned premiums, consisting of the portion of premiums related to future
risk
|
coverage for
the period beginning on the balance sheet date and ending on the following
expiration date of the contract (or the time limit stipulated in the
contract); and
|
||
|
·
|
The unexpired
risk provision covering the portion of claims and claims expenses that
exceeds the fraction of premiums booked net of deferred acquisition
costs.
|
|
·
|
The premiums
are recognized when they are written. They are generally earned using
straight-line and prorata temporis
rules.
|
|
·
|
By contrast,
large and major losses usually occur during hurricane season, primarily
between July to October for US
exposures.
|
|
·
|
Claims
handling expenses;
|
|
·
|
Acquisition
costs;
|
|
·
|
Administration
expenses;
|
|
·
|
Investment
management costs; and
|
|
·
|
Other
non-underwriting expenses.
|
(1)
|
PARIS RE
Acquisition France is represented together with PARIS RE Holdings France
in this organization chart.
|
(2)
|
Branch office
of PARIS RE.
|
(3)
|
PARIS RE Risc
Ltd. is not consolidated because the impact of its consolidation would not
be material.
|
(4)
|
PARIS RE
Bermuda Ltd has been merged with PARIS RE Switzerland
AG.
|
(5)
|
PARIS RE
Finance GIE is not consolidated because the impact of its consolidation
would not be material.
|
(1)
|
PARIS RE
Acquisition France is represented together with PARIS RE Holdings France
in this organization chart.
|
(2)
|
Branch office
of PARIS RE.
|
(3)
|
Risc Ltd. and
PARIS RE Latin America are not consolidated because the impact of their
consolidation would not be
material.
|
Years ended December 31, 2006 | |||||||||||
Footnote
|
Country | % of control in 2008 | % of interest in 2008 | Consolidation Method | % of control in 2007 | % of interest in 2007 | Consolidation Method | % of control in 2006 | % of interest in 2007 | Consolidation Method | |
Company
|
|||||||||||
PARIS RE
Holdings Ltd
|
(1)
|
Switzerland
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
-
|
-
|
-
|
(Mother
Company as from May 8 ,2007 )
|
|||||||||||
PARIS RE
Switzerland AG
|
(2)
|
Switzerland
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
PARIS RE
Holdings Ltd
|
(1)
|
Bermuda
|
-
|
-
|
-
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
(Mother Compan
y till May 8 ,2007 )
|
|||||||||||
PARIS RE
Bermuda Ltd
|
Bermuda
|
-
|
-
|
-
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
Luxembourg, Sarl
|
Luxembourg
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
Holdings France SA
|
(3)
|
France
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
PARIS RE
Acquisition France SAS
|
(3)
|
France
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
PARIS RE
SA
|
(3), (4),
(5)
|
France
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
Compagnie
Générale de Réassurance de Monte Carlo (CGRM) SA
|
(6)
|
Monaco
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
PARIS RE
America Insurance Company
|
USA
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
AXA Space,
Inc.
|
(7)
|
USA
|
-
|
-
|
-
|
100.0
|
100.0
|
Equity
|
100.0
|
100.0
|
Equity
|
PARIS RE Asia
Pacific Pte. Ltd.
|
(8)
|
Singapore
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
(1)
|
On May 7, 2007
PARIS RE, the parent company of the Group, was re-domiciled from Bermuda
to Switzerland.
|
(2)
|
Includes
former activity of PARIS RE Bermuda Ltd.
|
(3)
|
Represented by
a single block “PARIS RE Holdings France” in the organization
chart.
|
(4)
|
Includes a
branch office in Canada.
|
(5)
|
PARIS RE
(France) was formerly a wholly-owned subsidiary of COLISEE RE, to which
COLISEE RE transferred business in connection with the
Acquisition. PARIS RE (France) created a branch in Canada to
assume the non-life portfolio of COLISEE RE’s Canadian
branch.
|
(6)
|
Compagnie
Générale de Réassurance de Monte-Carlo (CGRM) Shares were legally
transferred to PARIS RE on January 10, 2007 but the
control of the entity was transferred to PARIS RE at the Closing
Date.
|
(7)
|
AXA Space Inc.
was consolidated using the equity method during 2007, despite the fact
that the company is wholly owned, because its
financial impact on the consolidated financial statements is
deemed insignificant. The company is a service provider
(underwriting
agency).
The company has been merged into PARIS RE America Insurance Company during 2008 first half year. |
(8)
|
AXA RE Asia
Pacific Pte. Ltd. Shares were legally transferred to PARIS RE on or before
July 17, 2007 but the control of the entity was
transferred to PARIS RE at the same time as the rest of the
business.
|
US $
thousand
|
||||||||||||||||||||||||||||
December
31, 2006
|
GROSS
|
Depreciation/
Impairment |
Exchange
variations
|
Total
variation
|
GROSS
|
Depreciation/
Impairment |
NET
|
|||||||||||||||||||||
July
1, 2006
|
Variation
|
December
31, 2006
|
||||||||||||||||||||||||||
Reserves
discount
|
356,668 | (62,998 | ) | 5,002 | (57,996 | ) | 363,322 | (64,650 | ) | 298,672 | ||||||||||||||||||
Unrealized
capital gains/losses purchased
|
43,943 | (35,969 | ) | 271 | (35,698 | ) | 45,068 | (36,824 | ) | 8,244 | ||||||||||||||||||
US
licences
|
7,350 | - | 7,350 | 7,350 | ||||||||||||||||||||||||
Intangible
linked to purchase
|
407,961 | (98,967 | ) | 5,273 | (93,694 | ) | 415,740 | (101,474 | ) | 314,266 | ||||||||||||||||||
Unrealized
capital gains/losses purchased of Compagnie générale de
réassurance
|
1,484 | |||||||||||||||||||||||||||
Total
revaluation gross of tax
|
409,445 | |||||||||||||||||||||||||||
Deferred
taxes
|
(133,515 | ) | ||||||||||||||||||||||||||
Total
revaluation net of tax
|
275,930 | |||||||||||||||||||||||||||
Shareholder's
equity
|
381,256 | |||||||||||||||||||||||||||
Revaluation
|
275,930 | |||||||||||||||||||||||||||
Investement
in afiliates
|
(315,753 | ) | ||||||||||||||||||||||||||
Recognition
of negative goodwill
|
341,433 |
US $
thousand
|
||||||||||||||||||||||||
December
31, 2008
|
December
31, 2007
|
|||||||||||||||||||||||
Gross
|
Depreciation/
Impairment |
Net
|
Gross
|
Depreciation/
Impairment |
Net
|
|||||||||||||||||||
Reserve
discount
|
408,474 | (216,646 | ) | 191,828 | 438,741 | (189,420 | ) | 249,321 | ||||||||||||||||
Unrealized
capital gains/losses purchased
|
47,335 | (47,335 | ) | - | 50,521 | (45,519 | ) | 5,002 | ||||||||||||||||
US
licenses
|
7,350 | - | 7,350 | 7,350 | - | 7,350 | ||||||||||||||||||
Value
business in force
|
463,159 | (263,981 | ) | 199,178 | 496,612 | (234,939 | ) | 261,673 | ||||||||||||||||
Right to
renew
|
68,501 | (43,772 | ) | 24,729 | 69,925 | (30,278 | ) | 39,647 | ||||||||||||||||
Software
|
11,812 | (10,777 | ) | 1,035 | 12,602 | (8,282 | ) | 4,320 | ||||||||||||||||
Other
intangibles
|
300 | (300 | ) | 0 | 1,259 | (365 | ) | 894 | ||||||||||||||||
Total
intangible assets
|
592,759 | (367,817 | ) | 224,942 | 580,398 | (273,865 | ) | 306,533 |
US $ thousand | ||||||||||||||||||||||||||||||||||||
Historical Net book value as of Dec 31, 2008 | Market value | Total unrealized gains and losses | Historical Net book value as of Dec 31, 2007 | Purchase price of asset remaining as at Dec 31, 2007 | Unrealized gains and losses Impact of purchase |
Market
value
|
Total unrealized gains and losses - Historical cost | Unrealized gains and losses - Purchase price | ||||||||||||||||||||||||||||
2008 | 2007 | |||||||||||||||||||||||||||||||||||
1 | 2 | 3=2-1 | 4 | 5=4-1 | 6=4-2 | |||||||||||||||||||||||||||||||
Cash and cash
equivalents
|
243,837 | 243,837 | - | 600,702 | 600,702 | - | 600,702 | |||||||||||||||||||||||||||||
Fixed
maturities available for sale
|
1,928,199 | 1,957,593 | 29,394 | 2,410,158 | 2,409,044 | (1,113 | ) | 2,426,767 | 16,609 | 17,723 | ||||||||||||||||||||||||||
Short term
investment available for sale
|
13,602 | 13,602 | - | - | - | - | - | - | - | |||||||||||||||||||||||||||
Equities
available for sale
|
0 | - | 0 | 95,468 | 101,823 | 6,355 | 115,976 | 20,508 | 14,153 | |||||||||||||||||||||||||||
Non
consolidated investment funds available for sale
|
57,431 | 58,081 | 649 | 96,298 | 96,058 | (240 | ) | 108,076 | 11,778 | 12,018 | ||||||||||||||||||||||||||
TOTAL
|
2,243,069 | 2,273,112 | 30,043 | 3,202,626 | 3,207,627 | 5,002 | 3,251,521 | 48,895 | 43,894 | |||||||||||||||||||||||||||
Fixed
maturities at fair value
|
- | - | - | - | ||||||||||||||||||||||||||||||||
Other assets
held at fair value
|
33,458 | 33,458 | - | 30,926 | 30,926 | 30,926 | ||||||||||||||||||||||||||||||
TOTAL
INVESTMENTS
|
2,276,526 | 2,306,570 | 30,043 | 3,233,552 | 3,238,553 | 5,002 | 3,282,447 | 48,895 | 43,894 | |||||||||||||||||||||||||||
Others assets
/ liabilities
|
176,701 | 228,784 | ||||||||||||||||||||||||||||||||||
Revenues of
Funds withheld asset
|
19,610 | 34,034 | ||||||||||||||||||||||||||||||||||
Funds
Withheld Asset
|
2,472,837 | 3,496,370 | ||||||||||||||||||||||||||||||||||
US $ thousand | ||||||||
Market
value of Funds Withheld Asset (FWA)
|
%
of Total
|
|||||||
December
31, 2008
|
||||||||
Debt
securities issued by Governments
|
737,272 | 37.7 | % | |||||
Debt
securities issued by Agencies
|
504,414 | 25.8 | % | |||||
Debt
securities Issued by Corporate
|
672,613 | 34.4 | % | |||||
Mortgage and
Asset-Backed Securities
|
24,950 | 1.3 | % | |||||
Debt
securities from other issuers
|
18,345 | 0.9 | % | |||||
TOTAL
|
1,957,593 | 100 | % |
US $
thousand
|
||||||||
Market
value of Funds Withheld Asset (FWA)
|
%
of Total
|
|||||||
December
31, 2007
|
||||||||
Debt
securities issued by French government
|
52,285 | 2.2 | % | |||||
Debt
securities issued by Foreign governments
|
647,740 | 26.7 | % | |||||
Debt
securities issued by French or Foreign Local
administration
|
423,292 | 17.4 | % | |||||
Debt
securities Issued by public and semi public sectors
|
378,402 | 15.6 | % | |||||
Debt
securities Issued by Corporates
|
863,948 | 35.6 | % | |||||
Mortgage and
asset-backed securities
|
58,282 | 2.4 | % | |||||
Debt
securities from other issuers
|
2,818 | 0.1 | % | |||||
TOTAL
|
2,426,767 | 100 | % |
US $
thousand
|
||||||||||||||||||||
December
31, 2008
|
2008
variation
|
December
31, 2007
|
2007
variation
|
December
31, 2006
|
||||||||||||||||
ABS
|
(26,994 | ) | (23,247 | ) | (3,747 | ) | (3,747 | ) | 0 | |||||||||||
Others
financial assets
|
(17,428 | ) | (9,431 | ) | (7,997 | ) | (3,173 | ) | (4,824 | ) | ||||||||||
Total
Impairment
|
(44,422 | ) | (32,678 | ) | (11,744 | ) | (6,920 | ) | (4,824 | ) |
US $ thousand | ||||||||||||||||||||||||||||||||||||||||
December 31, 2008 |
December 31,
2007
|
|||||||||||||||||||||||||||||||||||||||
Historical Net book value |
Market
value
|
Unrealized gains / Losses | Of which unrealized gains | Of which unrealized losses | Historical Net book value | Market value | Unrealized gains / Losses | Of which unrealized gains | Of which unrealized losses | |||||||||||||||||||||||||||||||
1
|
2 | 3=2-1 | 1 | 2 | 3=2-1 | |||||||||||||||||||||||||||||||||||
Fixed
maturities available for sale
|
2,038,553 | 2,077,754 | 39,201 | 57,019 | (17,818 | ) | 1,273,417 | 1,281,560 | 8,143 | 12,199 | (4,056 | ) | ||||||||||||||||||||||||||||
Short term
investment available for sale
|
38,129 | 38,129 | - | - | - | 458,607 | 458,607 | - | - | - | ||||||||||||||||||||||||||||||
Equities
available for sale
|
290 | 297 | 7 | 7 | - | 14,717 | 15,322 | 606 | 1,080 | (474 | ) | |||||||||||||||||||||||||||||
Non
consolidated investment funds available for sale (invested in
fixed maturities, equities and other assets)
|
84,254 | 84,835 | 581 | 581 | - | 262,514 | 262,769 | 255 | 3,102 | (2,847 | ) | |||||||||||||||||||||||||||||
Non
consolidated affiliates
|
1,869 | 1,566 | (303 | ) | - | (303 | ) | 2,154 | 1,949 | (205 | ) | 64 | (269 | ) | ||||||||||||||||||||||||||
FINANCIAL
INVESTED ASSETS
|
2,163,094 | 2,202,580 | 39,486 | 57,607 | (18,121 | ) | 2,011,408 | 2,020,207 | 8,799 | 16,445 | (7,646 | ) | ||||||||||||||||||||||||||||
Loans
|
4,359 | 4,359 | - | - | - | 3,430 | 3,430 | |||||||||||||||||||||||||||||||||
Investments in
affiliates - equity method
|
0 | 0 | 0 | - | 5,120 | 6,503 | 1,383 | 1,383 | - | |||||||||||||||||||||||||||||||
Cash and cash
equivalents
|
380,463 | 380,690 | 227 | 227 | - | 81,865 | 81,865 | |||||||||||||||||||||||||||||||||
TOTAL
DIRECT FINANCIAL INVESTMENTS
|
2,547,917 | 2,587,630 | 39,712 | 57,834 | (18,121 | ) | 2,101,823 | 2,112,005 | 10,181 | 17,827 | (7,646 | ) | ||||||||||||||||||||||||||||
US $
thousand
|
||||||||
Market
value
|
%
of Total
|
|||||||
December
31, 2008
|
||||||||
Debt
securities issued by Governments
|
634,458 | 30.5 | % | |||||
Debt
securities issued by Agencies
|
452,099 | 21.8 | % | |||||
Debt
securities Issued by Corporate
|
895,294 | 43.1 | % | |||||
Mortgage and
Asset-Backed Securities
|
95,903 | 4.6 | % | |||||
Debt
securities from other issuers
|
- | 0.0 | % | |||||
TOTAL
|
2,077,754 | 100 | % |
US $
thousand
|
||||||||
Market
value
|
%
of Total
|
|||||||
December
31, 2007
|
||||||||
Debt
securities issued by French governments
|
7,179 | 0.4 | % | |||||
Debt
securities issued by Foreign governments
|
500,494 | 28.8 | % | |||||
Debt
securities issued by French or Foreign Local
administration
|
2,315 | 0.1 | % | |||||
Debt
securities Issued by public and semi public sectors
|
307,026 | 17.6 | % | |||||
Debt
securities Issued by Corporates
|
843,215 | 48.5 | % | |||||
Mortgage and
asset-backed securities
|
79,279 | 4.6 | % | |||||
Debt
securities from other issuers
|
659 | 0.0 | % | |||||
TOTAL
|
1,740,167 | 100 | % |
US $
thousand
|
||||||||||||
December
31, 2008
|
2008
variation
|
December
31, 2007
|
||||||||||
ABS
|
- | - | ||||||||||
Other
bonds (1)
|
(868 | ) | (868 | ) | - | |||||||
Others
financial assets (2)
|
(100 | ) | (80 | ) | (20 | ) | ||||||
Total
Impairment
|
(968 | ) | (948 | ) | (20 | ) |
(1)
|
The variation of Other bonds
directly held impairment includes:
- Impact on
income statement of US $(886) thousand,
- Impact on
currency translation of US $18
thousand.
|
(2)
|
The variation of Other
financial assets directly held impairment includes:
- Impact on
income statement of US $(82) thousand,
- Impact on
currency translation of US $2
thousand.
|
US $
thousand
|
Direct
financial
investment
|
Financial
investment included
in
« Funds Withheld » |
Total
as of December
31, 2008
|
Direct
financial
investment
|
Financial
investment included
in
« Funds Withheld » |
Total
as of December
31, 2007
|
||||||||||||||||||
ABS
Residential
|
1,632 | 27,207 | 28,840 | 1,757 | 59,074 | 60,831 | ||||||||||||||||||
of
which “Subprime”
|
260 | 7,540 | 7,801 | 309 | 13,030 | 13,339 | ||||||||||||||||||
of
which “Alt A”
|
3,714 | 3,714 | 12,587 | 12,587 | ||||||||||||||||||||
of
which “Manufactured housing”
|
746 | 6,516 | 7,262 | 825 | 8,382 | 9,207 | ||||||||||||||||||
of
which “Prime”
|
627 | 9,437 | 10,064 | 623 | 25,075 | 25,698 | ||||||||||||||||||
CMBS
|
1,883 | 818 | 2,701 | 3,737 | 3,236 | 6,973 | ||||||||||||||||||
ABS
Auto
|
- | - | - | 15,120 | - | 15,120 | ||||||||||||||||||
ABS Credit
Card
|
- | - | - | 3,750 | 815 | 4,565 | ||||||||||||||||||
ABS
Equipment
|
- | - | - | 2,500 | - | 2,500 | ||||||||||||||||||
Agency
CMO/MBS
|
76,531 | 0 | 76,531 | 35,893 | - | 35,893 | ||||||||||||||||||
ABS St udent
Loan
|
16,009 | - | 16,009 | 16,311 | - | 16,311 | ||||||||||||||||||
Total
net book value
|
96,055 | 28,025 | 124,081 | 79,068 | 63,125 | 142,193 | ||||||||||||||||||
Unrealized
losses
|
(153 | ) | (3,074 | ) | (3,228 | ) | (151 | ) | (4,962 | ) | (5,113 | ) | ||||||||||||
Total
market value
|
95,902 | 24,951 | 120,853 | 78,917 | 58,163 | 137,080 | ||||||||||||||||||
Total
financial investments, cash and cash equivalent
|
5,060,466 | 5,608,375 | ||||||||||||||||||||||
%
of total financial investments
|
2.4 | % | 2.4 | % | ||||||||||||||||||||
|
·
|
For directly
held assets, the unrealized loss is booked through equity (“Other
Comprehensive Income”) except in the case of impairment, which is booked
through the profit and loss
statement.
|
|
·
|
For the
underlying assets of the Funds Withheld Asset, the unrealized losses after
impairment are offset against unrealized gains. The net amount are an
unrealized gain of US $30 million in 2008 and US $43.9 million in 2007,
which are not recognized in the balance sheet but disclosed in Note
6.1“Funds Withheld Asset”. In case of realized losses and impairment, the
revenue of the FWA will decrease
accordingly.
|
US $
thousand
|
||||||||||||||||||||||||
Detail
of unrealized losses on ABS
|
Direct financial
investment
|
Financial
investment included in
« Funds Withheld » |
Total
as of December 31, 2008
|
Direct
financial investment
|
Financial
investment included in
« Funds Withheld » |
Total
as of December 31, 2007
|
||||||||||||||||||
Unrealized
gains and losses on ABS before impairment (a)
|
(153 | ) | (30,068 | ) | (30,221 | ) | (151 | ) | (8,709 | ) | (8,860 | ) | ||||||||||||
Cumulated
impairment through balance sheet (b)
|
- | (26,994 | ) | (26,994 | ) | - | (3,747 | ) | (3,747 | ) | ||||||||||||||
Outstanding
unrealized gains and losses on ABS (a) – (b)
|
(153 | ) | (3,074 | ) | (3,227 | ) | (151 | ) | (4,962 | ) | (5,113 | ) | ||||||||||||
|
·
|
Lehman
Brothers: US $0.9 million (fully
impaired),
|
|
·
|
American
General Finance (AIG Subsidiary): US $3.7
million,
|
|
·
|
International
Lease Fin. Corp. (AIG Subsidiary): US $3.8
million,
|
|
·
|
iStar
Financial: US $3 million (a US $2 million payment has been received in
January 2009).
|
US $
thousand
|
December
31, 2008
|
|||||||||||
Affiliates
under available for sale
|
Net
acquisition cost
|
Equity
|
%
of control
|
|||||||||
Company
|
||||||||||||
GIE Paris Re
Finance
|
1,392 | 1,392 | 100 | % | ||||||||
PARIS RE Risc
Limited
|
477 | 174 | 100 | % | ||||||||
Investments
in non consolidated affiliates
|
1,869 | 1,566 | - |
US $
thousand
|
December
31, 2007
|
|||||||||||||||||||||||
Affiliates
under available for sale
|
Fair
value
|
Net
acquisition cost
|
Net
unrealized capital gain or losses
|
Equity
|
Of
which Net result
|
%
of control
|
||||||||||||||||||
Company
|
||||||||||||||||||||||||
PARIS RE
Latin America
|
1,713 | 1,649 | 64 | 1,713 | 248 | 100 | % | |||||||||||||||||
PARIS RE Risc
Limited
|
236 | 505 | (269 | ) | 236 | 1 | 100 | % | ||||||||||||||||
Investments
in non consolidated affiliates
|
1,949
|
2,154 | (205 | ) |
1,949
|
249 | - | |||||||||||||||||
Affiliate under equity
method
|
Fair
value
|
Net
acquisition cost
|
Consolidated
reserves
|
Equity
|
Of
which Net result
|
%
of control
|
||||||||||||||||||
Company
|
||||||||||||||||||||||||
AXA Space,
Inc.
|
6,503 | 5,120 | 1,383 | 6,557 | 608 | 100 | % | |||||||||||||||||
Affiliates
using the equity method
|
6,503 | 5,120 | 1,383 | 6,557 | 608 | - |
US $
thousand
|
||||||||||||||||||||||||
December 31,
2008
|
December 31,
2007
|
|||||||||||||||||||||||
France
|
Other
|
TOTAL
|
France
|
Other
|
TOTAL
|
|||||||||||||||||||
VBI related
to the Acquisition
|
51,738 | 11,024 | 62,762 | 67,504 | 17,553 | 85,057 | ||||||||||||||||||
Equalization
reserve
|
33,735 | - | 33,735 | 35,713 | - | 35,713 | ||||||||||||||||||
Tax
deficit
|
(7,209 | ) | - | (7,209 | ) | - | - | - | ||||||||||||||||
Other
(1)
|
(9,942 | ) | (5,673 | ) | (15,615 | ) | (28,817 | ) | (13,633 | ) | (42,450 | ) | ||||||||||||
Total
net deferred tax
|
68,322 | 5,351 | 73,673 | 74,400 | 3,920 | 78,320 | ||||||||||||||||||
Total
deferred tax liabilities
|
82,250 | 10,248 | 92,498 | 74,401 | 7,397 | 81,798 | ||||||||||||||||||
Total
deferred tax assets
|
(13,927 | ) | (4,897 | ) | (18,824 | ) | (2 | ) | (3,477 | ) | (3,479 | ) |
(1)
|
Include mainly
temporary differences
|
|
·
|
in
France:
|
|
·
|
Unrealized
exchange gain on financial assets (French article 38.4) US $(1,806)
thousand in 2008, US $9,195 thousand in
2007.
|
|
·
|
Deferred
acquisition costs:. US $3,786 thousand in 2008, US $6,621 thousand in
2007.
|
|
·
|
Restricted
Stock Units: US $ 3,425 in 2008.
|
|
·
|
Other: concern
mainly temporary differences on reserves of Canadian
branch.
|
US $
thousand
|
||||||||
December
31, 2008
|
December
31, 2007
|
|||||||
Cash
deposited with reinsurers (inward reinsurance)
|
17,483 | 12,203 | ||||||
Reinsurance
receivables (inward reinsurance) (1)
|
129,801 | 44,110 | ||||||
Reinsurance
receivables (outward reinsurance)
|
4,201 | 2,470 | ||||||
TOTAL
|
151,484 | 58,783 |
|
(1)
|
In 2008 all
renewals and new business are in the name of PARIS RE, following the
termination of the Issuance Agreement with COLISEE RE on September 30,
2007.
In 2007,
Receivables from cedants include bad debt allowance accounted as provision
for risk and charges in 2006 and reclassified in 2007. The bad
debt allowance was US $621 thousand as of 31 December 2007 as
compared to US $578 thousand as of 31
December 2006.
|
US $
thousand
|
||||||||
December
31, 2008
|
December
31, 2007
|
|||||||
Separate
account on employee benefit
|
291 | 562 | ||||||
Capital
subscribed not paid
|
- | - | ||||||
Current
accounts
|
1,877 | 2,709 | ||||||
Accrued and
overdue interest (1)
|
- | 130 | ||||||
Other
receivables (2)
|
55,904 | 102,467 | ||||||
Other long
term assets
|
388 | 472 | ||||||
TOTAL
|
58,460 | 106,340 |
|
(1)
|
After December
31, 2008, accrued and overdue interest has been reclassified in short term
investment available for sale.
|
|
(2)
|
For December
31, 2007, other receivables include US $82.6 million of tax advances paid
to the French Tax Authorities, partly undue and recovered for US $50
million in 2008.
As at December
31, 2008, other receivables include US $43 million income tax
prepayment.
|
US $
thousand
|
||||||||
December
31, 2008
|
December
31, 2007
|
|||||||
Premiums to
be written (inward reinsurance)
|
643,744 | 631,658 | ||||||
Commissions
to be written (inward reinsurance)
|
(157,312 | ) | (129,154 | ) | ||||
Commissions
on unearned premiums (inward reinsurance)
|
117,484 | 122,461 | ||||||
TOTAL
|
603,916 | 624,965 |
US $
thousand
|
|||||||||||
December
31, 2008
|
December
31, 2007
|
December
31,
2006
|
|||||||||
Directly held
assets before reclassifications
|
2,202,580 | 2,020,207 |
1,501,431
|
||||||||
Directly held
financial assets reclassified in cash equivalent
|
- | (369,729 | ) |
(1,030,019
|
) | ||||||
Directly held
financial assets after reclassifications
|
2,202,580 | 1,650,478 |
471,412
|
||||||||
Cash and cash
equivalent before reclassifications
|
380,690 | 81,865 |
413,605
|
||||||||
Directly held
financial assets reclassified in cash equivalent
|
- | 369,729 |
1,030,019
|
||||||||
Cash and cash
equivalent after reclassifications
|
380,690 | 451,594 |
1,443,624
|
Premium
|
||||||||||||||||||||||||||||
Number
of shares
|
Par
Value
|
Common
shares
|
Restricted
Shares Units(1)
|
Stock
Options(1)
|
Total
|
Par
Value & Premiums
|
||||||||||||||||||||||
Capital
and share premiums as at December 31, 2008
|
80,659,732 | 390,856 | 895,051 | 16,348 | 14,981 | 926,380 | 1,317,236 | |||||||||||||||||||||
Conversion of
general reserves (share premium) into free reserves (2)
|
(93,517 | ) | (93,517 | ) | (93,517 | ) | ||||||||||||||||||||||
Share buy
back
|
(4,897,373 | ) | (29,572 | ) | (52,070 | ) | (52,070 | ) | (81,642 | ) | ||||||||||||||||||
RSU and
SO
|
(21,271 | ) | 4,123 | (17,148 | ) | (17,148 | ) | |||||||||||||||||||||
Change in
number of shares and par value
|
(264,339 | ) | (264,339 | ) | ||||||||||||||||||||||||
Capital
and share premiums as at December 31, 2007
|
85,557,105 | 684,767 | 1,040,638 | 37,619 | 10,858 | 1,089,115 | 1,773,882 |
(1)
|
RSU and SO
granted to management and employees are recorded under expenses and
premiums according to their respective vesting
period.
|
(2)
|
This
reclassification of US $ 93.5 million is made between share premiums and
reserves and therefore has no impact on the total consolidated
shareholder’s equity.
|
US $
thousand
|
||||||||||||
Gross
|
|
Tax
|
Net
|
|||||||||
Unrealized
gains or losses of assets available for sale - at December 31,
2008 (1) =(2)+(3)+(5)
|
39,712 | (6,274 | ) | 33,438 | ||||||||
Foreign
exchange impact of
consolidation (2)
|
274 | 98 | 372 | |||||||||
Foreign
exchange impact
|
274 | 98 | 372 | |||||||||
Revaluation
of invested assets available for sale (without exchange impact of
consolidation) (3)=(4)+(5)
|
24,245 | (4,285 | ) | 19,961 | ||||||||
Revaluation
on acquisitions during the
year (4)
|
18,478 | (2,976 | ) | 15,501 | ||||||||
Invested
assets bought in previous
years (5)
|
5,768 | (1,308 | ) | 4,460 | ||||||||
Variations
relating to revaluation of assets
|
3,154 | (2,815 | ) | 339 | ||||||||
Variations
relating to foreign exchange impact on gains and losses
|
(44 | ) | (34 | ) | (78 | ) | ||||||
Variations
relating to foreign exchange impact on historical cost
|
5,126 | (132 | ) | 4,994 | ||||||||
Variations
relating to revaluation of assets after an impairment
|
969 | (89 | ) | 880 | ||||||||
Variations
relating to sale
|
(3,437 | ) | 1,762 | (1,675 | ) | |||||||
Unrealized
gains or losses of assets available for sale - at December 31,
2007 (5)=(6)+(7)+(10)
|
15,192 | (2,087 | ) | 13,105 | ||||||||
Foreign
exchange impact of
consolidation (6)
|
(163 | ) | 24 | (139 | ) | |||||||
Foreign
exchange impact
|
(163 | ) | 24 | (139 | ) | |||||||
Revaluation
of invested assets available for sale (without exchange
impact) (7)=(8)+(9)
|
9,262 | (1,269 | ) | 7,993 | ||||||||
Revaluation
on acquisitions during the
year (8)
|
11,008 | (1,715 | ) | 9,293 | ||||||||
Invested
assets bought in previous
years (9)
|
(1,746 | ) | 446 | (1,301 | ) | |||||||
Other
variations
|
(116 | ) | (116 | ) | ||||||||
Variations
relating to revaluation of assets
|
69 | 68 | 137 | |||||||||
Variations
relating to sale
|
(1,699 | ) | 377 | (1,322 | ) | |||||||
Unrealized
gains or losses of assets available for sale - at December 31,
2006 (10)=(11)+(12)+(13)
|
6,093 | (841 | ) | 5,252 | ||||||||
Revaluation
on acquisitions during the
year (11)
|
2,084 | (435 | ) | 1,649 | ||||||||
Invested
assets bought in previous
years (12)
|
4,009 | (406 | ) | 3,603 | ||||||||
Variations
relating to revaluation of assets
|
895 | 895 | ||||||||||
Variations
relating to foreign exchange impact on gains and losses
|
3,698 | (465 | ) | 3,233 | ||||||||
Variations
relating to foreign exchange impact on historical cost
|
(584 | ) | 59 | (525 | ) | |||||||
Unrealized
gains or losses of assets available for sale – at Incorporation
(13)
|
- | - | - |
US $
thousand
|
||||||||||||
12
month period ended December 31, 2008
|
12
month period ended December 31, 2007
|
Period
from incorporation to December 31, 2006
|
||||||||||
Opening
Shareholders' equity
|
2,474,115 | 2,090,777 | - | |||||||||
Dividends
|
- | - | ||||||||||
Capital
variation
|
(264,339 | ) | 100 | 1,636,194 | ||||||||
RSU and
stocks options (1)
|
(17,148 | ) | 27,087 | 16 322 | ||||||||
Treasury
shares
|
(81,642 | ) | (538 | ) | ||||||||
Capital
increase tied to IPO
|
- | 104,357 | ||||||||||
Currency
translation variation
|
69,872 | 163,512 | (3,139 | ) | ||||||||
Net profit
(loss)
|
(34,205 | ) | 87,038 | 437,013 | ||||||||
Revaluation
of available for sale assets (AFS)
|
19,961 | 7,993 | 5,252 | |||||||||
IPO fees
charged against share premiums
|
- | (11,752 | ) | |||||||||
Other
variations
|
5,146 | 5,541 | (865 | ) | ||||||||
Closing
Shareholders' equity
|
2,171,759 | 2,474,115 | 2,090,777 |
(1)
|
For December
31, 2008, the RSU and stock options amount of US $(17,148) thousand
includes the delivery of shares as at December 29, 2008 for US $(37,713)
thousand.
|
(Number)
December
31, 2008
|
RSU (1)
|
Stock
Options
|
Shares
|
Warrants
|
||||||||||||
Welcome
package
|
73,000 | |||||||||||||||
Standard
award
|
2,283,300 | 1,549,635 | ||||||||||||||
Supplemental
award
|
346,750 | 284,355 | ||||||||||||||
Employee
investments
|
301,555 | |||||||||||||||
Total
|
2,703,050 | 1,833,990 | 301,555 |
(1)
|
Restricted
Stock Units.
|
(Number)
December
31, 2008
|
RSU (1)
|
Stock
Options
|
||||||
Welcome
package
|
6,250 | |||||||
Standard
award
|
114,250 | 77,700 | ||||||
Total
|
120,250 | 77,700 |
(Number)
December
31, 2008
|
RSU (1)
|
Stock
Options
|
||||||
Standard
award
|
89,800 | 57,000 | ||||||
Award on
unvested RSU following decrease of capital
|
355,454 | |||||||
Award on
unvested Stock Options following decrease of capital
|
240,340 | |||||||
Total
|
685,594 | 57,000 |
(Numbers)
December
31, 2007
|
RSU (1)
|
Stock
Options
|
Shares
|
Warrants
|
||||||||||||
Welcome
package
|
81,000 | |||||||||||||||
Standard
award
|
2,391,985 | 1,625,680 | ||||||||||||||
Supplemental
award
|
346,750 | 284,355 | ||||||||||||||
Employee
investments
|
367,750 | 301,555 | ||||||||||||||
Total
|
2,819,735 | 1,910,035 | 367,750 | 301,555 |
(1)
|
Restricted
stock units
|
(Numbers)
December
31, 2007
|
RSU (1)
|
Stock
Options
|
||||||
Welcome
package
|
7,250 | |||||||
Standard
award
|
109,000 | 74,665 | ||||||
Total
|
116,250 | 74,665 |
(1)
|
Restricted
stock units.
|
(Numbers)
December
31, 2006
|
RSU (1)
|
SO (2)
|
Shares
|
Warrants
|
||||||||||||
2006 Equity
Award
|
||||||||||||||||
Welcome
Package
|
17,100 | |||||||||||||||
Standard
award
|
490,547 | 333,026 | ||||||||||||||
Supplemental
award
|
69,350 | 56,870 | ||||||||||||||
Employee
investments
|
73,550 | 60,311 | ||||||||||||||
Total
|
576,997 | 389,896 | 73,550 | 60,311 |
(1)
|
Restricted
stock units
|
(2)
|
Stock
options
|
|
·
|
A standard
award for key employees consisting in RSUs and SOs, conditioned upon
continued employment of the
beneficiary,
|
|
·
|
A standard
award in RSU linked to unvested RSUs and SOs following capital
reduction.
|
December
31, 2008
|
Standard
award:
|
Standard
award linked to compensation plan following decrease
capital:
|
|
RSU
|
Stock
Option
|
RSU
|
|
Grant
date
|
June 10,
2008
|
June 10,
2008
|
July 10,
2008
|
Vesting
date : 100 %
|
June 10,
2010
|
June 10,
2012
|
July 10,
2010
|
Initial value
of granted shares
|
CHF
22.51
|
CHF
18.22
|
|
Grant
price
|
CHF
22.51
|
||
Option
expiration date
|
June 10,
2018
|
||
|
·
|
A welcome
package for each new employee consisting in 250 RSUs per employee
conditioned upon continued employment of the
beneficiary,
|
|
·
|
One award for
key employees consisting in RSUs and SOs, conditioned upon continued
employment of the beneficiary.
|
December
31, 2007
|
||
RSU
Award
|
Stock Option
Grant
|
|
Grant
date
|
July 12,
2007
|
July 12,
2007
|
Vesting date:
100 %
|
July 12,
2009
|
July 12,
2011
|
Initial value
of granted shares
|
CHF
32.07
|
|
Grant
price
|
CHF
32.07
|
|
Option
expiration date
|
July 12,
2017
|
|
|
·
|
A welcome
package for each employee consisting in 50 RSUs per employee conditioned
upon continued employment of the
beneficiary,
|
|
·
|
One award for
key employees consisting in RSUs and SO, conditioned upon continued
employment of the beneficiary, and
|
|
·
|
One
supplemental award for certain employees consisting in RSUs and SO not
conditioned upon continued employment of the
beneficiary.
|
December
31, 2006
|
RSU
Award
|
Stock Option
Grant
|
Grant
Date:
|
September 30,
2006
|
September 30,
2006
|
Vesting Date:
100%
|
December 29,
2008
|
December 29,
2010
|
Initial value
of granted shares
|
$100
|
|
Grant
Price:
|
$100
|
|
Option
Expiration Date:
|
December 29,
2016
|
|
December
31, 2006
|
Shares
|
Warrants
|
Purchase
Date:
|
December 28,
2006
|
December 28,
2006
|
Maturity
|
10
years
|
|
Vesting :
Date: 100%
|
Immediate
|
Immediate
|
Purchase
price
|
$100
|
$0.01
|
Strike
price
|
$100
|
|
Restricted
transfer period
|
4 years or
until IPO
|
No transfer
(1)
|
Other
features
|
Dividend
protection
|
|
(1)
|
Before the end
of the period, transfers of the shares are subject to approval by the
Board of Directors, as are all transfers of
warrants.
|
December
31, 2008
|
|||||
Parameter
|
Method
|
Value
|
|||
Volatility
|
Listed
comparable companies
|
25% | |||
Expected
dividends
|
Management's
assessment
|
None
|
|||
Share
price
|
Value at
grant date, on June 10, 2008
|
CHF
22.51
|
|||
Risk-free
rate
|
USD yield
curve in EUR
|
4.95% | |||
Option
life
|
Stated in
contracts
|
10
years
|
|||
Vesting
condition (presence in the company)
|
Management's
assessment based on historical data
|
No
exit
|
|||
US $
thousand
|
||||||||||||||||
December
31, 2008
|
RSUs (1)
|
Stock
Options
|
Warrants
|
Grand
total
|
||||||||||||
Welcome
package
|
185 | 0 | 0 | 185 | ||||||||||||
Standard
award
|
9,751 | 18,215 | 0 | 27,967 | ||||||||||||
Supplemental
award
|
0 | 3,046 | 0 | 3,046 | ||||||||||||
Employee
investments
|
0 | 0 | 3,340 | 3,340 | ||||||||||||
Total
|
9,936 | 21,262 | 3,340 | 34,538 | ||||||||||||
US $
thousand
|
||||||||||||||||
December
31, 2008
|
RSUs(1)
|
Stock
Options
|
Warrants
|
Grand
total
|
||||||||||||
Welcome
package
|
695 | 0 | 0 | 695 | ||||||||||||
Standard
award
|
28,056 | 4,038 | 0 | 32,094 | ||||||||||||
Supplemental
award
|
0 | 0 | 0 | 0 | ||||||||||||
Employee
investments
|
0 | 0 | 0 | 0 | ||||||||||||
Total
|
28,752 | 4,038 | 0 | 32,789 | ||||||||||||
December
31, 2007
|
|||||
Parameter
|
Method
|
Value
|
|||
Volatility
|
Listed
comparable companies
|
25% | |||
Expected
dividends
|
Management's
assessment
|
None
|
|||
Share
price
|
Value at IPO
on July 13, 2007 (1)
|
CHF
32.07
|
|||
Risk-free
rate
|
USD yield
curve in EUR
|
4.91% | |||
Option
life
|
Stated in
contracts
|
10
years
|
|||
Vesting
condition (presence in the company)
|
Management's
assessment based on historical data
|
No
exit
|
|||
US $
thousand
|
||||||||||||||||||||
December
31, 2007
|
RSUs
|
Stock
Options
|
Shares
|
Warrants
|
Grand
total
|
|||||||||||||||
Welcome
package
|
1,821 | |||||||||||||||||||
Standard
award
|
51,604 | 17,210 | ||||||||||||||||||
Supplemental
award
|
6,973 | 2,803 | ||||||||||||||||||
Employee
investments
|
3,069 | |||||||||||||||||||
Total
|
60,398 | 20,013 | 0 | 3,069 | 83,480 | |||||||||||||||
US $
thousand
|
||||||||||||||||||||
December
31, 2007
|
RSUs
|
Stock
Options
|
Shares
|
Warrants
|
Grand
total
|
|||||||||||||||
Welcome
package
|
760 | |||||||||||||||||||
Standard
award
|
22,288 | 4,039 | ||||||||||||||||||
Supplemental
award
|
0 | 0 | ||||||||||||||||||
Employee
investments
|
0 | 0 | ||||||||||||||||||
Total
|
23,048 | 4,039 | 0 | 0 | 27,087 | |||||||||||||||
December
31, 2006
|
|||||
Parameter
|
Method
|
Value
|
|||
Volatility
|
Listed
comparable companies
|
25% | |||
Expected
dividends
|
Management’s
assessment
|
None
|
|||
Share
price
|
Transaction
with the initial investors (1)
|
US
$100
|
|||
Risk-free
rate
|
USD yield
curve
|
5.12% | |||
Option
life
|
Stated in
contracts
|
10
years
|
|||
Vesting
condition (presence in the company)
|
Management’s
assessment based on historical data
|
No
exit
|
|||
Total
ultimate cost
|
||||||||||||||||
US $
thousand
|
||||||||||||||||
December
31, 2006
|
RSU
|
SO
|
Shares
|
Warrants
|
||||||||||||
Welcome
Package
|
1,710 | |||||||||||||||
Standard
award
|
49,055 | 16,318 | ||||||||||||||
Supplemental
award
|
6,935 | 2,787 | ||||||||||||||
Employee
investments
|
0 | 2,955 | ||||||||||||||
Total
|
57,700 | 19,105 | 0 | 2,955 | ||||||||||||
Grand
total
|
79,760 | |||||||||||||||
2006
balance sheet impact
|
||||||||||||||||
US $
thousand
|
||||||||||||||||
December
31, 2006
|
RSU
|
SO
|
Shares
|
Warrants
|
||||||||||||
Welcome
Package
|
190 | |||||||||||||||
Standard
award
|
5,451 | 960 | ||||||||||||||
Supplemental
award
|
6,935 | 2,787 | ||||||||||||||
Employee
investments
|
2,955 | |||||||||||||||
Total
|
12,576 | 3,747 | 0 | 2,955 | ||||||||||||
Grand
total
|
19,277 |
US $
thousand
|
||||||||||||
December
31, 2008
|
December
31, 2007
|
|||||||||||
Gross
claims reserves
|
||||||||||||
Reserves for
claims expenses
|
22,215 | 24,362 | ||||||||||
Claims
reserves
|
3,247,313 | 3 433,856 | ||||||||||
Unexpired
risk reserves
|
5,022 | - | ||||||||||
Equalization
reserves
|
- | - | ||||||||||
Ceded
claims reserves
|
||||||||||||
Claims
reserves
|
(207,768 | ) | (115,185 | ) | ||||||||
Unexpired
risk reserves
|
- | - | ||||||||||
Total
net claims reserves
|
I
|
3,066,782 | 3,343,033 | |||||||||
Net
premium reserves
|
||||||||||||
Gross
unearned premium reserves
|
506,803 | 523,401 | ||||||||||
Ceded
unearned premium reserves
|
(22,599 | ) | (11,034 | ) | ||||||||
Total
net premium reserves
|
II
|
484,205 | 512,367 | |||||||||
TOTAL
GROSS TECHNICAL RESERVES
|
3,781,353 | 3,981,619 | ||||||||||
TOTAL
CEDED TECHNICAL RESERVES
|
(230,367 | ) | (126,219 | ) | ||||||||
TOTAL
NET TECHNICAL RESERVES
|
I
+ II
|
3,550,986 | 3,855,400 |
US $ thousand | ||||||||||||||||||||||||||||||||||||||||||||||||
December 31, 2008 |
December 31,
2007
|
|||||||||||||||||||||||||||||||||||||||||||||||
Notional amount of balance sheet at closing | < 1 year | 1 to 5 years | 5 to 10 years | More than 10 years | Net fair value at closing(1) | Notional amount on balance sheet at closing | < 1 year | 1 to 5 years | 5 to 10 years | More than 10 years | Net fair value at closing(1) | |||||||||||||||||||||||||||||||||||||
MATURITY OF HEDGE |
MATURITY OF
HEDGE
|
|||||||||||||||||||||||||||||||||||||||||||||||
Swaps | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||
Options
|
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||
Future
/ forward
|
6,439 | 6,439 | - | - | - | 6,439 | 7,193 | 7,193 | - | - | - | 7,193 | ||||||||||||||||||||||||||||||||||||
Credit
derivatives
|
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||
Other
derivatives
|
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||
TOTAL
|
6,439 | 6,439 | - | - | - | 6,439 | 7,193 | 7,193 | - | - | 7,193 | |||||||||||||||||||||||||||||||||||||
|
(1)
|
If the fair
value amount at closing is negative then it relates to an unrealized gain
which is reported in the liabilities part of the balance sheet with minus
sign. If the fair value amount at closing is positive then it relates to
an unrealized loss which is reported in the liability side of the balance
sheet.
|
US $
thousand
|
||||||||
December
31, 2008
|
December
31, 2007
|
|||||||
Employee
compensation and benefits (1)
|
11,339 | 13,368 | ||||||
Others
provisions (2)
|
608 | - | ||||||
TOTAL
|
11,947 | 13,368 |
(1)
|
Employee
compensation and benefits include: executive retirement plan, pension and
termination indemnities, minimum lifetime benefit, social security plan
for former executives and employee
awards.
|
(2)
|
Of which lawsuit contingency
provisions for US $487 thousand at December 31, 2008.
At December
31, 2007, Other provisions relate to receivable depreciation reclassified
in 2007 under Receivables, see Note
8.1.
|
US $
thousand
|
||||||||||||||||||||||||
Contributed
amounts
|
Dec.
31, 2008
|
Other (1)
|
P&L
impact
|
Dec.
31, 2007
|
Other (1)
|
P&L
impact
|
||||||||||||||||||
France
|
||||||||||||||||||||||||
Long term incentive
plan
|
- | - | - | - | 219 | -5,656 | ||||||||||||||||||
French incentive
plan
|
1,912 | (243 | ) | (2,291 | ) | 4,446 | 478 | -309 | ||||||||||||||||
Directors' pension
plans
|
2,410 | (52 | ) | 1,504 | 958 | 99 | 15 | |||||||||||||||||
Allowances for end of
career
|
2,658 | (138 | ) | 287 | 2,509 | 253 | 281 | |||||||||||||||||
Minimum
guaranteed
|
32 | (98 | ) | (1,666 | ) | 1,796 | 163 | 659 | ||||||||||||||||
Vacation
birthday
|
365 | (35 | ) | (249 | ) | 649 | 67 | 38 | ||||||||||||||||
Employee
service medals
|
0 | (9 | ) | (159 | ) | 168 | 18 | 4 | ||||||||||||||||
TOTAL
France
|
7,377 | (575 | ) | (2,573 | ) | 10,526 | 1,297 | (4,968 | ) | |||||||||||||||
Bermuda
(until
May 8, 2007) /
Switzerland
|
||||||||||||||||||||||||
Retirement
|
2,249 | (164 | ) | 1,224 | 1,189 | 74 | (284 | ) | ||||||||||||||||
TOTAL
Switzerland
|
2,249 | (164 | ) | 1,224 | 1,189 | 74 | (284 | ) | ||||||||||||||||
Canada
|
||||||||||||||||||||||||
Retirement
(2)
|
926 | (90 | ) | (637 | ) | 1,653 | 828 | - | ||||||||||||||||
TOTAL
Canada
|
926 | (90 | ) | (637 | ) | 1,653 | 828 | - | ||||||||||||||||
USA
|
||||||||||||||||||||||||
Bonuses
|
787 | - | 787 | - | - | - | ||||||||||||||||||
TOTAL
USA
|
787 | - | 787 | - | - | - | ||||||||||||||||||
TOTAL
|
11,339 | (829 | ) | (1,199 | ) | 13,368 | 2,200 | (5,252 | ) | |||||||||||||||
(1)
|
Other :
exchange rate impact and
reclassifications.
|
(2)
|
For 2007:
column “Other” represents principal impact of
SORIE.
|
December
31, 2008
|
Europe
|
North
America
|
Discount
rate
|
5.3%
|
7.5%
|
Salary
increases for inflation
|
3.0%
|
3.5%
|
Asset
yield
|
5.3%
|
7.0%
|
US $
thousand
|
||||||||
December
31, 2008
|
December
31, 2007
|
|||||||
Cash
deposited by reinsurers (outward reinsurance)
|
27,008 | 18,666 | ||||||
Reinsurance
payables (inward reinsurance)
|
53,247 | 23,307 | ||||||
Reinsurance
payables (outward reinsurance)
|
49,851 | 30,127 | ||||||
TOTAL
|
130,106 | 72,101 |
US $
thousand
|
||||||||
December
31, 2008
|
December
31, 2007
|
|||||||
Social
Security and tax payables
|
31,428 | 29,334 | ||||||
Current
accounts (1)
|
140 | 6,040 | ||||||
Accounts
payable on assets purchased
|
3,594 | 158 | ||||||
Accruals and
deferred income
|
43 | 141 | ||||||
Other
accounts payable
|
15,432 | 19,868 | ||||||
TOTAL
|
50,637 | 55,541 |
(1)
|
For December
31, 2007: principally with COLISEE RE and amount paid in July
2007.
|
US $
thousand
|
||||||||
December
31, 2008
|
December
31, 2007
|
|||||||
Premiums to
be written (outward reinsurance)
|
42,608 | 21,492 | ||||||
Commissions
to be written (outward reinsurance)
|
(20,545 | ) | (5,714 | ) | ||||
Commissions
on unearned premiums (outward reinsurance)
|
6,567 | 2,700 | ||||||
TOTAL
|
28,630 | 18,478 |
US $
thousand
|
||||||||||||
12 month
period ended December 31, 2007
As previously
published |
Reserve
Agreement
reclassification |
12
month period ended
December
31, 2007
presented
|
||||||||||
Gross
written premiums
|
1,240,229 | 36,765 | 1,276,994 | |||||||||
Total
Premium Revenues
|
1,240,229 | 36,765 | 1,276,994 | |||||||||
Premiums
ceded
|
(126,738 | ) | - | (126,738 | ) | |||||||
Net
written premiums
|
1,113,491 | 36,765 | 1,150,257 | |||||||||
Net variation
in unearned premium reserves
|
17,761 | 0 | 17,761 | |||||||||
Net
earned premiums
|
1,131,252 | 36,765 | 1,168,017 | |||||||||
Claims net of
retrocession
|
(695,147 | ) | (27,254 | ) | (722,401 | ) | ||||||
Of
which claims paid net of retrocession
|
(597,856 | ) | (27,254 | ) | (625,110 | ) | ||||||
Of
which claims reserves variation net of retrocession
|
(97,291 | ) | - | (97,291 | ) | |||||||
Commissions
and brokerage net of retrocession
|
(193,137 | ) | (9,512 | ) | (202,649 | ) | ||||||
Net
underwriting income
|
242,967 | 0 | 242,967 |
US $
thousand
|
||||||||||||
Period from
incorporation to December 31, 2006
As
previously
published |
Reserve
Agreement
reclassification |
Period from
incorporation to December 31, 2006
presented
|
||||||||||
Gross
written premiums
|
711,295 | 11,589 | 722,884 | |||||||||
Total
Premium Revenues
|
711,295 | 11,589 | 722,884 | |||||||||
Premiums
ceded
|
(15,598 | ) | - | (15,598 | ) | |||||||
Net
written premiums
|
695,696 | 11,589 | 707,286 | |||||||||
Net variation
in unearned premium reserves
|
(120,758 | ) | - | (120,758 | ) | |||||||
Net
earned premiums
|
574,938 | 11,589 | 586,527 | |||||||||
Claims net of
retrocession
|
(214,664 | ) | (38,837 | ) | (253,501 | ) | ||||||
Of
which claims paid net of retrocession
|
2 850,597 | (38,837 | ) | 2,811,760 | ||||||||
Of
which claims reserves variation net of retrocession
|
(3,065,261 | ) | - | (3,065,261 | ) | |||||||
Commissions
and brokerage net of retrocession
|
(149,156 | ) | 27,248 | (121,909 | ) | |||||||
Net
underwriting income
|
211,118 | - | 211,118 |
US $
thousand
|
||||||||||||||||
December
31, 2008
|
Currency
translation
|
2008
variation
|
December
31, 2007
|
|||||||||||||
Reserve
agreement - Asset
|
39,621 | (5,601 | ) | 17,362 | 27,860 | |||||||||||
Reserve
agreement - Liabilities (1)
|
(109,552 | ) | 6,625 | (2,071 | ) | (114,105 | ) | |||||||||
Reserve
agreement - Net
|
(69,931 | ) | 1,024 | 15,291 | (86,245 | ) |
(1)
|
2008 variation
includes a payment of US $58,575 thousand to COLISEE
RE.
|
US $
thousand
|
||||||||||||
12 month
period ended December 31, 2008
|
12 month
period ended
December
31, 2007
|
Period from incorporation to
December
31, 2006
|
||||||||||
Bonds
|
65,342 | 22,831 | 7,191 | |||||||||
Equities
|
(0 | ) | 599 | 393 | ||||||||
Other
financial assets available for sale
|
11,519 | 48,190 | - | |||||||||
Other assets
held by non consolidated investment funds
|
402 | 15,184 | - | |||||||||
Loans and
other loans
|
155 | (5 | ) | 535 | ||||||||
Other
investment income
|
217 | (1,304 | ) | 3,938 | ||||||||
Income from
Funds withheld Asset
|
133,742 | 147,513 | 129,534 | |||||||||
Income from
cash equivalent
|
17,106 | - | - | |||||||||
Debt
expense
|
||||||||||||
Expenses on
investments and loans
|
(2,723 | ) | (1,967 | ) | (583 | ) | ||||||
Investment
management
|
- | - | - | |||||||||
Net
investment incomes
|
225,760 | 231,041 | 141,008 | |||||||||
Bonds
|
2,485 | 2,009 | (639 | ) | ||||||||
Equities
|
(3,040 | ) | 3,931 | (361 | ) | |||||||
Non
Consolidated mutual funds invested in other assets (mainly money market
funds)
|
- | 1,152 | - | |||||||||
Cash
equivalent
|
3 | - | - | |||||||||
Net
capital gains and losses
|
(553 | ) | 7,092 | (1,000 | ) | |||||||
Variations in
investment impairment
|
(968 | ) | - | - | ||||||||
Exchange rate
impact
|
(161,004 | ) | (107,668 | ) | (1,881 | ) | ||||||
Valuation of
derivative instruments
|
383 | (6,154 | ) | - | ||||||||
Financial
results – other
|
(1,199 | ) | (12,609 | ) | 716 | |||||||
Net
financial income excluding debt expense
|
62,419 | 111,702 | 138,842 |
US $
thousand
|
||||||||
2008
|
2007
|
|||||||
Financial invested assets at historical
cost
|
||||||||
Invested
assets directly hold
|
2,547.9 | 2,101.8 | ||||||
Invested
assets of the FWA (including revenues of FWA)
|
2,296.1 | 3,267.6 | ||||||
Financial
invested assets at historical cost
|
4,844.1 | 5,369.4 | ||||||
Average
invested assets at historical cost
|
5,106.7 | |||||||
Revenues
|
||||||||
Net
investment income
|
225.8 | |||||||
Impact of FWA
(1)
|
(8.6 |
)
|
||||||
Net
income (1)
|
217.2
|
|||||||
Net capital
gains and losses
|
(0.6 |
)
|
||||||
Impairment
|
(1.0
|
)
|
||||||
Impact of FWA
(1)
|
16.4 | |||||||
Net
capital gains and losses (1)
|
14.9 | |||||||
Total
financial revenues (1)
|
232 | |||||||
Total
AVERAGE YIELD
|
4.5 |
%
|
US $
thousand
|
||||||||||||||||
12 month period ended December
31, 2007
(1)
|
12 month period ended December
31, 2007
(2)
|
|||||||||||||||
Excluding
FWA
|
Including
FWA
|
|||||||||||||||
Yield
|
Amount
|
Yield
|
Amount
|
|||||||||||||
Bonds and Short term investment available for
sale
|
||||||||||||||||
Investment
revenues (3)
|
4.16 | % | 71,021 | 4.34 | % | 178,073 | ||||||||||
Realized
capital gains
|
0.10 | % | 2,009 | 0.09 | % | 4,177 | ||||||||||
Total
revenues from bonds and Short term investment available for
sale
|
4.26 | % | 73,030 | 4.44 | % | 182,250 | ||||||||||
BONDS
AND SHORT TERM INVESTMENTS AVAILABLE FOR SALE (AVERAGE
VALUE) A
|
1,712,975 | 4,109,339 | ||||||||||||||
Equities
|
||||||||||||||||
Investment
revenues
|
2.05 | % | 599 | 3.04 | % | 3,810 | ||||||||||
Realized
capital gains
|
13.44 | % | 3,931 | 8.83 | % | 11,084 | ||||||||||
Total
revenues from equities
|
15.49 | % | 4,530 | 11.87 | % | 14,894 | ||||||||||
EQUITIES
(AVERAGE VALUE) B
|
29,245 | 125,458 | ||||||||||||||
Cash and cash equivalent
|
||||||||||||||||
Investment
revenues
|
4.91 | % | 15,101 | 4.57 | % | 40,958 | ||||||||||
Realized
capital gains
|
0.37 | % | 1,152 | 0.13 | % | 1,152 | ||||||||||
Total
revenues from cash and cash equivalent
|
5.28 | % | 16,253 | 4.69 | % | 42,110 | ||||||||||
CASH
AND CASH EQUIVALENT (Average
Value) C
|
307,824 | 896,942 | ||||||||||||||
Total
revenues
|
4.58 | % | 93,813 | 4.66 | % | 239,254 | ||||||||||
Total
AVERAGE VALUE D = A + B + C
|
2,050,044 | 5,131,739 |
(1)
|
Excluding
revenue from “Funds Withheld Assets” equal to US $147.5
million,
|
(2)
|
Including
revenue from “Funds Withheld Assets” as if asset were held
directly.
|
(3)
|
Yields from
bond investments and other assets available for sale are calculated in
consideration of annualized return relating to the reallocation of
short-term assets in a bond portfolio that is directly held and which was
acquired in the last quarter of
2007.
|
US $
thousand
|
||||||||||||||||
Period
from incorporation to
|
Period
from incorporation to
|
|||||||||||||||
December 31, 2006 (1)
|
December 31, 2006 (2)
|
|||||||||||||||
Excluding
FWA
|
Including
FWA
|
|||||||||||||||
Yield
|
Amount
|
Yield
|
Amount
|
|||||||||||||
Bonds
|
||||||||||||||||
Investment
revenues
|
3.24 | % | 7,191 | 4.18 | % | 45,518 | ||||||||||
Realized
capital gains
|
0.50 | % | 1,108 | 0.44 | % | 2,390 | ||||||||||
Total
revenues from bonds
|
3.74 | % | 8,299 | 4.39 | % | 47,908 | ||||||||||
BONDS
(AVERAGE VALUE)
|
221,789 | 1,090,164 | ||||||||||||||
Equities
|
||||||||||||||||
Investment
revenues
|
7.99 | % | 393 | 2.37 | % | 4,700 | ||||||||||
Realized
capital gains
|
(7.34 | %) | (361 | ) | 23.12 | % | 45,775 | |||||||||
Total
revenues from equities
|
0.65 | % | 32 | 25.50 | % | 50,476 | ||||||||||
EQUITIES
(AVERAGE VALUE)
|
4,918 | 197,949 | ||||||||||||||
Total
revenues Bonds + Equities
|
3.67 | % | 8,331 | 7.64 | % | 98,384 | ||||||||||
BONDS
+ EQUITIES (AVERAGE VALUE)
|
226,706 | 1,288,113 |
(1)
|
Excluding
revenue from “Funds Withheld Asset” for US $129.5
million.
|
(2)
|
Revenue from
Fund Withheld Asset split line by line as if asset were held
directly.
|
US $
thousand
|
||||||||||||
12 month
period ended December 31, 2008
|
12 month
period ended December 31, 2007
|
Period from incorporation
to
December
31, 2006
|
||||||||||
General
expenses by purpose
|
||||||||||||
Claims
expenses
|
(10,594 | ) | (14,752 | ) | (8,454 | ) | ||||||
Acquisition
costs
|
(62,387 | ) | (57,970 | ) | (46,362 | ) | ||||||
Administration
costs
|
(61,284 | ) | (60,139 | ) | (39,091 | ) | ||||||
Investment
management costs
|
(2,838 | ) | (5,450 | ) | (3,120 | ) | ||||||
Others
|
(17,642 | ) | (1,156 | ) | (28 | ) | ||||||
TOTAL
GENERAL EXPENSES BY PURPOSE
|
(154,745 | ) | (139,468 | ) | (97,055 | ) | ||||||
General
expenses by nature
|
||||||||||||
Personnel
expenses - without RSU / SO
|
(74,549 | ) | (58,136 | ) | (20,952 | ) | ||||||
RSU / SO
(1)
|
(32,789 | ) | (27,087 | ) | (19,182 | ) | ||||||
Set up Fees
and others extraordinary expenses (2)
|
(2,077 | ) | (6,539 | ) | (31,170 | ) | ||||||
Others
expenses
|
(45,330 | ) | (47,706 | ) | (25,751 | ) | ||||||
TOTAL
GENERAL EXPENSES BY NATURE
|
(154,745 | ) | (139,468 | ) | (97,055 | ) |
(1)
|
For December
31, 2008, the RSU and stock options amount includes:
- the delivery
of shares as at December 29, 2008 for US $(49,938) thousand,
- the reversal
of provision related to the delivery for US $37,713 thousand,
- the
variation of the year for US $(20,564)
thousand.
|
(2)
|
Set-up fees
and other extraordinary expenses in 2007 include:
- IPO fees in
the amount of US $0.9 million,
- Fees in
connection with the re domiciliation in Switzerland for an amount
of US $1.7 million,
- Stamp tax
(Switzerland) in the amount of US $4.0
million.
|
In number of
employees
|
||||||||||||
12
month period ended
December
31, 2008
|
12
month period ended
December
31, 2007
|
Period
from incorporation to December 31, 2006
|
||||||||||
Top
executives
|
23 | 24 | 24 | |||||||||
Executives
|
233 | 208 | 197 | |||||||||
Employees
|
133 | 135 | 122 | |||||||||
Average permanent staff
(1)
|
389 | 367 | 343 | |||||||||
Permanent
staff at closing date
|
396 | 382 | 347 | |||||||||
Personnel
expenses - without RSU / SO
|
(74,549 | ) | (58,136 | ) | (20,952 | ) | ||||||
RSU /
SO
|
(32,789 | ) | (27,087 | ) | (19,182 | ) | ||||||
Total
Personnel expenses
|
(107,338 | ) | (85,223 | ) | (40,134 | ) |
(1)
|
Full-time
equivalent staff count.
|
December
31, 2008
|
Function
|
Board
fees
|
RSU(1)
(2)
|
||||||||||||||
US
$ Gross
amounts
|
2008 (3)
|
2007 (3)
|
2008
|
2007
|
|||||||||||||
James
CAREY
|
Chairman of
the Board of Directors
|
85,000 | 0 | (4) | 30,061 | 25,862 | |||||||||||
Hans-Peter
GERHARDT
|
Director and
CEO
|
- | - | - | - | ||||||||||||
Anthony
Philip HOPE
|
Director
|
97,000 | 48,151 | 30,061 | 25,862 | ||||||||||||
Robert
HURST
|
Director
|
91,000 | 0 | (4) | 30,061 | 25,862 | |||||||||||
Bjorn
JANSLI
|
Director
|
74,000 | - | 30,061 | 25,862 | ||||||||||||
Edward J
KELLY III
|
Director
|
- | 27,877 | - | 25,862 | ||||||||||||
Jean
LANIER
|
Director
|
77,000 | 33,579 | 30,061 | 25,862 | ||||||||||||
Alban de
MAILLY NESLE
|
Director
|
86,000 | 25,976 | 30,061 | 25,862 | ||||||||||||
Roberto
MENDOZA
|
Director
|
98,000 | 27,877 | 30,061 | 25,862 | ||||||||||||
Brian
MODESITT
|
Director
|
104,000 | 0 | (4) | 30,061 | 25,862 | |||||||||||
David R.
TUNNELL
|
Director
|
88,000 | 0 | (4) | 30,061 | 25,862 | |||||||||||
John T.
SINNOTT
|
Director
|
33,600 | - | 30,061 | - | ||||||||||||
Nicolas
ZERBIB
|
Director
|
116,000 | 0 | (4) | 30,061 | 25,862 |
(1)
|
Market value
(Closing market price of the day of the
award).
|
(2)
|
RSU granted
within the Equity Incentive Plan for Non Employee
Directors.
|
(3)
|
First half
Board fees were paid during the second half. Second half board fees were
paid during the first half of the following
year.
|
(4)
|
Directors who
are also employees of investment firms that are shareholders were entitled
to fees after the IPO. Such fees were paid in April
2008.
|
December
31, 2008
|
Hans-Peter
GERHARDT (Director and CEO)
|
Other
members
|
|||||||||||||||||||
US $ (unless
otherwise noted)
Gross
amounts
|
CHF
|
EUR
|
US
$
|
SGD
|
US
$
|
||||||||||||||||
Fixed
compensation
|
2007
|
1,120,000 | 1,317,222 | ||||||||||||||||||
2008
|
1,120,000 | 1,450,423 | |||||||||||||||||||
Variable
compensation
|
2007
|
1,300,000 | 851,702 | 986,211 | (1) | ||||||||||||||||
2008
|
1,500,000 | 938,315 | (1) | ||||||||||||||||||
Special
Bonuses
|
2007
|
1,500,000 | (2) | 7,245,129 | (3) | 2,484,886 | (4) | ||||||||||||||
2008
|
0 | 0 | 0 | ||||||||||||||||||
Advantages in
kind and other
|
2007
|
160,000 | (5) | 23,931 | (5) | 472,844 | (6) | ||||||||||||||
2008
|
195,077 | (4) | 174,999 | (6) | |||||||||||||||||
Board
fees
|
2007
|
7,383 | 15,677 | ||||||||||||||||||
2008
|
12,000 | 17,029 | |||||||||||||||||||
RSU (7)
|
2007
|
0 | 0 | 6,013,062 | 7,238,569 | ||||||||||||||||
2008
|
7,500,148 | 9,034,181 | |||||||||||||||||||
SO (7)
|
2007
|
0 | 0 | 1,046,616 | 1,259,924 | ||||||||||||||||
2008
|
0 | 0 | 1,138,959 | 1,371,088 |
(1)
|
2007 variable
compensation was calculated according to AXA principles: in part on the
basis of AXA Group results, in another part on the basis of COLISEE RE
results and in another part on the basis of individual performance. 2008
variable compensation is calculated according to PARIS RE principles: in
part on the basis of PARIS RE Group results and in another part on the
basis of individual performance.
|
(2)
|
Sign on
bonus.
|
(3)
|
Long Term
Investment Plan (LTIP). The rights acquired by Mr. Gerhardt under the LTIP
on December 31, 2005 amounted to the sum of US $7,245,129. This
amount was received by the Company as part of the Transfer and was paid to
Mr. Gerhardt during the first quarter of 2007. Of the sums received,
Mr. Gerhardt reinvested US $5,000,000 in shares of the Company acquired at
a price of US $100 per share.
|
(4)
|
Special
bonuses included notably the final payment on a Long Term Investment Plan
(LTIP) put in place before the RSU/Stock-options plan and a transaction
bonus relating to the acquisition of the business of COLISEE RE by the
Group that was paid by PARIS RE (France) and re-invoiced to AXA
group.
|
(5)
|
Housing,
school allowance, health insurance, business car and moving
expense.
|
(6)
|
Include
advantages in kind (business car, an allowance for disability and death
and medical allowance), expatriation bonuses, special retirement plan and
school allowance (in favour of one member of the Management Board). The
variation between 2007 and 2008 amounts is explained in particular by the
decrease of the expatriation bonuses and by the decrease of disability,
death and health contributions (absence of special bonuses in
2008).
|
(7)
|
Market value
(Closing market price of the day of the award). RSU granted within the RSU
and stock option Plan.
|
|
·
|
Short-term
employee benefits: remuneration due to members of the Management Board in
respect of 2006, including fixed salary, bonuses, directors’ fees and
benefits in kind totaled US $8.6
million.
|
|
·
|
Long-term
employee benefits: amounts provisioned and recognized by PARIS RE and its
subsidiaries for the payment of pensions or retirement benefits to its
members of the Management Board totaled US $0.4
million.
|
|
·
|
Equity
compensation benefits: the expense booked in 2006 relating to share-based
remuneration granted to Management Board members was US $6.4
million.
|
US $
thousand
|
||||||||||||
12
month period ended
|
12
month period ended
|
Period from incorporation
to
|
||||||||||
December
31, 2008
|
December
31, 2007
|
December 31,
2006
|
||||||||||
Swiss
income tax
|
(6,030 | ) | (11,840 | ) | 0 | |||||||
Current
|
(5,543 | ) | (12,088 | ) | 0 | |||||||
Deferred
|
(487 | ) | 248 | 0 | ||||||||
Non
Swiss income tax
|
3,429 | 10,803 | 0 | |||||||||
Current
|
(784 | ) | (36,477 | ) | (72,975 | ) | ||||||
Deferred
|
4,213 | 47,280 | 15,151 | |||||||||
TOTAL
INCOME TAX
|
(2,601 | ) | (1,037 | ) | (57,825 | ) |
US $
thousand
|
12
month period ended
|
|||||||||||||||||||
December 31,
2008
|
France
|
Switzerland
|
Bermuda
|
Others
|
TOTAL
|
|||||||||||||||
Net
result after tax
|
(23,221 | ) | (10,061 | ) | 13,051 | (13,973 | ) | (34,205 | ) | |||||||||||
Net
result before tax
|
(26,180 | ) | (4,031 | ) | 13,051 | (14,444 | ) | (31,604 | ) | |||||||||||
Tax
and deferred taxes
|
2,958 | (6,030 | ) | - | 470 | (2,601 | ) | |||||||||||||
Calculated
tax rate
|
11.30 | % | -149.57 | % | 0.00 | % | 3.26 | % | -8.23 | % | ||||||||||
Impact of
permanent differences
|
6,054 | 1,034 | - | (733 | ) | 6,355 | ||||||||||||||
Tax losses
not activated (1)
|
- | 4,740 | - | 4,739 | 9,479 | |||||||||||||||
Tax rate
adjustment and other
|
- | 646 | - | (368 | ) | 278 | ||||||||||||||
Total
adjusted tax
|
9,012 | 390 | - | 4,108 | 13,511 | |||||||||||||||
Adjusted
tax rate
|
34.4 | % | 9.7 | % | 0.00 | % | 28.4 | % | 42.8 | % | ||||||||||
(1)
|
Deferred taxes
not activated on tax losses coming from holding companies of the
Group.
|
US $
thousand
|
12
month period ended
|
|||||||||||||||||||
December 31,
2007
|
France
|
Switzerland
|
Bermuda
|
Others
|
TOTAL
|
|||||||||||||||
Net
result after tax
|
(40,819 | ) | 119,924 | 40,897 | (32,964 | ) | 87,038 | |||||||||||||
Net
result before tax
|
(54,727 | ) | 131,764 | 40,897 | (29,858 | ) | 88,075 | |||||||||||||
Tax
and deferred taxes
|
13,909 | (11,840 | ) | - | (3,106 | ) | (1,037 | ) | ||||||||||||
Calculated
tax rate
|
25.41 | % | 8.99 | % | 0.00 | % | 10.40 | % | 1.18 | % | ||||||||||
Impact of
permanent differences
|
5,954 | - | - | 5,645 | 11,599 | |||||||||||||||
Consolidated
accounting entries with no tax entries
|
(1,027 | ) | (2,186 | ) | - | 1,373 | (1,840 | ) | ||||||||||||
Utilization
of tax losses (1)
|
- | 2,698 | - | - | 2,698 | |||||||||||||||
Total
adjusted tax
|
18,836 | (11,328 | ) | - | 3,912 | 11,420 | ||||||||||||||
Adjusted
tax rate
|
34.42 | % | 8.60 | % | 0.00 | % | 13.10 | % | 13.0 | % | ||||||||||
(1)
|
Deferred taxes
not activated on tax losses coming from holding companies of the
Group.
|
US $
thousand
|
Period
from incorporation to December 31, 2006
|
|||||||||||
December
31, 2006
|
France
|
Others
|
TOTAL
|
|||||||||
Net
result after tax
|
352,221 | 84,792 | 437,013 | |||||||||
Net
result before tax
|
402,363 | 92,475 | 494,837 | |||||||||
Tax
and deferred taxes
|
(50,142 | ) | (7,683 | ) | (57,825 | ) | ||||||
Calculated
tax rate
|
12.46 | % | 8.3 | % | 11.69 | % | ||||||
Impact of
permanent differences
|
3,222 | - | 3,222 | |||||||||
Consolidated
accounting entries with no tax entries
|
(88,328 | ) | (24,870 | ) | (113,198 | ) | ||||||
Utilization
of tax losses
|
- | - | - | |||||||||
Others
|
(3,286 | ) | 2,637 | (649 | ) | |||||||
Total
adjusted tax
|
(138,533 | ) | (29,916 | ) | (168,450 | ) | ||||||
Adjusted
tax rate
|
34.43 | % | 32.35 | % | 34.0 | % | ||||||
US $
thousand
|
||||||||||||||||
December
31, 2008
|
December
31, 2007
|
|||||||||||||||
GIVEN
|
RECEIVED
|
GIVEN
|
RECEIVED
|
|||||||||||||
Financing
commitments (1)
|
- | 246,886 | - | 146,394 | ||||||||||||
Pledged
assets (2)
|
13,641 | 881 | 13,930 | 883 | ||||||||||||
Investments
pledged
|
- | - | - | - | ||||||||||||
Real
collateral (received)
|
- | - | ||||||||||||||
Letters of
credit (3)
|
111,343 | 194 | 15,046 | - | ||||||||||||
Foreign
currency term operations (4)
|
77,319 | 83,757 | 72,461 | 65,268 | ||||||||||||
Other
derivatives
|
- | - | - | - | ||||||||||||
Commitments
linked with assets / capital contribution
|
- | - | - | - | ||||||||||||
Other
off-balance sheet commitments
|
0 | - | 1,211 | - | ||||||||||||
Total
off balance sheet commitments
|
202,301 | 331,717 | 102,648 | 212,545 |
(1)
|
Financing
commitments related to an unused credit
facility,
|
(2)
|
Guaranteed
assets relate to guarantees given to financial institution and
cedants,
|
(3)
|
Mainly include
letters of credit provided the Group to
cedants,
|
(4)
|
Exchange rate
future transactions include off balance sheet commitments (PARIS RE Group)
relating to foreign exchange coverage. The net impact of US $6.4 million
is shown in Note 13.
|
|
·
|
COLISEE RE
and its affiliates shall not employ any of the employees that were
included in the Transfer; and
|
|
·
|
the Company
and our affiliates shall not employ any of AXA LM's employees except for
any person who has not been employed by AXA LM or its affiliates for a
period of at least 60 days.
|
|
·
|
organization
of the Company and its subsidiaries including the preparation of
organizational documents and corporate and insurance regulatory filings
and approvals;
|
|
·
|
establishing
and maintaining banking, consulting, advising and other business
relationships for the Company and its
subsidiaries;
|
|
·
|
developing an
initial business plan of the
Company;
|
|
·
|
developing
and implementing corporate and business strategy and planning for the
Company and its subsidiaries, including plans and programs for improving
operating, marketing and financial performance, budgeting of future
corporate investments, and business acquisition and divestiture
strategies;
|
|
·
|
sourcing
senior employees of the Company and its subsidiaries and negotiating
employment terms;
|
|
·
|
providing
individuals to serve as directors or officers of the Company and its
subsidiaries;
|
|
·
|
business and
asset valuation and acquisition related advisory services;
and
|
|
·
|
structuring
of various administrative and other arrangements for the Company and its
subsidiaries.
|
|
·
|
The net
earnings per share is calculated on the basis of the average number of
shares weighted during the period. This calculation does not take into
account RSU, stock options and
warrants.
|
|
·
|
The fully
diluted net earnings per share is calculated on the basis of the diluted
shares outstanding, including stock options, restricted stock units and
warrants. The impact of the stock options and warrants on the total number
of diluted shares is based on the “in the money” value of these
instruments based on PARIS RE’s common stock
price.
|
US $
thousand
|
||||||||||||||||
12 month
period ended December
31, 2008
|
12 month
period ended December
31, 2007
|
Period from incorporation to
December
31, 2006
|
||||||||||||||
Group net
income
|
||||||||||||||||
Group
net income
|
A
|
(34,205 | ) | 87,038 | 437,013 | |||||||||||
Group
net income restated to include the impact of dilutive financial
instruments
|
B
|
(34,205 | ) | 87,038 | 437,013 | |||||||||||
Equity shares
(in thousands of units)
|
||||||||||||||||
Equity
shares (ordinary) weighted at opening
|
85,557 | 81,662 | 0 | |||||||||||||
Equity
shares (ordinary) weighted at closing
|
C
|
82,703 | 83,500 | 2,326 | ||||||||||||
Instruments
potentially dilutive
|
||||||||||||||||
- Restricted
Stock Units
|
209 | 1,904 | - | |||||||||||||
- Stock
options
|
- | 42 | - | |||||||||||||
-
Warrants
|
1,065 | 1,254 | - | |||||||||||||
Equity
shares (ordinary) weighted after impact of the instruments potentially
dilutive
|
D
|
83,977 | 86,700 | 2,326 | ||||||||||||
Net earning
per share (in US dollars)
|
||||||||||||||||
Net
earning per share
|
=
A/C
|
(0.41 | ) | 1.04 | 187.88 | |||||||||||
Net
earning per share diluted
|
=
B/D
|
(0.41 | ) | 1.00 | 187.88 |
|
·
|
production
(underwriting, rating, exposure)
|
|
·
|
financial
market operations (investment, liquidity,
insolvency)
|
|
·
|
technological
infrastructure and data processing
|
|
·
|
human
resources and outsourcing
|
|
·
|
legal and
regulatory compliance
|
|
·
|
business
operations (interruption, integrity,
reputation).
|
|
·
|
frequency or
severity of both natural and man-made catastrophic
events;
|
|
·
|
levels of
capacity and demand;
|
|
·
|
price
competition;
|
|
·
|
general
economic conditions; and
|
|
·
|
changes in
legislation, case law and prevailing concepts of
liability.
|
US $
thousand
|
||||||||||||||||
December
31, 2008
|
%
|
December
31, 2007
|
%
|
|||||||||||||
Property
|
752,165 | 24.7 | % | 945,995 | 28.5 | % | ||||||||||
Casualty
|
1,390,783 | 45.8 | % | 1,522,238 | 45.9 | % | ||||||||||
Marine,
Aviation & Space
|
288,762 | 9.5 | % | 339,794 | 10.2 | % | ||||||||||
Credit /
Surety
|
124,416 | 4.1 | % | 116,962 | 3.5 | % | ||||||||||
Life,
Accident and Health
|
81,698 | 2.7 | % | 70,708 | 2.1 | % | ||||||||||
Facultative
|
401,721 | 13.2 | % | 322,973 | 9.7 | % | ||||||||||
Total
Net Claims reserves
|
3,039,546 | 100 | % | 3,318,670 | 100 | % |
12 month period ended
December 31, 2008
US
$ million
|
||||||||||||||||||||||||||||
Europe
|
United
States
|
Asia
Oceania
Australia New Zealand |
Caribbean
& Latin America
|
Canada
|
Africa
Middle East Gulf
|
Total
|
||||||||||||||||||||||
Property
|
236 | 150 | 90 | 54 | 51 | 28 | 609 | |||||||||||||||||||||
Casualty
|
43 | 142 | 2 | 1 | 31 | 5 | 222 | |||||||||||||||||||||
Marine, Aviation
& Space
|
66 | 21 | 8 | 1 | 0 | 6 | 102 | |||||||||||||||||||||
Credit &
Surety
|
95 | 19 | 2 | 1 | 13 | 2 | 131 | |||||||||||||||||||||
Facultative
|
102 | 37 | 31 | 39 | 6 | 24 | 239 | |||||||||||||||||||||
Life,
Accident & Health
|
8 | 4 | 1 | 23 | 0 | 63 | 100 | |||||||||||||||||||||
TOTAL
|
550 | 374 | 133 | 118 | 100 | 128 | 1,404 | |||||||||||||||||||||
Adjustment of Quota Share Retrocession Agreement | (1 | ) | ||||||||||||||||||||||||||
CONSOLIDATED INCOME STATEMENT - Gross written premiums | 1,403 |
US $
million
|
|
2007
|
%
|
|||||||
Year
ended
|
||||||||
European
Union
|
581 | 41 | % | |||||
United
States
|
389 | 28 | % | |||||
Asia and
Oceania ( including Australia and New Zealand)
|
125 | 9 | % | |||||
Caribbean and
Latin America
|
104 | 7 | % | |||||
Canada
|
109 | 8 | % | |||||
Africa and
Middle East Gulf
|
102 | 7 | % | |||||
Total
Gross premium adjusted
|
1,411 | 100 | % | |||||
Adjustment of
Quota Share Retrocession Agreement
|
(134 | ) | ||||||
CONSOLIDATED INCOME STATEMENT-
Gross written premiums
|
1,277 |
US $
million
|
||||||||
2007
|
%
|
|||||||
Year
ended
|
||||||||
Property
|
540 | 38 | % | |||||
Casualty
|
221 | 16 | % | |||||
Marine /
Aviation / Space
|
106 | 8 | % | |||||
Facultative
|
319 | 23 | % | |||||
Life /
Accident & Health
|
83 | 6 | % | |||||
Credit &
Surety
|
141 | 10 | % | |||||
TOTAL
Gross premium adjusted
|
1,411 | 100 | % | |||||
Adjustment of
Quota Share Retrocession Agreement
|
(134 | ) | ||||||
CONSOLIDATED INCOME STATEMENT-
Gross written premiums
|
1,277 |
US $
million
|
||||||||
Period from incorporation to
December
31, 2006
|
%
|
|||||||
Europe
|
292 | 41 | % | |||||
United
States
|
213 | 30 | % | |||||
Asia and
Oceania ( including Australia and New Zealand)
|
64 | 9 | % | |||||
Caribbean and
Latin America
|
50 | 7 | % | |||||
Canada
|
50 | 7 | % | |||||
Africa and
Middle East Gulf
|
43 | 6 | % | |||||
Total
|
711 | 100 | % | |||||
Adjustment of
Reserve Agreement (cf. Note 17)
|
12 | 100 | % | |||||
CONSOLIDATED
INCOME STATEMENT
Gross written
premiums
|
723 |
US $
million
|
||||||||
Period from incorporation to
December
31, 2006
|
%
|
|||||||
France
|
351 | 80.4 | % | |||||
Canada
|
79 | 18.0 | % | |||||
Asia
|
34 | 7.8 | % | |||||
United
states
|
11 | 2.5 | % | |||||
Switzerland
|
(2 | ) | (0.6 | %) | ||||
Luxembourg
|
(2 | ) | (0.4 | %) | ||||
Bermuda
|
(34 | ) | (7.8 | %) | ||||
Total
|
437 | 100.0 | % |
|
·
|
a 6% Property
quota-share treaty provided by a Bermuda-based reinsurer with an A.M. Best
“A” rating,
|
|
·
|
a 24%
Property quota-share treaty provided by a Bermuda-based via the Triomphe
Re side-car facility, fully collateralized to the benefit of PARIS
RE,
|
|
·
|
a series of
quota-share and excess of loss treaties covering the Facultative book of
business; with a retention level significantly greater than that of 2007
for this business.
|
|
·
|
a 16.25%
property quota share with a Bermuda reinsurer with an A.M. Best rating of
“A”,
|
|
·
|
a 24%
property quota share with a Bermuda reinsurer by way of a fully
collateralized side-car and,
|
|
·
|
various quota
shares and excess of loss programs covering the Facultative book of
business.
|
|
·
|
a 12.5%
property quota share placed for 2 years with a Bermuda reinsurer whose
A.M. Best rating is A;
|
|
·
|
an excess of
loss protection up to US $600 million;
and
|
|
·
|
another
Excess of loss to supplement the previous one from US $600 million to US
$800 million, placed at 76.25%.
|
|
·
|
Allocation
mainly in bonds since 2008 with an average rating of AA- and duration of
3.5 years aligned with the average duration of claims
reserves.
|
|
·
|
Equity
allocation portfolio subsequently sold in January, 2008 and no decision
taken to this day to reinvest in this class of
assets.
|
|
·
|
No real
estate directly held, no ABS non guaranteed, no CDO’s, no CLO’s, no high
yield investments nor emerging markets
exposure.
|
US $ thousand | |||||||||||||||||||||||||||||||||||||||||||||||||
Market value of Fixed Maturities, issued by: | |||||||||||||||||||||||||||||||||||||||||||||||||
December
31, 2008
|
Governments
|
%
of Total
|
Agencies
|
%
of Total
|
Corporate
|
%
of Total
|
ABS
|
%
of Total
|
Other
|
%
of Total
|
Total
market value
|
%
of Total
|
|||||||||||||||||||||||||||||||||||||
AAA
|
978,421 | 71.3 | % | 927,358 | 97.0 | % | 363,222 | 23.2 | % | 99,200 | 82.1 | % | - | 0.0 | % | 2,368,200 | 58.7 | % | |||||||||||||||||||||||||||||||
AA+
|
48,812 | 3.6 | % | 9,553 | 1.0 | % | 35,482 | 2.3 | % | 1,280 | 1.1 | % | - | 0.0 | % | 95,128 | 2.4 | % | |||||||||||||||||||||||||||||||
AA
|
102,355 | 7.5 | % | 8,609 | 0.9 | % | 105,660 | 6.7 | % | 4,666 | 3.9 | % | - | 0.0 | % | 221,291 | 5.5 | % | |||||||||||||||||||||||||||||||
AA-
|
50,884 | 3.7 | % | - | 0.0 | % | 125,754 | 8.0 | % | 349 | 0.3 | % | - | 0.0 | % | 176,987 | 4.4 | % | |||||||||||||||||||||||||||||||
A+ | 150,684 | 11.0 | % | - | 0.0 | % | 247,191 | 15.8 | % | 2,998 | 2.5 | % | - | 0.0 | % | 400,872 | 9.9 | % | |||||||||||||||||||||||||||||||
A | 19,322 | 1.4 | % | 4,712 | 0.5 | % | 327,179 | 20.9 | % | 5,594 | 4.6 | % | - | 0.0 | % | 356,807 | 8.8 | % | |||||||||||||||||||||||||||||||
A- | 17,889 | 1.3 | % | - | 0.0 | % | 140,623 | 9.0 | % | 1,503 | 1.2 | % | - | 0.0 | % | 160,015 | 4.0 | % | |||||||||||||||||||||||||||||||
BBB+
|
- | 0.0 | % | - | 0.0 | % | 111,271 | 7.1 | % | 3,156 | 2.6 | % | - | 0.0 | % | 114,428 | 2.8 | % | |||||||||||||||||||||||||||||||
BBB
|
307 | 0.0 | % | - | 0.0 | % | 79,454 | 5.1 | % | 1,375 | 1.1 | % | - | 0.0 | % | 81,136 | 2.0 | % | |||||||||||||||||||||||||||||||
BBB-
|
394 | 0.0 | % | - | 0.0 | % | 20,732 | 1.3 | % | - | 0.0 | % | - | 0.0 | % | 21,126 | 0.5 | % | |||||||||||||||||||||||||||||||
BB+
|
- | 0.0 | % | - | 0.0 | % | - | 0.0 | % | 110 | 0.1 | % | - | 0.0 | % | 110 | 0.0 | % | |||||||||||||||||||||||||||||||
B- | - | 0.0 | % | - | 0.0 | % | - | 0.0 | % | 561 | 0.5 | % | - | 0.0 | % | 561 | 0.0 | % | |||||||||||||||||||||||||||||||
Others
|
2,661 | 0.2 | % | 6,282 | 0.7 | % | 11,337 | 0.7 | % | 61 | 0.1 | % | 18,345 | 100.0 | % | 38,686 | 1.0. | % | |||||||||||||||||||||||||||||||
Total
|
1,371,729 | 100 | % | 956,513 | 100 | % | 1,567,906 | 100 | % | 120,854 | 100 | % | 18,345 | 100 | % | 4,035,347 | 100 | % |
US $
thousand
|
||||||||||||||||||||||||
December
31, 2007
|
Market
value of directly held assets
|
%
of Total
|
Market
value of Fund Withheld
|
%
of Total
|
TOTAL
|
%
of Total
|
||||||||||||||||||
AAA
|
926,420 | 53.2 | % | 1 535,276 | 63.3 | % | 2,461,696 | 59.1 | % | |||||||||||||||
AA
+
|
146,809 | 8.4 | % | 107,286 | 4.4 | % | 254,095 | 6.1 | % | |||||||||||||||
AA
|
138,409 | 8.0 | % | 169,828 | 7.0 | % | 308,237 | 7.4 | % | |||||||||||||||
AA
-
|
80,241 | 4.6 | % | 69,356 | 2.9 | % | 149,597 | 3.6 | % | |||||||||||||||
A
+
|
88,475 | 5.1 | % | 114,197 | 4.7 | % | 202,672 | 4.9 | % | |||||||||||||||
A
|
96,885 | 5.6 | % | 44,579 | 1.8 | % | 141,464 | 3.4 | % | |||||||||||||||
A-
|
15,556 | 0.9 | % | 28,775 | 1.2 | % | 44,331 | 1.1 | % | |||||||||||||||
BBB
+
|
38,986 | 2.2 | % | 14,923 | 0.6 | % | 53,909 | 1.3 | % | |||||||||||||||
BBB
|
15,014 | 0.9 | % | 26,781 | 1.1 | % | 41,795 | 1.0 | % | |||||||||||||||
BBB
-
|
14,033 | 0.8 | % | 3,949 | 0.2 | % | 17,982 | 0.4 | % | |||||||||||||||
BB
+
|
- | 0.0 | % | 964 | 0.0 | % | 964 | 0.0 | % | |||||||||||||||
B-
|
- | 0.0 | % | 1,180 | 0.0 | % | 1,180 | 0.0 | % | |||||||||||||||
Others (1)
|
179,339 | 10.3 | % | 309,673 | 12.8 | % | 489,012 | 11.7 | % | |||||||||||||||
Total
|
1,740,167 | 100 | % | 2,426,767 | 100 | % | 4,166,934 | 100 | % |
(1)
|
Others include
US $484 million of short term investments with rating (A-1+) in
2007.
|
US $
thousand
|
||||||||||||||||||||||||
December 31,
2007
|
Market
value of directly held assets
|
%
of Total
|
Market
value of Funds Withheld
|
%
of Total
|
TOTAL
Market value
|
%
of Total
|
||||||||||||||||||
Financial
institutions
|
8,221 | 53.6 | % | 17,382 | 15.0 | % | 25,603 | 19.5 | % | |||||||||||||||
Consumer
goods
|
2,668 | 17.4 | % | 29,763 | 25.7 | % | 32,431 | 24.7 | % | |||||||||||||||
Energy
|
353 | 2.3 | % | 11,955 | 10.3 | % | 12,308 | 9.4 | % | |||||||||||||||
Communication
|
347 | 2.3 | % | 11,763 | 10.1 | % | 12,110 | 9.2 | % | |||||||||||||||
Manufacturing
/ Pharma
|
169 | 1.1 | % | 27,694 | 23.9 | % | 27,863 | 21.2 | % | |||||||||||||||
Utilities
|
- | 0.0 | % | 15,065 | 13.0 | % | 15,065 | 11.5 | % | |||||||||||||||
Basic
Materials
|
- | 0.0 | % | - | 0.0 | % | - | 0.0 | % | |||||||||||||||
Technology
& Telecom
|
2,406 | 15.7 | % | 2,354 | 2.0 | % | 4,760 | 3.6 | % | |||||||||||||||
Other and
direct holdings
|
1,158 | 7.6 | % | - | 0.0 | % | 1,158 | 0.9 | % | |||||||||||||||
TOTAL
|
15,322 | 100 | % | 115,976 | 100 | % | 131,298 | 100 | % |
US $
thousand
|
||||||||
December
31, 2008
|
%
of total technical reserve ceded
|
|||||||
A++
|
12,939 | 7 | % | |||||
A+ (1)
|
10,780 | 6 | % | |||||
A-
|
19,068 | 10 | % | |||||
A (2)
|
89,579 | 46 | % | |||||
Collateralized (3)
|
62,306 | 32 | % | |||||
Total
technical reserves at risk (PARIS RE)
|
194,672 | 100 | % | |||||
of which
business ceded under AXA RE stamp
|
(55,282 | ) | ||||||
recoverables
covered by the Reserve Agreement
|
68,378 | |||||||
Total
ceded claims reserves
|
207,768 | |||||||
Ceded
unearned premium reserves
|
22,599 | |||||||
Total
ceded technical reserves
|
230,367 |
(1)
|
Except for
Euler Hermes Reinsurance (US $9.5 million) which is rated AA by
S&P.
|
(2)
|
Except for
Nisshin (US $1.7 million) which is rated A by
S&P.
|
(3)
|
Triomphe Re is
a collateralized sidecar with full collateral obligations towards PARIS
RE.
A sidecar is a
special purpose reinsurance vehicle reinsuring business from PARIS RE via
a quota share agreement. The counterparty risk is kept to a minimum
because the exposure of the reinsurer is collateralized for the benefit of
the cedant (in this case PARIS RE). The collateral consists of
highly-rated assets (AA and higher) with a duration based on that of the
risks incurred and adapted to the pay-out
patterns.
|
US $
thousand
|
||||||||
December
31, 2007
|
%
of total technical reserve ceded
|
|||||||
A++
|
31,768 | 25 | % | |||||
A+
|
49,327 | 39 | % | |||||
A-
|
747 | 1 | % | |||||
A
|
8,148 | 6 | % | |||||
bbb
(1)
|
36,230 | 29 | % | |||||
Total
technical reserve ceded
|
126,219 | 100 | % |
(1)
|
Triomphe Re is
a collateralized sidecar rated bbb by A.M.Best but with full collateral
obligations towards PARIS RE. A ‘sidecar’ is a special purpose
reinsurance vehicle reinsuring business from PARIS RE via a quota share
agreement. The counterparty risk is kept to a minimum because the exposure
of the reinsurer is collateralized for the benefit of the cedant (in this
case PARIS RE). The collateral consists of highly-rated assets (AA and
better) with a duration based on that of the risks incurred and adapted to
the pay-out patterns.
|
US $
million
|
||||||||||||||||||||
December 31,
2008
|
Assets
|
Liabilities
|
Shareholders
Equity
|
Net
position 2008
|
Net
position 2007
|
|||||||||||||||
US
Dollars
|
3,766 | 2,244 | 13 | 1,509 | 1,714 | |||||||||||||||
Euro
|
1,496 | 1,273 | 343 | (120 | ) | 31 | ||||||||||||||
Canadian
Dollars
|
549 | 354 | 10 | 185 | 173 | |||||||||||||||
Singapore Dollars
|
308 | 70 | 38 | 200 | 151 | |||||||||||||||
Swiss
Francs
|
13 | 28 | 1,768 | (1,783 | ) | (2,021 | ) | |||||||||||||
Other
currencies
|
259 | 251 | 0 | 9 | (47 | ) | ||||||||||||||
Total
|
6,392 | 4,220 | 2,172 | - | - |
USD
|
EUR
|
CAD
|
SGD
|
Other
|
||||||||||||||||
2008
|
85 | % | -7 | % | 10 | % | 11 | % | 1 | % | ||||||||||
2007
|
85 | % | 2 | % | 9 | % | 7 | % | -2 | % |
US $
thousand
|
||||||||||||
December
31, 2007
|
Market
Value
|
if
$ Var +10% (1)
|
if
$ Var -10% (1)
|
|||||||||
Fixed
maturities available for sale
|
3,708,326 | 3,851,329 | 3,564,850 | |||||||||
Equities
available for sale
|
131,298 | 144,214 | 118,382 | |||||||||
Short term
investment available for sale
|
458,607 | 469,833 | 447,380 | |||||||||
Non
consolidated investment funds available for sale
|
370,845 | 377,316 | 364,373 | |||||||||
Other assets
held at fair value
|
30,926 | 34,019 | 27,834 | |||||||||
Cash &
Other Investments
|
682,566 | 724,552 | 640,595 | |||||||||
Total
|
5,382,570 | 5,601,264 | 5,163,413 |
(1)
|
The impact
would be mainly in income
statement.
|
1-
|
All the new
investments of PARIS RE Group, including assets held in COLISEE RE’s
“Funds Withheld Asset”, were taken into account in the calculation of the
sensitivity analysis for the market
value.
|
2-
|
For new PARIS
RE investments in the form of cash, the variation in the fair value is
considered nil.
|
3-
|
It is
considered that there is no correlation between the equity and the bond
markets.
|
4-
|
For the bond
portfolios, sensitivity indicators (duration and convexity) were taken
into consideration for each share in order to calculate the variation in
fair value.
|
5-
|
For each
share investment, the variation in fair value was determined on the basis
of its beta indicator.
|
US $
million
|
||||||||||||||||
December 31,
2007
|
Assets
|
Liabilities
|
Shareholders
Equity
|
Net
position
|
||||||||||||
US
Dollars
|
3,932 | 2,208 | 10 | 1,714 | ||||||||||||
Euro
|
1,631 | 1,203 | 398 | 31 | ||||||||||||
Canadian
Dollars
|
673 | 470 | 30 | 173 | ||||||||||||
Singapore
Dollars
|
290 | 113 | 27 | 151 | ||||||||||||
Swiss
Francs
|
2 | 13 | 2,009 | (2,021 | ) | |||||||||||
Yen's
|
65 | 17 | 0 | 48 | ||||||||||||
Other
currencies
|
273 | 368 | 0 | (95 | ) | |||||||||||
Total
|
6,866 | 4,392 | 2,474 | 0 |
US $
million
|
||||||||||||||||||||
December
31, 2008
|
Market
Value
|
Var
-200BP
|
Var
-100BP
|
Var
+100BP
|
Var
+200BP
|
|||||||||||||||
Fixed
maturities
|
4,035 | 4,327 | 4,177 | 3,902 | 3,778 | |||||||||||||||
7.2 | % | 3.5 | % | (3.3 | %) | (6.4 | %) |
US $
thousand
|
||||||||||||||||||||
December
31, 2007
|
Market
Value
|
Var+
100BP (1)
|
Var
-100BP (1)
|
Equity
Var
-10% (2)
|
Equity
Var
-20% (2) |
|||||||||||||||
Fixed
maturities available for sale
|
3,708,327 | 3,617,640 | 3,802,465 | 3,708,327 | 3,708,327 | |||||||||||||||
Equities
available for sale
|
131,298 | 131,298 | 131,298 | 118,506 | 106,247 | |||||||||||||||
Short term
investment available for sale
|
458,607 | 458,607 | 458,607 | 458,607 | 458,607 | |||||||||||||||
Non
consolidated investment funds available for sale
|
370,845 | 370,845 | 370,845 | 361,763 | 352,740 | |||||||||||||||
Other assets
held at fair value
|
30,926 | 30,926 | 30,926 | 30,926 | 30,926 | |||||||||||||||
Cash &
Other Investments
|
682,567 | 682,572 | 682,572 | 682,572 | 682,572 | |||||||||||||||
Total
|
5,382,570 | 5,291,888 | 5,476,713 | 5,360,701 | 5,339,419 |
(1)
|
The impact
would be mainly in shareholders' equity (OCI) and be accounted in the
income statement in case of experiencing a credit
event,
|
(2)
|
Impact in
shareholders' equity (OCI) except for the values represented by equities
which would be impaired and the corresponding charge would be in the
income statement,
|
1-
|
All the new
investments of PARIS RE Group, including assets held in COLISEE RE’s
“Funds Withheld Assets”, were taken into account in the calculation of the
sensitivity analysis for the market
value.
|
2-
|
For new PARIS
RE investments in the form of cash, the variation in the fair value is
considered nil.
|
3-
|
It is
considered that there is no correlation between the equity and the bond
markets.
|
4-
|
For the bond
portfolios, sensitivity indicators (duration and convexity) were taken
into consideration for each share in order to calculate the variation in
fair value.
|
5-
|
For each
share investment, the variation in fair value was determined on the basis
of its beta indicator.
|
US $
thousand
|
||||||||||||||||||||||||
December
31, 2008
|
December
31, 2007
|
|||||||||||||||||||||||
Market
Value
|
Var
+100 BP
|
Var
-100 BP
|
Market
Value
|
Var
+100 BP
|
Var
-100 BP
|
|||||||||||||||||||
Reserves
discount
|
191,828 | 224,417 | 150,417 | 249,319 | 309,242 | 186,317 | ||||||||||||||||||
Unrealized
capital gains/losses purchased
|
- | - | - | 5,004 | 5,004 | 5,004 | ||||||||||||||||||
US
licenses
|
7,350 | 7,350 | 7,350 | 7,350 | 7,350 | 7,350 | ||||||||||||||||||
Portfolio
valuation (VBI)
|
199,178 | 231,767 | 157,767 | 261,673 | 321,594 | 198,669 | ||||||||||||||||||
16.40 | % | (20.80 | %) |
1-
|
It is
considered that there is no correlation between the VBI and the equity
markets.
|
2-
|
US licenses
are not sensitive to interest
rates.
|
3-
|
Unrealized
capital gains/losses are not sensitive to interest rates because they are
fixed at the purchase date.
|
|
·
|
The cash
management and the liquidity of the Funds Withheld Asset.
Paris Re has
chosen a cash-flow matching approach to build the asset portfolio: the
expected annual liquidity needed to pay the claim is expected to be met by
the maturity of bonds for the same claims amount.
|
|
·
|
The ongoing
business of PARIS RE.
PARIS RE has
a liquid, highly rated, short duration bond portfolio to
provide adequate liquidity. The average duration is targeted
2.5 – 3.5 years in 2008.
|
US $
million
|
||||||||||||||||||||||||||||
December
31, 2008
|
2003
AND
PRIOR YEARS
|
2004
|
2005
|
2006
|
2007
|
2008
|
TOTAL
|
|||||||||||||||||||||
UNDERWRITING
YEARS
|
||||||||||||||||||||||||||||
Estimate
of cumulative claims (1)
|
||||||||||||||||||||||||||||
At end of
underwriting year
|
973 | 1,384 | 685 | 702 | 902 | |||||||||||||||||||||||
1 year
later
|
1,006 | 1,283 | 672 | 736 | ||||||||||||||||||||||||
2 years
later
|
995 | 1,224 | 633 | |||||||||||||||||||||||||
3 years
later
|
983 | 1,218 | ||||||||||||||||||||||||||
4 years
later
|
968 | |||||||||||||||||||||||||||
Estimate
of cumulative claims at December 31, 2008
|
968 | 1,218 | 633 | 736 | 902 | |||||||||||||||||||||||
Cumulative
payments at December 31, 2008
|
762 | 805 | 368 | 314 | 77 | |||||||||||||||||||||||
Unpaid
cumulative claims as at December 31, 2008
|
206 | 412 | 265 | 421 | 825 | |||||||||||||||||||||||
Estimate of
claims occurring on or after January 1, 2009 (2)
|
0 | 1 | 5 | 16 | 270 | |||||||||||||||||||||||
Claims
reserves as at December 31, 2008
|
1,190 | 205 | 412 | 260 | 406 | 556 | 3,028 | |||||||||||||||||||||
Other
portfolios: Claims reserves as at December 31, 2008 (3)
|
11 | |||||||||||||||||||||||||||
Unearned
Premiums reserves, Unexpired Risks reserves and Unallocated Loss
Adjustment Expenses reserves
|
511 | |||||||||||||||||||||||||||
All
portfolios-Net technical reserves as at December 31, 2008
|
3,551 |
(1)
|
Claims include
Allocated Loss Adjustment Expenses
(ALAE).
|
(2)
|
Claims deemed
to be covered by the Unearned Premium Reserve as at December 31,
2008.
|
(3)
|
Life, Accident
& Health business underwritten in 2005 and prior years
periods.
|
US $ million | ||||||||||||||||||||||
December
31, 2007
|
2002
and prior years
|
2003
|
2004
|
2005
|
2006
|
2007
|
TOTAL
|
|||||||||||||||
UNDERWRITING
YEARS
|
||||||||||||||||||||||
Estimate
of cumulative claims (1)
|
||||||||||||||||||||||
At end of
underwriting year
|
873 | 992 | 1,430 | 720 | 743 | |||||||||||||||||
1 year
later
|
818 | 1,022 | 1,333 | 709 | ||||||||||||||||||
2 years
later
|
744 | 1,011 | 1,273 | |||||||||||||||||||
3 years
later
|
706 | 998 | ||||||||||||||||||||
4 years
later
|
732 | |||||||||||||||||||||
Estimate
of cumulative claims at December 31, 2007
|
732 | 998 | 1,273 | 709 | 743 | |||||||||||||||||
Cumulative
payments at December 31, 2007
|
525 | 739 | 744 | 267 | 59 | |||||||||||||||||
Unpaid
cumulative claims as at December 31, 2007
|
207 | 260 | 530 | 441 | 684 | |||||||||||||||||
Estimate of
claims occurring on or after January 1, 2008 (2)
|
1 | 2 | 4 | 13 | 251 | |||||||||||||||||
Claims
reserves as at December 31, 2007
|
1,452
|
206 | 257 | 526 | 428 | 433 |
3,301
|
|||||||||||||||
Other
portfolios: Claims reserves as at December 31, 2007 (3)
|
18
|
|||||||||||||||||||||
Unearned
Premiums reserves and Unallocated Loss Adjustment Expenses
reserves
|
536
|
All
portfolios-Net technical reserves as at December 31, 2007
|
3,855
|
(1)
|
Claims include
Allocated Loss Adjustment Expenses
(ALAE),
|
(2)
|
Claims deemed
to be covered by the Unearned Premium Reserve as of December 31,
2007,
|
(3)
|
Life, Accident
& Health business underwritten in 2005 and prior years
periods.
|
December
31, 2008
(%
of current reserves)
|
N
+ 1
|
N
+ 2
|
N
+ 3
|
N
+ 4
|
N
+ 5
|
N
+ 6
|
N
+ 7
|
N
+ 8
|
N
+ 9
|
N
+ 10 and years following
|
Yearly
|
39%
|
23%
|
12%
|
8%
|
5%
|
3%
|
2%
|
2%
|
2%
|
3%
|
Cumulative
|
39%
|
62%
|
75%
|
82%
|
88%
|
91%
|
93%
|
95%
|
97%
|
100%
|
December
31, 2007
(%
of current reserves)
|
N
+ 1
|
N
+ 2
|
N
+ 3
|
N
+ 4
|
N
+ 5
|
N
+ 6
|
N
+ 7
|
N
+ 8
|
N
+ 9
|
N
+ 10
|
Yearly
|
45%
|
25%
|
11%
|
6%
|
4%
|
3%
|
2%
|
1%
|
1%
|
1%
|
Cumulative
|
45%
|
70%
|
81%
|
87%
|
91%
|
94%
|
96%
|
97%
|
99%
|
100%
|
US $ thousand | ||||||||||||||||||||||||||||||||||||||||||||||||
USD
Market Value
|
%
|
EUR
Market Value
|
%
|
CAD
Market Value
|
%
|
SGD
Market Value
|
%
|
Others
Market Value
|
%
|
Total
Market Value
|
%
|
|||||||||||||||||||||||||||||||||||||
Fixed
maturities issued by Governments
|
535,092 | 17.7 | % | 304,016 | 30.8 | % | 319,516 | 70.7 | % | 169,455 | 63.4 | % | 43,651 | 27.4 | % | 1,371,730 | 28.0 | % | ||||||||||||||||||||||||||||||
Fixed
maturities issued by Agencies
|
836,204 | 27.6 | % | 81,875 | 8.3 | % | 0.0 | % | 35,308 | 13.2 | % | 3,125 | 2.0 | % | 956,513 | 19.5 | % | |||||||||||||||||||||||||||||||
Fixed
maturities Issued by Corporate
|
1,083,835 | 35.8 | % | 372,944 | 37.8 | % | 82,541 | 18.3 | % | 27,671 | 10.3 | % | 915 | 0.6 | % | 1,567,906 | 32.0 | % | ||||||||||||||||||||||||||||||
Mortgage and
Asset-Backed Securities
|
119,540 | 3.9 | % | - | 0.0 | % | - | 0.0 | % | 1,313 | 0.5 | % | 0 | 0.0 | % | 120,853 | 2.5 | % | ||||||||||||||||||||||||||||||
Fixed
maturities from other issuers
|
18,345 | 0.6 | % | - | 0.0 | % | - | 0.0 | % | - | 0.0 | % | - | 0.0 | % | 18,345 | 0.4 | % | ||||||||||||||||||||||||||||||
Fixed
maturities available for sale
|
2,593,017 | 85.6 | % | 758,835 | 76.8 | % | 402,056 | 89.0 | % | 233,747 | 87.4 | % | 47,691 | 30.0 | % | 4,035,347 | 82.5 | % | ||||||||||||||||||||||||||||||
Cash and cash
equivalents
|
415,395 | 13.7 | % | 56,075 | 5.7 | % | 15,799 | 3.5 | % | 33,430 | 12.5 | % | 103,828 | 65.3 | % | 624,527 | 12.8 | % | ||||||||||||||||||||||||||||||
Other
financial invesments
|
19,558 | 0.6 | % | 172,864 | 17.5 | % | 34,074 | 7.5 | % | 245 | 0.1 | % | 7,584 | 4.8 | % | 234,325 | 4.8 | % | ||||||||||||||||||||||||||||||
Total
assets invested
|
3,027,970 | 100 | % | 987,774 | 100 | % | 451,929 | 100 | % | 267,422 | 100 | % | 159,103 | 100 | % | 4,894,199 | 100 | % | ||||||||||||||||||||||||||||||
% of total
invested assets
|
62 | % | 20 | % | 9 | % | 5 | % | 3 | % | 100 | % |
US $ thousand | ||||||||||||||||||||||||||||||||||||||||||||||||
USD
Market Value
|
%
|
EUR
Market Value
|
%
|
CAD
Market Value
|
%
|
SGD
Market Value
|
%
|
Others
Market Value
|
%
|
Total
Market Value
|
%
|
|||||||||||||||||||||||||||||||||||||
Fixed
maturities available for sale
|
2,273,542 | 71.1 | % | 607,308 | 51.4 | % | 538,633 | 96.4 | % | 193,199 | 77.8 | % | 95,644 | 48.9 | % | 3,708,326 | 68.9 | % | ||||||||||||||||||||||||||||||
Short term
investment available for sale
|
353,427 | 11.1 | % | 104,939 | 8.9 | % | - | 0.0 | % | - | 0.0 | % | 241 | 0.1 | % | 458,607 | 8.5 | % | ||||||||||||||||||||||||||||||
Equities
available for sale
|
2,135 | 0.1 | % | 114,269 | 9.7 | % | - | 0.0 | % | 14,811 | 6.0 | % | 83 | 0.0 | % | 131,298 | 2.4 | % | ||||||||||||||||||||||||||||||
Non
consolidated investment funds available for sale
|
306,061 | 9.6 | % | 31,979 | 2.7 | % | - | 0.0 | % | - | 0.0 | % | 32,806 | 16.8 | % | 370,846 | 6.9 | % | ||||||||||||||||||||||||||||||
Other assets
held at fair value
|
- | 0.0 | % | 30,926 | 2.6 | % | - | 0.0 | % | - | 0.0 | % | - | 0.0 | % | 30,926 | 0.6 | % | ||||||||||||||||||||||||||||||
Cash and cash
equivalents
|
262,785 | 8.2 | % | 292,455 | 24.7 | % | 19,953 | 3.6 | % | 40,457 | 16.3 | % | 66,916 | 34.2 | % | 682,566 | 12.7 | % | ||||||||||||||||||||||||||||||
Total
assets invested
|
3,197,950 | 100 | % | 1,181,876 | 100 | % | 558,586 | 100 | % | 248,467 | 100 | % | 195,690 | 100 | % | 5,382,570 | 100 | % | ||||||||||||||||||||||||||||||
% of total
invested assets
|
59 | % | 22 | % | 10 | % | 5 | % | 4 | % | 100 | % |
·
|
Losses
|
|
·
|
Klaus, a
Windstorm, that occurred in January 24, 2009, a major loss in Europe: the
company’s exposure related to Klaus is estimated at US $19.4 million net
impact(1).
|
|
·
|
One large
loss: Victorian bushfires, (Australia, on February 7, 2009) for a US $6.8
million net impact.
|
·
|
Subordinated
debt
|
·
|
Distribution
of capital
|
·
|
Internal
reorganization
|
|
·
|
On April 24,
2009, PARIS RE Acquisition France has been merged with PARIS RE
Holdings France pursuant to Article L236.-1 of the French “Code de Commerce” as
simplified merger. PARIS RE Holdings France held 100% PARIS RE Acquisition
shares. PARIS RE Acquisition France’s Assets and liabilities has
been transferred to PARIS RE Holdings France retroactively on
January 1st,
2009 at net book value. The merger has no effect on the consolidated
financial statements.
|
|
·
|
Sale of CGRM
head office in Monaco. In connection with the planned
dissolution of PARIS RE's subsidiary in Monaco, the Company has sold its
office on May the 4th. The company has generated a gain net of tax of
approximately EUR3,2 million which will be accounted for during the second
quarter.
|
|
·
|
The
liquidation of PARIS RE Luxembourg was effective in 2009 second quarter.
This liquidation has limited effect on the 2009 second quarter
Financial statement.
|
|
·
|
Registration
of PARIS RE Insurance Company in 2009 second
quarter.
|
·
|
PartnerRe
combination agreement
|
PARIS
RE Holdings
Limited
Consolidated
Balance
Sheet
as of March 31,
2009
and the
related
consolidated
statement of
income,
Shareholders’
equity
and cash flows for
the
three month
periods
ended March
31, 2009
and
2008
|
Review
report of Independent Registered Public Accounting Firm
To
the Board of Directors of PARIS RE Holdings Limited
We
have reviewed the accompanying consolidated balance sheet of PARIS RE
Holdings Limited and its subsidiaries (the “Company”) as of March 31, 2009
and the related consolidated statements of income, Shareholders’ equity
and cash flows for the three-month periods ended March 31, 2009 and 2008.
These interim financial statements are the responsibility of the Company’s
management.
We
conducted our review in accordance with the standards of the Public
Company Accounting Oversight Board (United States). A review of interim
financial information consists of principally applying analytical
procedures and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit
conducted in accordance with the standards of the Public Company
Accounting Oversight Board (United States), the objective of which is the
expression of an opinion regarding the financial statements taken as a
whole. Accordingly, we do not express such an opinion.
Based
on our review, we are not aware of any material modifications that should
be made to such financial statements for them to be in conformity with
International Financial Reporting Standards (IFRS) as issued by the
International Accounting Standards Board. Without qualifying our opinion,
we draw attention to note 2.1 to the financial statements describing the
impact of IFRS 8 “Operating segments” adoption.
We
have previously audited, in accordance with standards of the Public
Company Accounting Oversight Board (United States), the consolidated
balance sheet of the Company as of December 31, 2008, and the related
statements of operations, stockholders’ equity and cash flows for the year
then ended (not presented herein); and in our report dated August 4, 2009,
we expressed an unqualified opinion. In our opinion, the
information set forth in the accompanying balance sheet as of December 31,
2008 is fairly stated, in all material respects, in relation to the
balance sheet from which it has been derived. Courbevoie, August 5, 2009 |
/s/
Jean-Claude Pauly
|
||
M A Z A R S | ||
Jean-Claude
Pauly
Partner
|
||
US $
thousand
|
||||||||||||
ASSETS
|
Note
|
March
31, 2009
|
December
31, 2008
|
|||||||||
Intangible
assets
|
||||||||||||
Value of
Business in Force (VBI)
|
172,793 | 199,178 | ||||||||||
Other
intangible assets
|
21,031 | 25,764 | ||||||||||
TOTAL
INTANGIBLE ASSETS
|
4
|
193,824 | 224,942 | |||||||||
Invested
Assets
|
||||||||||||
Financial
invested assets
|
||||||||||||
Funds
Withheld Asset (FWA)
|
5.1
|
2,330,021 | 2,472,837 | |||||||||
Directly held
assets
|
5.2
|
2,221,260 | 2,202,580 | |||||||||
Loans
|
5.2
|
4,318 | 4,359 | |||||||||
Investments
in associates - equity method
|
5.2
|
0 | 0 | |||||||||
TOTAL
FINANCIAL INVESTED ASSETS
|
4,555,598 | 4,679,776 | ||||||||||
CEDED
TECHNICAL RESERVES
|
9
|
281,967 | 230,367 | |||||||||
DEFERRED
TAX ASSETS
|
6
|
31,582 | 18,825 | |||||||||
Other
assets
|
||||||||||||
Fixed
assets
|
3,691 | 3,601 | ||||||||||
Receivables
arising from reinsurance operations
|
7.1
|
128,040 | 151,484 | |||||||||
Reserve
agreement
|
13
|
37,031 | 39,621 | |||||||||
Other
operating receivables
|
7.2
|
55,055 | 58,460 | |||||||||
Technical
accruals - assets
|
7.3
|
964,796 | 603,916 | |||||||||
TOTAL
OTHER ASSETS
|
1,188,612 | 857,082 | ||||||||||
CASH
AND CASH EQUIVALENTS
|
502,398 | 380,690 | ||||||||||
TOTAL
ASSETS
|
6,753,982 | 6,391,681 |
US $
thousand
|
||||||||||||
LIABILITIES
|
Note
|
March
31, 2009
|
December
31, 2008
|
|||||||||
SHAREHOLDERS'
EQUITY
|
||||||||||||
Capital and
capital in excess of nominal value
|
8.1
|
1,175,668 | 1,317,236 | |||||||||
Retained
earnings and other reserves
|
627,910 | 658,483 | ||||||||||
Currency
translation reserves
|
122,998 | 230,245 | ||||||||||
Consolidated
result
|
118,595 | (34,205 | ) | |||||||||
TOTAL
SHAREHOLDERS' EQUITY
|
8
|
2,045,171 | 2,171,759 | |||||||||
Liabilities
relating to reinsurance and investment contracts
|
||||||||||||
Gross
technical reserves
|
9
|
4,059,527 | 3,781,353 | |||||||||
Foreign
Exchange natural hedging
|
10
|
4,065 | 6,439 | |||||||||
TOTAL
LIABILITIES RELATING TO REINSURANCE AND INVESTMENT
CONTRACTS
|
4,063,592 | 3,787,792 | ||||||||||
PROVISIONS
FOR RISKS AND CHARGES
|
13,093 | 11,947 | ||||||||||
DEFERRED
TAX LIABILITIES
|
6
|
89,760 | 92,498 | |||||||||
DEBT
|
11
|
- | - | |||||||||
Other
liabilities
|
||||||||||||
Payables
relating to reinsurance operations
|
12.1
|
146,220 | 130,106 | |||||||||
Reserve
agreement
|
13
|
105,634 | 109,552 | |||||||||
Payables -
current tax position
|
21,278 | 8,761 | ||||||||||
Other
operating payables
|
12.2
|
194,752 | 50,637 | |||||||||
Technical
accruals - liabilities
|
12.3
|
74,482 | 28,630 | |||||||||
TOTAL
OTHER PAYABLES
|
542,366 | 327,686 | ||||||||||
TOTAL
LIABILITIES
|
6,753,982 | 6,391,681 |
US $
thousand
|
3
months
|
|||||||||||
Note
|
March
31, 2009
|
March
31, 2008
|
||||||||||
Gross
written premiums
|
667,223 | 775,321 | ||||||||||
Total
Premium Revenues
|
667,223 | 775,321 | ||||||||||
Premiums
ceded
|
(92,015 | ) | (134,048 | ) | ||||||||
Net
written premiums
|
575,207 | 641,273 | ||||||||||
Net variation
in unearned premium reserves
|
(275,712 | ) | (359,397 | ) | ||||||||
Net
earned premiums
|
299,496 | 281,875 | ||||||||||
Claims net of
retrocession
|
(201,888 | ) | (171,453 | ) | ||||||||
of
which claims paid net of retrocession
|
(193,632 | ) | (237,379 | ) | ||||||||
of
which claims reserves variation net of retrocession
|
(8,255 | ) | 65,925 | |||||||||
Commissions
and brokerage net of retrocession
|
(46,450 | ) | (51,681 | ) | ||||||||
Net
underwriting income
|
14
|
51,158 | 58,741 | |||||||||
Net
investment income
|
43,607 | 69,578 | ||||||||||
Net capital
gains and losses
|
(237 | ) | 1,082 | |||||||||
Valuation of
derivative instruments
|
2,089 | 4,480 | ||||||||||
Variations in
investment impairment
|
5.1
5.2
|
(364 | ) | - | ||||||||
Exchange rate
impact
|
75,401 | (188,001 | ) | |||||||||
Financial
results – other
|
(182 | ) | (806 | ) | ||||||||
Net
financial income excluding debt expense
|
120,314 | (113,667 | ) | |||||||||
Net
financial income including debt expense
|
15
|
120,314 | (113,667 | ) | ||||||||
Net income
from investments in associates using the equity method
|
- | - | ||||||||||
General
expenses
|
(27,792 | ) | (40,056 | ) | ||||||||
Net
income before amortization of intangibles
|
143,680 | (94,982 | ) | |||||||||
Amortization
of intangibles
|
(21,638 | ) | (32,661 | ) | ||||||||
Net
income before recognition of negative goodwill
|
122,042 | (127,644 | ) | |||||||||
Goodwill
impairment
|
- | - | ||||||||||
Net
income before tax
|
122,042 | (127,644 | ) | |||||||||
Income
tax
|
16
|
(3,447 | ) | (1,881 | ) | |||||||
TOTAL
NET INCOME
|
118,595 | (129,525 | ) | |||||||||
Earnings per
share (US
$)
|
17
|
1.47 | (1.52 | ) | ||||||||
Diluted
earning per share (US
$)
|
17
|
1.46 | (1.47 | ) |
US $
thousand
|
3
months
|
3
months
|
||||||
March
31, 2009
|
March
31, 2008
|
|||||||
Net
income of the period
|
118,595 | (129,525 | ) | |||||
Reserves
relating to changes in fair value through shareholders’ equity (1)
|
3,588 | 19,199 | ||||||
Translation
reserves
|
(107,246 | ) | 208,440 | |||||
Net
gains and losses recognized directly through shareholders’
equity
|
(103,658 | ) | 227,639 | |||||
Total
recognized income and expense for the period
|
14,936 | 98,114 |
(1)
|
Related
revaluation of available for sale assets (AFS).
|
US $
thousand
|
3
months
|
|||||||
March
31, 2009
|
March
31, 2008
|
|||||||
Net
profit (loss)
|
118,595 | (129,525 | ) | |||||
Adjustments:
|
||||||||
Income from
associates
|
- | - | ||||||
Depreciation
and provisions
|
23,526 | 35,073 | ||||||
Change in
reinsurance technical reserves
|
235,701 | 297,986 | ||||||
Fair value
gains - losses
|
296 | 2,696 | ||||||
Profit / loss
on disposal and dilution profit and loss
|
(3,819 | ) | 1,094 | |||||
Revenues
& expenses with no effect on cash flow
|
(81,460 | ) | 169,325 | |||||
Income
tax
|
3,447 | 1,822 | ||||||
Effect of
changes in working capital
|
(223,065 | ) | (314,622 | ) | ||||
Effect of
changes of current account - Quota share COLISEE RE (formerly
named AXA RE)
|
99,320 | 71,347 | ||||||
Tax
paid
|
(2,015 | ) | (1,936 | ) | ||||
Cash
flows from operating activities
|
170,528 | 133,321 | ||||||
Effect of
changes in group structure
|
- | 13,448 | ||||||
Purchase and
sale of intangible and tangible assets
|
4,298 | (575 | ) | |||||
Purchase of
financial invested assets
|
(267,487 | ) | (817,831 | ) | ||||
Sale of
financial invested assets
|
211,874 | 748,153 | ||||||
Increase
(decrease) in loans and advances made
|
- | - | ||||||
Dividends
received
|
- | - | ||||||
Cash
flows from (used in) investing activities
|
(51,316 | ) | (56,806 | ) | ||||
Proceeds from
issue of shares
|
0 | - | ||||||
Treasury
shares
|
(473 | ) | (9,491 | ) | ||||
Authorised
capital issued but uncalled
|
- | - | ||||||
RSU and
stocks options
|
1,017 | 8,474 | ||||||
Net financial
interest paid
|
- | 3 | ||||||
Dividends to
be paid to group shareholders
|
0 | - | ||||||
Cash
flows from (used in) financing activities
|
544 | (1,015 | ) | |||||
Effects of
exchange rate changes
|
1,952 | 4,641 | ||||||
Increase
(decrease) in cash and cash equivalents
|
121,708 | 80,133 | ||||||
Cash position at
opening
|
380,690 | 451,594 | ||||||
Cash
position at closing
|
502,398 | 531,727 | ||||||
Variation
of cash
|
121,708 | 80,133 |
|
·
|
Klaus, a
Windstorm, that occurred in January 2009, a major loss in Europe: the
company’s exposure related to Klaus is estimated at US $19.4 million net
impact(1).
|
|
·
|
One large
loss: Victorian bushfires, (Australia, on February 7, 2009) for a US $6.8
million net impact.
|
|
·
|
Hurricane
Ike, a major loss in USA which occurred in September 2008: the net impact
of this event, estimated at US $130 million as at December 31, 2008, has
decreased to US $120 million as at March 31, 2009. The variance between
those two periods is due to cedants’ information
received.
|
(1)
|
Net impact = pre tax net of
reinsurance and reinstatement
premiums.
|
|
·
|
IFRS 8,
Operating segments.
|
|
·
|
Revised IAS
1, Presentation of financial
statements.
|
|
·
|
Amendment to
IAS 23, Borrowing costs.
|
|
·
|
Amendment to
IFRS 2, Share-Based payment, makes vesting contingent on service
conditions and performance conditions
only.
|
|
·
|
Amendment to
IAS 32, Financial instruments presentation and to IAS 1 Presentation of
financial statements – Puttable shares and obligations arising only on
liquidation.
|
|
·
|
Improvements
to IFRS published on May 22, 2008 comprise non-urgent, minor
amendments to standards.
|
|
·
|
IFRIC 13,
Customer loyalty programmes.
|
|
·
|
IFRIC 15,
Agreement for the construction of real
estate
|
|
·
|
IFRIC 16,
Hedges of a net investment in a Foreign
operation.
|
|
·
|
Property:
reinsurance coverage for physical damages caused by fire and related
perils such as explosion, lightning, storm, flood, earthquake and
terrorism, as well as coverage for business interruption and loss of rent
as a result of those perils.
|
|
·
|
Casualty:
reinsurance coverage for motor risks, medical malpractice, general
liability and professional liability as well as workers
compensation.
|
|
·
|
Marine/Aviation/Space:
Our marine, aviation and space, or MAS, line of business provides
reinsurance coverage for insurance companies writing in the marine,
aviation and space lines.
|
|
·
|
Credit/Surety:
reinsurance of Credit and Surety Insurance contracts. Credit insurance
protects the seller against the risk of non-payment and customer
insolvency and surety insurance relates primarily to completion bonds,
performance bonds and other forms of security written but specialized
surety insurers.
|
|
·
|
Facultative:
Our facultative line of business provides property facultative
reinsurance, energy onshore and offshore coverage as well as credit and
surety, weather-related products and sports, leisure and entertainment
coverage and is managed separately from the other lines of
business.
|
|
·
|
Life/accident
and health: coverage of exposures on an individual basis as well as group
coverage written by primary
insurers.
|
Classification
|
Foreign
Exchange rate
|
Impacts
|
Examples
|
|
Monetary
items
|
Any
|
Closing
rate
|
P&L
|
Bonds, receivables,
technical reserves
|
Non-monetary
items at fair value
|
Available for
Sale (OCI) (1)
|
Rate on the
date of fair value assessment
|
Equity
|
Listed
shares
|
Available for
Sale (P&L) (2)
|
Rate on the
date of fair value assessment
|
P&L
|
Fair value
option
|
|
Non-monetary
items at cost
|
Any
|
Not
revaluated
|
-
|
Value
business in force, operating real
estate
|
(1)
|
Available
for sale with variation of fair value through other comprehensive
income.
|
(2)
|
Available
for sale with variation of fair value through profit and loss
income.
|
3 months
|
12
months
|
|||
March 31,
2009
|
December 31,
2008
|
|||
Average
rate
|
Closing
rate
|
Average
rate
|
Closing
rate
|
|
Swiss
Franc
|
0.873
|
0.878
|
0.927
|
0.937
|
Canadian
dollar
|
0.809
|
0.798
|
0.959
|
0.819
|
Singaporean
dollar
|
0.668
|
0.658
|
0.710
|
0.694
|
Euro
|
1.315
|
1.331
|
1.480
|
1.392
|
(i)
|
a discount
rate between 3.5% - 5%, according to the
currency
|
(ii)
|
the
anticipated payout pattern of such
reserves
|
|
·
|
assets held to maturity (HTM)
accounted for at amortized
cost;
|
|
·
|
loans & receivables (including
unquoted debt instruments) accounted for at amortized
cost
|
|
·
|
trading assets by nature and
equivalent assets (designated on option) accounted for at fair value, with
changes in fair value through profit or
loss;
|
|
·
|
assets available for sale
(AFS) accounted for at fair value with
changes in fair value reflected in shareholders’
equity
|
Accounting
|
|
Available
for sale through OCI
|
Variation of
fair value through equity (OCI) and adjusted for
impairment
|
Fair
value through P&L
|
Variation of
fair value through P&L
|
Held to
maturity
|
Amortized
cost adjusted for impairment
|
Loans
and receivables
|
US $
million
|
|||||||||||||||||
Characteristics
|
Type
of financial assets
|
Fair
value of direct assets
|
Historical
cost of assets in the FWA
|
TOTAL
|
%
|
||||||||||||
Active market
(1)
|
Government
bonds
|
677.1 | 844.6 | 1 521.7 | 37.0 | % | |||||||||||
Agency
bonds
|
406.2 | 289.9 | 696.1 | 16.9 | % | ||||||||||||
SUB
TOTAL
|
1,083.3 | 1,134.5 | 2,217.8 | 53.9 | % | ||||||||||||
Technical
valuation using observable inputs / markets with medium liquidity
(2)
|
Corporate
bonds with medium liquidity
|
946.4 | 712.7 | 1 659.1 | 40.3 | % | |||||||||||
Government
with medium liquidity
|
10.1 | 1.1 | 11.2 | 0.3 | % | ||||||||||||
SUB
TOTAL
|
956.6 | 713.8 | 1,670.4 | 40.6 | % | ||||||||||||
Technical
valuation using non observable inputs / Market with low or no liquidity
(3)
|
Corporate
bonds with low liquidity
|
61.3 | 14.2 | 75.5 | 1.8 | % | |||||||||||
Other bonds
with low liquidity
|
- | 18.0 | 18.0 | 0.4 | % | ||||||||||||
ABS
|
93.3 | 21.4 | 114.7 | 2.8 | % | ||||||||||||
Non quoted
funds, equities, bonds and real estate funds
|
2.9 | 13.7 | 16.6 | 0.4 | % | ||||||||||||
Non
consolidated affiliates
|
1.5 | - | 1.5 | 0.0 | % | ||||||||||||
SUB
TOTAL
|
159.0 | 67.3 | 226.4 | 5.5 | % | ||||||||||||
TOTAL
|
2,198.9 | 1,915.7 | 4,114.5 | 100.0 | % | ||||||||||||
Other
financial assets (4)
|
529.1 | 414.4 | 943.5 | ||||||||||||||
TOTAL
FINANCIAL ASSETS
|
2,728.0 | 2,330.0 | 5,058.0 |
(1)
|
An active
market is a market in which there is a significant volume of
trades and in which financial assets are traded over the counter,
electronically traded, daily priced from external pricing vendors or
priced by brokers.
|
(2)
|
The medium
liquidity market is a less active
market.
|
(3)
|
The low
liquidity market is a market in which the volume of trades is
limited.
|
(4)
|
Other
financial assets include cash, cash equivalent, other assets of FWA,
loans, and deposits.
|
|
·
|
in net income for the exchange
difference applicable to the amortized cost of the asset,
and
|
|
·
|
in shareholders’ equity for the
remaining foreign exchange
difference.
|
|
·
|
significant financial difficulty
of the issuer;
|
|
·
|
the risk of non-performance of a
contract due to non-payment or to a delay in the payment of principal or
of interest;
|
|
·
|
the lender, for economic or legal
reasons, grants a concession it would not otherwise
grant;
|
|
·
|
the risk of bankruptcy or of
financial restructuring of the
issuer;
|
|
·
|
the risk of deterioration of
equity markets following financial
crisis;
|
|
·
|
the existence of objective data
indicating a measurable decrease in the estimated future cash flow of the
financial asset, or an adverse development of the payment status of
borrowers indicating the risk of asset default;
or
|
|
·
|
a significant or continuous
decline in fair value below its amortized
cost.
|
Nature
|
General
comments
|
Other
|
|
Available for sale (OCI) |
Equity
|
Impairment
criteria:
- loss > 20
%,
or
- loss for a
period more than 6 consecutive months.
|
Irreversible
|
Fixed
maturity
|
Fixed
maturity are impaired in case of credit event.
Criteria
allowing to detect a credit event:
- BIG (Below investment grade),
investment for which the rating is < BBB :
Individual
assessment of unrealized losses:
· loss
for a period more than 12 months,
or
·
loss for a period more than 6 months and > 20 % at
closing.
- IG (Investment grade),
investment for which the rating is ≥ BBB:
Individual assessment of unrealized losses :
· loss
for a period more than 6 months and > 20 % (but less than 50
%) at closing
or
· loss > 50
% at closing.
In case where
credit risk can be covered:
no
impairment
|
Reversible
|
|
Debt
|
Risk of recoverability on the
total amount due by the issuer
|
Reversible
|
|
Loans
|
Based on actualized future cash
flow
|
Reversible
|
|
Fair value through
P&L
|
AFS P&L
|
Not
applicable
|
|
·
|
If unrealized
losses are superior to 50% : PARIS RE will report an impairment charge in
the income statement which corresponds to 100% of the unrealized
losses;
|
|
·
|
If unrealized
losses are superior to 20% and less than 50%: PARIS RE will report an
impairment charge in the income statement which corresponds to 100% of the
unrealized loss when two of the three below criteria are
met:
|
|
o
|
consistent
unrealized loss for a period of six consecutive months and greater than
20% at the date of the closing,
|
|
o
|
a rating of less than
A-,
|
|
o
|
a solvency ratio below 100 %
(where the value of the underlying collateral less the delinquency rate
falls below 100 %).
|
|
·
|
the economic characteristics and
risks of the embedded derivative are not closely related to the economic
characteristics and risks of the host
contract;
|
|
·
|
a separate instrument with the
same terms as the embedded derivative would meet the definition of a
derivative; and
|
|
·
|
the hybrid (combined) instrument
is not measured at fair value, any change in fair value being recognized
in profit or loss.
|
|
·
|
reserves for
unearned premiums, consisting of the portion of premiums related to future
risk coverage for the period beginning on the balance sheet date and
ending on the following expiration date of the contract (or the time limit
stipulated in the contract); and
|
|
·
|
the unexpired
risk provision covering the portion of claims and claims expenses that
exceeds the fraction of premiums booked net of deferred acquisition
costs.
|
|
·
|
The Premiums
are recognized when they are written. They are generally earned using
straight-line and prorata temporis
rules.
|
|
·
|
By contrast,
large and major losses usually occur during hurricane season, primarily
between July to October for US
exposures.
|
(1)
|
The
liquidation of PARIS RE Luxembourg will be effective in Q2 2009 (see Note
18).
|
(2)
|
PARIS RE
Acquisition France is represented together with PARIS RE Holdings France
in this organization chart. On April 24, 2009, PARIS RE Acquisition France
was merged with PARIS RE Holdings France (see Note
18).
|
(3)
|
Branch office
of PARIS RE.
|
(4)
|
PARIS RE Risc
Ltd. is not consolidated because the impact of its consolidation would not
be material.
|
(5)
|
The
dissolution of Compagnie Générale de Réassurance de Monte Carlo will be
effective in Q2 2009 (see Note 18).
|
(6)
|
PARIS RE
Finance GIE is not consolidated because the impact of its consolidation
would not be material.
|
Company
|
Footnote
|
Country
|
%
of control in 2009
|
%
of interest in
2009
|
Consolidation
Method
|
%
of control in 2008
|
%
of interest in
2008
|
Consolidation
Method
|
PARIS RE
Holdings Ltd
|
Switzerland
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
Switzerland AG
|
Switzerland
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
Luxembourg, Sarl
|
Luxembourg
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
Holdings France SA
|
France
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
Acquisition France SAS
|
France
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
SA
|
(1)
|
France
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
Compagnie
Générale de Réassurance de Monte Carlo (CGRM) SA
|
Monaco
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE
America Insurance Company
|
USA
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
|
PARIS RE Asia
Pacific Pte. Ltd.
|
Singapore
|
100.0
|
100.0
|
Global
|
100.0
|
100.0
|
Global
|
(1)
|
Includes a
branch office in Canada.
|
US $
thousand
|
||||||||||||||||||||||||
March
31, 2009
|
December
31, 2008
|
|||||||||||||||||||||||
Gross
|
Depreciation/
Impairment
|
Net
|
Gross
|
Depreciation/
Impairment
|
Net
|
|||||||||||||||||||
Reserve
discount
|
391,087 | (225,644 | ) | 165,443 | 408,474 | (216,646 | ) | 191,828 | ||||||||||||||||
Unrealized
capital gains/losses purchased
|
45,307 | (45,307 | ) | - | 47,335 | (47,335 | ) | - | ||||||||||||||||
US
licenses
|
7,350 | - | 7,350 | 7,350 | - | 7,350 | ||||||||||||||||||
Value
business in force
|
443,744 | (270,951 | ) | 172,793 | 463,159 | (263,981 | ) | 199,178 | ||||||||||||||||
Right to
renew
|
65,608 | (45,379 | ) | 20,229 | 68,501 | (43,772 | ) | 24,729 | ||||||||||||||||
Software
|
11,306 | (10,503 | ) | 803 | 11,812 | (10,777 | ) | 1,035 | ||||||||||||||||
Other
intangibles
|
341 | (341 | ) | (0 | ) | 300 | (300 | ) | (0 | ) | ||||||||||||||
Total
intangible assets
|
520,999 | (327,174 | ) | 193,824 | 592,759 | (367,817 | ) | 224,942 |
US $
thousand
|
||||||||||||||||||||||||
Historical
Net book value as of March 31, 2009
|
Market
value
|
Total
unrealized gains and losses
|
Historical
Net book value as of December 31, 2008
|
Market
value
|
Total
unrealized gains and losses
|
|||||||||||||||||||
Cash and cash
equivalents
|
156,492 | 157,473 | 981 | 243,837 | 243,837 | - | ||||||||||||||||||
Fixed
maturities available for sale
|
1,902,134 | 1,911,181 | 9,047 | 1,928,199 | 1,957,593 | 29,394 | ||||||||||||||||||
Short term
investment available for sale
|
- | - | - | 13,602 | 13,602 | - | ||||||||||||||||||
Equities
available for sale
|
0 | - | 0 | 0 | - | 0 | ||||||||||||||||||
Non
consolidated investment funds available for sale
|
13,527 | 13,667 | 140 | 57,431 | 58,081 | 649 | ||||||||||||||||||
TOTAL
|
2,072,153 | 2,082,321 | 10,168 | 2,243,069 | 2,273,112 | 30,043 | ||||||||||||||||||
Fixed
maturities at fair value
|
- | - | - | - | - | - | ||||||||||||||||||
Other assets
held at fair value
|
24,929 | 24,929 | 0 | 33,458 | 33,458 | - | ||||||||||||||||||
TOTAL INVESTMENTS
|
2,097,082 | 2,107,250 | 10,168 | 2,276,526 | 2,306,570 | 30,043 | ||||||||||||||||||
Others assets
/ liabilities
|
210,538 | 176,701 | ||||||||||||||||||||||
Revenues of
Funds withheld asset
|
22,401 | 19,610 | ||||||||||||||||||||||
Funds
Withheld Asset
|
2,330,021 | 2,472,837 | ||||||||||||||||||||||
US $
thousand
|
||||||||||||
March
31,
2009
|
2009
variation
|
December
31, 2008
|
||||||||||
ABS
|
(31,791 | ) | (4,797 | ) | (26,994 | ) | ||||||
Others
financial assets (1)
|
(21,676 | ) | (4,248 | ) | (17,428 | ) | ||||||
Total
Impairment
|
(53,468 | ) | (9,045 | ) | (44,422 | ) |
(1)
|
The Others
financial assets impairment include impairment of Real estate funds for US
$(13.8) million at March 31, 2009 with a 2009 variation of US $(4.2)
million.
|
US
$ thousand
|
||||||||||||||||||||||||||||||||||||||||
March
31, 2009
|
December
31, 2008
|
|||||||||||||||||||||||||||||||||||||||
Historical
Net book value
|
Market
value
|
Unrealized gains/
Losses
|
Of which unrealized gains
|
Of which unrealized losses
|
Historical
Net book value
|
Market
value
|
Unrealized gains/
Losses
|
Of which unrealized gains
|
Of
which unrealized losses
|
|||||||||||||||||||||||||||||||
1
|
2
|
3
= 2 - 1
|
|
|
|
|||||||||||||||||||||||||||||||||||
Fixed
maturities available for sale
|
2,152,070 | 2,194,370 | 42,300 | 59,669 | (17,369 | ) | 2,038,553 | 2,077,754 | 39,201 | 57,019 | (17,818 | ) | ||||||||||||||||||||||||||||
Short
term investment available for sale
|
23,588 | 23,588 | - | - | - | 38,129 | 38,129 | - | - | - | ||||||||||||||||||||||||||||||
Equities
available for sale
|
230 | 255 | 25 | 25 | - | 290 | 297 | 7 | 7 | - | ||||||||||||||||||||||||||||||
Non
consolidated investment funds available
|
||||||||||||||||||||||||||||||||||||||||
for
sale (invested in fixed maturities, equities
|
1,325 | 1,501 | 176 | 176 | - | 84,254 | 84,835 | 581 | 581 | - | ||||||||||||||||||||||||||||||
and
other assets)
|
||||||||||||||||||||||||||||||||||||||||
Non
consolidated affiliates
|
1,837 | 1,547 | (290 | ) | - | (290 | ) | 1,869 | 1,566 | (303 | ) | - | (303 | ) | ||||||||||||||||||||||||||
FINANCIAL
INVESTED ASSETS
|
2,179,050 | 2,221,260 | 42,211 | 59,870 | (17,659 | ) | 2,163,094 | 2,202,580 | 39,486 | 57,607 | (18,121 | ) | ||||||||||||||||||||||||||||
Loans
|
4,318 | 4,318 | - | - | - | 4,359 | 4,359 | - | - | - | ||||||||||||||||||||||||||||||
Investments
in affiliates - equity method
|
(0 | ) | (0 | ) | (0 | ) | - | 0 | 0 | 0 | - | |||||||||||||||||||||||||||||
Cash
and cash equivalents
|
501,810 | 502,398 | 587 | 587 | - | 380,463 | 380,690 | 227 | 227 | - | ||||||||||||||||||||||||||||||
TOTAL
DIRECT FINANCIAL INVESTMENTS
|
2,685,178 | 2,727,975 | 42,797 | 60,457 | (17,659 | ) | 2,547,917 | 2,587,630 | 39,712 | 57,834 | (18,121 | ) | ||||||||||||||||||||||||||||
US $
thousand
|
||||||||||||
March
31,
2009
|
2009
variation
|
December
31, 2008
|
||||||||||
ABS
|
(326 | ) | (326 | ) | - | |||||||
Other
bonds (1)
|
(822 | ) | 46 | (868 | ) | |||||||
Others
financial assets
|
(136 | ) | (36 | ) | (100 | ) | ||||||
Total
Impairment
|
(1,285 | ) | (316 | ) | (968 | ) |
(1)
|
The variation
of Other bonds directly held impairment is the impact on currency
translation.
|
US
$ thousand
|
Direct
financial
investment
|
Financial
investment
included
in
« Funds Withheld
»
|
Total
as of
March
31, 2009
|
Direct
financial
investment
|
Financial
investment
included
in
« Funds Withheld
»
|
Total
as of December
31, 2008
|
||||||||||||||||||
ABS
Residential
|
1,252 | 20,664 | 21,917 | 1,632 | 27,207 | 28,840 | ||||||||||||||||||
of
which “Subprime”
|
251 | 5,325 | 5,577 | 260 | 7,540 | 7,801 | ||||||||||||||||||
of
which “Alt A”
|
- | 3,178 | 3,178 | - | 3,714 | 3,714 | ||||||||||||||||||
of
which “Manufactured housing”
|
386 | 6,067 | 6,453 | 746 | 6,516 | 7,262 | ||||||||||||||||||
of
which “Prime”
|
614 | 6,094 | 6,708 | 627 | 9,437 | 10,064 | ||||||||||||||||||
CMBS
|
1,827 | 765 | 2,592 | 1,883 | 818 | 2,701 | ||||||||||||||||||
ABS
Auto
|
- | - | - | - | - | - | ||||||||||||||||||
ABS
Credit Card
|
- | - | - | - | - | - | ||||||||||||||||||
ABS
Equipment
|
- | - | - | - | - | - | ||||||||||||||||||
Agency
CMO/MBS
|
74,684 | 0 | 74,684 | 76,531 | 0 | 76,531 | ||||||||||||||||||
ABS
Student Loan
|
14,821 | - | 14,821 | 16,009 | - | 16,009 | ||||||||||||||||||
Total
net book value as at March 31, 2009
|
92,584 | 21,429 | 114,013 | 96,055 | 28,025 | 124,081 | ||||||||||||||||||
Unrealized
losses
|
720 | (1,832 | ) | (1,112 | ) | (153 | ) | (3,074 | ) | (3,228 | ) | |||||||||||||
Total
market value as at March 31, 2009
|
93,304 | 19,597 | 112,901 | 95,902 | 24,951 | 120,853 | ||||||||||||||||||
Total
financial investments, cash and cash equivalent
|
5,057,996 | 5,060,466 | ||||||||||||||||||||||
%
of total financial investments
|
2.2 | % | 2.4 | % | ||||||||||||||||||||
|
·
|
For directly
held assets, the unrealized loss is booked through equity (“Other
Comprehensive Income”) except in the case of impairment, which is booked
through the profit and loss
statement.
|
|
·
|
For the
underlying assets of the Funds Withheld Asset, the unrealized losses after
impairment are
|
US $
thousand
|
||||||||||||||||||||||||
Detail
of unrealized losses on ABS
|
Direct financial
investment
|
Financial
investment included in
« Funds Withheld » |
Total
as of March 31, 2009
|
Direct
financial investment
|
Financial
investment included in
<« Funds Withheld » |
Total
as of December 31, 2008
|
||||||||||||||||||
Unrealized
gains and losses on ABS before impairment (a)
|
383 | (33,623 | ) | (33,240 | ) | (153 | ) | (30,608 | ) | (30,221 | ) | |||||||||||||
Cumulated
impairment through balance sheet (b)
|
(337 | ) | (31,791 | ) | (32,128 | ) | - | (26,994 | ) | (26,994 | ) | |||||||||||||
Outstanding
unrealized gains and losses on ABS (a) – (b)
|
720 | (1,832 | ) | (1,112 | ) | (153 | ) | (3,074 | ) | (3,227 | ) | |||||||||||||
|
·
|
Lehman
Brothers: US $0.9 million (fully
impaired),
|
|
·
|
American
General Finance (AIG Subsidiary): US $3.7
million,
|
|
·
|
International
Lease Fin. Corp. (AIG Subsidiary): US $3.8
million,
|
|
·
|
iStar
Financial: US $1 million.
|
US $
thousand
|
||||||||||||||||||||||||
March 31,
2009
|
December 31,
2008
|
|||||||||||||||||||||||
France
|
Other
|
TOTAL
|
France
|
Other
|
TOTAL
|
|||||||||||||||||||
VBI related
to the Acquisition
|
43,448 | 10,570 | 54,019 | 51,738 | 11,024 | 62,762 | ||||||||||||||||||
Equalization
reserve
|
32,206 | 32,206 | 33,735 | - | 33,735 | |||||||||||||||||||
Tax
losses
|
(32,621 | ) | - | (32,621 | ) | (7,209 | ) | - | (7,209 | ) | ||||||||||||||
Temporary
differences
|
9,114 | (4,540 | ) | 4,574 | (9,942 | ) | (5,673 | ) | (15,615 | ) | ||||||||||||||
Total
net deferred tax
|
52,148 | 6,030 | 58,179 | 68,322 | 5,351 | 73,673 | ||||||||||||||||||
Total
deferred tax liabilities
|
79,005 | 10,755 | 89,760 | 82,250 | 10,248 | 92,498 | ||||||||||||||||||
Total
deferred tax assets
|
(26,857 | ) | (4,724 | ) | (31,582 | ) | (13,927 | ) | (4,897 | ) | (18,825 | ) |
US $
thousand
|
||||||||
March
31, 2009
|
December
31, 2008
|
|||||||
Cash
deposited with reinsurers (inward reinsurance)
|
26,864 | 17,483 | ||||||
Reinsurance
receivables (inward reinsurance)
|
77,427 | 129,801 | ||||||
Reinsurance
receivables (outward reinsurance)
|
23,750 | 4,201 | ||||||
TOTAL
|
128,040 | 151,484 |
US $
thousand
|
||||||||
March
31, 2009
|
December
31, 2008
|
|||||||
Separate
account on employee benefit
|
237 | 291 | ||||||
Current
accounts
|
641 | 1,877 | ||||||
Other
receivables (1)
|
53,844 | 55,904 | ||||||
Other long
term assets
|
333 | 388 | ||||||
TOTAL
|
55,055 | 58,460 |
(1)
|
As at December
31, 2008, other receivables include US $43 million income tax
prepayment.
|
US $
thousand
|
||||||||
March
31, 2009
|
December
31, 2008
|
|||||||
Premiums to
be written (inward reinsurance)
|
1,010,266 | 643,744 | ||||||
Commissions
to be written (inward reinsurance)
|
(214,812 | ) | (157,312 | ) | ||||
Commissions
on unearned premiums (inward reinsurance)
|
169,342 | 117,484 | ||||||
TOTAL
|
964,796 | 603,916 |
Premium | ||||||||||||||||||||||||||||
Number of
shares
|
Par
Value
|
Common
shares |
Restricted Shares
Units(1)
|
Stock
Options(1)
|
Total
|
Par
Value & Premiums
|
||||||||||||||||||||||
Capital and
share premiums as at December 31, 2008
|
80,659,732 | 390,856 | 895,051 | 16,348 | 14,981 | 926,380 | 1,317,236 | |||||||||||||||||||||
Change in
number of shares and Par value
|
(150,842 | ) | (150,842 | ) | ||||||||||||||||||||||||
RSU and
SO
|
212 | 804 | 1,017 | 1,017 | ||||||||||||||||||||||||
Share buy
back
|
(38,848 | ) | (221 | ) | (252 | ) | (252 | ) | (473 | ) | ||||||||||||||||||
Cancellation
of share buy back dividends
|
8,731 | 8,731 | ||||||||||||||||||||||||||
Capital and
share premiums as at March 31, 2009
|
80,620,884 | 248,524 | 894,799 | 16,560 | 15,785 | 927,145 | 1,175,668 |
(1)
|
RSU and SO
granted to management and employees are recorded under expenses and
premiums according to their respective vesting
period.
|
US $
thousand
|
||||||||||||
Gross
|
Tax
|
Net
|
||||||||||
Unrealized
gains or losses of assets available for sale - Opening (1)
|
39,712 | (6,274 | ) | 33,438 | ||||||||
Variations
relating to sale
|
(890 | ) | 137 | (753 | ) | |||||||
Variations
relating to revaluation of assets after an impairment
|
330 | (32 | ) | 298 | ||||||||
Variations
relating to foreign exchange impact on historical cost
|
84 | (9 | ) | 76 | ||||||||
Variations
relating to foreign exchange impact on gains and losses
|
1,370 | (169 | ) | 1,201 | ||||||||
Variations
relating to revaluation of assets
|
1,362 | (621 | ) | 740 | ||||||||
Other
variations
|
0 | 0 | 0 | |||||||||
Invested
assets bought in previous years (2)
|
2,256 | (695 | ) | 1,561 | ||||||||
Revaluation
on acquisitions during the year (3)
|
2,896 | (870 | ) | 2,026 | ||||||||
Revaluation
of invested assets available for sale (without exchange impact of
consolidation) (4) = (2)+(3)
|
5,152 | (1,565 | ) | 3,588 | ||||||||
Foreign
exchange impact of consolidation (5)
|
(2,066 | ) | 266 | (1,800 | ) | |||||||
Unrealized
gains or losses of assets available for sale - Closing (6) =
(1)+(4)+(5)
|
42,798 | (7,573 | ) | 35,225 |
US $ thousand | ||||||||
March
31, 2009
|
December
31, 2008
|
|||||||
Opening
Shareholders' equity
|
2,171,759 | 2,474,115 | ||||||
Dividends
|
- | -, | ||||||
Capital
variation
|
(150,842 | ) | (264,339 | ) | ||||
RSU and
stocks options
|
1,017 | (17,148 | ) | |||||
Treasury
shares (1)
|
8,302 | (81,642 | ) | |||||
Capital
increase tied to IPO
|
- | - | ||||||
Currency
translation variation
|
(107,246 | ) | 69,872 | |||||
Net profit
(loss)
|
118,595 | (34,205 | ) | |||||
Revaluation
of available for sale assets (AFS)
|
3,588 | 19,961 | ||||||
IPO fees
charged against share premiums
|
- | - | ||||||
Other
variations
|
- | 5,146 | ||||||
Closing
Shareholders' equity
|
2,045,171 | 2,171,759 |
(1)
|
At March 31,
2009, the amount of Treasury shares includes US $44 thousand of
cancellation of treasury shares capital
gain.
|
US $
thousand
|
||||||||||||
March
31, 2009
|
December
31, 2008
|
|||||||||||
Gross
claims reserves
|
||||||||||||
Reserves for
claims expenses
|
22,528 | 22,215 | ||||||||||
Claims
reserves
|
3,187,661 | 3,247,313 | ||||||||||
Unexpired
risk reserves
|
12,010 | 5,022 | ||||||||||
Equalization
reserves
|
0 | - | ||||||||||
Ceded
claims reserves
|
||||||||||||
Claims
reserves
|
(198,598 | ) | (207,768 | ) | ||||||||
Unexpired
risk reserves
|
- | - | ||||||||||
Total
net claims reserves
|
I
|
3,023,601 | 3,066,782 | |||||||||
Net
premium reserves
|
||||||||||||
Gross
unearned premium reserves
|
837,328 | 506,803 | ||||||||||
Ceded
unearned premium reserves
|
(83,369 | ) | (22,599 | ) | ||||||||
Total
net premium reserves
|
II
|
753,959 | 484,205 | |||||||||
TOTAL
GROSS TECHNICAL RESERVES
|
4,059,527 | 3,781,353 | ||||||||||
TOTAL
CEDED TECHNICAL RESERVES
|
(281,967 | ) | (230,367 | ) | ||||||||
TOTAL
NET TECHNICAL RESERVES
|
I
+ II
|
3,777,560 | 3,550,986 |
US $
thousand
|
||||||||||||||||||||||||
Notional
amount on balance sheet at closing
|
<
1 year
|
1
to 5 years
|
5
to 10 years
|
More
than 10 years
|
Net fair value at closing
(1)
|
|||||||||||||||||||
MATURITY
OF HEDGE
|
||||||||||||||||||||||||
Swaps
|
- | - | - | - | - | - | ||||||||||||||||||
Options
|
- | - | - | - | - | - | ||||||||||||||||||
Future
/ forward
|
4,065 | 4,065 | - | - | - | 4,065 | ||||||||||||||||||
Credit
derivatives
|
- | - | - | - | - | - | ||||||||||||||||||
Other
derivatives
|
- | - | - | - | - | - | ||||||||||||||||||
TOTAL
|
4,065 | 4,065 | - | - | - | 4,065 | ||||||||||||||||||
(1)
|
If the fair
value amount at closing is negative then it relates to an unrealized gain
which is reported in the liabilities part of the balance sheet with minus
sign. If the fair value amount at closing is positive then it relates to
an unrealized loss which is reported in the liability side of the balance
sheet.
|
US $
thousand
|
||||||||
March
31, 2009
|
December
31, 2008
|
|||||||
Cash
deposited by reinsurers (outward reinsurance)
|
27,096 | 27,008 | ||||||
Reinsurance
payables (inward reinsurance)
|
61,405 | 53,247 | ||||||
Reinsurance
payables (outward reinsurance)
|
57,719 | 49,851 | ||||||
TOTAL
|
146,220 | 130,106 |
US $
thousand
|
||||||||
March
31, 2009
|
December
31, 2008
|
|||||||
Social
Security and tax payables
|
32,952 | 31,428 | ||||||
Current
accounts
|
316 | 140 | ||||||
Accounts
payable on assets purchased
|
1 | 3,594 | ||||||
Accruals and
deferred income
|
3,825 | 43 | ||||||
Other
accounts payable (1)
|
157,658 | 15,432 | ||||||
TOTAL
|
194,752 | 50,637 |
(1)
|
At March 31,
2009, Other accounts payable include US $142 million of dividends to be
paid on May 5, 2009.
|
US $
thousand
|
||||||||
March
31, 2009
|
December
31, 2008
|
|||||||
Premiums to
be written (outward reinsurance)
|
85,308 | 42,608 | ||||||
Commissions
to be written (outward reinsurance)
|
(26,184 | ) | (20,545 | ) | ||||
Commissions
on unearned premiums (outward reinsurance)
|
15,357 | 6,567 | ||||||
TOTAL
|
74,482 | 28,630 |
US $
thousand
|
3
months
|
|||||||||||
March
31, 2008
published
|
Reserve
Agreement
reclassification
|
March
31, 2008
presented
|
||||||||||
Gross
written premiums
|
768,694 | 6,627 | 775,321 | |||||||||
Total
Premium Revenues
|
768,694 | 6,627 | 775,321 | |||||||||
Premiums
ceded
|
(134,048 | ) | - | (134,048 | ) | |||||||
Net
written premiums
|
634,646 | 6,627 | 641,273 | |||||||||
Net variation
in unearned premium reserves
|
(359,397 | ) | - | (359,397 | ) | |||||||
Net
earned premiums
|
275,248 | 6,627 | 281,875 | |||||||||
Claims net of
retrocession
|
(166,414 | ) | (5,040 | ) | (171,453 | ) | ||||||
of
which claims paid net of retrocession
|
(232,339 | ) | (5,040 | ) | (237,379 | ) | ||||||
of
which claims reserves variation net of retrocession
|
65,925 | - | 65,925 | |||||||||
Commissions
and brokerage net of retrocession
|
(50,094 | ) | (1,588 | ) | (51,681 | ) | ||||||
Net
underwriting income
|
58,741 | (0 | ) | 58,741 |
US $
thousand
|
||||||||||||||||
March
31, 2009
|
Currency
translation
|
2009
variation
|
December
31, 2008
|
|||||||||||||
Reserve
agreement - Asset
|
37,031 | (1,349 | ) | (1,241 | ) | 39,621 | ||||||||||
Reserve
agreement - Liabilities
|
(105,634 | ) | 5,467 | (1,550 | ) | (109,552 | ) | |||||||||
Reserve
agreement - Net
|
(68,603 | ) | 4,118 | (2,790 | ) | (69,931 | ) |
Property
|
Casualty
|
Marine
/ Aviation / Space
|
Credit
/ Surety
|
Facultatives
|
Life
/ Accident & Health
|
TOTAL
|
||||||||||||||||||||||||||||||||||||||||||||||||||
3
Months Ended March 31
|
2009
|
2008
|
2009
|
2008
|
2009
|
2008
|
2009
|
2008
|
2009
|
2008
|
2009
|
2008
|
2009
|
2008
|
||||||||||||||||||||||||||||||||||||||||||
Gross
written premiums
|
312 | 334 | 131 | 137 | 51 | 67 | 92 | 135 | 44 | 51 | 37 | 52 | 667 | 775 | ||||||||||||||||||||||||||||||||||||||||||
Net
written premiums
|
256 | 236 | 131 | 136 | 49 | 67 | 83 | 125 | 20 | 28 | 37 | 49 | 575 | 641 | ||||||||||||||||||||||||||||||||||||||||||
Net
earned premiums
|
140 | 105 | 55 | 54 | 26 | 28 | 24 | 34 | 33 | 45 | 21 | 17 | 299 | 282 | ||||||||||||||||||||||||||||||||||||||||||
Claims
net of retrocession
|
-67 | -48 | -40 | -40 | -18 | -17 | -42 | -15 | -18 | -40 | -17 | -11 | -202 | -171 | ||||||||||||||||||||||||||||||||||||||||||
Commissions
& brokerage net of retrocession
|
-17 | -13 | -12 | -11 | -3 | -5 | -8 | -12 | -4 | -7 | -2 | -4 | -46 | -52 | ||||||||||||||||||||||||||||||||||||||||||
Net
underwriting income
|
56 | 43 | 4 | 2 | 5 | 6 | -27 | 7 | 11 | -2 | 2 | 2 | 51 | 59 | ||||||||||||||||||||||||||||||||||||||||||
General
expenses
|
-12 | -19 | -5 | -6 | -2 | -3 | -2 | -2 | -6 | -8 | -2 | -2 | -28 | -40 | ||||||||||||||||||||||||||||||||||||||||||
Net
underwriting income after general expense
|
45 | 25 | -1 | -4 | 2 | 3 | -29 | 5 | 5 | -10 | 0 | 0 | 23 | 19 | ||||||||||||||||||||||||||||||||||||||||||
Other
incomes / expenses not allocated
|
95 | -148 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
CONSOLIDATED INCOME STATEMENT - Net income | 119 | -130 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total
loss ratio net of reinsurance
|
47.6 | % | 45.9 | % | 72.0 | % | 74.5 | % | 69.9 | % | 61.6 | % | 179.7 | % | 45.2 | % | 53.7 | % | 89.3 | % | 80.5 | % | 63.8 | % | 67.4 | % | 60.8 | % | ||||||||||||||||||||||||||||
Net
commissions & brokerage ratio
|
12.2 | % | 12.7 | % | 21.2 | % | 21.3 | % | 12.8 | % | 16.3 | % | 33.8 | % | 34.8 | % | 12.6 | % | 15.6 | % | 10.0 | % | 21.7 | % | 15.5 | % | 18.3 | % | ||||||||||||||||||||||||||||
General
Expense Ratio
|
8.4 | % | 17.7 | % | 8.2 | % | 12.0 | % | 8.0 | % | 10.3 | % | 7.9 | % | 5.4 | % | 17.8 | % | 18.3 | % | 7.7 | % | 11.6 | % | 9.3 | % | 14.2 | % | ||||||||||||||||||||||||||||
Combined
Ratio
|
68.2 | % | 76.3 | % | 101.5 | % | 107.8 | % | 90.7 | % | 88.3 | % | 221.5 | % | 85.4 | % | 84.1 | % | 123.2 | % | 98.2 | % | 97.2 | % | 92.2 | % | 93.3 | % |
US $
thousand
|
3 months
|
|||||||
March
31, 2009
|
March
31, 2008
|
|||||||
Bonds
|
21,033 | 13,248 | ||||||
Equities
|
- | 18 | ||||||
Other
financial assets available for sale
|
162 | 2,337 | ||||||
Other assets
held by non consolidated investment funds
|
101 | 111 | ||||||
Loans and
other loans
|
39 | 28 | ||||||
Other
investment income
|
119 | 2,924 | ||||||
Income from
Funds withheld Asset
|
22,559 | 48,348 | ||||||
Income from
cash equivalent
|
1,203 | 3,347 | ||||||
Expenses on
investments and loans
|
(1,610 | ) | (783 | ) | ||||
Net
investment incomes
|
43,607 | 69,578 | ||||||
Bonds
|
(244 | ) | 4,087 | |||||
Equities
|
(0 | ) | (3,005 | ) | ||||
Cash
equivalent
|
8 | - | ||||||
Net
capital gains and losses
|
(237 | ) | 1,082 | |||||
Variations in
investment impairment
|
(364 | ) | ||||||
Exchange rate
impact
|
75,401 | (188,001 | ) | |||||
Valuation of
derivative instruments
|
2,089 | 4,480 | ||||||
Financial
results - Other
|
(182 | ) | (806 | ) | ||||
Net
financial income excluding debt expenses
|
120,314 | (113,667 | ) |
US $
thousand
|
||||||||
March
31, 2009
|
March
31, 2008
|
|||||||
Swiss
income tax
|
(12,292 | ) | 3,744 | |||||
Current
|
(12,289 | ) | - | |||||
Deferred
|
(3 | ) | 3,744 | |||||
Non
Swiss income tax
|
8,844 | (5,626 | ) | |||||
Current
|
(4,342 | ) | (16,189 | ) | ||||
Deferred
|
13,186 | 10,563 | ||||||
TOTAL
INCOME TAX
|
(3,447 | ) | (1,881 | ) |
US
$ thousand
|
March
31, 2009
|
March
31, 2008
|
||||||||||||||||||||||||||||||||||
France
|
Switzerland
|
Others
|
TOTAL
|
Swizerland
|
France
|
Bermuda
|
Others
|
TOTAL
|
||||||||||||||||||||||||||||
Net
result after tax
|
(31,272 | ) | 132,361 | 17,506 | 118,595 | (128,043 | ) | 5,172 | 7,022 | (13,676 | ) | (129,525 | ) | |||||||||||||||||||||||
Net
result before tax
|
(44,313 | ) | 144,652 | 21,702 | 122,042 | (131,787 | ) | 11,329 | 7,022 | (14,208 | ) | (127,644 | ) | |||||||||||||||||||||||
Tax
and deferred taxes
|
13,041 | (12,292 | ) | (4,197 | ) | (3,447 | ) | 3,744 | (6,157 | ) | - | 532 | (1,881 | ) | ||||||||||||||||||||||
Calculated
tax rate
|
29.43 | % | 8.50 | % | 19.34 | % | 2.82 | % | 2.84 | % | 54.35 | % | 0.00 | % | 3.70 | % | -1.47 | % | ||||||||||||||||||
Impact of
permanent differences
|
2,214 | - | 8,343 | 10,557 | 1,717 | (1,297 | ) | 420 | ||||||||||||||||||||||||||||
Utilization or
not of tax losses (1)
|
- | (1,480 | ) | (8,805 | ) | (10,285 | ) | 6,737 | 1,263 | 8,000 | ||||||||||||||||||||||||||
Tax rate
adjustment and other
|
- | - | 493 | 1,947 | 2,440 | |||||||||||||||||||||||||||||||
Total
adjusted tax
|
15,255 | (13,772 | ) | (4,658 | ) | (3,175 | ) | 10,481 | (3,946 | ) | - | 2,444 | 8,978 | |||||||||||||||||||||||
Adjusted
tax rate
|
34.4 | % | 9.5 | % | 21.5 | % | 2.6 | % | 8.0 | % | 34.8 | % | 0.0 | % | 17.2 | % | 7.0 | % | ||||||||||||||||||
(1)
|
Deferred taxes
not activated on tax losses comes from holding companies of the PARIS RE
Group.
|
|
·
|
The net
earnings per share is calculated on the basis of the average number of
shares weighted during the period. This calculation does not take into
account RSU, stock options and
warrants.
|
|
·
|
The fully
diluted net earnings per share is calculated on the basis of the diluted
shares outstanding, including stock options, restricted stock units and
warrants. The impact of the stock options and warrants on the total number
of diluted shares is based on the “in the money” value of theses
instruments based on PARIS RE’s common stock
price.
|
US $
thousand
|
3
months
|
|||||||||||
March
31, 2009
|
March
31, 2008
|
|||||||||||
Group net
income
|
||||||||||||
Group
net income
|
A
|
118,595 | (129,525 | ) | ||||||||
Group
net income restated to include the impact of dilutive financial
instruments
|
B
|
118,595 | (129,525 | ) | ||||||||
Equity shares
(in thousands of units)
|
||||||||||||
Equity
shares (ordinary) weighted at opening
|
80,660 | 83,500 | ||||||||||
Equity
shares (ordinary) weighted at closing
|
C
|
80,627 | 85,303 | |||||||||
Instruments
potentially dilutive
|
||||||||||||
- Restricted
Stock Units
|
391 | 2,072 | ||||||||||
- Stock
options
|
- | 16 | ||||||||||
-
Warrants
|
- | 477 | ||||||||||
Equity
shares (ordinary) weighted after impact of the instruments potentially
dilutive
|
D
|
81,017 | 87,868 | |||||||||
Net earning
per share (in US dollars)
|
||||||||||||
Net
earning per share
|
=
A/C
|
1.47 | (1.52 | ) | ||||||||
Net
earning per share diluted
|
=
B/D
|
1.46 | (1.47 | ) |
|
·
|
On April 24,
2009, PARIS RE Acquisition France has been merged with PARIS RE
Holdings France pursuant to Article L236.-1 of the French “Code de
Commerce” as simplified merger. PARIS RE Holdings France held 100% PARIS
RE Acquisition shares. PARIS RE Acquisition France’s Assets and
liabilities has been transferred to PARIS RE Holdings France
retroactively on January 1st,
2009 at net book value. The merger has no effect on the consolidated
financial statements.
|
|
·
|
Sale of CGRM
head office in Monaco. In connection with the planned
dissolution of PARIS RE's subsidiary in Monaco, the Company has sold its
office on May the 4th. The company has generated a gain net of tax of
approximately EUR3.2 million which will be accounted for during the second
quarter.
|
|
·
|
The
liquidation of PARIS RE Luxembourg was effective in 2009 second quarter.
This liquidation has limited effect on the 2009 second quarter
Financial statement.
|
|
·
|
Registration
of PARIS RE Insurance Company in 2009 second
quarter.
|
Very
truly yours,
|
||
/s/
UBS Securities LLC
|
||
UBS
SECURITIES LLC
|
5TH
FLOOR,
WELLESLEY HOUSE
SOUTH
90
PITTS BAY RD.
PEMBROKE
HM08, BERMUDA
|
VOTE BY INTERNET -
www.proxyvote.com
Use the Internet to transmit your
voting instructions and for electronic delivery of information up until
11:59 P.M. Eastern Time on , 2009.
Have your proxy card
in hand when you access the web site and follow the instructions to obtain
your records and to create an electronic voting instruction
form.
Electronic Delivery of Future
PROXY MATERIALS
If you would like to reduce the
costs incurred by our
company in mailing proxy materials, you can consent to receiving all
future proxy statements, proxy cards and annual reports electronically via
e-mail or the Internet. To sign up for electronic delivery, please follow
the instructions above to vote using the Internet and, when
prompted, indicate that you agree to receive or access proxy materials
electronically in future years.
VOTE BY PHONE -
1-800-690-6903
Use any touch-tone telephone to
transmit your voting instructions up until 11:59 P.M. Eastern Time on
, 2009. Have your proxy card in hand when you call and then follow
the instructions.
VOTE BY
MAIL
Mark, sign and date your proxy
card and return it in the postage-paid envelope we have provided or return
it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: | |
KEEP
THIS PORTION FOR YOUR RECORDS
|
|
DETACH
AND RETURN THIS PORTION ONLY
|
|
THIS
PROXY
CARD
IS
VALID
ONLY
WHEN
SIGNED
AND
DATED.
|
The Board of Directors recommends you | |||||||||||||||
vote FOR the following proposal(s): | |||||||||||||||
For
|
Against
|
Abstain
|
|||||||||||||
1
|
To approve the
issuance of PartnerRe Ltd. common shares and securities exercisable or
exchangeable for PartnerRe Ltd. common shares in connection with the
series of transactions to acquire PARIS RE Holdings Limited described in
the accompanying proxy statement.
|
0
|
0
|
0
|
|||||||||||
|
|||||||||||||||
2 |
To approve the increase in the size of the board of directors of PartnerRe Ltd. from 11 to 12.
|
0
|
0
|
0
|
|||||||||||
3 |
To approve the
amendment to PartnerRe Ltd.'s 2005 Employee Equity Plan, as amended and
restated, to increase the number of PartnerRe Ltd. common shares available
for issuance and to increase the number of PartnerRe Ltd. common shares
that may be awarded as restricted shares or restricted share
units.
|
0
|
0
|
0
|
|||||||||||
Please sign
exactly as your name(s) appear(s) hereon. When signing as attorney,
executor, administrator, or other fiduciary, please give full title as
such. Joint owners should each sign personally. All holders must sign. If
a corporation or partnership, please sign in full corporate or partnership
name, by authorized officer.
|
|||||||||||||||
Signature [PLEASE SIGN WITHIN BOX] | Date | Signature (Joint Owners) | Date | ||||||||||||
Important
Notice Regarding the Availability of Proxy Materials for the Special
Meeting: The
Notice of Special General Meeting and Proxy Statement
is/are available at www.proxyvote.com.
|
|
PROXY
- PartnerRe Ltd.
|
|||||||
This
Proxy is solicited on behalf of the Board of Directors of PartnerRe
Ltd.
in
connection with our Special General Meeting of Shareholders to be held
on , 2009
The
undersigned shareholder of PartnerRe Ltd. hereby appoints John A.
Rollwagen and Patrick A. Thiele, each the true and lawful attorney, agent
and proxy of the undersigned, with full power of substitution to vote all
of our Common Shares, $1.00 par value per share, which the undersigned may
be entitled to vote at the Special General Meeting of Shareholders to be
held , 2009 and at any adjournment or
postponement of such meeting with all powers which the undersigned would
possess if personally present, for the purposes set forth on the reverse
side hereof.
This
Proxy will be voted as directed or, if no direction is indicated, it will
be voted FOR the approval of proposals 1, 2 and 3 described on the reverse
side. In their discretion, the proxies are authorized to vote this proxy
upon such other business as may properly come before the Special General
Meeting or any adjournment or postponement therof.
|
|||||||
Please
complete, sign, date and return this card using the enclosed
envelope.
|
|||||||